id	sid	tid	token	lemma	pos
ajlm-1261	1	1	abstract	abstract	ADJ
ajlm-1261	1	2	introduction	introduction	NOUN
ajlm-1261	1	3	methods	method	NOUN
ajlm-1261	1	4	results	result	VERB
ajlm-1261	1	5	discussion	discussion	NOUN
ajlm-1261	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1261	1	7	references	reference	NOUN
ajlm-1261	1	8	about	about	ADP
ajlm-1261	1	9	the	the	DET
ajlm-1261	1	10	author(s	author(s	NOUN
ajlm-1261	1	11	)	)	PUNCT
ajlm-1261	1	12	adeyemi	adeyemi	ADV
ajlm-1261	1	13	t.	t.	PROPN
ajlm-1261	1	14	adeyemo	adeyemo	PROPN
ajlm-1261	1	15	department	department	PROPN
ajlm-1261	1	16	of	of	ADP
ajlm-1261	1	17	medical	medical	ADJ
ajlm-1261	1	18	microbiology	microbiology	NOUN
ajlm-1261	1	19	and	and	CCONJ
ajlm-1261	1	20	parasitology	parasitology	NOUN
ajlm-1261	1	21	,	,	PUNCT
ajlm-1261	1	22	obafemi	obafemi	PROPN
ajlm-1261	1	23	awolowo	awolowo	PROPN
ajlm-1261	1	24	university	university	PROPN
ajlm-1261	1	25	teaching	teaching	NOUN
ajlm-1261	1	26	hospitals	hospital	NOUN
ajlm-1261	1	27	,	,	PUNCT
ajlm-1261	1	28	ile	ile	PROPN
ajlm-1261	1	29	-	-	PUNCT
ajlm-1261	1	30	ife	ife	PROPN
ajlm-1261	1	31	,	,	PUNCT
ajlm-1261	1	32	nigeria	nigeria	PROPN
ajlm-1261	2	1	babatope	babatope	PROPN
ajlm-1261	2	2	kolawole	kolawole	PROPN
ajlm-1261	2	3	department	department	PROPN
ajlm-1261	2	4	of	of	ADP
ajlm-1261	2	5	medicine	medicine	NOUN
ajlm-1261	2	6	,	,	PUNCT
ajlm-1261	2	7	faculty	faculty	NOUN
ajlm-1261	2	8	of	of	ADP
ajlm-1261	2	9	clinical	clinical	ADJ
ajlm-1261	2	10	science	science	NOUN
ajlm-1261	2	11	,	,	PUNCT
ajlm-1261	2	12	obafemi	obafemi	PROPN
ajlm-1261	2	13	awolowo	awolowo	PROPN
ajlm-1261	2	14	university	university	PROPN
ajlm-1261	2	15	,	,	PUNCT
ajlm-1261	2	16	ile	ile	PROPN
ajlm-1261	2	17	-	-	PUNCT
ajlm-1261	2	18	ife	ife	PROPN
ajlm-1261	2	19	,	,	PUNCT
ajlm-1261	2	20	nigeria	nigeria	PROPN
ajlm-1261	2	21	vincent	vincent	PROPN
ajlm-1261	2	22	o.	o.	PROPN
ajlm-1261	2	23	rotimi	rotimi	PROPN
ajlm-1261	2	24	department	department	PROPN
ajlm-1261	2	25	of	of	ADP
ajlm-1261	2	26	microbiology	microbiology	NOUN
ajlm-1261	2	27	,	,	PUNCT
ajlm-1261	2	28	faculty	faculty	NOUN
ajlm-1261	2	29	of	of	ADP
ajlm-1261	2	30	medicine	medicine	NOUN
ajlm-1261	2	31	,	,	PUNCT
ajlm-1261	2	32	kuwait	kuwait	PROPN
ajlm-1261	2	33	university	university	PROPN
ajlm-1261	2	34	,	,	PUNCT
ajlm-1261	2	35	kuwait	kuwait	PROPN
ajlm-1261	2	36	city	city	PROPN
ajlm-1261	2	37	,	,	PUNCT
ajlm-1261	3	1	kuwait	kuwait	PROPN
ajlm-1261	3	2	aaron	aaron	PROPN
ajlm-1261	3	3	o.	o.	PROPN
ajlm-1261	4	1	aboderin	aboderin	PROPN
ajlm-1261	4	2	department	department	PROPN
ajlm-1261	4	3	of	of	ADP
ajlm-1261	4	4	medical	medical	ADJ
ajlm-1261	4	5	microbiology	microbiology	NOUN
ajlm-1261	4	6	and	and	CCONJ
ajlm-1261	4	7	parasitology	parasitology	NOUN
ajlm-1261	4	8	,	,	PUNCT
ajlm-1261	4	9	obafemi	obafemi	PROPN
ajlm-1261	4	10	awolowo	awolowo	PROPN
ajlm-1261	4	11	university	university	PROPN
ajlm-1261	4	12	teaching	teaching	NOUN
ajlm-1261	4	13	hospitals	hospital	NOUN
ajlm-1261	4	14	,	,	PUNCT
ajlm-1261	4	15	ile	ile	PROPN
ajlm-1261	4	16	-	-	PUNCT
ajlm-1261	4	17	ife	ife	PROPN
ajlm-1261	4	18	,	,	PUNCT
ajlm-1261	4	19	nigeria	nigeria	PROPN
ajlm-1261	4	20	department	department	PROPN
ajlm-1261	4	21	of	of	ADP
ajlm-1261	4	22	medical	medical	ADJ
ajlm-1261	4	23	microbiology	microbiology	NOUN
ajlm-1261	4	24	and	and	CCONJ
ajlm-1261	4	25	parasitology	parasitology	NOUN
ajlm-1261	4	26	,	,	PUNCT
ajlm-1261	4	27	faculty	faculty	NOUN
ajlm-1261	4	28	of	of	ADP
ajlm-1261	4	29	basic	basic	ADJ
ajlm-1261	4	30	medical	medical	ADJ
ajlm-1261	4	31	science	science	NOUN
ajlm-1261	4	32	,	,	PUNCT
ajlm-1261	4	33	obafemi	obafemi	PROPN
ajlm-1261	4	34	awolowo	awolowo	PROPN
ajlm-1261	4	35	university	university	PROPN
ajlm-1261	4	36	,	,	PUNCT
ajlm-1261	4	37	ile	ile	PROPN
ajlm-1261	4	38	-	-	PUNCT
ajlm-1261	4	39	ife	ife	PROPN
ajlm-1261	4	40	,	,	PUNCT
ajlm-1261	4	41	nigeria	nigeria	PROPN
ajlm-1261	4	42	citation	citation	PROPN
ajlm-1261	4	43	adeyemo	adeyemo	ADV
ajlm-1261	4	44	at	at	ADP
ajlm-1261	4	45	,	,	PUNCT
ajlm-1261	4	46	kolawole	kolawole	PROPN
ajlm-1261	4	47	b	b	PROPN
ajlm-1261	4	48	,	,	PUNCT
ajlm-1261	4	49	rotimi	rotimi	PROPN
ajlm-1261	4	50	vo	vo	NOUN
ajlm-1261	4	51	,	,	PUNCT
ajlm-1261	4	52	aboderin	aboderin	NOUN
ajlm-1261	4	53	ao	ao	PROPN
ajlm-1261	4	54	.	.	PUNCT
ajlm-1261	5	1	multicentre	multicentre	PROPN
ajlm-1261	5	2	study	study	NOUN
ajlm-1261	5	3	of	of	ADP
ajlm-1261	5	4	the	the	DET
ajlm-1261	5	5	burden	burden	NOUN
ajlm-1261	5	6	of	of	ADP
ajlm-1261	5	7	multidrug	multidrug	NOUN
ajlm-1261	5	8	-	-	PUNCT
ajlm-1261	5	9	resistant	resistant	ADJ
ajlm-1261	5	10	bacteria	bacteria	NOUN
ajlm-1261	5	11	in	in	ADP
ajlm-1261	5	12	the	the	DET
ajlm-1261	5	13	aetiology	aetiology	NOUN
ajlm-1261	5	14	of	of	ADP
ajlm-1261	5	15	infected	infected	ADJ
ajlm-1261	5	16	diabetic	diabetic	ADJ
ajlm-1261	5	17	foot	foot	NOUN
ajlm-1261	5	18	ulcers	ulcer	NOUN
ajlm-1261	5	19	.	.	PUNCT
ajlm-1261	6	1	afr	afr	PROPN
ajlm-1261	6	2	j	j	PROPN
ajlm-1261	6	3	lab	lab	PROPN
ajlm-1261	6	4	med	med	PROPN
ajlm-1261	6	5	.	.	PUNCT
ajlm-1261	7	1	2021;10(1	2021;10(1	NUM
ajlm-1261	7	2	)	)	PUNCT
ajlm-1261	7	3	,	,	PUNCT
ajlm-1261	7	4	a1261	a1261	PROPN
ajlm-1261	7	5	.	.	PROPN
ajlm-1261	7	6	https://doi.org/10.4102/ajlm.v10i1.1261	https://doi.org/10.4102/ajlm.v10i1.1261	PROPN
ajlm-1261	7	7	original	original	ADJ
ajlm-1261	7	8	research	research	NOUN
ajlm-1261	7	9	multicentre	multicentre	NOUN
ajlm-1261	7	10	study	study	NOUN
ajlm-1261	7	11	of	of	ADP
ajlm-1261	7	12	the	the	DET
ajlm-1261	7	13	burden	burden	NOUN
ajlm-1261	7	14	of	of	ADP
ajlm-1261	7	15	multidrug	multidrug	NOUN
ajlm-1261	7	16	-	-	PUNCT
ajlm-1261	7	17	resistant	resistant	ADJ
ajlm-1261	7	18	bacteria	bacteria	NOUN
ajlm-1261	7	19	in	in	ADP
ajlm-1261	7	20	the	the	DET
ajlm-1261	7	21	aetiology	aetiology	NOUN
ajlm-1261	7	22	of	of	ADP
ajlm-1261	7	23	infected	infected	ADJ
ajlm-1261	7	24	diabetic	diabetic	ADJ
ajlm-1261	7	25	foot	foot	NOUN
ajlm-1261	7	26	ulcers	ulcer	NOUN
ajlm-1261	7	27	adeyemi	adeyemi	ADV
ajlm-1261	7	28	t.	t.	PROPN
ajlm-1261	7	29	adeyemo	adeyemo	NOUN
ajlm-1261	7	30	,	,	PUNCT
ajlm-1261	7	31	babatope	babatope	PROPN
ajlm-1261	7	32	kolawole	kolawole	PROPN
ajlm-1261	7	33	,	,	PUNCT
ajlm-1261	7	34	vincent	vincent	PROPN
ajlm-1261	7	35	o.	o.	PROPN
ajlm-1261	7	36	rotimi	rotimi	PROPN
ajlm-1261	7	37	,	,	PUNCT
ajlm-1261	7	38	aaron	aaron	PROPN
ajlm-1261	7	39	o.	o.	PROPN
ajlm-1261	7	40	aboderin	aboderin	PROPN
ajlm-1261	7	41	received	receive	VERB
ajlm-1261	7	42	:	:	PUNCT
ajlm-1261	7	43	03	03	NUM
ajlm-1261	7	44	may	may	PROPN
ajlm-1261	7	45	2020	2020	NUM
ajlm-1261	7	46	;	;	PUNCT
ajlm-1261	7	47	accepted	accept	VERB
ajlm-1261	7	48	:	:	PUNCT
ajlm-1261	7	49	22	22	NUM
ajlm-1261	7	50	oct	oct	PROPN
ajlm-1261	7	51	.	.	PROPN
ajlm-1261	7	52	2020	2020	NUM
ajlm-1261	7	53	;	;	PUNCT
ajlm-1261	7	54	published	publish	VERB
ajlm-1261	7	55	:	:	PUNCT
ajlm-1261	8	1	23	23	NUM
ajlm-1261	8	2	mar	mar	PROPN
ajlm-1261	8	3	.	.	PROPN
ajlm-1261	8	4	2021	2021	NUM
ajlm-1261	8	5	copyright	copyright	NOUN
ajlm-1261	8	6	:	:	PUNCT
ajlm-1261	8	7	©	©	PROPN
ajlm-1261	8	8	2021	2021	NUM
ajlm-1261	8	9	.	.	PUNCT
ajlm-1261	9	1	the	the	DET
ajlm-1261	9	2	author(s	author(s	PROPN
ajlm-1261	9	3	)	)	PUNCT
ajlm-1261	9	4	.	.	PUNCT
ajlm-1261	10	1	licensee	licensee	NOUN
ajlm-1261	10	2	:	:	PUNCT
ajlm-1261	10	3	aosis	aosis	NOUN
ajlm-1261	10	4	.	.	PUNCT
ajlm-1261	11	1	this	this	PRON
ajlm-1261	11	2	is	be	AUX
ajlm-1261	11	3	an	an	DET
ajlm-1261	11	4	open	open	ADJ
ajlm-1261	11	5	access	access	NOUN
ajlm-1261	11	6	article	article	NOUN
ajlm-1261	11	7	distributed	distribute	VERB
ajlm-1261	11	8	under	under	ADP
ajlm-1261	11	9	the	the	DET
ajlm-1261	11	10	terms	term	NOUN
ajlm-1261	11	11	of	of	ADP
ajlm-1261	11	12	the	the	DET
ajlm-1261	11	13	creative	creative	ADJ
ajlm-1261	11	14	commons	common	NOUN
ajlm-1261	11	15	attribution	attribution	NOUN
ajlm-1261	11	16	license	license	NOUN
ajlm-1261	11	17	,	,	PUNCT
ajlm-1261	11	18	which	which	PRON
ajlm-1261	11	19	permits	permit	VERB
ajlm-1261	11	20	unrestricted	unrestricted	ADJ
ajlm-1261	11	21	use	use	NOUN
ajlm-1261	11	22	,	,	PUNCT
ajlm-1261	11	23	distribution	distribution	NOUN
ajlm-1261	11	24	,	,	PUNCT
ajlm-1261	11	25	and	and	CCONJ
ajlm-1261	11	26	reproduction	reproduction	NOUN
ajlm-1261	11	27	in	in	ADP
ajlm-1261	11	28	any	any	DET
ajlm-1261	11	29	medium	medium	NOUN
ajlm-1261	11	30	,	,	PUNCT
ajlm-1261	11	31	provided	provide	VERB
ajlm-1261	11	32	the	the	DET
ajlm-1261	11	33	original	original	ADJ
ajlm-1261	11	34	work	work	NOUN
ajlm-1261	11	35	is	be	AUX
ajlm-1261	11	36	properly	properly	ADV
ajlm-1261	11	37	cited	cite	VERB
ajlm-1261	11	38	.	.	PUNCT
ajlm-1261	12	1	abstract	abstract	ADJ
ajlm-1261	12	2	background	background	NOUN
ajlm-1261	12	3	:	:	PUNCT
ajlm-1261	12	4	infected	infect	VERB
ajlm-1261	12	5	diabetic	diabetic	ADJ
ajlm-1261	12	6	foot	foot	NOUN
ajlm-1261	12	7	ulcer	ulcer	NOUN
ajlm-1261	12	8	(	(	PUNCT
ajlm-1261	12	9	idfu	idfu	PROPN
ajlm-1261	12	10	)	)	PUNCT
ajlm-1261	12	11	is	be	AUX
ajlm-1261	12	12	a	a	DET
ajlm-1261	12	13	public	public	ADJ
ajlm-1261	12	14	health	health	NOUN
ajlm-1261	12	15	issue	issue	NOUN
ajlm-1261	12	16	and	and	CCONJ
ajlm-1261	12	17	the	the	DET
ajlm-1261	12	18	leading	lead	VERB
ajlm-1261	12	19	cause	cause	NOUN
ajlm-1261	12	20	of	of	ADP
ajlm-1261	12	21	non	non	ADJ
ajlm-1261	12	22	-	-	ADJ
ajlm-1261	12	23	traumatic	traumatic	ADJ
ajlm-1261	12	24	limb	limb	NOUN
ajlm-1261	12	25	amputation	amputation	NOUN
ajlm-1261	12	26	.	.	PUNCT
ajlm-1261	13	1	very	very	ADV
ajlm-1261	13	2	few	few	ADJ
ajlm-1261	13	3	published	publish	VERB
ajlm-1261	13	4	data	datum	NOUN
ajlm-1261	13	5	on	on	ADP
ajlm-1261	13	6	idfu	idfu	ADJ
ajlm-1261	13	7	exist	exist	VERB
ajlm-1261	13	8	in	in	ADP
ajlm-1261	13	9	most	most	ADJ
ajlm-1261	13	10	west	west	ADJ
ajlm-1261	13	11	african	african	ADJ
ajlm-1261	13	12	countries	country	NOUN
ajlm-1261	13	13	.	.	PUNCT
ajlm-1261	14	1	objective	objective	NOUN
ajlm-1261	14	2	:	:	PUNCT
ajlm-1261	14	3	the	the	DET
ajlm-1261	14	4	study	study	NOUN
ajlm-1261	14	5	investigated	investigate	VERB
ajlm-1261	14	6	the	the	DET
ajlm-1261	14	7	aetiology	aetiology	NOUN
ajlm-1261	14	8	and	and	CCONJ
ajlm-1261	14	9	antibacterial	antibacterial	ADJ
ajlm-1261	14	10	drug	drug	NOUN
ajlm-1261	14	11	resistance	resistance	NOUN
ajlm-1261	14	12	burden	burden	NOUN
ajlm-1261	14	13	of	of	ADP
ajlm-1261	14	14	idfu	idfu	NOUN
ajlm-1261	14	15	in	in	ADP
ajlm-1261	14	16	tertiary	tertiary	ADJ
ajlm-1261	14	17	hospitals	hospital	NOUN
ajlm-1261	14	18	in	in	ADP
ajlm-1261	14	19	osun	osun	PROPN
ajlm-1261	14	20	state	state	PROPN
ajlm-1261	14	21	,	,	PUNCT
ajlm-1261	14	22	nigeria	nigeria	PROPN
ajlm-1261	14	23	,	,	PUNCT
ajlm-1261	14	24	between	between	ADP
ajlm-1261	14	25	july	july	PROPN
ajlm-1261	14	26	2016	2016	NUM
ajlm-1261	14	27	and	and	CCONJ
ajlm-1261	14	28	april	april	PROPN
ajlm-1261	14	29	2017	2017	NUM
ajlm-1261	14	30	.	.	PUNCT
ajlm-1261	15	1	methods	method	NOUN
ajlm-1261	15	2	:	:	PUNCT
ajlm-1261	15	3	isolates	isolate	NOUN
ajlm-1261	15	4	were	be	AUX
ajlm-1261	15	5	cultured	cultured	ADJ
ajlm-1261	15	6	from	from	ADP
ajlm-1261	15	7	tissue	tissue	NOUN
ajlm-1261	15	8	biopsies	biopsy	NOUN
ajlm-1261	15	9	or	or	CCONJ
ajlm-1261	15	10	aspirates	aspirate	NOUN
ajlm-1261	15	11	collected	collect	VERB
ajlm-1261	15	12	from	from	ADP
ajlm-1261	15	13	patients	patient	NOUN
ajlm-1261	15	14	with	with	ADP
ajlm-1261	15	15	idfu	idfu	PROPN
ajlm-1261	15	16	.	.	PUNCT
ajlm-1261	16	1	bacterial	bacterial	ADJ
ajlm-1261	16	2	identification	identification	NOUN
ajlm-1261	16	3	,	,	PUNCT
ajlm-1261	16	4	antibiotic	antibiotic	ADJ
ajlm-1261	16	5	susceptibility	susceptibility	NOUN
ajlm-1261	16	6	testing	testing	NOUN
ajlm-1261	16	7	and	and	CCONJ
ajlm-1261	16	8	phenotypic	phenotypic	ADJ
ajlm-1261	16	9	detection	detection	NOUN
ajlm-1261	16	10	of	of	ADP
ajlm-1261	16	11	extended	extend	VERB
ajlm-1261	16	12	-	-	PUNCT
ajlm-1261	16	13	spectrum	spectrum	NOUN
ajlm-1261	16	14	beta	beta	NOUN
ajlm-1261	16	15	-	-	PUNCT
ajlm-1261	16	16	lactamase	lactamase	NOUN
ajlm-1261	16	17	and	and	CCONJ
ajlm-1261	16	18	carbapenemase	carbapenemase	NOUN
ajlm-1261	16	19	production	production	NOUN
ajlm-1261	16	20	were	be	AUX
ajlm-1261	16	21	done	do	VERB
ajlm-1261	16	22	by	by	ADP
ajlm-1261	16	23	established	establish	VERB
ajlm-1261	16	24	protocols	protocol	NOUN
ajlm-1261	16	25	.	.	PUNCT
ajlm-1261	17	1	specific	specific	ADJ
ajlm-1261	17	2	resistance	resistance	NOUN
ajlm-1261	17	3	genes	gene	NOUN
ajlm-1261	17	4	were	be	AUX
ajlm-1261	17	5	detected	detect	VERB
ajlm-1261	17	6	by	by	ADP
ajlm-1261	17	7	polymerase	polymerase	NOUN
ajlm-1261	17	8	chain	chain	NOUN
ajlm-1261	17	9	reaction	reaction	NOUN
ajlm-1261	17	10	.	.	PUNCT
ajlm-1261	18	1	results	result	NOUN
ajlm-1261	18	2	:	:	PUNCT
ajlm-1261	18	3	there	there	PRON
ajlm-1261	18	4	were	be	VERB
ajlm-1261	18	5	218	218	NUM
ajlm-1261	18	6	microorganisms	microorganism	NOUN
ajlm-1261	18	7	isolated	isolate	VERB
ajlm-1261	18	8	from	from	ADP
ajlm-1261	18	9	93	93	NUM
ajlm-1261	18	10	idfus	idfu	NOUN
ajlm-1261	18	11	,	,	PUNCT
ajlm-1261	18	12	comprising	comprise	VERB
ajlm-1261	18	13	129	129	NUM
ajlm-1261	18	14	(	(	PUNCT
ajlm-1261	18	15	59.2	59.2	NUM
ajlm-1261	18	16	%	%	NOUN
ajlm-1261	18	17	)	)	PUNCT
ajlm-1261	18	18	gram	gram	NOUN
ajlm-1261	18	19	-	-	PUNCT
ajlm-1261	18	20	negative	negative	ADJ
ajlm-1261	18	21	bacilli	bacilli	NOUN
ajlm-1261	18	22	(	(	PUNCT
ajlm-1261	18	23	gnb	gnb	PROPN
ajlm-1261	18	24	)	)	PUNCT
ajlm-1261	18	25	,	,	PUNCT
ajlm-1261	18	26	59	59	NUM
ajlm-1261	18	27	(	(	PUNCT
ajlm-1261	18	28	27.1	27.1	NUM
ajlm-1261	18	29	%	%	NOUN
ajlm-1261	18	30	)	)	PUNCT
ajlm-1261	18	31	gram	gram	NOUN
ajlm-1261	18	32	-	-	PUNCT
ajlm-1261	18	33	positive	positive	ADJ
ajlm-1261	18	34	cocci	cocci	NOUN
ajlm-1261	18	35	and	and	CCONJ
ajlm-1261	18	36	29	29	NUM
ajlm-1261	18	37	(	(	PUNCT
ajlm-1261	18	38	13.3	13.3	NUM
ajlm-1261	18	39	%	%	NOUN
ajlm-1261	18	40	)	)	PUNCT
ajlm-1261	18	41	anaerobic	anaerobic	ADJ
ajlm-1261	18	42	bacteria	bacteria	NOUN
ajlm-1261	18	43	.	.	PUNCT
ajlm-1261	19	1	the	the	DET
ajlm-1261	19	2	top	top	ADJ
ajlm-1261	19	3	five	five	NUM
ajlm-1261	19	4	facultative	facultative	ADJ
ajlm-1261	19	5	anaerobic	anaerobic	NOUN
ajlm-1261	19	6	bacteria	bacteria	NOUN
ajlm-1261	19	7	isolated	isolate	VERB
ajlm-1261	19	8	were	be	AUX
ajlm-1261	19	9	:	:	PUNCT
ajlm-1261	19	10	staphylococcus	staphylococcus	NOUN
ajlm-1261	19	11	aureus	aureus	NOUN
ajlm-1261	19	12	(	(	PUNCT
ajlm-1261	19	13	34	34	NUM
ajlm-1261	19	14	;	;	PUNCT
ajlm-1261	19	15	15.6	15.6	NUM
ajlm-1261	19	16	%	%	NOUN
ajlm-1261	19	17	)	)	PUNCT
ajlm-1261	19	18	,	,	PUNCT
ajlm-1261	19	19	escherichia	escherichia	NOUN
ajlm-1261	19	20	coli	coli	NOUN
ajlm-1261	19	21	(	(	PUNCT
ajlm-1261	19	22	23	23	NUM
ajlm-1261	19	23	;	;	PUNCT
ajlm-1261	19	24	10.6	10.6	NUM
ajlm-1261	19	25	%	%	NOUN
ajlm-1261	19	26	)	)	PUNCT
ajlm-1261	19	27	,	,	PUNCT
ajlm-1261	19	28	pseudomonas	pseudomona	VERB
ajlm-1261	19	29	aeruginosa	aeruginosa	NOUN
ajlm-1261	19	30	(	(	PUNCT
ajlm-1261	19	31	20	20	NUM
ajlm-1261	19	32	;	;	PUNCT
ajlm-1261	19	33	9.2	9.2	NUM
ajlm-1261	19	34	%	%	NOUN
ajlm-1261	19	35	)	)	PUNCT
ajlm-1261	19	36	,	,	PUNCT
ajlm-1261	19	37	klebsiella	klebsiella	NOUN
ajlm-1261	19	38	pneumoniae	pneumoniae	ADJ
ajlm-1261	19	39	(	(	PUNCT
ajlm-1261	19	40	19	19	NUM
ajlm-1261	19	41	;	;	PUNCT
ajlm-1261	19	42	8.7	8.7	NUM
ajlm-1261	19	43	%	%	NOUN
ajlm-1261	19	44	)	)	PUNCT
ajlm-1261	19	45	and	and	CCONJ
ajlm-1261	19	46	citrobacter	citrobacter	ADJ
ajlm-1261	19	47	spp	spp	NOUN
ajlm-1261	19	48	.	.	PUNCT
ajlm-1261	20	1	(	(	PUNCT
ajlm-1261	20	2	19	19	NUM
ajlm-1261	20	3	;	;	PUNCT
ajlm-1261	20	4	8.7	8.7	NUM
ajlm-1261	20	5	%	%	NOUN
ajlm-1261	20	6	)	)	PUNCT
ajlm-1261	20	7	.	.	PUNCT
ajlm-1261	21	1	the	the	DET
ajlm-1261	21	2	most	most	ADV
ajlm-1261	21	3	common	common	ADJ
ajlm-1261	21	4	anaerobes	anaerobe	NOUN
ajlm-1261	21	5	were	be	AUX
ajlm-1261	21	6	bacteroides	bacteroide	VERB
ajlm-1261	21	7	spp	spp	NOUN
ajlm-1261	21	8	.	.	PUNCT
ajlm-1261	22	1	(	(	PUNCT
ajlm-1261	22	2	7	7	NUM
ajlm-1261	22	3	;	;	PUNCT
ajlm-1261	22	4	3.2	3.2	NUM
ajlm-1261	22	5	%	%	NOUN
ajlm-1261	22	6	)	)	PUNCT
ajlm-1261	22	7	and	and	CCONJ
ajlm-1261	22	8	peptostreptococcus	peptostreptococcus	NOUN
ajlm-1261	22	9	anaerobius	anaerobius	NOUN
ajlm-1261	22	10	(	(	PUNCT
ajlm-1261	22	11	6	6	NUM
ajlm-1261	22	12	;	;	PUNCT
ajlm-1261	22	13	2.8	2.8	NUM
ajlm-1261	22	14	%	%	NOUN
ajlm-1261	22	15	)	)	PUNCT
ajlm-1261	22	16	.	.	PUNCT
ajlm-1261	23	1	seventy	seventy	NUM
ajlm-1261	23	2	-	-	PUNCT
ajlm-1261	23	3	four	four	NUM
ajlm-1261	23	4	idfus	idfus	NOUN
ajlm-1261	23	5	(	(	PUNCT
ajlm-1261	23	6	80	80	NUM
ajlm-1261	23	7	%	%	NOUN
ajlm-1261	23	8	)	)	PUNCT
ajlm-1261	23	9	were	be	AUX
ajlm-1261	23	10	infected	infect	VERB
ajlm-1261	23	11	by	by	ADP
ajlm-1261	23	12	multidrug	multidrug	NOUN
ajlm-1261	23	13	-	-	PUNCT
ajlm-1261	23	14	resistant	resistant	ADJ
ajlm-1261	23	15	bacteria	bacteria	NOUN
ajlm-1261	23	16	,	,	PUNCT
ajlm-1261	23	17	predominantly	predominantly	ADV
ajlm-1261	23	18	methicillin	methicillin	NOUN
ajlm-1261	23	19	-	-	PUNCT
ajlm-1261	23	20	resistant	resistant	ADJ
ajlm-1261	23	21	s.	s.	PROPN
ajlm-1261	23	22	aureus	aureus	PROPN
ajlm-1261	23	23	and	and	CCONJ
ajlm-1261	23	24	gnb	gnb	PROPN
ajlm-1261	23	25	producing	produce	VERB
ajlm-1261	23	26	extended	extend	VERB
ajlm-1261	23	27	-	-	PUNCT
ajlm-1261	23	28	spectrum	spectrum	NOUN
ajlm-1261	23	29	β	β	NOUN
ajlm-1261	23	30	-	-	NOUN
ajlm-1261	23	31	lactamases	lactamase	NOUN
ajlm-1261	23	32	,	,	PUNCT
ajlm-1261	23	33	mainly	mainly	ADV
ajlm-1261	23	34	of	of	ADP
ajlm-1261	23	35	the	the	DET
ajlm-1261	23	36	ctx	ctx	NOUN
ajlm-1261	23	37	-	-	PROPN
ajlm-1261	23	38	m	m	NOUN
ajlm-1261	23	39	variety	variety	NOUN
ajlm-1261	23	40	.	.	PUNCT
ajlm-1261	24	1	only	only	ADV
ajlm-1261	24	2	4	4	NUM
ajlm-1261	24	3	(	(	PUNCT
ajlm-1261	24	4	3.1	3.1	NUM
ajlm-1261	24	5	%	%	NOUN
ajlm-1261	24	6	)	)	PUNCT
ajlm-1261	25	1	gnb	gnb	PROPN
ajlm-1261	25	2	produced	produce	VERB
ajlm-1261	25	3	carbapenemases	carbapenemase	NOUN
ajlm-1261	25	4	encoded	encode	VERB
ajlm-1261	25	5	predominantly	predominantly	ADV
ajlm-1261	25	6	by	by	ADP
ajlm-1261	25	7	blavim	blavim	NOUN
ajlm-1261	25	8	.	.	PUNCT
ajlm-1261	26	1	factors	factor	NOUN
ajlm-1261	26	2	associated	associate	VERB
ajlm-1261	26	3	with	with	ADP
ajlm-1261	26	4	presence	presence	NOUN
ajlm-1261	26	5	of	of	ADP
ajlm-1261	26	6	multidrug	multidrug	NOUN
ajlm-1261	26	7	-	-	PUNCT
ajlm-1261	26	8	resistant	resistant	ADJ
ajlm-1261	26	9	bacteria	bacteria	NOUN
ajlm-1261	26	10	were	be	AUX
ajlm-1261	26	11	peripheral	peripheral	ADJ
ajlm-1261	26	12	neuropathy	neuropathy	ADJ
ajlm-1261	26	13	(	(	PUNCT
ajlm-1261	26	14	adjusted	adjust	VERB
ajlm-1261	26	15	odds	odd	NOUN
ajlm-1261	26	16	ratio	ratio	NOUN
ajlm-1261	27	1	[	[	X
ajlm-1261	27	2	aor	aor	X
ajlm-1261	27	3	]	]	X
ajlm-1261	27	4	=	=	PUNCT
ajlm-1261	27	5	4.05	4.05	NUM
ajlm-1261	27	6	,	,	PUNCT
ajlm-1261	27	7	p	p	NOUN
ajlm-1261	27	8	=	=	NOUN
ajlm-1261	27	9	0.04	0.04	NUM
ajlm-1261	27	10	)	)	PUNCT
ajlm-1261	27	11	and	and	CCONJ
ajlm-1261	27	12	duration	duration	NOUN
ajlm-1261	27	13	of	of	ADP
ajlm-1261	27	14	foot	foot	NOUN
ajlm-1261	27	15	infection	infection	NOUN
ajlm-1261	27	16	of	of	ADP
ajlm-1261	27	17	more	more	ADJ
ajlm-1261	27	18	than	than	ADP
ajlm-1261	27	19	1	1	NUM
ajlm-1261	27	20	month	month	NOUN
ajlm-1261	27	21	(	(	PUNCT
ajlm-1261	27	22	aor	aor	NOUN
ajlm-1261	27	23	=	=	NOUN
ajlm-1261	27	24	7.63	7.63	NUM
ajlm-1261	27	25	,	,	PUNCT
ajlm-1261	27	26	p	p	X
ajlm-1261	27	27	=	=	NOUN
ajlm-1261	27	28	0.02	0.02	NUM
ajlm-1261	27	29	)	)	PUNCT
ajlm-1261	27	30	.	.	PUNCT
ajlm-1261	28	1	conclusion	conclusion	NOUN
ajlm-1261	28	2	:	:	PUNCT
ajlm-1261	28	3	multidrug	multidrug	NOUN
ajlm-1261	28	4	-	-	PUNCT
ajlm-1261	28	5	resistant	resistant	ADJ
ajlm-1261	28	6	facultative	facultative	ADJ
ajlm-1261	28	7	anaerobic	anaerobic	NOUN
ajlm-1261	28	8	bacteria	bacteria	NOUN
ajlm-1261	28	9	are	be	AUX
ajlm-1261	28	10	overrepresented	overrepresente	VERB
ajlm-1261	28	11	as	as	ADP
ajlm-1261	28	12	agents	agent	NOUN
ajlm-1261	28	13	of	of	ADP
ajlm-1261	28	14	idfu	idfu	PROPN
ajlm-1261	28	15	.	.	PUNCT
ajlm-1261	29	1	a	a	DET
ajlm-1261	29	2	relatively	relatively	ADV
ajlm-1261	29	3	low	low	ADJ
ajlm-1261	29	4	proportion	proportion	NOUN
ajlm-1261	29	5	of	of	ADP
ajlm-1261	29	6	the	the	DET
ajlm-1261	29	7	aetiological	aetiological	ADJ
ajlm-1261	29	8	agents	agent	NOUN
ajlm-1261	29	9	were	be	AUX
ajlm-1261	29	10	anaerobic	anaerobic	ADJ
ajlm-1261	29	11	bacteria	bacteria	NOUN
ajlm-1261	29	12	.	.	PUNCT
ajlm-1261	30	1	keywords	keyword	NOUN
ajlm-1261	30	2	:	:	PUNCT
ajlm-1261	30	3	infection	infection	NOUN
ajlm-1261	30	4	;	;	PUNCT
ajlm-1261	30	5	diabetic	diabetic	ADJ
ajlm-1261	30	6	foot	foot	NOUN
ajlm-1261	30	7	;	;	PUNCT
ajlm-1261	30	8	ulcers	ulcer	NOUN
ajlm-1261	30	9	;	;	PUNCT
ajlm-1261	30	10	multidrug	multidrug	NOUN
ajlm-1261	30	11	-	-	PUNCT
ajlm-1261	30	12	resistance	resistance	NOUN
ajlm-1261	30	13	;	;	PUNCT
ajlm-1261	30	14	bacteria	bacteria	NOUN
ajlm-1261	30	15	;	;	PUNCT
ajlm-1261	30	16	antibiotic	antibiotic	ADJ
ajlm-1261	30	17	;	;	PUNCT
ajlm-1261	30	18	anaerobic	anaerobic	NOUN
ajlm-1261	30	19	culture	culture	NOUN
ajlm-1261	30	20	;	;	PUNCT
ajlm-1261	30	21	samples	sample	NOUN
ajlm-1261	30	22	.	.	PUNCT
ajlm-1261	31	1	introduction	introduction	NOUN
ajlm-1261	31	2	infected	infect	VERB
ajlm-1261	31	3	diabetic	diabetic	ADJ
ajlm-1261	31	4	foot	foot	NOUN
ajlm-1261	31	5	ulcer	ulcer	NOUN
ajlm-1261	31	6	(	(	PUNCT
ajlm-1261	31	7	idfu	idfu	PROPN
ajlm-1261	31	8	)	)	PUNCT
ajlm-1261	31	9	is	be	AUX
ajlm-1261	31	10	associated	associate	VERB
ajlm-1261	31	11	with	with	ADP
ajlm-1261	31	12	inlammation	inlammation	NOUN
ajlm-1261	31	13	or	or	CCONJ
ajlm-1261	31	14	purulence	purulence	NOUN
ajlm-1261	31	15	occurring	occur	VERB
ajlm-1261	31	16	in	in	ADP
ajlm-1261	31	17	sites	site	NOUN
ajlm-1261	31	18	below	below	ADP
ajlm-1261	31	19	the	the	DET
ajlm-1261	31	20	ankle	ankle	NOUN
ajlm-1261	31	21	in	in	ADP
ajlm-1261	31	22	persons	person	NOUN
ajlm-1261	31	23	with	with	ADP
ajlm-1261	31	24	diabetes	diabetes	NOUN
ajlm-1261	31	25	mellitus.1	mellitus.1	NOUN
ajlm-1261	32	1	it	it	PRON
ajlm-1261	32	2	is	be	AUX
ajlm-1261	32	3	a	a	DET
ajlm-1261	32	4	major	major	ADJ
ajlm-1261	32	5	global	global	ADJ
ajlm-1261	32	6	public	public	ADJ
ajlm-1261	32	7	health	health	NOUN
ajlm-1261	32	8	issue	issue	NOUN
ajlm-1261	32	9	with	with	ADP
ajlm-1261	32	10	a	a	DET
ajlm-1261	32	11	substantial	substantial	ADJ
ajlm-1261	32	12	medical	medical	ADJ
ajlm-1261	32	13	,	,	PUNCT
ajlm-1261	32	14	socio	socio	NOUN
ajlm-1261	32	15	-	-	PUNCT
ajlm-1261	32	16	economic	economic	ADJ
ajlm-1261	32	17	and	and	CCONJ
ajlm-1261	32	18	psychological	psychological	ADJ
ajlm-1261	32	19	burden	burden	NOUN
ajlm-1261	32	20	.	.	PUNCT
ajlm-1261	33	1	infected	infected	ADJ
ajlm-1261	33	2	diabetic	diabetic	ADJ
ajlm-1261	33	3	foot	foot	NOUN
ajlm-1261	33	4	ulcer	ulcer	NOUN
ajlm-1261	33	5	is	be	AUX
ajlm-1261	33	6	one	one	NUM
ajlm-1261	33	7	of	of	ADP
ajlm-1261	33	8	the	the	DET
ajlm-1261	33	9	most	most	ADV
ajlm-1261	33	10	common	common	ADJ
ajlm-1261	33	11	diabetes	diabetes	NOUN
ajlm-1261	33	12	-	-	PUNCT
ajlm-1261	33	13	related	relate	VERB
ajlm-1261	33	14	infections	infection	NOUN
ajlm-1261	33	15	in	in	ADP
ajlm-1261	33	16	clinical	clinical	ADJ
ajlm-1261	33	17	practice	practice	NOUN
ajlm-1261	33	18	,	,	PUNCT
ajlm-1261	33	19	and	and	CCONJ
ajlm-1261	33	20	a	a	DET
ajlm-1261	33	21	common	common	ADJ
ajlm-1261	33	22	indication	indication	NOUN
ajlm-1261	33	23	for	for	ADP
ajlm-1261	33	24	hospital	hospital	NOUN
ajlm-1261	33	25	admission.1	admission.1	PROPN
ajlm-1261	33	26	ulceration	ulceration	NOUN
ajlm-1261	33	27	often	often	ADV
ajlm-1261	33	28	precedes	precede	VERB
ajlm-1261	33	29	foot	foot	NOUN
ajlm-1261	33	30	infection	infection	NOUN
ajlm-1261	33	31	in	in	ADP
ajlm-1261	33	32	diabetic	diabetic	ADJ
ajlm-1261	33	33	patients	patient	NOUN
ajlm-1261	33	34	,	,	PUNCT
ajlm-1261	33	35	with	with	ADP
ajlm-1261	33	36	peripheral	peripheral	ADJ
ajlm-1261	33	37	vascular	vascular	ADJ
ajlm-1261	33	38	disease	disease	NOUN
ajlm-1261	33	39	,	,	PUNCT
ajlm-1261	33	40	peripheral	peripheral	ADJ
ajlm-1261	33	41	neuropathy	neuropathy	ADJ
ajlm-1261	33	42	and	and	CCONJ
ajlm-1261	33	43	visual	visual	ADJ
ajlm-1261	33	44	impairment	impairment	NOUN
ajlm-1261	33	45	and	and	CCONJ
ajlm-1261	33	46	immunological	immunological	ADJ
ajlm-1261	33	47	disturbances	disturbance	NOUN
ajlm-1261	33	48	also	also	ADV
ajlm-1261	33	49	playing	play	VERB
ajlm-1261	33	50	contributory	contributory	ADJ
ajlm-1261	33	51	roles	role	NOUN
ajlm-1261	33	52	.	.	PUNCT
ajlm-1261	34	1	infection	infection	NOUN
ajlm-1261	34	2	impairs	impair	VERB
ajlm-1261	34	3	the	the	DET
ajlm-1261	34	4	healing	healing	NOUN
ajlm-1261	34	5	process	process	NOUN
ajlm-1261	34	6	and	and	CCONJ
ajlm-1261	34	7	aggravates	aggravate	VERB
ajlm-1261	34	8	the	the	DET
ajlm-1261	34	9	condition	condition	NOUN
ajlm-1261	34	10	of	of	ADP
ajlm-1261	34	11	patients	patient	NOUN
ajlm-1261	34	12	with	with	ADP
ajlm-1261	34	13	diabetic	diabetic	ADJ
ajlm-1261	34	14	foot	foot	NOUN
ajlm-1261	34	15	ulcer	ulcer	NOUN
ajlm-1261	34	16	(	(	PUNCT
ajlm-1261	34	17	dfu	dfu	PROPN
ajlm-1261	34	18	)	)	PUNCT
ajlm-1261	34	19	and	and	CCONJ
ajlm-1261	34	20	could	could	AUX
ajlm-1261	34	21	lead	lead	VERB
ajlm-1261	34	22	to	to	ADP
ajlm-1261	34	23	great	great	ADJ
ajlm-1261	34	24	disability	disability	NOUN
ajlm-1261	34	25	,	,	PUNCT
ajlm-1261	34	26	septicaemia	septicaemia	NOUN
ajlm-1261	34	27	and	and	CCONJ
ajlm-1261	34	28	death	death	NOUN
ajlm-1261	34	29	if	if	SCONJ
ajlm-1261	34	30	not	not	PART
ajlm-1261	34	31	promptly	promptly	ADV
ajlm-1261	34	32	and	and	CCONJ
ajlm-1261	34	33	properly	properly	ADV
ajlm-1261	34	34	managed	manage	VERB
ajlm-1261	34	35	.	.	PUNCT
ajlm-1261	35	1	at	at	ADP
ajlm-1261	35	2	7.2	7.2	NUM
ajlm-1261	35	3	%	%	NOUN
ajlm-1261	35	4	(	(	PUNCT
ajlm-1261	35	5	95	95	NUM
ajlm-1261	35	6	%	%	NOUN
ajlm-1261	35	7	confidence	confidence	NOUN
ajlm-1261	35	8	interval	interval	NOUN
ajlm-1261	35	9	[	[	X
ajlm-1261	35	10	ci	ci	X
ajlm-1261	35	11	]	]	X
ajlm-1261	35	12	:	:	PUNCT
ajlm-1261	35	13	5.1–9.3	5.1–9.3	NUM
ajlm-1261	35	14	%	%	NOUN
ajlm-1261	35	15	)	)	PUNCT
ajlm-1261	35	16	and	and	CCONJ
ajlm-1261	35	17	higher	high	ADJ
ajlm-1261	35	18	than	than	ADP
ajlm-1261	35	19	the	the	DET
ajlm-1261	35	20	global	global	ADJ
ajlm-1261	35	21	prevalence	prevalence	NOUN
ajlm-1261	35	22	of	of	ADP
ajlm-1261	35	23	6.3	6.3	NUM
ajlm-1261	35	24	%	%	NOUN
ajlm-1261	35	25	(	(	PUNCT
ajlm-1261	35	26	95	95	NUM
ajlm-1261	35	27	%	%	NOUN
ajlm-1261	35	28	ci	ci	NOUN
ajlm-1261	35	29	:	:	PUNCT
ajlm-1261	35	30	5.4–7.3	5.4–7.3	NUM
ajlm-1261	35	31	%	%	NOUN
ajlm-1261	35	32	)	)	PUNCT
ajlm-1261	35	33	,	,	PUNCT
ajlm-1261	35	34	africa	africa	PROPN
ajlm-1261	35	35	has	have	VERB
ajlm-1261	35	36	the	the	DET
ajlm-1261	35	37	second	second	ADJ
ajlm-1261	35	38	highest	high	ADJ
ajlm-1261	35	39	global	global	ADJ
ajlm-1261	35	40	prevalence	prevalence	NOUN
ajlm-1261	35	41	of	of	ADP
ajlm-1261	35	42	dfu	dfu	PROPN
ajlm-1261	35	43	,	,	PUNCT
ajlm-1261	35	44	a	a	DET
ajlm-1261	35	45	precursor	precursor	NOUN
ajlm-1261	35	46	of	of	ADP
ajlm-1261	35	47	idfu.2	idfu.2	PROPN
ajlm-1261	35	48	foot	foot	NOUN
ajlm-1261	35	49	infections	infection	NOUN
ajlm-1261	35	50	are	be	AUX
ajlm-1261	35	51	more	more	ADV
ajlm-1261	35	52	common	common	ADJ
ajlm-1261	35	53	and	and	CCONJ
ajlm-1261	35	54	lethal	lethal	ADJ
ajlm-1261	35	55	in	in	ADP
ajlm-1261	35	56	africa	africa	PROPN
ajlm-1261	35	57	than	than	SCONJ
ajlm-1261	35	58	elsewhere	elsewhere	ADV
ajlm-1261	35	59	globally.3	globally.3	NOUN
ajlm-1261	35	60	between	between	ADP
ajlm-1261	35	61	25	25	NUM
ajlm-1261	35	62	%	%	NOUN
ajlm-1261	35	63	and	and	CCONJ
ajlm-1261	35	64	60	60	NUM
ajlm-1261	35	65	%	%	NOUN
ajlm-1261	35	66	of	of	ADP
ajlm-1261	35	67	diabetic	diabetic	ADJ
ajlm-1261	35	68	patients	patient	NOUN
ajlm-1261	35	69	with	with	ADP
ajlm-1261	35	70	a	a	DET
ajlm-1261	35	71	background	background	NOUN
ajlm-1261	35	72	foot	foot	NOUN
ajlm-1261	35	73	ulcer	ulcer	NOUN
ajlm-1261	35	74	will	will	AUX
ajlm-1261	35	75	develop	develop	VERB
ajlm-1261	35	76	idfu	idfu	ADJ
ajlm-1261	35	77	which	which	PRON
ajlm-1261	35	78	remains	remain	VERB
ajlm-1261	35	79	a	a	DET
ajlm-1261	35	80	major	major	ADJ
ajlm-1261	35	81	reason	reason	NOUN
ajlm-1261	35	82	for	for	ADP
ajlm-1261	35	83	non	non	ADJ
ajlm-1261	35	84	-	-	ADJ
ajlm-1261	35	85	traumatic	traumatic	ADJ
ajlm-1261	35	86	amputation	amputation	NOUN
ajlm-1261	35	87	of	of	ADP
ajlm-1261	35	88	the	the	DET
ajlm-1261	35	89	lower	low	ADJ
ajlm-1261	35	90	limbs.4	limbs.4	NOUN
ajlm-1261	35	91	the	the	DET
ajlm-1261	35	92	foot	foot	NOUN
ajlm-1261	35	93	infection	infection	NOUN
ajlm-1261	35	94	can	can	AUX
ajlm-1261	35	95	progress	progress	VERB
ajlm-1261	35	96	to	to	PART
ajlm-1261	35	97	irreversible	irreversible	VERB
ajlm-1261	35	98	septic	septic	ADJ
ajlm-1261	35	99	gangrene	gangrene	NOUN
ajlm-1261	35	100	which	which	PRON
ajlm-1261	35	101	often	often	ADV
ajlm-1261	35	102	necessitates	necessitate	VERB
ajlm-1261	35	103	life	life	NOUN
ajlm-1261	35	104	-	-	PUNCT
ajlm-1261	35	105	saving	save	VERB
ajlm-1261	35	106	amputation	amputation	NOUN
ajlm-1261	35	107	of	of	ADP
ajlm-1261	35	108	the	the	DET
ajlm-1261	35	109	lower	low	ADJ
ajlm-1261	35	110	limb.5	limb.5	ADJ
ajlm-1261	35	111	patients	patient	NOUN
ajlm-1261	35	112	with	with	ADP
ajlm-1261	35	113	idfu	idfu	PROPN
ajlm-1261	35	114	have	have	VERB
ajlm-1261	35	115	15–46	15–46	NUM
ajlm-1261	35	116	times	time	NOUN
ajlm-1261	35	117	higher	high	ADJ
ajlm-1261	35	118	risk	risk	NOUN
ajlm-1261	35	119	of	of	ADP
ajlm-1261	35	120	limb	limb	NOUN
ajlm-1261	35	121	amputation	amputation	NOUN
ajlm-1261	35	122	than	than	ADP
ajlm-1261	35	123	those	those	PRON
ajlm-1261	35	124	with	with	ADP
ajlm-1261	35	125	non	non	ADJ
ajlm-1261	35	126	-	-	ADJ
ajlm-1261	35	127	diabetic	diabetic	ADJ
ajlm-1261	35	128	related	related	ADJ
ajlm-1261	35	129	ulcers.6	ulcers.6	PROPN
ajlm-1261	35	130	more	more	ADJ
ajlm-1261	35	131	than	than	ADP
ajlm-1261	35	132	1	1	NUM
ajlm-1261	35	133	million	million	NUM
ajlm-1261	35	134	diabetic	diabetic	ADJ
ajlm-1261	35	135	patients	patient	NOUN
ajlm-1261	35	136	may	may	AUX
ajlm-1261	35	137	require	require	VERB
ajlm-1261	35	138	limb	limb	NOUN
ajlm-1261	35	139	amputation	amputation	NOUN
ajlm-1261	35	140	worldwide	worldwide	ADV
ajlm-1261	35	141	yearly	yearly	ADV
ajlm-1261	35	142	,	,	PUNCT
ajlm-1261	35	143	and	and	CCONJ
ajlm-1261	35	144	a	a	DET
ajlm-1261	35	145	greater	great	ADJ
ajlm-1261	35	146	percentage	percentage	NOUN
ajlm-1261	35	147	of	of	ADP
ajlm-1261	35	148	them	they	PRON
ajlm-1261	35	149	are	be	AUX
ajlm-1261	35	150	in	in	ADP
ajlm-1261	35	151	developing	develop	VERB
ajlm-1261	35	152	countries.7	countries.7	NOUN
ajlm-1261	35	153	wide	wide	ADJ
ajlm-1261	35	154	varieties	variety	NOUN
ajlm-1261	35	155	of	of	ADP
ajlm-1261	35	156	organisms	organism	NOUN
ajlm-1261	35	157	,	,	PUNCT
ajlm-1261	35	158	including	include	VERB
ajlm-1261	35	159	anaerobic	anaerobic	ADJ
ajlm-1261	35	160	bacteria	bacteria	NOUN
ajlm-1261	35	161	,	,	PUNCT
ajlm-1261	35	162	have	have	AUX
ajlm-1261	35	163	been	be	AUX
ajlm-1261	35	164	implicated	implicate	VERB
ajlm-1261	35	165	in	in	ADP
ajlm-1261	35	166	the	the	DET
ajlm-1261	35	167	aetiology	aetiology	NOUN
ajlm-1261	35	168	of	of	ADP
ajlm-1261	35	169	idfu	idfu	NOUN
ajlm-1261	35	170	depending	depend	VERB
ajlm-1261	35	171	on	on	ADP
ajlm-1261	35	172	the	the	DET
ajlm-1261	35	173	severity	severity	NOUN
ajlm-1261	35	174	of	of	ADP
ajlm-1261	35	175	infection	infection	NOUN
ajlm-1261	35	176	and	and	CCONJ
ajlm-1261	35	177	time	time	NOUN
ajlm-1261	35	178	from	from	ADP
ajlm-1261	35	179	onset	onset	NOUN
ajlm-1261	35	180	to	to	ADP
ajlm-1261	35	181	presentation	presentation	NOUN
ajlm-1261	35	182	at	at	ADP
ajlm-1261	35	183	healthcare	healthcare	NOUN
ajlm-1261	35	184	facilities	facility	NOUN
ajlm-1261	35	185	.	.	PUNCT
ajlm-1261	36	1	advanced	advance	VERB
ajlm-1261	36	2	idfus	idfus	NOUN
ajlm-1261	36	3	with	with	ADP
ajlm-1261	36	4	features	feature	NOUN
ajlm-1261	36	5	of	of	ADP
ajlm-1261	36	6	sepsis	sepsis	NOUN
ajlm-1261	36	7	at	at	ADP
ajlm-1261	36	8	admission	admission	NOUN
ajlm-1261	36	9	usually	usually	ADV
ajlm-1261	36	10	harbour	harbour	VERB
ajlm-1261	36	11	anaerobic	anaerobic	NOUN
ajlm-1261	36	12	pathogens.8	pathogens.8	PROPN
ajlm-1261	36	13	the	the	DET
ajlm-1261	36	14	emergence	emergence	NOUN
ajlm-1261	36	15	and	and	CCONJ
ajlm-1261	36	16	current	current	ADJ
ajlm-1261	36	17	global	global	ADJ
ajlm-1261	36	18	threat	threat	NOUN
ajlm-1261	36	19	of	of	ADP
ajlm-1261	36	20	antimicrobial	antimicrobial	ADJ
ajlm-1261	36	21	resistance	resistance	NOUN
ajlm-1261	36	22	in	in	ADP
ajlm-1261	36	23	the	the	DET
ajlm-1261	36	24	face	face	NOUN
ajlm-1261	36	25	of	of	ADP
ajlm-1261	36	26	dwindling	dwindle	VERB
ajlm-1261	36	27	antibiotics	antibiotic	NOUN
ajlm-1261	36	28	in	in	ADP
ajlm-1261	36	29	the	the	DET
ajlm-1261	36	30	development	development	NOUN
ajlm-1261	36	31	pipeline	pipeline	NOUN
ajlm-1261	36	32	has	have	AUX
ajlm-1261	36	33	added	add	VERB
ajlm-1261	36	34	a	a	DET
ajlm-1261	36	35	new	new	ADJ
ajlm-1261	36	36	twist	twist	NOUN
ajlm-1261	36	37	to	to	ADP
ajlm-1261	36	38	the	the	DET
ajlm-1261	36	39	burden	burden	NOUN
ajlm-1261	36	40	of	of	ADP
ajlm-1261	36	41	idfu.9	idfu.9	NOUN
ajlm-1261	36	42	increasing	increase	VERB
ajlm-1261	36	43	involvement	involvement	NOUN
ajlm-1261	36	44	of	of	ADP
ajlm-1261	36	45	multidrug	multidrug	NOUN
ajlm-1261	36	46	-	-	PUNCT
ajlm-1261	36	47	resistant	resistant	ADJ
ajlm-1261	36	48	organisms	organism	NOUN
ajlm-1261	36	49	(	(	PUNCT
ajlm-1261	36	50	organisms	organism	NOUN
ajlm-1261	36	51	resistant	resistant	ADJ
ajlm-1261	36	52	to	to	ADP
ajlm-1261	36	53	at	at	ADV
ajlm-1261	36	54	least	least	ADV
ajlm-1261	36	55	three	three	NUM
ajlm-1261	36	56	different	different	ADJ
ajlm-1261	36	57	antimicrobial	antimicrobial	ADJ
ajlm-1261	36	58	classes)10	classes)10	PROPN
ajlm-1261	36	59	in	in	ADP
ajlm-1261	36	60	diabetic	diabetic	ADJ
ajlm-1261	36	61	patients	patient	NOUN
ajlm-1261	36	62	with	with	ADP
ajlm-1261	36	63	infected	infected	ADJ
ajlm-1261	36	64	foot	foot	NOUN
ajlm-1261	36	65	ulcers	ulcer	NOUN
ajlm-1261	36	66	has	have	AUX
ajlm-1261	36	67	significantly	significantly	ADV
ajlm-1261	36	68	reduced	reduce	VERB
ajlm-1261	36	69	antibiotic	antibiotic	ADJ
ajlm-1261	36	70	treatment	treatment	NOUN
ajlm-1261	36	71	options	option	NOUN
ajlm-1261	36	72	,	,	PUNCT
ajlm-1261	36	73	thus	thus	ADV
ajlm-1261	36	74	posing	pose	VERB
ajlm-1261	36	75	a	a	DET
ajlm-1261	36	76	serious	serious	ADJ
ajlm-1261	36	77	challenge	challenge	NOUN
ajlm-1261	36	78	particularly	particularly	ADV
ajlm-1261	36	79	in	in	ADP
ajlm-1261	36	80	resource	resource	NOUN
ajlm-1261	36	81	-	-	PUNCT
ajlm-1261	36	82	constrained	constrain	VERB
ajlm-1261	36	83	lowand	lowand	ADJ
ajlm-1261	36	84	middle	middle	ADJ
ajlm-1261	36	85	-	-	PUNCT
ajlm-1261	36	86	income	income	NOUN
ajlm-1261	36	87	countries	country	NOUN
ajlm-1261	36	88	where	where	SCONJ
ajlm-1261	36	89	access	access	NOUN
ajlm-1261	36	90	to	to	ADP
ajlm-1261	36	91	antimicrobial	antimicrobial	ADJ
ajlm-1261	36	92	drugs	drug	NOUN
ajlm-1261	36	93	is	be	AUX
ajlm-1261	36	94	of	of	ADP
ajlm-1261	36	95	grave	grave	ADJ
ajlm-1261	36	96	concern.11	concern.11	NOUN
ajlm-1261	36	97	it	it	PRON
ajlm-1261	36	98	has	have	AUX
ajlm-1261	36	99	also	also	ADV
ajlm-1261	36	100	increased	increase	VERB
ajlm-1261	36	101	the	the	DET
ajlm-1261	36	102	length	length	NOUN
ajlm-1261	36	103	of	of	ADP
ajlm-1261	36	104	hospital	hospital	NOUN
ajlm-1261	36	105	stay	stay	NOUN
ajlm-1261	36	106	and	and	CCONJ
ajlm-1261	36	107	cost	cost	NOUN
ajlm-1261	36	108	of	of	ADP
ajlm-1261	36	109	treatment	treatment	NOUN
ajlm-1261	36	110	,	,	PUNCT
ajlm-1261	36	111	and	and	CCONJ
ajlm-1261	36	112	caused	cause	VERB
ajlm-1261	36	113	additional	additional	ADJ
ajlm-1261	36	114	morbidity	morbidity	NOUN
ajlm-1261	36	115	and	and	CCONJ
ajlm-1261	36	116	mortality.12	mortality.12	VERB
ajlm-1261	36	117	these	these	DET
ajlm-1261	36	118	situations	situation	NOUN
ajlm-1261	36	119	have	have	AUX
ajlm-1261	36	120	assumed	assume	VERB
ajlm-1261	36	121	worrisome	worrisome	ADJ
ajlm-1261	36	122	trends	trend	NOUN
ajlm-1261	36	123	in	in	ADP
ajlm-1261	36	124	which	which	PRON
ajlm-1261	36	125	resistance	resistance	NOUN
ajlm-1261	36	126	is	be	AUX
ajlm-1261	36	127	building	build	VERB
ajlm-1261	36	128	up	up	ADP
ajlm-1261	36	129	to	to	ADP
ajlm-1261	36	130	antibiotics	antibiotic	NOUN
ajlm-1261	36	131	of	of	ADP
ajlm-1261	36	132	last	last	ADJ
ajlm-1261	36	133	resort	resort	NOUN
ajlm-1261	36	134	;	;	PUNCT
ajlm-1261	36	135	pathogens	pathogen	NOUN
ajlm-1261	36	136	showing	show	VERB
ajlm-1261	36	137	considerable	considerable	ADJ
ajlm-1261	36	138	resistance	resistance	NOUN
ajlm-1261	36	139	to	to	ADP
ajlm-1261	36	140	vancomycin	vancomycin	PROPN
ajlm-1261	36	141	and	and	CCONJ
ajlm-1261	36	142	carbapenems	carbapenem	NOUN
ajlm-1261	36	143	are	be	AUX
ajlm-1261	36	144	particularly	particularly	ADV
ajlm-1261	36	145	becoming	become	VERB
ajlm-1261	36	146	more	more	ADV
ajlm-1261	36	147	common	common	ADJ
ajlm-1261	36	148	as	as	ADP
ajlm-1261	36	149	agents	agent	NOUN
ajlm-1261	36	150	of	of	ADP
ajlm-1261	36	151	foot	foot	NOUN
ajlm-1261	36	152	infection	infection	NOUN
ajlm-1261	36	153	in	in	ADP
ajlm-1261	36	154	diabetic	diabetic	ADJ
ajlm-1261	36	155	patients.13	patients.13	NOUN
ajlm-1261	36	156	various	various	ADJ
ajlm-1261	36	157	studies	study	NOUN
ajlm-1261	36	158	have	have	AUX
ajlm-1261	36	159	reported	report	VERB
ajlm-1261	36	160	many	many	ADJ
ajlm-1261	36	161	independent	independent	ADJ
ajlm-1261	36	162	risk	risk	NOUN
ajlm-1261	36	163	factors	factor	NOUN
ajlm-1261	36	164	and	and	CCONJ
ajlm-1261	36	165	predictors	predictor	NOUN
ajlm-1261	36	166	of	of	ADP
ajlm-1261	36	167	multidrug	multidrug	NOUN
ajlm-1261	36	168	-	-	PUNCT
ajlm-1261	36	169	resistant	resistant	ADJ
ajlm-1261	36	170	idfu	idfu	NOUN
ajlm-1261	36	171	including	include	VERB
ajlm-1261	36	172	previous	previous	ADJ
ajlm-1261	36	173	hospitalisation	hospitalisation	NOUN
ajlm-1261	36	174	for	for	ADP
ajlm-1261	36	175	the	the	DET
ajlm-1261	36	176	same	same	ADJ
ajlm-1261	36	177	wound	wound	NOUN
ajlm-1261	36	178	,	,	PUNCT
ajlm-1261	36	179	prolonged	prolong	VERB
ajlm-1261	36	180	antibiotic	antibiotic	ADJ
ajlm-1261	36	181	therapy	therapy	NOUN
ajlm-1261	36	182	,	,	PUNCT
ajlm-1261	36	183	ulcer	ulcer	NOUN
ajlm-1261	36	184	type	type	NOUN
ajlm-1261	36	185	and	and	CCONJ
ajlm-1261	36	186	increased	increase	VERB
ajlm-1261	36	187	ulcer	ulcer	NOUN
ajlm-1261	36	188	size	size	NOUN
ajlm-1261	36	189	,	,	PUNCT
ajlm-1261	36	190	presence	presence	NOUN
ajlm-1261	36	191	of	of	ADP
ajlm-1261	36	192	osteomyelitis	osteomyelitis	NOUN
ajlm-1261	36	193	,	,	PUNCT
ajlm-1261	36	194	poor	poor	ADJ
ajlm-1261	36	195	glycaemic	glycaemic	ADJ
ajlm-1261	36	196	control	control	NOUN
ajlm-1261	36	197	,	,	PUNCT
ajlm-1261	36	198	prolonged	prolong	VERB
ajlm-1261	36	199	duration	duration	NOUN
ajlm-1261	36	200	of	of	ADP
ajlm-1261	36	201	foot	foot	NOUN
ajlm-1261	36	202	ulcer	ulcer	NOUN
ajlm-1261	36	203	infection	infection	NOUN
ajlm-1261	36	204	as	as	ADV
ajlm-1261	36	205	well	well	ADV
ajlm-1261	36	206	as	as	ADP
ajlm-1261	36	207	proliferative	proliferative	ADJ
ajlm-1261	36	208	retinopathy.14,15,16,17,18	retinopathy.14,15,16,17,18	NOUN
ajlm-1261	36	209	according	accord	VERB
ajlm-1261	36	210	to	to	ADP
ajlm-1261	36	211	bakele	bakele	PROPN
ajlm-1261	36	212	et	et	PROPN
ajlm-1261	36	213	al	al	PROPN
ajlm-1261	36	214	.	.	PROPN
ajlm-1261	36	215	,	,	PUNCT
ajlm-1261	36	216	predictors	predictor	NOUN
ajlm-1261	36	217	of	of	ADP
ajlm-1261	36	218	lower	low	ADJ
ajlm-1261	36	219	limb	limb	NOUN
ajlm-1261	36	220	amputation	amputation	NOUN
ajlm-1261	36	221	by	by	ADP
ajlm-1261	36	222	multivariate	multivariate	NOUN
ajlm-1261	36	223	logistic	logistic	ADJ
ajlm-1261	36	224	regression	regression	NOUN
ajlm-1261	36	225	analysis	analysis	NOUN
ajlm-1261	36	226	were	be	AUX
ajlm-1261	36	227	advanced	advanced	ADJ
ajlm-1261	36	228	ulcer	ulcer	NOUN
ajlm-1261	36	229	grade	grade	NOUN
ajlm-1261	36	230	,	,	PUNCT
ajlm-1261	36	231	inappropriate	inappropriate	ADJ
ajlm-1261	36	232	antibiotic	antibiotic	ADJ
ajlm-1261	36	233	use	use	NOUN
ajlm-1261	36	234	,	,	PUNCT
ajlm-1261	36	235	overweight	overweight	ADJ
ajlm-1261	36	236	,	,	PUNCT
ajlm-1261	36	237	obesity	obesity	NOUN
ajlm-1261	36	238	,	,	PUNCT
ajlm-1261	36	239	poor	poor	ADJ
ajlm-1261	36	240	blood	blood	NOUN
ajlm-1261	36	241	glucose	glucose	NOUN
ajlm-1261	36	242	control	control	NOUN
ajlm-1261	36	243	and	and	CCONJ
ajlm-1261	36	244	neuropathy.19	neuropathy.19	NOUN
ajlm-1261	36	245	furthermore	furthermore	ADV
ajlm-1261	36	246	,	,	PUNCT
ajlm-1261	36	247	albuminuria	albuminuria	PROPN
ajlm-1261	36	248	,	,	PUNCT
ajlm-1261	36	249	diabetic	diabetic	ADJ
ajlm-1261	36	250	nephropathy	nephropathy	NOUN
ajlm-1261	36	251	and	and	CCONJ
ajlm-1261	36	252	charcot	charcot	PROPN
ajlm-1261	36	253	arthropathy	arthropathy	ADJ
ajlm-1261	36	254	were	be	AUX
ajlm-1261	36	255	noted	note	VERB
ajlm-1261	36	256	as	as	ADP
ajlm-1261	36	257	predictors	predictor	NOUN
ajlm-1261	36	258	of	of	ADP
ajlm-1261	36	259	poor	poor	ADJ
ajlm-1261	36	260	healing	healing	NOUN
ajlm-1261	36	261	of	of	ADP
ajlm-1261	36	262	diabetic	diabetic	ADJ
ajlm-1261	36	263	foot	foot	NOUN
ajlm-1261	36	264	ulcer.20	ulcer.20	PROPN
ajlm-1261	36	265	a	a	DET
ajlm-1261	36	266	recent	recent	ADJ
ajlm-1261	36	267	systematic	systematic	ADJ
ajlm-1261	36	268	review	review	NOUN
ajlm-1261	36	269	and	and	CCONJ
ajlm-1261	36	270	meta	meta	NOUN
ajlm-1261	36	271	-	-	PUNCT
ajlm-1261	36	272	analysis	analysis	NOUN
ajlm-1261	36	273	on	on	ADP
ajlm-1261	36	274	the	the	DET
ajlm-1261	36	275	global	global	ADJ
ajlm-1261	36	276	burden	burden	NOUN
ajlm-1261	36	277	of	of	ADP
ajlm-1261	36	278	diabetic	diabetic	ADJ
ajlm-1261	36	279	foot	foot	NOUN
ajlm-1261	36	280	ulceration	ulceration	NOUN
ajlm-1261	36	281	in	in	ADP
ajlm-1261	36	282	cameroon	cameroon	PROPN
ajlm-1261	36	283	,	,	PUNCT
ajlm-1261	36	284	west	west	PROPN
ajlm-1261	36	285	africa	africa	PROPN
ajlm-1261	36	286	,	,	PUNCT
ajlm-1261	36	287	concluded	conclude	VERB
ajlm-1261	36	288	that	that	SCONJ
ajlm-1261	36	289	paucity	paucity	NOUN
ajlm-1261	36	290	of	of	ADP
ajlm-1261	36	291	data	datum	NOUN
ajlm-1261	36	292	impedes	impede	VERB
ajlm-1261	36	293	strategies	strategy	NOUN
ajlm-1261	36	294	for	for	ADP
ajlm-1261	36	295	treatment	treatment	NOUN
ajlm-1261	36	296	and	and	CCONJ
ajlm-1261	36	297	prevention	prevention	NOUN
ajlm-1261	36	298	of	of	ADP
ajlm-1261	36	299	foot	foot	NOUN
ajlm-1261	36	300	infections	infection	NOUN
ajlm-1261	36	301	in	in	ADP
ajlm-1261	36	302	diabetic	diabetic	ADJ
ajlm-1261	36	303	patients.2	patients.2	PROPN
ajlm-1261	36	304	thus	thus	ADV
ajlm-1261	36	305	,	,	PUNCT
ajlm-1261	36	306	our	our	PRON
ajlm-1261	36	307	study	study	NOUN
ajlm-1261	36	308	was	be	AUX
ajlm-1261	36	309	designed	design	VERB
ajlm-1261	36	310	to	to	PART
ajlm-1261	36	311	determine	determine	VERB
ajlm-1261	36	312	the	the	DET
ajlm-1261	36	313	prevalent	prevalent	ADJ
ajlm-1261	36	314	bacteria	bacteria	NOUN
ajlm-1261	36	315	involved	involve	VERB
ajlm-1261	36	316	in	in	ADP
ajlm-1261	36	317	idfus	idfus	NOUN
ajlm-1261	36	318	,	,	PUNCT
ajlm-1261	36	319	assess	assess	VERB
ajlm-1261	36	320	the	the	DET
ajlm-1261	36	321	burden	burden	NOUN
ajlm-1261	36	322	of	of	ADP
ajlm-1261	36	323	multidrug	multidrug	NOUN
ajlm-1261	36	324	-	-	PUNCT
ajlm-1261	36	325	resistance	resistance	NOUN
ajlm-1261	36	326	(	(	PUNCT
ajlm-1261	36	327	mdr	mdr	PROPN
ajlm-1261	36	328	)	)	PUNCT
ajlm-1261	36	329	among	among	ADP
ajlm-1261	36	330	the	the	DET
ajlm-1261	36	331	isolates	isolate	NOUN
ajlm-1261	36	332	and	and	CCONJ
ajlm-1261	36	333	evaluate	evaluate	VERB
ajlm-1261	36	334	the	the	DET
ajlm-1261	36	335	associated	associated	ADJ
ajlm-1261	36	336	risk	risk	NOUN
ajlm-1261	36	337	factors	factor	NOUN
ajlm-1261	36	338	.	.	PUNCT
ajlm-1261	37	1	methods	method	NOUN
ajlm-1261	37	2	ethical	ethical	ADJ
ajlm-1261	37	3	considerations	consideration	NOUN
ajlm-1261	37	4	ethical	ethical	ADJ
ajlm-1261	37	5	approval	approval	NOUN
ajlm-1261	37	6	for	for	ADP
ajlm-1261	37	7	this	this	DET
ajlm-1261	37	8	study	study	NOUN
ajlm-1261	37	9	was	be	AUX
ajlm-1261	37	10	granted	grant	VERB
ajlm-1261	37	11	by	by	ADP
ajlm-1261	37	12	the	the	DET
ajlm-1261	37	13	ethics	ethic	NOUN
ajlm-1261	37	14	and	and	CCONJ
ajlm-1261	37	15	research	research	NOUN
ajlm-1261	37	16	committees	committee	NOUN
ajlm-1261	37	17	of	of	ADP
ajlm-1261	37	18	the	the	DET
ajlm-1261	37	19	obafemi	obafemi	PROPN
ajlm-1261	37	20	awolowo	awolowo	PROPN
ajlm-1261	37	21	university	university	PROPN
ajlm-1261	37	22	teaching	teaching	NOUN
ajlm-1261	37	23	hospitals	hospital	NOUN
ajlm-1261	37	24	complex	complex	ADJ
ajlm-1261	37	25	and	and	CCONJ
ajlm-1261	37	26	ladoke	ladoke	ADJ
ajlm-1261	37	27	akintola	akintola	PROPN
ajlm-1261	37	28	university	university	PROPN
ajlm-1261	37	29	college	college	PROPN
ajlm-1261	37	30	of	of	ADP
ajlm-1261	37	31	technology	technology	NOUN
ajlm-1261	37	32	with	with	ADP
ajlm-1261	37	33	protocol	protocol	NOUN
ajlm-1261	37	34	numbers	number	NOUN
ajlm-1261	37	35	erc/2015/11/02	erc/2015/11/02	PUNCT
ajlm-1261	37	36	and	and	CCONJ
ajlm-1261	37	37	lth	lth	PROPN
ajlm-1261	37	38	/	/	SYM
ajlm-1261	37	39	er/2016/01/254	er/2016/01/254	PROPN
ajlm-1261	37	40	.	.	PUNCT
ajlm-1261	38	1	information	information	NOUN
ajlm-1261	38	2	about	about	ADP
ajlm-1261	38	3	the	the	DET
ajlm-1261	38	4	study	study	NOUN
ajlm-1261	38	5	and	and	CCONJ
ajlm-1261	38	6	participant	participant	ADJ
ajlm-1261	38	7	involvement	involvement	NOUN
ajlm-1261	38	8	was	be	AUX
ajlm-1261	38	9	fully	fully	ADV
ajlm-1261	38	10	explained	explain	VERB
ajlm-1261	38	11	to	to	ADP
ajlm-1261	38	12	patients	patient	NOUN
ajlm-1261	38	13	,	,	PUNCT
ajlm-1261	38	14	and	and	CCONJ
ajlm-1261	38	15	properly	properly	ADV
ajlm-1261	38	16	signed	sign	VERB
ajlm-1261	38	17	and	and	CCONJ
ajlm-1261	38	18	dated	date	VERB
ajlm-1261	38	19	written	write	VERB
ajlm-1261	38	20	informed	inform	VERB
ajlm-1261	38	21	consent	consent	NOUN
ajlm-1261	38	22	forms	form	NOUN
ajlm-1261	38	23	were	be	AUX
ajlm-1261	38	24	obtained	obtain	VERB
ajlm-1261	38	25	from	from	ADP
ajlm-1261	38	26	patients	patient	NOUN
ajlm-1261	38	27	before	before	ADP
ajlm-1261	38	28	their	their	PRON
ajlm-1261	38	29	recruitment	recruitment	NOUN
ajlm-1261	38	30	into	into	ADP
ajlm-1261	38	31	the	the	DET
ajlm-1261	38	32	study	study	NOUN
ajlm-1261	38	33	.	.	PUNCT
ajlm-1261	39	1	results	result	NOUN
ajlm-1261	39	2	of	of	ADP
ajlm-1261	39	3	wound	wound	ADJ
ajlm-1261	39	4	biopsy	biopsy	NOUN
ajlm-1261	39	5	microscopy	microscopy	NOUN
ajlm-1261	39	6	,	,	PUNCT
ajlm-1261	39	7	culture	culture	NOUN
ajlm-1261	39	8	and	and	CCONJ
ajlm-1261	39	9	sensitivity	sensitivity	NOUN
ajlm-1261	39	10	were	be	AUX
ajlm-1261	39	11	made	make	VERB
ajlm-1261	39	12	available	available	ADJ
ajlm-1261	39	13	for	for	ADP
ajlm-1261	39	14	patients	patient	NOUN
ajlm-1261	39	15	’	'	PUNCT
ajlm-1261	39	16	management	management	NOUN
ajlm-1261	39	17	.	.	PUNCT
ajlm-1261	40	1	study	study	NOUN
ajlm-1261	40	2	population	population	NOUN
ajlm-1261	40	3	the	the	DET
ajlm-1261	40	4	prospective	prospective	ADJ
ajlm-1261	40	5	,	,	PUNCT
ajlm-1261	40	6	cross	cross	ADJ
ajlm-1261	40	7	-	-	ADJ
ajlm-1261	40	8	sectional	sectional	ADJ
ajlm-1261	40	9	,	,	PUNCT
ajlm-1261	40	10	multicentre	multicentre	NOUN
ajlm-1261	40	11	,	,	PUNCT
ajlm-1261	40	12	hospital	hospital	NOUN
ajlm-1261	40	13	-	-	PUNCT
ajlm-1261	40	14	based	base	VERB
ajlm-1261	40	15	study	study	NOUN
ajlm-1261	40	16	was	be	AUX
ajlm-1261	40	17	carried	carry	VERB
ajlm-1261	40	18	out	out	ADP
ajlm-1261	40	19	in	in	ADP
ajlm-1261	40	20	osun	osun	PROPN
ajlm-1261	40	21	state	state	PROPN
ajlm-1261	40	22	,	,	PUNCT
ajlm-1261	40	23	southwest	southwest	PROPN
ajlm-1261	40	24	nigeria	nigeria	PROPN
ajlm-1261	40	25	,	,	PUNCT
ajlm-1261	40	26	between	between	ADP
ajlm-1261	40	27	july	july	PROPN
ajlm-1261	40	28	2016	2016	NUM
ajlm-1261	40	29	and	and	CCONJ
ajlm-1261	40	30	april	april	PROPN
ajlm-1261	40	31	2017	2017	NUM
ajlm-1261	40	32	.	.	PUNCT
ajlm-1261	41	1	it	it	PRON
ajlm-1261	41	2	included	include	VERB
ajlm-1261	41	3	three	three	NUM
ajlm-1261	41	4	existing	exist	VERB
ajlm-1261	41	5	tertiary	tertiary	ADJ
ajlm-1261	41	6	healthcare	healthcare	NOUN
ajlm-1261	41	7	facilities	facility	NOUN
ajlm-1261	41	8	in	in	ADP
ajlm-1261	41	9	the	the	DET
ajlm-1261	41	10	state	state	NOUN
ajlm-1261	41	11	:	:	PUNCT
ajlm-1261	41	12	obafemi	obafemi	PROPN
ajlm-1261	41	13	awolowo	awolowo	PROPN
ajlm-1261	41	14	university	university	PROPN
ajlm-1261	41	15	teaching	teaching	NOUN
ajlm-1261	41	16	hospitals	hospital	NOUN
ajlm-1261	41	17	complex	complex	ADJ
ajlm-1261	41	18	,	,	PUNCT
ajlm-1261	41	19	wesley	wesley	PROPN
ajlm-1261	41	20	guild	guild	PROPN
ajlm-1261	41	21	hospital	hospital	PROPN
ajlm-1261	41	22	,	,	PUNCT
ajlm-1261	41	23	ilesa	ilesa	NOUN
ajlm-1261	41	24	,	,	PUNCT
ajlm-1261	41	25	and	and	CCONJ
ajlm-1261	41	26	ladoke	ladoke	ADJ
ajlm-1261	41	27	akintola	akintola	PROPN
ajlm-1261	41	28	university	university	PROPN
ajlm-1261	41	29	of	of	ADP
ajlm-1261	41	30	technology	technology	NOUN
ajlm-1261	41	31	teaching	teaching	NOUN
ajlm-1261	41	32	hospital	hospital	NOUN
ajlm-1261	41	33	,	,	PUNCT
ajlm-1261	41	34	osogbo	osogbo	VERB
ajlm-1261	41	35	.	.	PUNCT
ajlm-1261	42	1	all	all	DET
ajlm-1261	42	2	consecutive	consecutive	ADJ
ajlm-1261	42	3	diabetic	diabetic	ADJ
ajlm-1261	42	4	patients	patient	NOUN
ajlm-1261	42	5	(	(	PUNCT
ajlm-1261	42	6	both	both	CCONJ
ajlm-1261	42	7	hospitalised	hospitalised	ADJ
ajlm-1261	42	8	and	and	CCONJ
ajlm-1261	42	9	outpatients	outpatient	NOUN
ajlm-1261	42	10	)	)	PUNCT
ajlm-1261	42	11	with	with	ADP
ajlm-1261	42	12	foot	foot	NOUN
ajlm-1261	42	13	infections	infection	NOUN
ajlm-1261	42	14	meeting	meet	VERB
ajlm-1261	42	15	the	the	DET
ajlm-1261	42	16	criteria	criterion	NOUN
ajlm-1261	42	17	for	for	ADP
ajlm-1261	42	18	diagnosis	diagnosis	NOUN
ajlm-1261	42	19	of	of	ADP
ajlm-1261	42	20	idfu	idfu	ADV
ajlm-1261	42	21	seen	see	VERB
ajlm-1261	42	22	and	and	CCONJ
ajlm-1261	42	23	managed	manage	VERB
ajlm-1261	42	24	at	at	ADP
ajlm-1261	42	25	these	these	DET
ajlm-1261	42	26	hospitals	hospital	NOUN
ajlm-1261	42	27	were	be	AUX
ajlm-1261	42	28	recruited	recruit	VERB
ajlm-1261	42	29	into	into	ADP
ajlm-1261	42	30	the	the	DET
ajlm-1261	42	31	study	study	NOUN
ajlm-1261	42	32	.	.	PUNCT
ajlm-1261	43	1	they	they	PRON
ajlm-1261	43	2	were	be	AUX
ajlm-1261	43	3	clinically	clinically	ADV
ajlm-1261	43	4	assessed	assess	VERB
ajlm-1261	43	5	and	and	CCONJ
ajlm-1261	43	6	foot	foot	NOUN
ajlm-1261	43	7	lesions	lesion	NOUN
ajlm-1261	43	8	graded	grade	VERB
ajlm-1261	43	9	according	accord	VERB
ajlm-1261	43	10	to	to	ADP
ajlm-1261	43	11	the	the	DET
ajlm-1261	43	12	diabetic	diabetic	ADJ
ajlm-1261	43	13	foot	foot	NOUN
ajlm-1261	43	14	infection	infection	NOUN
ajlm-1261	43	15	severity	severity	NOUN
ajlm-1261	43	16	classification	classification	NOUN
ajlm-1261	43	17	system	system	NOUN
ajlm-1261	43	18	issued	issue	VERB
ajlm-1261	43	19	by	by	ADP
ajlm-1261	43	20	the	the	DET
ajlm-1261	43	21	infectious	infectious	ADJ
ajlm-1261	43	22	disease	disease	NOUN
ajlm-1261	43	23	society	society	NOUN
ajlm-1261	43	24	of	of	ADP
ajlm-1261	43	25	america.8	america.8	NOUN
ajlm-1261	43	26	only	only	ADV
ajlm-1261	43	27	non	non	ADJ
ajlm-1261	43	28	-	-	ADJ
ajlm-1261	43	29	duplicate	duplicate	ADJ
ajlm-1261	43	30	patients	patient	NOUN
ajlm-1261	43	31	and	and	CCONJ
ajlm-1261	43	32	samples	sample	NOUN
ajlm-1261	43	33	were	be	AUX
ajlm-1261	43	34	included	include	VERB
ajlm-1261	43	35	in	in	ADP
ajlm-1261	43	36	the	the	DET
ajlm-1261	43	37	study	study	NOUN
ajlm-1261	43	38	.	.	PUNCT
ajlm-1261	44	1	all	all	DET
ajlm-1261	44	2	inpatients	inpatient	NOUN
ajlm-1261	44	3	were	be	AUX
ajlm-1261	44	4	followed	follow	VERB
ajlm-1261	44	5	up	up	ADP
ajlm-1261	44	6	with	with	ADP
ajlm-1261	44	7	regular	regular	ADJ
ajlm-1261	44	8	check	check	NOUN
ajlm-1261	44	9	-	-	PUNCT
ajlm-1261	44	10	ups	up	NOUN
ajlm-1261	44	11	physically	physically	ADV
ajlm-1261	44	12	in	in	ADP
ajlm-1261	44	13	the	the	DET
ajlm-1261	44	14	wards	ward	NOUN
ajlm-1261	44	15	until	until	SCONJ
ajlm-1261	44	16	they	they	PRON
ajlm-1261	44	17	either	either	CCONJ
ajlm-1261	44	18	died	die	VERB
ajlm-1261	44	19	or	or	CCONJ
ajlm-1261	44	20	were	be	AUX
ajlm-1261	44	21	discharged	discharge	VERB
ajlm-1261	44	22	.	.	PUNCT
ajlm-1261	45	1	sample	sample	NOUN
ajlm-1261	45	2	collection	collection	NOUN
ajlm-1261	45	3	and	and	CCONJ
ajlm-1261	45	4	bacterial	bacterial	ADJ
ajlm-1261	45	5	identification	identification	NOUN
ajlm-1261	45	6	aspirates	aspirate	NOUN
ajlm-1261	45	7	were	be	AUX
ajlm-1261	45	8	obtained	obtain	VERB
ajlm-1261	45	9	from	from	ADP
ajlm-1261	45	10	deep	deep	ADJ
ajlm-1261	45	11	-	-	PUNCT
ajlm-1261	45	12	seated	seat	VERB
ajlm-1261	45	13	abscesses	abscess	NOUN
ajlm-1261	45	14	,	,	PUNCT
ajlm-1261	45	15	and	and	CCONJ
ajlm-1261	45	16	tissue	tissue	NOUN
ajlm-1261	45	17	samples	sample	NOUN
ajlm-1261	45	18	were	be	AUX
ajlm-1261	45	19	collected	collect	VERB
ajlm-1261	45	20	after	after	ADP
ajlm-1261	45	21	washing	wash	VERB
ajlm-1261	45	22	the	the	DET
ajlm-1261	45	23	wound	wound	NOUN
ajlm-1261	45	24	vigorously	vigorously	ADV
ajlm-1261	45	25	with	with	ADP
ajlm-1261	45	26	sterile	sterile	ADJ
ajlm-1261	45	27	saline	saline	NOUN
ajlm-1261	45	28	and	and	CCONJ
ajlm-1261	45	29	debridement	debridement	NOUN
ajlm-1261	45	30	of	of	ADP
ajlm-1261	45	31	the	the	DET
ajlm-1261	45	32	slough	slough	NOUN
ajlm-1261	45	33	to	to	PART
ajlm-1261	45	34	exclude	exclude	VERB
ajlm-1261	45	35	mere	mere	ADJ
ajlm-1261	45	36	colonisers	coloniser	NOUN
ajlm-1261	45	37	.	.	PUNCT
ajlm-1261	46	1	necrotic	necrotic	ADJ
ajlm-1261	46	2	tissues	tissue	NOUN
ajlm-1261	46	3	were	be	AUX
ajlm-1261	46	4	curetted	curet	VERB
ajlm-1261	46	5	into	into	ADP
ajlm-1261	46	6	anaerobic	anaerobic	ADJ
ajlm-1261	46	7	basal	basal	ADJ
ajlm-1261	46	8	broth	broth	NOUN
ajlm-1261	46	9	(	(	PUNCT
ajlm-1261	46	10	oxoid	oxoid	PROPN
ajlm-1261	46	11	,	,	PUNCT
ajlm-1261	46	12	basingstoke	basingstoke	PROPN
ajlm-1261	46	13	,	,	PUNCT
ajlm-1261	46	14	hants	hant	NOUN
ajlm-1261	46	15	,	,	PUNCT
ajlm-1261	46	16	united	united	ADJ
ajlm-1261	46	17	kingdom	kingdom	PROPN
ajlm-1261	46	18	)	)	PUNCT
ajlm-1261	46	19	for	for	ADP
ajlm-1261	46	20	anaerobic	anaerobic	ADJ
ajlm-1261	46	21	culture	culture	NOUN
ajlm-1261	46	22	.	.	PUNCT
ajlm-1261	47	1	the	the	DET
ajlm-1261	47	2	samples	sample	NOUN
ajlm-1261	47	3	were	be	AUX
ajlm-1261	47	4	immediately	immediately	ADV
ajlm-1261	47	5	transported	transport	VERB
ajlm-1261	47	6	to	to	ADP
ajlm-1261	47	7	the	the	DET
ajlm-1261	47	8	laboratory	laboratory	NOUN
ajlm-1261	47	9	and	and	CCONJ
ajlm-1261	47	10	processed	process	VERB
ajlm-1261	47	11	within	within	ADP
ajlm-1261	47	12	2	2	NUM
ajlm-1261	47	13	h	h	NOUN
ajlm-1261	47	14	of	of	ADP
ajlm-1261	47	15	sample	sample	NOUN
ajlm-1261	47	16	collection	collection	NOUN
ajlm-1261	47	17	by	by	ADP
ajlm-1261	47	18	inoculating	inoculate	VERB
ajlm-1261	47	19	them	they	PRON
ajlm-1261	47	20	onto	onto	ADP
ajlm-1261	47	21	a	a	DET
ajlm-1261	47	22	set	set	NOUN
ajlm-1261	47	23	of	of	ADP
ajlm-1261	47	24	selective	selective	ADJ
ajlm-1261	47	25	and	and	CCONJ
ajlm-1261	47	26	non	non	ADJ
ajlm-1261	47	27	-	-	ADJ
ajlm-1261	47	28	selective	selective	ADJ
ajlm-1261	47	29	media	medium	NOUN
ajlm-1261	47	30	which	which	PRON
ajlm-1261	47	31	were	be	AUX
ajlm-1261	47	32	:	:	PUNCT
ajlm-1261	47	33	5	5	NUM
ajlm-1261	47	34	%	%	NOUN
ajlm-1261	47	35	(	(	PUNCT
ajlm-1261	47	36	volume	volume	NOUN
ajlm-1261	47	37	/	/	SYM
ajlm-1261	47	38	volume	volume	NOUN
ajlm-1261	47	39	)	)	PUNCT
ajlm-1261	47	40	sheep	sheep	NOUN
ajlm-1261	47	41	blood	blood	NOUN
ajlm-1261	47	42	agar	agar	NOUN
ajlm-1261	47	43	(	(	PUNCT
ajlm-1261	47	44	ba	ba	NOUN
ajlm-1261	47	45	;	;	PUNCT
ajlm-1261	47	46	oxoid	oxoid	PROPN
ajlm-1261	47	47	,	,	PUNCT
ajlm-1261	47	48	basingstoke	basingstoke	PROPN
ajlm-1261	47	49	,	,	PUNCT
ajlm-1261	47	50	hants	hant	NOUN
ajlm-1261	47	51	,	,	PUNCT
ajlm-1261	47	52	united	united	ADJ
ajlm-1261	47	53	kingdom	kingdom	PROPN
ajlm-1261	47	54	)	)	PUNCT
ajlm-1261	47	55	,	,	PUNCT
ajlm-1261	47	56	macconkey	macconkey	NOUN
ajlm-1261	47	57	agar	agar	NOUN
ajlm-1261	47	58	(	(	PUNCT
ajlm-1261	47	59	oxoid	oxoid	PROPN
ajlm-1261	47	60	,	,	PUNCT
ajlm-1261	47	61	basingstoke	basingstoke	PROPN
ajlm-1261	47	62	,	,	PUNCT
ajlm-1261	47	63	hants	hant	NOUN
ajlm-1261	47	64	,	,	PUNCT
ajlm-1261	47	65	united	united	ADJ
ajlm-1261	47	66	kingdom	kingdom	PROPN
ajlm-1261	47	67	)	)	PUNCT
ajlm-1261	47	68	,	,	PUNCT
ajlm-1261	47	69	chocolate	chocolate	NOUN
ajlm-1261	47	70	agar	agar	NOUN
ajlm-1261	47	71	and	and	CCONJ
ajlm-1261	47	72	anaerobic	anaerobic	ADJ
ajlm-1261	47	73	basal	basal	NOUN
ajlm-1261	47	74	agar	agar	NOUN
ajlm-1261	47	75	(	(	PUNCT
ajlm-1261	47	76	oxoid	oxoid	PROPN
ajlm-1261	47	77	,	,	PUNCT
ajlm-1261	47	78	basingstoke	basingstoke	PROPN
ajlm-1261	47	79	,	,	PUNCT
ajlm-1261	47	80	hants	hant	NOUN
ajlm-1261	47	81	,	,	PUNCT
ajlm-1261	47	82	united	united	ADJ
ajlm-1261	47	83	kingdom	kingdom	PROPN
ajlm-1261	47	84	)	)	PUNCT
ajlm-1261	47	85	supplemented	supplement	VERB
ajlm-1261	47	86	with	with	ADP
ajlm-1261	47	87	5	5	NUM
ajlm-1261	47	88	%	%	NOUN
ajlm-1261	47	89	(	(	PUNCT
ajlm-1261	47	90	abscesses	abscess	NOUN
ajlm-1261	47	91	)	)	PUNCT
ajlm-1261	47	92	laked	lake	VERB
ajlm-1261	47	93	sheep	sheep	NOUN
ajlm-1261	47	94	blood	blood	NOUN
ajlm-1261	47	95	,	,	PUNCT
ajlm-1261	47	96	vitamin	vitamin	NOUN
ajlm-1261	47	97	k1	k1	NOUN
ajlm-1261	47	98	(	(	PUNCT
ajlm-1261	47	99	1	1	NUM
ajlm-1261	47	100	µg	µg	NOUN
ajlm-1261	47	101	/	/	SYM
ajlm-1261	47	102	ml	ml	NOUN
ajlm-1261	47	103	)	)	PUNCT
ajlm-1261	47	104	,	,	PUNCT
ajlm-1261	47	105	l	l	NOUN
ajlm-1261	47	106	-	-	ADJ
ajlm-1261	47	107	cysteine	cysteine	ADJ
ajlm-1261	47	108	hydrochloride	hydrochloride	NOUN
ajlm-1261	47	109	(	(	PUNCT
ajlm-1261	47	110	5	5	NUM
ajlm-1261	47	111	µg	µg	NOUN
ajlm-1261	47	112	/	/	SYM
ajlm-1261	47	113	ml	ml	NOUN
ajlm-1261	47	114	)	)	PUNCT
ajlm-1261	47	115	and	and	CCONJ
ajlm-1261	47	116	gentamicin	gentamicin	NOUN
ajlm-1261	47	117	(	(	PUNCT
ajlm-1261	47	118	100	100	NUM
ajlm-1261	47	119	µg	µg	ADJ
ajlm-1261	47	120	/	/	SYM
ajlm-1261	47	121	ml	ml	NOUN
ajlm-1261	47	122	)	)	PUNCT
ajlm-1261	47	123	(	(	PUNCT
ajlm-1261	47	124	gentamicin	gentamicin	VERB
ajlm-1261	47	125	blood	blood	NOUN
ajlm-1261	47	126	agar	agar	NOUN
ajlm-1261	47	127	)	)	PUNCT
ajlm-1261	47	128	.	.	PUNCT
ajlm-1261	48	1	inoculated	inoculate	VERB
ajlm-1261	48	2	plain	plain	ADJ
ajlm-1261	48	3	ba	ba	PROPN
ajlm-1261	48	4	and	and	CCONJ
ajlm-1261	48	5	macconkey	macconkey	NOUN
ajlm-1261	48	6	agar	agar	NOUN
ajlm-1261	48	7	plates	plate	NOUN
ajlm-1261	48	8	were	be	AUX
ajlm-1261	48	9	incubated	incubate	VERB
ajlm-1261	48	10	in	in	ADP
ajlm-1261	48	11	air	air	NOUN
ajlm-1261	48	12	and	and	CCONJ
ajlm-1261	48	13	chocolate	chocolate	NOUN
ajlm-1261	48	14	agar	agar	NOUN
ajlm-1261	48	15	plates	plate	NOUN
ajlm-1261	48	16	in	in	ADP
ajlm-1261	48	17	co2	co2	NOUN
ajlm-1261	48	18	at	at	ADP
ajlm-1261	48	19	37	37	NUM
ajlm-1261	48	20	°	°	NOUN
ajlm-1261	48	21	c	c	NOUN
ajlm-1261	48	22	for	for	ADP
ajlm-1261	48	23	24	24	NUM
ajlm-1261	48	24	h.	h.	NOUN
ajlm-1261	48	25	inoculated	inoculate	VERB
ajlm-1261	48	26	plain	plain	ADJ
ajlm-1261	48	27	gentamicin	gentamicin	VERB
ajlm-1261	48	28	ba	ba	NOUN
ajlm-1261	48	29	plates	plate	NOUN
ajlm-1261	48	30	,	,	PUNCT
ajlm-1261	48	31	as	as	ADV
ajlm-1261	48	32	well	well	ADV
ajlm-1261	48	33	as	as	ADP
ajlm-1261	48	34	gentamicin	gentamicin	ADJ
ajlm-1261	48	35	ba	ba	NOUN
ajlm-1261	48	36	with	with	ADP
ajlm-1261	48	37	kanamycin	kanamycin	PROPN
ajlm-1261	48	38	(	(	PUNCT
ajlm-1261	48	39	75	75	NUM
ajlm-1261	48	40	µg	µg	NOUN
ajlm-1261	48	41	/	/	SYM
ajlm-1261	48	42	l	l	NOUN
ajlm-1261	48	43	)	)	PUNCT
ajlm-1261	48	44	and	and	CCONJ
ajlm-1261	48	45	vancomycin	vancomycin	PROPN
ajlm-1261	48	46	(	(	PUNCT
ajlm-1261	48	47	5	5	NUM
ajlm-1261	48	48	µg	µg	ADJ
ajlm-1261	48	49	/	/	SYM
ajlm-1261	48	50	l	l	NOUN
ajlm-1261	48	51	)	)	PUNCT
ajlm-1261	48	52	supplements	supplement	NOUN
ajlm-1261	48	53	,	,	PUNCT
ajlm-1261	48	54	were	be	AUX
ajlm-1261	48	55	incubated	incubate	VERB
ajlm-1261	48	56	under	under	ADP
ajlm-1261	48	57	anaerobic	anaerobic	ADJ
ajlm-1261	48	58	conditions	condition	NOUN
ajlm-1261	48	59	made	make	VERB
ajlm-1261	48	60	up	up	ADP
ajlm-1261	48	61	of	of	ADP
ajlm-1261	48	62	80	80	NUM
ajlm-1261	48	63	%	%	NOUN
ajlm-1261	48	64	h2	h2	NOUN
ajlm-1261	48	65	,	,	PUNCT
ajlm-1261	48	66	10	10	NUM
ajlm-1261	48	67	%	%	NOUN
ajlm-1261	48	68	co2	co2	NOUN
ajlm-1261	48	69	and	and	CCONJ
ajlm-1261	48	70	10	10	NUM
ajlm-1261	48	71	%	%	NOUN
ajlm-1261	48	72	n2	n2	NOUN
ajlm-1261	48	73	for	for	ADP
ajlm-1261	48	74	48	48	NUM
ajlm-1261	48	75	h	h	NOUN
ajlm-1261	48	76	and	and	CCONJ
ajlm-1261	48	77	extended	extend	VERB
ajlm-1261	48	78	for	for	ADP
ajlm-1261	48	79	5	5	NUM
ajlm-1261	48	80	days	day	NOUN
ajlm-1261	48	81	if	if	SCONJ
ajlm-1261	48	82	necessary	necessary	ADJ
ajlm-1261	48	83	;	;	PUNCT
ajlm-1261	48	84	anaerobiosis	anaerobiosis	NOUN
ajlm-1261	48	85	was	be	AUX
ajlm-1261	48	86	achieved	achieve	VERB
ajlm-1261	48	87	using	use	VERB
ajlm-1261	48	88	a	a	DET
ajlm-1261	48	89	bactron	bactron	PROPN
ajlm-1261	48	90	anaerobic	anaerobic	PROPN
ajlm-1261	48	91	chamber	chamber	PROPN
ajlm-1261	48	92	(	(	PUNCT
ajlm-1261	48	93	sheldon	sheldon	PROPN
ajlm-1261	48	94	manufacturing	manufacturing	PROPN
ajlm-1261	48	95	,	,	PUNCT
ajlm-1261	48	96	inc	inc	PROPN
ajlm-1261	48	97	.	.	PROPN
ajlm-1261	48	98	,	,	PUNCT
ajlm-1261	48	99	cornelius	cornelius	PROPN
ajlm-1261	48	100	,	,	PUNCT
ajlm-1261	48	101	oregon	oregon	PROPN
ajlm-1261	48	102	,	,	PUNCT
ajlm-1261	48	103	united	united	PROPN
ajlm-1261	48	104	states	states	PROPN
ajlm-1261	48	105	)	)	PUNCT
ajlm-1261	48	106	.	.	PUNCT
ajlm-1261	49	1	representative	representative	ADJ
ajlm-1261	49	2	colonies	colony	NOUN
ajlm-1261	49	3	were	be	AUX
ajlm-1261	49	4	identified	identify	VERB
ajlm-1261	49	5	by	by	ADP
ajlm-1261	49	6	colonial	colonial	ADJ
ajlm-1261	49	7	morphology	morphology	NOUN
ajlm-1261	49	8	,	,	PUNCT
ajlm-1261	49	9	gram	gram	NOUN
ajlm-1261	49	10	staining	stain	VERB
ajlm-1261	49	11	characteristics	characteristic	NOUN
ajlm-1261	49	12	and	and	CCONJ
ajlm-1261	49	13	conventional	conventional	ADJ
ajlm-1261	49	14	biochemical	biochemical	ADJ
ajlm-1261	49	15	tests	test	NOUN
ajlm-1261	49	16	including	include	VERB
ajlm-1261	49	17	catalase	catalase	NOUN
ajlm-1261	49	18	and	and	CCONJ
ajlm-1261	49	19	oxidase	oxidase	NOUN
ajlm-1261	49	20	tests	test	NOUN
ajlm-1261	49	21	.	.	PUNCT
ajlm-1261	50	1	facultative	facultative	ADJ
ajlm-1261	50	2	anaerobic	anaerobic	NOUN
ajlm-1261	50	3	gram	gram	NOUN
ajlm-1261	50	4	-	-	PUNCT
ajlm-1261	50	5	negative	negative	ADJ
ajlm-1261	50	6	bacilli	bacilli	NOUN
ajlm-1261	50	7	(	(	PUNCT
ajlm-1261	50	8	gnb	gnb	PROPN
ajlm-1261	50	9	)	)	PUNCT
ajlm-1261	50	10	and	and	CCONJ
ajlm-1261	50	11	streptococcus	streptococcus	VERB
ajlm-1261	50	12	spp	spp	NOUN
ajlm-1261	50	13	.	.	PUNCT
ajlm-1261	50	14	were	be	AUX
ajlm-1261	50	15	further	far	ADV
ajlm-1261	50	16	identified	identify	VERB
ajlm-1261	50	17	with	with	ADP
ajlm-1261	50	18	microbact	microbact	NOUN
ajlm-1261	50	19	™	™	VERB
ajlm-1261	50	20	gnb	gnb	PROPN
ajlm-1261	50	21	24e	24e	PRON
ajlm-1261	50	22	(	(	PUNCT
ajlm-1261	50	23	oxoid	oxoid	PROPN
ajlm-1261	50	24	,	,	PUNCT
ajlm-1261	50	25	basingstoke	basingstoke	PROPN
ajlm-1261	50	26	,	,	PUNCT
ajlm-1261	50	27	hants	hant	NOUN
ajlm-1261	50	28	,	,	PUNCT
ajlm-1261	50	29	united	united	ADJ
ajlm-1261	50	30	kingdom	kingdom	PROPN
ajlm-1261	50	31	)	)	PUNCT
ajlm-1261	50	32	and	and	CCONJ
ajlm-1261	50	33	rapid	rapid	ADJ
ajlm-1261	50	34	™	™	NOUN
ajlm-1261	50	35	str	str	NOUN
ajlm-1261	50	36	(	(	PUNCT
ajlm-1261	50	37	thermo	thermo	NOUN
ajlm-1261	50	38	fisher	fisher	PROPN
ajlm-1261	50	39	scientific	scientific	PROPN
ajlm-1261	50	40	,	,	PUNCT
ajlm-1261	50	41	remel	remel	NOUN
ajlm-1261	50	42	products	product	NOUN
ajlm-1261	50	43	,	,	PUNCT
ajlm-1261	50	44	lexena	lexena	PROPN
ajlm-1261	50	45	,	,	PUNCT
ajlm-1261	50	46	kansas	kansas	PROPN
ajlm-1261	50	47	,	,	PUNCT
ajlm-1261	50	48	united	united	PROPN
ajlm-1261	50	49	states	states	PROPN
ajlm-1261	50	50	)	)	PUNCT
ajlm-1261	50	51	,	,	PUNCT
ajlm-1261	50	52	while	while	SCONJ
ajlm-1261	50	53	staphylococcus	staphylococcus	NOUN
ajlm-1261	50	54	spp	spp	NOUN
ajlm-1261	50	55	.	.	PUNCT
ajlm-1261	51	1	were	be	AUX
ajlm-1261	51	2	further	far	ADV
ajlm-1261	51	3	identified	identify	VERB
ajlm-1261	51	4	with	with	ADP
ajlm-1261	51	5	a	a	DET
ajlm-1261	51	6	coagulase	coagulase	NOUN
ajlm-1261	51	7	test	test	NOUN
ajlm-1261	51	8	,	,	PUNCT
ajlm-1261	51	9	characteristic	characteristic	ADJ
ajlm-1261	51	10	growth	growth	NOUN
ajlm-1261	51	11	appearance	appearance	NOUN
ajlm-1261	51	12	on	on	ADP
ajlm-1261	51	13	mannitol	mannitol	NOUN
ajlm-1261	51	14	salt	salt	NOUN
ajlm-1261	51	15	agar	agar	NOUN
ajlm-1261	51	16	and	and	CCONJ
ajlm-1261	51	17	a	a	DET
ajlm-1261	51	18	dnase	dnase	NOUN
ajlm-1261	51	19	test	test	NOUN
ajlm-1261	51	20	.	.	PUNCT
ajlm-1261	52	1	the	the	DET
ajlm-1261	52	2	obligate	obligate	NOUN
ajlm-1261	52	3	anaerobes	anaerobe	NOUN
ajlm-1261	52	4	were	be	AUX
ajlm-1261	52	5	identified	identify	VERB
ajlm-1261	52	6	by	by	ADP
ajlm-1261	52	7	rapid	rapid	ADJ
ajlm-1261	52	8	™	™	PROPN
ajlm-1261	52	9	ana	ana	PROPN
ajlm-1261	52	10	ii	ii	PROPN
ajlm-1261	52	11	(	(	PUNCT
ajlm-1261	52	12	thermo	thermo	PROPN
ajlm-1261	52	13	fisher	fisher	PROPN
ajlm-1261	52	14	scientific	scientific	PROPN
ajlm-1261	52	15	,	,	PUNCT
ajlm-1261	52	16	remel	remel	NOUN
ajlm-1261	52	17	products	product	NOUN
ajlm-1261	52	18	,	,	PUNCT
ajlm-1261	52	19	lexena	lexena	PROPN
ajlm-1261	52	20	,	,	PUNCT
ajlm-1261	52	21	kansas	kansas	PROPN
ajlm-1261	52	22	,	,	PUNCT
ajlm-1261	52	23	united	united	PROPN
ajlm-1261	52	24	states	states	PROPN
ajlm-1261	52	25	)	)	PUNCT
ajlm-1261	52	26	.	.	PUNCT
ajlm-1261	53	1	yeast	yeast	NOUN
ajlm-1261	53	2	isolates	isolate	NOUN
ajlm-1261	53	3	were	be	AUX
ajlm-1261	53	4	identified	identify	VERB
ajlm-1261	53	5	by	by	ADP
ajlm-1261	53	6	gram	gram	NOUN
ajlm-1261	53	7	staining	stain	VERB
ajlm-1261	53	8	and	and	CCONJ
ajlm-1261	53	9	germ	germ	NOUN
ajlm-1261	53	10	tube	tube	NOUN
ajlm-1261	53	11	tests	test	NOUN
ajlm-1261	53	12	.	.	PUNCT
ajlm-1261	54	1	quality	quality	NOUN
ajlm-1261	54	2	control	control	NOUN
ajlm-1261	54	3	strains	strain	NOUN
ajlm-1261	54	4	,	,	PUNCT
ajlm-1261	54	5	staphylococcus	staphylococcus	NOUN
ajlm-1261	54	6	aureus	aureus	PROPN
ajlm-1261	54	7	atcc	atcc	PROPN
ajlm-1261	54	8	25923	25923	NUM
ajlm-1261	54	9	,	,	PUNCT
ajlm-1261	54	10	escherichia	escherichia	NOUN
ajlm-1261	54	11	coli	coli	NOUN
ajlm-1261	54	12	atcc	atcc	NOUN
ajlm-1261	54	13	25922	25922	NUM
ajlm-1261	54	14	,	,	PUNCT
ajlm-1261	54	15	bacteroides	bacteroide	VERB
ajlm-1261	54	16	fragilis	fragili	NOUN
ajlm-1261	54	17	atcc	atcc	PROPN
ajlm-1261	54	18	25285	25285	NUM
ajlm-1261	54	19	and	and	CCONJ
ajlm-1261	54	20	peptostreptococcus	peptostreptococcus	NOUN
ajlm-1261	54	21	anaerobius	anaerobius	NOUN
ajlm-1261	54	22	atcc	atcc	PROPN
ajlm-1261	54	23	27337	27337	NUM
ajlm-1261	54	24	,	,	PUNCT
ajlm-1261	54	25	were	be	AUX
ajlm-1261	54	26	used	use	VERB
ajlm-1261	54	27	to	to	PART
ajlm-1261	54	28	assess	assess	VERB
ajlm-1261	54	29	the	the	DET
ajlm-1261	54	30	quality	quality	NOUN
ajlm-1261	54	31	of	of	ADP
ajlm-1261	54	32	the	the	DET
ajlm-1261	54	33	media	medium	NOUN
ajlm-1261	54	34	and	and	CCONJ
ajlm-1261	54	35	identification	identification	NOUN
ajlm-1261	54	36	systems	system	NOUN
ajlm-1261	54	37	.	.	PUNCT
ajlm-1261	55	1	the	the	DET
ajlm-1261	55	2	quality	quality	NOUN
ajlm-1261	55	3	of	of	ADP
ajlm-1261	55	4	our	our	PRON
ajlm-1261	55	5	bacterial	bacterial	ADJ
ajlm-1261	55	6	identification	identification	NOUN
ajlm-1261	55	7	system	system	NOUN
ajlm-1261	55	8	and	and	CCONJ
ajlm-1261	55	9	procedures	procedure	NOUN
ajlm-1261	55	10	(	(	PUNCT
ajlm-1261	55	11	for	for	ADP
ajlm-1261	55	12	aerobes	aerobe	NOUN
ajlm-1261	55	13	,	,	PUNCT
ajlm-1261	55	14	facultative	facultative	ADJ
ajlm-1261	55	15	anaerobes	anaerobe	NOUN
ajlm-1261	55	16	and	and	CCONJ
ajlm-1261	55	17	obligate	obligate	NOUN
ajlm-1261	55	18	anaerobes	anaerobe	NOUN
ajlm-1261	55	19	)	)	PUNCT
ajlm-1261	55	20	were	be	AUX
ajlm-1261	55	21	assured	assure	VERB
ajlm-1261	55	22	by	by	ADP
ajlm-1261	55	23	ensuring	ensure	VERB
ajlm-1261	55	24	that	that	SCONJ
ajlm-1261	55	25	the	the	DET
ajlm-1261	55	26	control	control	NOUN
ajlm-1261	55	27	bacterial	bacterial	ADJ
ajlm-1261	55	28	strains	strain	NOUN
ajlm-1261	55	29	were	be	AUX
ajlm-1261	55	30	identified	identify	VERB
ajlm-1261	55	31	to	to	ADP
ajlm-1261	55	32	their	their	PRON
ajlm-1261	55	33	names	name	NOUN
ajlm-1261	55	34	.	.	PUNCT
ajlm-1261	56	1	antibiotic	antibiotic	ADJ
ajlm-1261	56	2	susceptibility	susceptibility	NOUN
ajlm-1261	56	3	test	test	NOUN
ajlm-1261	56	4	antibiotic	antibiotic	ADJ
ajlm-1261	56	5	susceptibility	susceptibility	NOUN
ajlm-1261	56	6	testing	testing	NOUN
ajlm-1261	56	7	for	for	ADP
ajlm-1261	56	8	aerobes	aerobe	NOUN
ajlm-1261	56	9	and	and	CCONJ
ajlm-1261	56	10	facultative	facultative	ADJ
ajlm-1261	56	11	anaerobes	anaerobe	NOUN
ajlm-1261	56	12	was	be	AUX
ajlm-1261	56	13	performed	perform	VERB
ajlm-1261	56	14	using	use	VERB
ajlm-1261	56	15	the	the	DET
ajlm-1261	56	16	modified	modified	ADJ
ajlm-1261	56	17	kirby	kirby	PROPN
ajlm-1261	56	18	-	-	PUNCT
ajlm-1261	56	19	bauer	bauer	PROPN
ajlm-1261	56	20	disc	disc	NOUN
ajlm-1261	56	21	diffusion	diffusion	NOUN
ajlm-1261	56	22	technique	technique	NOUN
ajlm-1261	56	23	as	as	SCONJ
ajlm-1261	56	24	recommended	recommend	VERB
ajlm-1261	56	25	by	by	ADP
ajlm-1261	56	26	the	the	DET
ajlm-1261	56	27	clinical	clinical	ADJ
ajlm-1261	56	28	and	and	CCONJ
ajlm-1261	56	29	laboratory	laboratory	NOUN
ajlm-1261	56	30	standards	standard	NOUN
ajlm-1261	56	31	institute	institute	PROPN
ajlm-1261	56	32	(	(	PUNCT
ajlm-1261	56	33	clsi).21	clsi).21	PROPN
ajlm-1261	56	34	gram	gram	NOUN
ajlm-1261	56	35	-	-	PUNCT
ajlm-1261	56	36	positive	positive	ADJ
ajlm-1261	56	37	isolates	isolate	NOUN
ajlm-1261	56	38	were	be	AUX
ajlm-1261	56	39	tested	test	VERB
ajlm-1261	56	40	with	with	ADP
ajlm-1261	56	41	the	the	DET
ajlm-1261	56	42	following	follow	VERB
ajlm-1261	56	43	antibiotic	antibiotic	ADJ
ajlm-1261	56	44	discs	disc	NOUN
ajlm-1261	56	45	(	(	PUNCT
ajlm-1261	56	46	oxoid	oxoid	PROPN
ajlm-1261	56	47	,	,	PUNCT
ajlm-1261	56	48	basingstoke	basingstoke	PROPN
ajlm-1261	56	49	,	,	PUNCT
ajlm-1261	56	50	hants	hant	NOUN
ajlm-1261	56	51	,	,	PUNCT
ajlm-1261	56	52	united	united	ADJ
ajlm-1261	56	53	kingdom	kingdom	PROPN
ajlm-1261	56	54	):	):	PUNCT
ajlm-1261	56	55	penicillin	penicillin	NOUN
ajlm-1261	56	56	(	(	PUNCT
ajlm-1261	56	57	10	10	NUM
ajlm-1261	56	58	µg	µg	NOUN
ajlm-1261	56	59	)	)	PUNCT
ajlm-1261	56	60	,	,	PUNCT
ajlm-1261	56	61	cefuroxime	cefuroxime	ADJ
ajlm-1261	56	62	(	(	PUNCT
ajlm-1261	56	63	30	30	NUM
ajlm-1261	56	64	µg	µg	NOUN
ajlm-1261	56	65	)	)	PUNCT
ajlm-1261	56	66	,	,	PUNCT
ajlm-1261	56	67	ceftriaxone	ceftriaxone	NOUN
ajlm-1261	56	68	(	(	PUNCT
ajlm-1261	56	69	30	30	NUM
ajlm-1261	56	70	µg	µg	NOUN
ajlm-1261	56	71	)	)	PUNCT
ajlm-1261	56	72	,	,	PUNCT
ajlm-1261	56	73	cefepime	cefepime	X
ajlm-1261	56	74	(	(	PUNCT
ajlm-1261	56	75	30	30	NUM
ajlm-1261	56	76	µg	µg	NOUN
ajlm-1261	56	77	)	)	PUNCT
ajlm-1261	56	78	,	,	PUNCT
ajlm-1261	56	79	co	co	NOUN
ajlm-1261	56	80	-	-	NOUN
ajlm-1261	56	81	amoxiclav	amoxiclav	ADJ
ajlm-1261	56	82	(	(	PUNCT
ajlm-1261	56	83	20/10	20/10	NUM
ajlm-1261	56	84	µg	µg	NOUN
ajlm-1261	56	85	)	)	PUNCT
ajlm-1261	56	86	,	,	PUNCT
ajlm-1261	56	87	ciprofloxacin	ciprofloxacin	NOUN
ajlm-1261	56	88	(	(	PUNCT
ajlm-1261	56	89	5	5	NUM
ajlm-1261	56	90	µg	µg	NOUN
ajlm-1261	56	91	)	)	PUNCT
ajlm-1261	56	92	,	,	PUNCT
ajlm-1261	56	93	chloramphenicol	chloramphenicol	NOUN
ajlm-1261	56	94	(	(	PUNCT
ajlm-1261	56	95	30	30	NUM
ajlm-1261	56	96	µg	µg	NOUN
ajlm-1261	56	97	)	)	PUNCT
ajlm-1261	56	98	,	,	PUNCT
ajlm-1261	56	99	gentamicin	gentamicin	NOUN
ajlm-1261	56	100	(	(	PUNCT
ajlm-1261	56	101	10	10	NUM
ajlm-1261	56	102	µg	µg	NOUN
ajlm-1261	56	103	)	)	PUNCT
ajlm-1261	56	104	,	,	PUNCT
ajlm-1261	56	105	amikacin	amikacin	PROPN
ajlm-1261	56	106	(	(	PUNCT
ajlm-1261	56	107	10	10	NUM
ajlm-1261	56	108	µg	µg	NOUN
ajlm-1261	56	109	)	)	PUNCT
ajlm-1261	56	110	,	,	PUNCT
ajlm-1261	56	111	trimethoprim	trimethoprim	NOUN
ajlm-1261	56	112	-	-	PUNCT
ajlm-1261	56	113	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-1261	56	114	(	(	PUNCT
ajlm-1261	56	115	1.25	1.25	NUM
ajlm-1261	56	116	µg/23.75	µg/23.75	NOUN
ajlm-1261	56	117	µg	µg	NOUN
ajlm-1261	56	118	)	)	PUNCT
ajlm-1261	56	119	,	,	PUNCT
ajlm-1261	56	120	cefoxitin	cefoxitin	NOUN
ajlm-1261	56	121	(	(	PUNCT
ajlm-1261	56	122	30	30	NUM
ajlm-1261	56	123	µg	µg	NOUN
ajlm-1261	56	124	)	)	PUNCT
ajlm-1261	56	125	,	,	PUNCT
ajlm-1261	56	126	erythromycin	erythromycin	NOUN
ajlm-1261	56	127	(	(	PUNCT
ajlm-1261	56	128	15	15	NUM
ajlm-1261	56	129	µg	µg	NOUN
ajlm-1261	56	130	)	)	PUNCT
ajlm-1261	56	131	,	,	PUNCT
ajlm-1261	57	1	ampicillin	ampicillin	NOUN
ajlm-1261	57	2	-	-	PUNCT
ajlm-1261	57	3	sulbactam	sulbactam	NOUN
ajlm-1261	57	4	(	(	PUNCT
ajlm-1261	57	5	10	10	NUM
ajlm-1261	57	6	µg/10	µg/10	PROPN
ajlm-1261	57	7	µg	µg	NOUN
ajlm-1261	57	8	)	)	PUNCT
ajlm-1261	57	9	,	,	PUNCT
ajlm-1261	57	10	piperacillin	piperacillin	NOUN
ajlm-1261	57	11	-	-	PUNCT
ajlm-1261	57	12	tazobactam	tazobactam	NOUN
ajlm-1261	57	13	(	(	PUNCT
ajlm-1261	57	14	100	100	NUM
ajlm-1261	57	15	µg/10	µg/10	PROPN
ajlm-1261	57	16	µg	µg	NOUN
ajlm-1261	57	17	)	)	PUNCT
ajlm-1261	57	18	and	and	CCONJ
ajlm-1261	57	19	vancomycin	vancomycin	PROPN
ajlm-1261	57	20	(	(	PUNCT
ajlm-1261	57	21	30	30	NUM
ajlm-1261	57	22	µg	µg	NOUN
ajlm-1261	57	23	)	)	PUNCT
ajlm-1261	57	24	.	.	PUNCT
ajlm-1261	58	1	vancomycin	vancomycin	PROPN
ajlm-1261	58	2	(	(	PUNCT
ajlm-1261	58	3	256–0.015	256–0.015	PROPN
ajlm-1261	58	4	µg	µg	ADV
ajlm-1261	58	5	/	/	SYM
ajlm-1261	58	6	ml	ml	NOUN
ajlm-1261	58	7	)	)	PUNCT
ajlm-1261	58	8	minimum	minimum	ADJ
ajlm-1261	58	9	inhibitory	inhibitory	ADJ
ajlm-1261	58	10	concentration	concentration	NOUN
ajlm-1261	58	11	(	(	PUNCT
ajlm-1261	58	12	mic	mic	ADJ
ajlm-1261	58	13	)	)	PUNCT
ajlm-1261	58	14	strip	strip	NOUN
ajlm-1261	58	15	(	(	PUNCT
ajlm-1261	58	16	oxoid	oxoid	PROPN
ajlm-1261	58	17	,	,	PUNCT
ajlm-1261	58	18	basingstoke	basingstoke	PROPN
ajlm-1261	58	19	,	,	PUNCT
ajlm-1261	58	20	hants	hant	NOUN
ajlm-1261	58	21	,	,	PUNCT
ajlm-1261	58	22	united	united	ADJ
ajlm-1261	58	23	kingdom	kingdom	PROPN
ajlm-1261	58	24	)	)	PUNCT
ajlm-1261	58	25	was	be	AUX
ajlm-1261	58	26	used	use	VERB
ajlm-1261	58	27	to	to	PART
ajlm-1261	58	28	test	test	VERB
ajlm-1261	58	29	for	for	ADP
ajlm-1261	58	30	vancomycin	vancomycin	PROPN
ajlm-1261	58	31	resistance	resistance	NOUN
ajlm-1261	58	32	among	among	ADP
ajlm-1261	58	33	methicillin	methicillin	NOUN
ajlm-1261	58	34	-	-	PUNCT
ajlm-1261	58	35	resistant	resistant	ADJ
ajlm-1261	58	36	s.	s.	PROPN
ajlm-1261	58	37	aureus	aureus	PROPN
ajlm-1261	58	38	(	(	PUNCT
ajlm-1261	58	39	mrsa	mrsa	NOUN
ajlm-1261	58	40	)	)	PUNCT
ajlm-1261	58	41	.	.	PUNCT
ajlm-1261	59	1	gram	gram	NOUN
ajlm-1261	59	2	-	-	PUNCT
ajlm-1261	59	3	negative	negative	ADJ
ajlm-1261	59	4	isolates	isolate	NOUN
ajlm-1261	59	5	were	be	AUX
ajlm-1261	59	6	tested	test	VERB
ajlm-1261	59	7	with	with	ADP
ajlm-1261	59	8	the	the	DET
ajlm-1261	59	9	following	follow	VERB
ajlm-1261	59	10	antibiotic	antibiotic	ADJ
ajlm-1261	59	11	discs	disc	NOUN
ajlm-1261	59	12	(	(	PUNCT
ajlm-1261	59	13	oxoid	oxoid	PROPN
ajlm-1261	59	14	,	,	PUNCT
ajlm-1261	59	15	basingstoke	basingstoke	PROPN
ajlm-1261	59	16	,	,	PUNCT
ajlm-1261	59	17	hants	hant	NOUN
ajlm-1261	59	18	,	,	PUNCT
ajlm-1261	59	19	united	united	ADJ
ajlm-1261	59	20	kingdom	kingdom	PROPN
ajlm-1261	59	21	):	):	PUNCT
ajlm-1261	59	22	ceftriaxone	ceftriaxone	PROPN
ajlm-1261	59	23	(	(	PUNCT
ajlm-1261	59	24	30	30	NUM
ajlm-1261	59	25	µg	µg	NOUN
ajlm-1261	59	26	)	)	PUNCT
ajlm-1261	59	27	,	,	PUNCT
ajlm-1261	59	28	ceftazidime	ceftazidime	NOUN
ajlm-1261	59	29	(	(	PUNCT
ajlm-1261	59	30	30	30	NUM
ajlm-1261	59	31	µg	µg	NOUN
ajlm-1261	59	32	)	)	PUNCT
ajlm-1261	59	33	,	,	PUNCT
ajlm-1261	59	34	cefotaxime	cefotaxime	NOUN
ajlm-1261	59	35	(	(	PUNCT
ajlm-1261	59	36	30	30	NUM
ajlm-1261	59	37	µg	µg	NOUN
ajlm-1261	59	38	)	)	PUNCT
ajlm-1261	59	39	,	,	PUNCT
ajlm-1261	59	40	cefepime	cefepime	X
ajlm-1261	59	41	(	(	PUNCT
ajlm-1261	59	42	30	30	NUM
ajlm-1261	59	43	µg	µg	NOUN
ajlm-1261	59	44	)	)	PUNCT
ajlm-1261	59	45	,	,	PUNCT
ajlm-1261	59	46	co	co	NOUN
ajlm-1261	59	47	-	-	NOUN
ajlm-1261	59	48	amoxiclav	amoxiclav	ADJ
ajlm-1261	59	49	(	(	PUNCT
ajlm-1261	59	50	20/10	20/10	NUM
ajlm-1261	59	51	µg	µg	NOUN
ajlm-1261	59	52	)	)	PUNCT
ajlm-1261	59	53	,	,	PUNCT
ajlm-1261	59	54	ciprofloxacin	ciprofloxacin	NOUN
ajlm-1261	59	55	(	(	PUNCT
ajlm-1261	59	56	5	5	NUM
ajlm-1261	59	57	µg	µg	NOUN
ajlm-1261	59	58	)	)	PUNCT
ajlm-1261	59	59	,	,	PUNCT
ajlm-1261	59	60	gentamicin	gentamicin	NOUN
ajlm-1261	59	61	(	(	PUNCT
ajlm-1261	59	62	10	10	NUM
ajlm-1261	59	63	µg	µg	NOUN
ajlm-1261	59	64	)	)	PUNCT
ajlm-1261	59	65	,	,	PUNCT
ajlm-1261	59	66	amikacin	amikacin	PROPN
ajlm-1261	59	67	(	(	PUNCT
ajlm-1261	59	68	10	10	NUM
ajlm-1261	59	69	µg	µg	NOUN
ajlm-1261	59	70	)	)	PUNCT
ajlm-1261	59	71	,	,	PUNCT
ajlm-1261	59	72	chloramphenicol	chloramphenicol	NOUN
ajlm-1261	59	73	(	(	PUNCT
ajlm-1261	59	74	30	30	NUM
ajlm-1261	59	75	µg	µg	NOUN
ajlm-1261	59	76	)	)	PUNCT
ajlm-1261	59	77	,	,	PUNCT
ajlm-1261	59	78	aztreonam	aztreonam	NOUN
ajlm-1261	59	79	(	(	PUNCT
ajlm-1261	59	80	30	30	NUM
ajlm-1261	59	81	µg	µg	NOUN
ajlm-1261	59	82	)	)	PUNCT
ajlm-1261	59	83	,	,	PUNCT
ajlm-1261	59	84	trimethoprim	trimethoprim	NOUN
ajlm-1261	59	85	-	-	PUNCT
ajlm-1261	59	86	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-1261	59	87	(	(	PUNCT
ajlm-1261	59	88	1.25	1.25	NUM
ajlm-1261	59	89	µg/23.75	µg/23.75	NOUN
ajlm-1261	59	90	µg	µg	NOUN
ajlm-1261	59	91	)	)	PUNCT
ajlm-1261	59	92	,	,	PUNCT
ajlm-1261	59	93	ampicillin	ampicillin	NOUN
ajlm-1261	59	94	-	-	PUNCT
ajlm-1261	59	95	sulbactam	sulbactam	NOUN
ajlm-1261	59	96	(	(	PUNCT
ajlm-1261	59	97	10	10	NUM
ajlm-1261	59	98	µg/10	µg/10	PROPN
ajlm-1261	59	99	µg	µg	NOUN
ajlm-1261	59	100	)	)	PUNCT
ajlm-1261	59	101	,	,	PUNCT
ajlm-1261	59	102	piperacillin	piperacillin	NOUN
ajlm-1261	59	103	-	-	PUNCT
ajlm-1261	59	104	tazobactam	tazobactam	NOUN
ajlm-1261	59	105	(	(	PUNCT
ajlm-1261	59	106	100	100	NUM
ajlm-1261	59	107	µg/10	µg/10	PROPN
ajlm-1261	59	108	µg	µg	NOUN
ajlm-1261	59	109	)	)	PUNCT
ajlm-1261	59	110	,	,	PUNCT
ajlm-1261	59	111	cefoxitin	cefoxitin	NOUN
ajlm-1261	59	112	(	(	PUNCT
ajlm-1261	59	113	30	30	NUM
ajlm-1261	59	114	µg	µg	NOUN
ajlm-1261	59	115	)	)	PUNCT
ajlm-1261	59	116	,	,	PUNCT
ajlm-1261	59	117	meropenem	meropenem	PROPN
ajlm-1261	59	118	(	(	PUNCT
ajlm-1261	59	119	10	10	NUM
ajlm-1261	59	120	µg	µg	NOUN
ajlm-1261	59	121	)	)	PUNCT
ajlm-1261	59	122	and	and	CCONJ
ajlm-1261	59	123	ertapenem	ertapenem	PROPN
ajlm-1261	59	124	(	(	PUNCT
ajlm-1261	59	125	10	10	NUM
ajlm-1261	59	126	µg	µg	NOUN
ajlm-1261	59	127	)	)	PUNCT
ajlm-1261	59	128	.	.	PUNCT
ajlm-1261	60	1	discrete	discrete	ADJ
ajlm-1261	60	2	colonies	colony	NOUN
ajlm-1261	60	3	were	be	AUX
ajlm-1261	60	4	emulsified	emulsify	VERB
ajlm-1261	60	5	in	in	ADP
ajlm-1261	60	6	sterile	sterile	ADJ
ajlm-1261	60	7	saline	saline	NOUN
ajlm-1261	60	8	to	to	PART
ajlm-1261	60	9	match	match	VERB
ajlm-1261	60	10	0.5	0.5	NUM
ajlm-1261	60	11	mcfarland	mcfarland	NOUN
ajlm-1261	60	12	turbidity	turbidity	NOUN
ajlm-1261	60	13	standards	standard	NOUN
ajlm-1261	60	14	from	from	ADP
ajlm-1261	60	15	where	where	SCONJ
ajlm-1261	60	16	confluence	confluence	NOUN
ajlm-1261	60	17	inocula	inoculum	NOUN
ajlm-1261	60	18	were	be	AUX
ajlm-1261	60	19	made	make	VERB
ajlm-1261	60	20	on	on	ADP
ajlm-1261	60	21	mueller	mueller	PROPN
ajlm-1261	60	22	-	-	PUNCT
ajlm-1261	60	23	hinton	hinton	PROPN
ajlm-1261	60	24	agar	agar	NOUN
ajlm-1261	60	25	(	(	PUNCT
ajlm-1261	60	26	mha	mha	NOUN
ajlm-1261	60	27	)	)	PUNCT
ajlm-1261	60	28	plates	plate	NOUN
ajlm-1261	60	29	with	with	ADP
ajlm-1261	60	30	sterile	sterile	ADJ
ajlm-1261	60	31	cotton	cotton	NOUN
ajlm-1261	60	32	swabs	swab	NOUN
ajlm-1261	60	33	.	.	PUNCT
ajlm-1261	61	1	the	the	DET
ajlm-1261	61	2	swabbed	swab	VERB
ajlm-1261	61	3	mha	mha	NOUN
ajlm-1261	61	4	plates	plate	NOUN
ajlm-1261	61	5	were	be	AUX
ajlm-1261	61	6	allowed	allow	VERB
ajlm-1261	61	7	to	to	PART
ajlm-1261	61	8	dry	dry	VERB
ajlm-1261	61	9	at	at	ADP
ajlm-1261	61	10	room	room	NOUN
ajlm-1261	61	11	temperature	temperature	NOUN
ajlm-1261	61	12	and	and	CCONJ
ajlm-1261	61	13	a	a	DET
ajlm-1261	61	14	set	set	NOUN
ajlm-1261	61	15	of	of	ADP
ajlm-1261	61	16	six	six	NUM
ajlm-1261	61	17	antibiotic	antibiotic	ADJ
ajlm-1261	61	18	discs	disc	NOUN
ajlm-1261	61	19	were	be	AUX
ajlm-1261	61	20	placed	place	VERB
ajlm-1261	61	21	evenly	evenly	ADV
ajlm-1261	61	22	spaced	space	VERB
ajlm-1261	61	23	on	on	ADP
ajlm-1261	61	24	each	each	PRON
ajlm-1261	61	25	of	of	ADP
ajlm-1261	61	26	the	the	DET
ajlm-1261	61	27	plates	plate	NOUN
ajlm-1261	61	28	.	.	PUNCT
ajlm-1261	62	1	vancomycin	vancomycin	PROPN
ajlm-1261	62	2	resistance	resistance	PROPN
ajlm-1261	62	3	was	be	AUX
ajlm-1261	62	4	tested	test	VERB
ajlm-1261	62	5	in	in	ADP
ajlm-1261	62	6	the	the	DET
ajlm-1261	62	7	methicillin	methicillin	NOUN
ajlm-1261	62	8	-	-	PUNCT
ajlm-1261	62	9	resistant	resistant	ADJ
ajlm-1261	62	10	s.	s.	PROPN
ajlm-1261	62	11	aureus	aureus	PROPN
ajlm-1261	62	12	isolates	isolate	NOUN
ajlm-1261	62	13	by	by	ADP
ajlm-1261	62	14	placing	place	VERB
ajlm-1261	62	15	a	a	DET
ajlm-1261	62	16	mic	mic	ADJ
ajlm-1261	62	17	evaluation	evaluation	NOUN
ajlm-1261	62	18	strip	strip	NOUN
ajlm-1261	62	19	(	(	PUNCT
ajlm-1261	62	20	oxoid	oxoid	PROPN
ajlm-1261	62	21	,	,	PUNCT
ajlm-1261	62	22	basingstoke	basingstoke	PROPN
ajlm-1261	62	23	,	,	PUNCT
ajlm-1261	62	24	hants	hant	NOUN
ajlm-1261	62	25	,	,	PUNCT
ajlm-1261	62	26	united	united	ADJ
ajlm-1261	62	27	kingdom	kingdom	PROPN
ajlm-1261	62	28	)	)	PUNCT
ajlm-1261	62	29	on	on	ADP
ajlm-1261	62	30	inoculated	inoculate	VERB
ajlm-1261	62	31	mha	mha	PROPN
ajlm-1261	62	32	.	.	PUNCT
ajlm-1261	63	1	after	after	ADP
ajlm-1261	63	2	18–24	18–24	NUM
ajlm-1261	63	3	h	h	PROPN
ajlm-1261	63	4	of	of	ADP
ajlm-1261	63	5	incubation	incubation	NOUN
ajlm-1261	63	6	,	,	PUNCT
ajlm-1261	63	7	the	the	DET
ajlm-1261	63	8	diameter	diameter	NOUN
ajlm-1261	63	9	of	of	ADP
ajlm-1261	63	10	the	the	DET
ajlm-1261	63	11	zone	zone	NOUN
ajlm-1261	63	12	of	of	ADP
ajlm-1261	63	13	inhibition	inhibition	NOUN
ajlm-1261	63	14	around	around	ADP
ajlm-1261	63	15	each	each	DET
ajlm-1261	63	16	antibiotic	antibiotic	ADJ
ajlm-1261	63	17	disc	disc	NOUN
ajlm-1261	63	18	was	be	AUX
ajlm-1261	63	19	measured	measure	VERB
ajlm-1261	63	20	and	and	CCONJ
ajlm-1261	63	21	recorded	record	VERB
ajlm-1261	63	22	.	.	PUNCT
ajlm-1261	64	1	vancomycin	vancomycin	PROPN
ajlm-1261	64	2	mic	mic	ADJ
ajlm-1261	64	3	values	value	NOUN
ajlm-1261	64	4	were	be	AUX
ajlm-1261	64	5	also	also	ADV
ajlm-1261	64	6	recorded	record	VERB
ajlm-1261	64	7	for	for	ADP
ajlm-1261	64	8	the	the	DET
ajlm-1261	64	9	s.	s.	PROPN
ajlm-1261	64	10	aureus	aureus	PROPN
ajlm-1261	64	11	.	.	PUNCT
ajlm-1261	65	1	zones	zone	NOUN
ajlm-1261	65	2	of	of	ADP
ajlm-1261	65	3	inhibition	inhibition	NOUN
ajlm-1261	65	4	of	of	ADP
ajlm-1261	65	5	each	each	DET
ajlm-1261	65	6	antibiotic	antibiotic	NOUN
ajlm-1261	65	7	as	as	ADV
ajlm-1261	65	8	well	well	ADV
ajlm-1261	65	9	as	as	ADP
ajlm-1261	65	10	vancomycin	vancomycin	PROPN
ajlm-1261	65	11	mic	mic	ADJ
ajlm-1261	65	12	values	value	NOUN
ajlm-1261	65	13	were	be	AUX
ajlm-1261	65	14	interpreted	interpret	VERB
ajlm-1261	65	15	as	as	ADP
ajlm-1261	65	16	‘	'	PUNCT
ajlm-1261	65	17	sensitive	sensitive	ADJ
ajlm-1261	65	18	’	'	PUNCT
ajlm-1261	65	19	,	,	PUNCT
ajlm-1261	65	20	‘	'	PUNCT
ajlm-1261	65	21	intermediate	intermediate	ADJ
ajlm-1261	65	22	’	'	PUNCT
ajlm-1261	65	23	or	or	CCONJ
ajlm-1261	65	24	‘	'	PUNCT
ajlm-1261	65	25	resistant	resistant	ADJ
ajlm-1261	65	26	’	'	PUNCT
ajlm-1261	65	27	in	in	ADP
ajlm-1261	65	28	accordance	accordance	NOUN
ajlm-1261	65	29	with	with	ADP
ajlm-1261	65	30	clsi	clsi	ADJ
ajlm-1261	65	31	guidelines.21	guidelines.21	ADJ
ajlm-1261	65	32	isolates	isolate	NOUN
ajlm-1261	65	33	with	with	ADP
ajlm-1261	65	34	intermediate	intermediate	ADJ
ajlm-1261	65	35	sensitivity	sensitivity	NOUN
ajlm-1261	65	36	were	be	AUX
ajlm-1261	65	37	regarded	regard	VERB
ajlm-1261	65	38	as	as	ADP
ajlm-1261	65	39	‘	'	PUNCT
ajlm-1261	65	40	resistant	resistant	ADJ
ajlm-1261	65	41	’	'	PUNCT
ajlm-1261	65	42	.	.	PUNCT
ajlm-1261	66	1	the	the	DET
ajlm-1261	66	2	quality	quality	NOUN
ajlm-1261	66	3	of	of	ADP
ajlm-1261	66	4	antibiotic	antibiotic	ADJ
ajlm-1261	66	5	susceptibility	susceptibility	NOUN
ajlm-1261	66	6	testing	testing	NOUN
ajlm-1261	66	7	consumables	consumable	NOUN
ajlm-1261	66	8	(	(	PUNCT
ajlm-1261	66	9	including	include	VERB
ajlm-1261	66	10	antibiotic	antibiotic	ADJ
ajlm-1261	66	11	discs	disc	NOUN
ajlm-1261	66	12	and	and	CCONJ
ajlm-1261	66	13	mha	mha	NOUN
ajlm-1261	66	14	)	)	PUNCT
ajlm-1261	66	15	and	and	CCONJ
ajlm-1261	66	16	procedures	procedure	NOUN
ajlm-1261	66	17	were	be	AUX
ajlm-1261	66	18	assured	assure	VERB
ajlm-1261	66	19	with	with	ADP
ajlm-1261	66	20	bacterial	bacterial	ADJ
ajlm-1261	66	21	control	control	NOUN
ajlm-1261	66	22	strains	strain	NOUN
ajlm-1261	66	23	(	(	PUNCT
ajlm-1261	66	24	e.	e.	PROPN
ajlm-1261	66	25	coli	coli	PROPN
ajlm-1261	66	26	atcc	atcc	PROPN
ajlm-1261	66	27	25922	25922	NUM
ajlm-1261	66	28	,	,	PUNCT
ajlm-1261	66	29	s.	s.	PROPN
ajlm-1261	66	30	aureus	aureus	PROPN
ajlm-1261	66	31	atcc	atcc	PROPN
ajlm-1261	66	32	25923	25923	NUM
ajlm-1261	66	33	and	and	CCONJ
ajlm-1261	66	34	s.	s.	PROPN
ajlm-1261	66	35	aureus	aureus	PROPN
ajlm-1261	66	36	atcc	atcc	PROPN
ajlm-1261	66	37	43300	43300	NUM
ajlm-1261	66	38	)	)	PUNCT
ajlm-1261	66	39	.	.	PUNCT
ajlm-1261	67	1	zones	zone	NOUN
ajlm-1261	67	2	of	of	ADP
ajlm-1261	67	3	inhibition	inhibition	NOUN
ajlm-1261	67	4	of	of	ADP
ajlm-1261	67	5	tested	test	VERB
ajlm-1261	67	6	antibiotics	antibiotic	NOUN
ajlm-1261	67	7	on	on	ADP
ajlm-1261	67	8	the	the	DET
ajlm-1261	67	9	bacterial	bacterial	ADJ
ajlm-1261	67	10	control	control	NOUN
ajlm-1261	67	11	strains	strain	NOUN
ajlm-1261	67	12	fell	fall	VERB
ajlm-1261	67	13	within	within	ADP
ajlm-1261	67	14	their	their	PRON
ajlm-1261	67	15	quality	quality	NOUN
ajlm-1261	67	16	control	control	NOUN
ajlm-1261	67	17	ranges	range	VERB
ajlm-1261	67	18	according	accord	VERB
ajlm-1261	67	19	to	to	ADP
ajlm-1261	67	20	clsi.21	clsi.21	ADJ
ajlm-1261	67	21	extended	extend	VERB
ajlm-1261	67	22	-	-	PUNCT
ajlm-1261	67	23	spectrum	spectrum	NOUN
ajlm-1261	67	24	β	β	NOUN
ajlm-1261	67	25	-	-	PUNCT
ajlm-1261	67	26	lactamase	lactamase	ADJ
ajlm-1261	67	27	production	production	NOUN
ajlm-1261	67	28	was	be	AUX
ajlm-1261	67	29	confirmed	confirm	VERB
ajlm-1261	67	30	among	among	ADP
ajlm-1261	67	31	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-1261	67	32	and	and	CCONJ
ajlm-1261	67	33	other	other	ADJ
ajlm-1261	67	34	gnb	gnb	PROPN
ajlm-1261	67	35	that	that	PRON
ajlm-1261	67	36	showed	show	VERB
ajlm-1261	67	37	reduced	reduce	VERB
ajlm-1261	67	38	susceptibility	susceptibility	NOUN
ajlm-1261	67	39	to	to	ADP
ajlm-1261	67	40	at	at	ADV
ajlm-1261	67	41	least	least	ADV
ajlm-1261	67	42	one	one	NUM
ajlm-1261	67	43	of	of	ADP
ajlm-1261	67	44	the	the	DET
ajlm-1261	67	45	tested	test	VERB
ajlm-1261	67	46	third	third	ADJ
ajlm-1261	67	47	-	-	PUNCT
ajlm-1261	67	48	generation	generation	NOUN
ajlm-1261	67	49	cephalosporins	cephalosporin	NOUN
ajlm-1261	67	50	(	(	PUNCT
ajlm-1261	67	51	cefotaxime	cefotaxime	NOUN
ajlm-1261	67	52	30	30	NUM
ajlm-1261	67	53	µg	µg	NOUN
ajlm-1261	67	54	,	,	PUNCT
ajlm-1261	67	55	ceftazidime	ceftazidime	NOUN
ajlm-1261	67	56	30	30	NUM
ajlm-1261	67	57	µg	µg	ADV
ajlm-1261	67	58	and	and	CCONJ
ajlm-1261	67	59	ceftriaxone	ceftriaxone	PROPN
ajlm-1261	67	60	30	30	NUM
ajlm-1261	67	61	µg	µg	NOUN
ajlm-1261	67	62	)	)	PUNCT
ajlm-1261	67	63	or	or	CCONJ
ajlm-1261	67	64	aztreonam	aztreonam	NOUN
ajlm-1261	67	65	(	(	PUNCT
ajlm-1261	67	66	30	30	NUM
ajlm-1261	67	67	µg	µg	NOUN
ajlm-1261	67	68	)	)	PUNCT
ajlm-1261	67	69	by	by	ADP
ajlm-1261	67	70	a	a	DET
ajlm-1261	67	71	combination	combination	NOUN
ajlm-1261	67	72	disc	disc	NOUN
ajlm-1261	67	73	diffusion	diffusion	NOUN
ajlm-1261	67	74	test	test	NOUN
ajlm-1261	67	75	(	(	PUNCT
ajlm-1261	67	76	cddt).21	cddt).21	PROPN
ajlm-1261	67	77	cddt	cddt	NOUN
ajlm-1261	67	78	was	be	AUX
ajlm-1261	67	79	done	do	VERB
ajlm-1261	67	80	using	use	VERB
ajlm-1261	67	81	both	both	DET
ajlm-1261	67	82	single	single	ADJ
ajlm-1261	67	83	discs	disc	NOUN
ajlm-1261	67	84	of	of	ADP
ajlm-1261	67	85	cefotaxime	cefotaxime	NOUN
ajlm-1261	67	86	(	(	PUNCT
ajlm-1261	67	87	30	30	NUM
ajlm-1261	67	88	µg	µg	NOUN
ajlm-1261	67	89	)	)	PUNCT
ajlm-1261	67	90	and	and	CCONJ
ajlm-1261	67	91	ceftazidime	ceftazidime	NOUN
ajlm-1261	67	92	(	(	PUNCT
ajlm-1261	67	93	30	30	NUM
ajlm-1261	67	94	µg	µg	NOUN
ajlm-1261	67	95	)	)	PUNCT
ajlm-1261	67	96	and	and	CCONJ
ajlm-1261	67	97	their	their	PRON
ajlm-1261	67	98	respective	respective	ADJ
ajlm-1261	67	99	clavulanic	clavulanic	ADJ
ajlm-1261	67	100	acid	acid	NOUN
ajlm-1261	67	101	containing	contain	VERB
ajlm-1261	67	102	discs	disc	NOUN
ajlm-1261	67	103	(	(	PUNCT
ajlm-1261	67	104	cetotaxime	cetotaxime	NOUN
ajlm-1261	67	105	-	-	PUNCT
ajlm-1261	67	106	clavulanate	clavulanate	NOUN
ajlm-1261	67	107	30/10	30/10	NUM
ajlm-1261	67	108	µg	µg	ADJ
ajlm-1261	67	109	,	,	PUNCT
ajlm-1261	67	110	ceftazidime	ceftazidime	NOUN
ajlm-1261	67	111	-	-	PUNCT
ajlm-1261	67	112	clavulanate	clavulanate	NOUN
ajlm-1261	67	113	30/10	30/10	NUM
ajlm-1261	67	114	µg	µg	NOUN
ajlm-1261	67	115	)	)	PUNCT
ajlm-1261	67	116	.	.	PUNCT
ajlm-1261	68	1	a	a	DET
ajlm-1261	68	2	5	5	NUM
ajlm-1261	68	3	mm	mm	NOUN
ajlm-1261	68	4	or	or	CCONJ
ajlm-1261	68	5	more	more	ADJ
ajlm-1261	68	6	increase	increase	NOUN
ajlm-1261	68	7	in	in	ADP
ajlm-1261	68	8	zone	zone	NOUN
ajlm-1261	68	9	of	of	ADP
ajlm-1261	68	10	inhibition	inhibition	NOUN
ajlm-1261	68	11	of	of	ADP
ajlm-1261	68	12	one	one	NUM
ajlm-1261	68	13	or	or	CCONJ
ajlm-1261	68	14	more	more	ADJ
ajlm-1261	68	15	combination	combination	NOUN
ajlm-1261	68	16	discs	disc	NOUN
ajlm-1261	68	17	as	as	SCONJ
ajlm-1261	68	18	compared	compare	VERB
ajlm-1261	68	19	with	with	ADP
ajlm-1261	68	20	their	their	PRON
ajlm-1261	68	21	respective	respective	ADJ
ajlm-1261	68	22	single	single	ADJ
ajlm-1261	68	23	discs	disc	NOUN
ajlm-1261	68	24	was	be	AUX
ajlm-1261	68	25	taken	take	VERB
ajlm-1261	68	26	as	as	SCONJ
ajlm-1261	68	27	confirmatory	confirmatory	ADJ
ajlm-1261	68	28	evidence	evidence	NOUN
ajlm-1261	68	29	of	of	ADP
ajlm-1261	68	30	extended	extend	VERB
ajlm-1261	68	31	-	-	PUNCT
ajlm-1261	68	32	spectrum	spectrum	NOUN
ajlm-1261	68	33	beta	beta	NOUN
ajlm-1261	68	34	-	-	PUNCT
ajlm-1261	68	35	lactamase	lactamase	NOUN
ajlm-1261	68	36	(	(	PUNCT
ajlm-1261	68	37	esbl	esbl	NOUN
ajlm-1261	68	38	)	)	PUNCT
ajlm-1261	68	39	production.21	production.21	NOUN
ajlm-1261	68	40	ampc	ampc	NOUN
ajlm-1261	68	41	beta	beta	NOUN
ajlm-1261	68	42	-	-	PUNCT
ajlm-1261	68	43	lactamase	lactamase	NOUN
ajlm-1261	68	44	production	production	NOUN
ajlm-1261	68	45	was	be	AUX
ajlm-1261	68	46	detected	detect	VERB
ajlm-1261	68	47	by	by	ADP
ajlm-1261	68	48	ampc	ampc	NOUN
ajlm-1261	68	49	disc	disc	NOUN
ajlm-1261	68	50	test	test	NOUN
ajlm-1261	68	51	as	as	SCONJ
ajlm-1261	68	52	described	describe	VERB
ajlm-1261	68	53	by	by	ADP
ajlm-1261	68	54	anjali	anjali	PROPN
ajlm-1261	68	55	et	et	PROPN
ajlm-1261	68	56	al	al	PROPN
ajlm-1261	68	57	.	.	PROPN
ajlm-1261	69	1	on	on	ADP
ajlm-1261	69	2	isolates	isolate	NOUN
ajlm-1261	69	3	which	which	PRON
ajlm-1261	69	4	show	show	VERB
ajlm-1261	69	5	resistance	resistance	NOUN
ajlm-1261	69	6	to	to	ADP
ajlm-1261	69	7	at	at	ADV
ajlm-1261	69	8	least	least	ADV
ajlm-1261	69	9	one	one	NUM
ajlm-1261	69	10	third	third	ADJ
ajlm-1261	69	11	-	-	PUNCT
ajlm-1261	69	12	generation	generation	NOUN
ajlm-1261	69	13	cephalosporin	cephalosporin	NOUN
ajlm-1261	69	14	and	and	CCONJ
ajlm-1261	69	15	a	a	DET
ajlm-1261	69	16	β	β	NOUN
ajlm-1261	69	17	-	-	PUNCT
ajlm-1261	69	18	lactamase	lactamase	ADJ
ajlm-1261	69	19	inhibitor.22	inhibitor.22	ADJ
ajlm-1261	69	20	a	a	DET
ajlm-1261	69	21	broth	broth	ADJ
ajlm-1261	69	22	culture	culture	NOUN
ajlm-1261	69	23	of	of	ADP
ajlm-1261	69	24	e.	e.	PROPN
ajlm-1261	69	25	coli	coli	PROPN
ajlm-1261	69	26	atcc	atcc	PROPN
ajlm-1261	69	27	25922	25922	NUM
ajlm-1261	69	28	was	be	AUX
ajlm-1261	69	29	adjusted	adjust	VERB
ajlm-1261	69	30	to	to	ADP
ajlm-1261	69	31	0.5	0.5	NUM
ajlm-1261	69	32	mcfarland	mcfarland	PROPN
ajlm-1261	69	33	turbidity	turbidity	NOUN
ajlm-1261	69	34	standard	standard	NOUN
ajlm-1261	69	35	and	and	CCONJ
ajlm-1261	69	36	inoculated	inoculate	VERB
ajlm-1261	69	37	onto	onto	ADP
ajlm-1261	69	38	mha	mha	PROPN
ajlm-1261	69	39	plates	plate	NOUN
ajlm-1261	69	40	.	.	PUNCT
ajlm-1261	70	1	sterile	sterile	ADJ
ajlm-1261	70	2	filter	filter	NOUN
ajlm-1261	70	3	paper	paper	NOUN
ajlm-1261	70	4	discs	disc	NOUN
ajlm-1261	70	5	(	(	PUNCT
ajlm-1261	70	6	6	6	NUM
ajlm-1261	70	7	mm	mm	NOUN
ajlm-1261	70	8	)	)	PUNCT
ajlm-1261	70	9	were	be	AUX
ajlm-1261	70	10	moistened	moisten	VERB
ajlm-1261	70	11	with	with	ADP
ajlm-1261	70	12	distilled	distil	VERB
ajlm-1261	70	13	water	water	NOUN
ajlm-1261	70	14	(	(	PUNCT
ajlm-1261	70	15	about	about	ADV
ajlm-1261	70	16	20	20	NUM
ajlm-1261	70	17	µl	µl	NOUN
ajlm-1261	70	18	)	)	PUNCT
ajlm-1261	70	19	and	and	CCONJ
ajlm-1261	70	20	up	up	ADP
ajlm-1261	70	21	to	to	PART
ajlm-1261	70	22	five	five	NUM
ajlm-1261	70	23	colonies	colony	NOUN
ajlm-1261	70	24	of	of	ADP
ajlm-1261	70	25	the	the	DET
ajlm-1261	70	26	test	test	NOUN
ajlm-1261	70	27	organism	organism	NOUN
ajlm-1261	70	28	was	be	AUX
ajlm-1261	70	29	transferred	transfer	VERB
ajlm-1261	70	30	onto	onto	ADP
ajlm-1261	70	31	the	the	DET
ajlm-1261	70	32	filter	filter	NOUN
ajlm-1261	70	33	paper	paper	NOUN
ajlm-1261	70	34	.	.	PUNCT
ajlm-1261	71	1	afterwards	afterwards	ADV
ajlm-1261	71	2	,	,	PUNCT
ajlm-1261	71	3	a	a	DET
ajlm-1261	71	4	cefoxitin	cefoxitin	NOUN
ajlm-1261	71	5	(	(	PUNCT
ajlm-1261	71	6	30	30	NUM
ajlm-1261	71	7	µg	µg	NOUN
ajlm-1261	71	8	)	)	PUNCT
ajlm-1261	71	9	disc	disc	NOUN
ajlm-1261	71	10	and	and	CCONJ
ajlm-1261	71	11	the	the	DET
ajlm-1261	71	12	inoculated	inoculate	VERB
ajlm-1261	71	13	filter	filter	NOUN
ajlm-1261	71	14	paper	paper	NOUN
ajlm-1261	71	15	disc	disc	NOUN
ajlm-1261	71	16	were	be	AUX
ajlm-1261	71	17	placed	place	VERB
ajlm-1261	71	18	next	next	ADV
ajlm-1261	71	19	to	to	ADP
ajlm-1261	71	20	each	each	DET
ajlm-1261	71	21	other	other	ADJ
ajlm-1261	71	22	and	and	CCONJ
ajlm-1261	71	23	almost	almost	ADV
ajlm-1261	71	24	touching	touch	VERB
ajlm-1261	71	25	on	on	ADP
ajlm-1261	71	26	inoculated	inoculated	ADJ
ajlm-1261	71	27	media	medium	NOUN
ajlm-1261	71	28	.	.	PUNCT
ajlm-1261	72	1	this	this	DET
ajlm-1261	72	2	setup	setup	NOUN
ajlm-1261	72	3	was	be	AUX
ajlm-1261	72	4	incubated	incubate	VERB
ajlm-1261	72	5	overnight	overnight	ADV
ajlm-1261	72	6	at	at	ADP
ajlm-1261	72	7	37	37	NUM
ajlm-1261	72	8	°	°	NOUN
ajlm-1261	72	9	c	c	NOUN
ajlm-1261	72	10	.	.	PUNCT
ajlm-1261	73	1	a	a	DET
ajlm-1261	73	2	flattening	flattening	NOUN
ajlm-1261	73	3	or	or	CCONJ
ajlm-1261	73	4	indentation	indentation	NOUN
ajlm-1261	73	5	of	of	ADP
ajlm-1261	73	6	the	the	DET
ajlm-1261	73	7	zone	zone	NOUN
ajlm-1261	73	8	of	of	ADP
ajlm-1261	73	9	inhibition	inhibition	NOUN
ajlm-1261	73	10	of	of	ADP
ajlm-1261	73	11	cefoxitin	cefoxitin	NOUN
ajlm-1261	73	12	in	in	ADP
ajlm-1261	73	13	the	the	DET
ajlm-1261	73	14	vicinity	vicinity	NOUN
ajlm-1261	73	15	of	of	ADP
ajlm-1261	73	16	the	the	DET
ajlm-1261	73	17	test	test	NOUN
ajlm-1261	73	18	disc	disc	NOUN
ajlm-1261	73	19	(	(	PUNCT
ajlm-1261	73	20	inoculated	inoculate	VERB
ajlm-1261	73	21	filter	filter	NOUN
ajlm-1261	73	22	paper	paper	NOUN
ajlm-1261	73	23	)	)	PUNCT
ajlm-1261	73	24	indicated	indicate	VERB
ajlm-1261	73	25	a	a	DET
ajlm-1261	73	26	phenotypic	phenotypic	ADJ
ajlm-1261	73	27	confirmatory	confirmatory	NOUN
ajlm-1261	73	28	evidence	evidence	NOUN
ajlm-1261	73	29	of	of	ADP
ajlm-1261	73	30	ampc	ampc	PROPN
ajlm-1261	73	31	β	β	NOUN
ajlm-1261	73	32	-	-	PUNCT
ajlm-1261	73	33	lactamase	lactamase	ADJ
ajlm-1261	73	34	production.22	production.22	NOUN
ajlm-1261	73	35	gram	gram	NOUN
ajlm-1261	73	36	-	-	PUNCT
ajlm-1261	73	37	negative	negative	ADJ
ajlm-1261	73	38	bacilli	bacilli	NOUN
ajlm-1261	73	39	with	with	ADP
ajlm-1261	73	40	intermediate	intermediate	ADJ
ajlm-1261	73	41	sensitivity	sensitivity	NOUN
ajlm-1261	73	42	or	or	CCONJ
ajlm-1261	73	43	resistance	resistance	NOUN
ajlm-1261	73	44	to	to	ADP
ajlm-1261	73	45	one	one	NUM
ajlm-1261	73	46	or	or	CCONJ
ajlm-1261	73	47	more	more	ADJ
ajlm-1261	73	48	carbapenems	carbapenem	NOUN
ajlm-1261	73	49	were	be	AUX
ajlm-1261	73	50	tested	test	VERB
ajlm-1261	73	51	for	for	ADP
ajlm-1261	73	52	production	production	NOUN
ajlm-1261	73	53	of	of	ADP
ajlm-1261	73	54	carbapenemases	carbapenemase	NOUN
ajlm-1261	73	55	by	by	ADP
ajlm-1261	73	56	the	the	DET
ajlm-1261	73	57	modified	modified	PROPN
ajlm-1261	73	58	hodge	hodge	PROPN
ajlm-1261	73	59	test	test	NOUN
ajlm-1261	73	60	and	and	CCONJ
ajlm-1261	73	61	interpreted	interpret	VERB
ajlm-1261	73	62	by	by	ADP
ajlm-1261	73	63	clsi	clsi	ADJ
ajlm-1261	73	64	guidelines.21	guidelines.21	ADJ
ajlm-1261	73	65	organisms	organism	NOUN
ajlm-1261	73	66	that	that	PRON
ajlm-1261	73	67	were	be	AUX
ajlm-1261	73	68	phenotypically	phenotypically	ADV
ajlm-1261	73	69	mdr	mdr	NOUN
ajlm-1261	73	70	,	,	PUNCT
ajlm-1261	73	71	including	include	VERB
ajlm-1261	73	72	esbl	esbl	NOUN
ajlm-1261	73	73	-	-	PUNCT
ajlm-1261	73	74	producing	produce	VERB
ajlm-1261	73	75	gnb	gnb	NOUN
ajlm-1261	73	76	,	,	PUNCT
ajlm-1261	73	77	carbapenem	carbapenem	NOUN
ajlm-1261	73	78	-	-	PUNCT
ajlm-1261	73	79	resistant	resistant	ADJ
ajlm-1261	73	80	gnb	gnb	NOUN
ajlm-1261	73	81	and	and	CCONJ
ajlm-1261	73	82	mrsa	mrsa	NOUN
ajlm-1261	73	83	,	,	PUNCT
ajlm-1261	73	84	were	be	AUX
ajlm-1261	73	85	further	far	ADV
ajlm-1261	73	86	tested	test	VERB
ajlm-1261	73	87	for	for	ADP
ajlm-1261	73	88	resistance	resistance	NOUN
ajlm-1261	73	89	-	-	PUNCT
ajlm-1261	73	90	determining	determine	VERB
ajlm-1261	73	91	genes	gene	NOUN
ajlm-1261	73	92	using	use	VERB
ajlm-1261	73	93	polymerase	polymerase	NOUN
ajlm-1261	73	94	chain	chain	NOUN
ajlm-1261	73	95	reaction	reaction	NOUN
ajlm-1261	73	96	(	(	PUNCT
ajlm-1261	73	97	pcr)-based	pcr)-base	VERB
ajlm-1261	73	98	protocols	protocol	NOUN
ajlm-1261	73	99	with	with	ADP
ajlm-1261	73	100	specific	specific	ADJ
ajlm-1261	73	101	oligonucleotide	oligonucleotide	NOUN
ajlm-1261	73	102	primers23–27	primers23–27	NOUN
ajlm-1261	73	103	(	(	PUNCT
ajlm-1261	73	104	table	table	NOUN
ajlm-1261	73	105	1	1	NUM
ajlm-1261	73	106	)	)	PUNCT
ajlm-1261	73	107	;	;	PUNCT
ajlm-1261	73	108	template	template	NOUN
ajlm-1261	73	109	bacterial	bacterial	ADJ
ajlm-1261	73	110	dna	dna	NOUN
ajlm-1261	73	111	was	be	AUX
ajlm-1261	73	112	extracted	extract	VERB
ajlm-1261	73	113	by	by	ADP
ajlm-1261	73	114	the	the	DET
ajlm-1261	73	115	boiling	boil	VERB
ajlm-1261	73	116	method.28	method.28	NOUN
ajlm-1261	73	117	electrophoresis	electrophoresis	NOUN
ajlm-1261	73	118	of	of	ADP
ajlm-1261	73	119	each	each	DET
ajlm-1261	73	120	pcr	pcr	ADJ
ajlm-1261	73	121	product	product	NOUN
ajlm-1261	73	122	(	(	PUNCT
ajlm-1261	73	123	5	5	NUM
ajlm-1261	73	124	µl	µl	NOUN
ajlm-1261	73	125	)	)	PUNCT
ajlm-1261	73	126	was	be	AUX
ajlm-1261	73	127	carried	carry	VERB
ajlm-1261	73	128	out	out	ADP
ajlm-1261	73	129	in	in	ADP
ajlm-1261	73	130	1.5	1.5	NUM
ajlm-1261	73	131	%	%	NOUN
ajlm-1261	73	132	(	(	PUNCT
ajlm-1261	73	133	weight	weight	NOUN
ajlm-1261	73	134	/	/	SYM
ajlm-1261	73	135	volume	volume	NOUN
ajlm-1261	73	136	)	)	PUNCT
ajlm-1261	73	137	agarose	agarose	NOUN
ajlm-1261	73	138	gel	gel	NOUN
ajlm-1261	73	139	(	(	PUNCT
ajlm-1261	73	140	biomatik	biomatik	NOUN
ajlm-1261	73	141	,	,	PUNCT
ajlm-1261	73	142	kitchener	kitchener	PROPN
ajlm-1261	73	143	,	,	PUNCT
ajlm-1261	73	144	ontario	ontario	PROPN
ajlm-1261	73	145	,	,	PUNCT
ajlm-1261	73	146	canada	canada	PROPN
ajlm-1261	73	147	)	)	PUNCT
ajlm-1261	73	148	in	in	ADP
ajlm-1261	73	149	1x	1x	PROPN
ajlm-1261	73	150	tris	tris	ADJ
ajlm-1261	73	151	-	-	PUNCT
ajlm-1261	73	152	acetate	acetate	NOUN
ajlm-1261	73	153	-	-	PUNCT
ajlm-1261	73	154	edta	edta	NOUN
ajlm-1261	73	155	(	(	PUNCT
ajlm-1261	73	156	tae	tae	NOUN
ajlm-1261	73	157	)	)	PUNCT
ajlm-1261	73	158	buffer	buffer	NOUN
ajlm-1261	73	159	for	for	ADP
ajlm-1261	73	160	45	45	NUM
ajlm-1261	73	161	min	min	NOUN
ajlm-1261	73	162	.	.	PUNCT
ajlm-1261	74	1	the	the	DET
ajlm-1261	74	2	size	size	NOUN
ajlm-1261	74	3	of	of	ADP
ajlm-1261	74	4	amplified	amplify	VERB
ajlm-1261	74	5	products	product	NOUN
ajlm-1261	74	6	was	be	AUX
ajlm-1261	74	7	estimated	estimate	VERB
ajlm-1261	74	8	using	use	VERB
ajlm-1261	74	9	100	100	NUM
ajlm-1261	74	10	base	base	NOUN
ajlm-1261	74	11	pairs	pair	NOUN
ajlm-1261	74	12	molecular	molecular	ADJ
ajlm-1261	74	13	weight	weight	NOUN
ajlm-1261	74	14	marker	marker	NOUN
ajlm-1261	74	15	(	(	PUNCT
ajlm-1261	74	16	100–1200	100–1200	NUM
ajlm-1261	74	17	base	base	NOUN
ajlm-1261	74	18	pairs	pair	NOUN
ajlm-1261	74	19	)	)	PUNCT
ajlm-1261	74	20	.	.	PUNCT
ajlm-1261	75	1	table	table	NOUN
ajlm-1261	75	2	1	1	NUM
ajlm-1261	75	3	:	:	PUNCT
ajlm-1261	75	4	 	 	SPACE
ajlm-1261	75	5	oligonucleotides	oligonucleotide	VERB
ajlm-1261	75	6	primers	primer	NOUN
ajlm-1261	75	7	and	and	CCONJ
ajlm-1261	75	8	amplification	amplification	NOUN
ajlm-1261	75	9	reactions	reaction	NOUN
ajlm-1261	75	10	for	for	ADP
ajlm-1261	75	11	targeted	target	VERB
ajlm-1261	75	12	resistance	resistance	NOUN
ajlm-1261	75	13	genes	gene	NOUN
ajlm-1261	75	14	.	.	PUNCT
ajlm-1261	76	1	statistical	statistical	ADJ
ajlm-1261	76	2	analysis	analysis	NOUN
ajlm-1261	76	3	data	datum	NOUN
ajlm-1261	76	4	analysis	analysis	NOUN
ajlm-1261	76	5	was	be	AUX
ajlm-1261	76	6	performed	perform	VERB
ajlm-1261	76	7	with	with	ADP
ajlm-1261	76	8	statistical	statistical	ADJ
ajlm-1261	76	9	package	package	NOUN
ajlm-1261	76	10	for	for	ADP
ajlm-1261	76	11	social	social	ADJ
ajlm-1261	76	12	sciences	science	NOUN
ajlm-1261	76	13	version	version	NOUN
ajlm-1261	76	14	20	20	NUM
ajlm-1261	76	15	(	(	PUNCT
ajlm-1261	76	16	spss	spss	PROPN
ajlm-1261	76	17	inc	inc	PROPN
ajlm-1261	76	18	.	.	PROPN
ajlm-1261	76	19	,	,	PUNCT
ajlm-1261	76	20	chicago	chicago	PROPN
ajlm-1261	76	21	,	,	PUNCT
ajlm-1261	76	22	illinois	illinois	PROPN
ajlm-1261	76	23	,	,	PUNCT
ajlm-1261	76	24	united	united	PROPN
ajlm-1261	76	25	states	states	PROPN
ajlm-1261	76	26	)	)	PUNCT
ajlm-1261	76	27	.	.	PUNCT
ajlm-1261	77	1	comparison	comparison	NOUN
ajlm-1261	77	2	of	of	ADP
ajlm-1261	77	3	mean	mean	ADJ
ajlm-1261	77	4	values	value	NOUN
ajlm-1261	77	5	was	be	AUX
ajlm-1261	77	6	done	do	VERB
ajlm-1261	77	7	using	use	VERB
ajlm-1261	77	8	the	the	DET
ajlm-1261	77	9	student	student	NOUN
ajlm-1261	77	10	’s	’s	PART
ajlm-1261	77	11	t	t	PROPN
ajlm-1261	77	12	-	-	PUNCT
ajlm-1261	77	13	test	test	NOUN
ajlm-1261	77	14	for	for	ADP
ajlm-1261	77	15	continuous	continuous	ADJ
ajlm-1261	77	16	variables	variable	NOUN
ajlm-1261	77	17	and	and	CCONJ
ajlm-1261	77	18	the	the	DET
ajlm-1261	77	19	chi	chi	ADJ
ajlm-1261	77	20	-	-	PUNCT
ajlm-1261	77	21	square	square	ADJ
ajlm-1261	77	22	test	test	NOUN
ajlm-1261	77	23	for	for	ADP
ajlm-1261	77	24	categorical	categorical	ADJ
ajlm-1261	77	25	variables	variable	NOUN
ajlm-1261	77	26	.	.	PUNCT
ajlm-1261	78	1	risk	risk	NOUN
ajlm-1261	78	2	factors	factor	NOUN
ajlm-1261	78	3	for	for	ADP
ajlm-1261	78	4	infection	infection	NOUN
ajlm-1261	78	5	of	of	ADP
ajlm-1261	78	6	diabetic	diabetic	ADJ
ajlm-1261	78	7	foot	foot	NOUN
ajlm-1261	78	8	by	by	ADP
ajlm-1261	78	9	mdr	mdr	PROPN
ajlm-1261	78	10	organisms	organism	NOUN
ajlm-1261	78	11	were	be	AUX
ajlm-1261	78	12	identified	identify	VERB
ajlm-1261	78	13	by	by	ADP
ajlm-1261	78	14	logistic	logistic	ADJ
ajlm-1261	78	15	regression	regression	NOUN
ajlm-1261	78	16	analysis	analysis	NOUN
ajlm-1261	78	17	.	.	PUNCT
ajlm-1261	79	1	logistic	logistic	ADJ
ajlm-1261	79	2	regression	regression	NOUN
ajlm-1261	79	3	was	be	AUX
ajlm-1261	79	4	used	use	VERB
ajlm-1261	79	5	to	to	PART
ajlm-1261	79	6	determine	determine	VERB
ajlm-1261	79	7	predictive	predictive	ADJ
ajlm-1261	79	8	associations	association	NOUN
ajlm-1261	79	9	of	of	ADP
ajlm-1261	79	10	variables	variable	NOUN
ajlm-1261	79	11	that	that	PRON
ajlm-1261	79	12	showed	show	VERB
ajlm-1261	79	13	statistical	statistical	ADJ
ajlm-1261	79	14	significance	significance	NOUN
ajlm-1261	79	15	by	by	ADP
ajlm-1261	79	16	bivariate	bivariate	ADJ
ajlm-1261	79	17	analysis	analysis	NOUN
ajlm-1261	79	18	.	.	PUNCT
ajlm-1261	80	1	a	a	DET
ajlm-1261	80	2	p	p	NOUN
ajlm-1261	80	3	-	-	PUNCT
ajlm-1261	80	4	value	value	NOUN
ajlm-1261	80	5	of	of	ADP
ajlm-1261	80	6	less	less	ADJ
ajlm-1261	80	7	than	than	ADP
ajlm-1261	80	8	0.05	0.05	NUM
ajlm-1261	80	9	was	be	AUX
ajlm-1261	80	10	considered	consider	VERB
ajlm-1261	80	11	to	to	PART
ajlm-1261	80	12	be	be	AUX
ajlm-1261	80	13	statistically	statistically	ADV
ajlm-1261	80	14	significant	significant	ADJ
ajlm-1261	80	15	.	.	PUNCT
ajlm-1261	81	1	results	result	VERB
ajlm-1261	81	2	sociodemographic	sociodemographic	ADJ
ajlm-1261	81	3	and	and	CCONJ
ajlm-1261	81	4	clinical	clinical	ADJ
ajlm-1261	81	5	characteristics	characteristic	NOUN
ajlm-1261	81	6	of	of	ADP
ajlm-1261	81	7	patients	patient	NOUN
ajlm-1261	81	8	ninety	ninety	NUM
ajlm-1261	81	9	patients	patient	NOUN
ajlm-1261	81	10	(	(	PUNCT
ajlm-1261	81	11	53	53	NUM
ajlm-1261	81	12	male	male	NOUN
ajlm-1261	81	13	and	and	CCONJ
ajlm-1261	81	14	37	37	NUM
ajlm-1261	81	15	female	female	NOUN
ajlm-1261	81	16	)	)	PUNCT
ajlm-1261	81	17	presented	present	VERB
ajlm-1261	81	18	with	with	ADP
ajlm-1261	81	19	93	93	NUM
ajlm-1261	81	20	idfus	idfu	NOUN
ajlm-1261	81	21	during	during	ADP
ajlm-1261	81	22	the	the	DET
ajlm-1261	81	23	11	11	NUM
ajlm-1261	81	24	-	-	PUNCT
ajlm-1261	81	25	month	month	NOUN
ajlm-1261	81	26	study	study	NOUN
ajlm-1261	81	27	period	period	NOUN
ajlm-1261	81	28	.	.	PUNCT
ajlm-1261	82	1	the	the	DET
ajlm-1261	82	2	patients	patient	NOUN
ajlm-1261	82	3	ranged	range	VERB
ajlm-1261	82	4	between	between	ADP
ajlm-1261	82	5	18	18	NUM
ajlm-1261	82	6	and	and	CCONJ
ajlm-1261	82	7	85	85	NUM
ajlm-1261	82	8	years	year	NOUN
ajlm-1261	82	9	(	(	PUNCT
ajlm-1261	82	10	mean	mean	NOUN
ajlm-1261	82	11	54.7	54.7	NUM
ajlm-1261	82	12	±	±	NUM
ajlm-1261	82	13	12.8	12.8	NUM
ajlm-1261	82	14	years	year	NOUN
ajlm-1261	82	15	)	)	PUNCT
ajlm-1261	82	16	of	of	ADP
ajlm-1261	82	17	age	age	NOUN
ajlm-1261	82	18	.	.	PUNCT
ajlm-1261	83	1	of	of	ADP
ajlm-1261	83	2	the	the	DET
ajlm-1261	83	3	93	93	NUM
ajlm-1261	83	4	cases	case	NOUN
ajlm-1261	83	5	of	of	ADP
ajlm-1261	83	6	foot	foot	NOUN
ajlm-1261	83	7	infections	infection	NOUN
ajlm-1261	83	8	,	,	PUNCT
ajlm-1261	83	9	56	56	NUM
ajlm-1261	83	10	(	(	PUNCT
ajlm-1261	83	11	60.2	60.2	NUM
ajlm-1261	83	12	%	%	NOUN
ajlm-1261	83	13	)	)	PUNCT
ajlm-1261	83	14	had	have	AUX
ajlm-1261	83	15	lasted	last	VERB
ajlm-1261	83	16	for	for	ADP
ajlm-1261	83	17	at	at	ADV
ajlm-1261	83	18	least	least	ADV
ajlm-1261	83	19	1	1	NUM
ajlm-1261	83	20	month	month	NOUN
ajlm-1261	83	21	,	,	PUNCT
ajlm-1261	83	22	and	and	CCONJ
ajlm-1261	83	23	70	70	NUM
ajlm-1261	83	24	(	(	PUNCT
ajlm-1261	83	25	75.3	75.3	NUM
ajlm-1261	83	26	%	%	NOUN
ajlm-1261	83	27	)	)	PUNCT
ajlm-1261	83	28	were	be	AUX
ajlm-1261	83	29	in	in	ADP
ajlm-1261	83	30	-	-	PUNCT
ajlm-1261	83	31	hospital	hospital	NOUN
ajlm-1261	83	32	patients	patient	NOUN
ajlm-1261	83	33	.	.	PUNCT
ajlm-1261	84	1	sixty	sixty	NUM
ajlm-1261	84	2	-	-	PUNCT
ajlm-1261	84	3	six	six	NUM
ajlm-1261	84	4	(	(	PUNCT
ajlm-1261	84	5	71.0	71.0	NUM
ajlm-1261	84	6	%	%	NOUN
ajlm-1261	84	7	)	)	PUNCT
ajlm-1261	84	8	of	of	ADP
ajlm-1261	84	9	the	the	DET
ajlm-1261	84	10	ulcers	ulcer	NOUN
ajlm-1261	84	11	were	be	AUX
ajlm-1261	84	12	categorised	categorise	VERB
ajlm-1261	84	13	as	as	ADP
ajlm-1261	84	14	wagner	wagner	PROPN
ajlm-1261	84	15	’s	’s	PART
ajlm-1261	84	16	grade	grade	NOUN
ajlm-1261	84	17	3	3	NUM
ajlm-1261	84	18	and	and	CCONJ
ajlm-1261	84	19	above	above	ADV
ajlm-1261	84	20	.	.	PUNCT
ajlm-1261	85	1	most	most	ADJ
ajlm-1261	85	2	(	(	PUNCT
ajlm-1261	85	3	n	n	NOUN
ajlm-1261	85	4	=	=	SYM
ajlm-1261	85	5	74	74	NUM
ajlm-1261	85	6	;	;	PUNCT
ajlm-1261	85	7	82.2	82.2	NUM
ajlm-1261	85	8	%	%	NOUN
ajlm-1261	85	9	)	)	PUNCT
ajlm-1261	85	10	of	of	ADP
ajlm-1261	85	11	the	the	DET
ajlm-1261	85	12	patients	patient	NOUN
ajlm-1261	85	13	used	use	VERB
ajlm-1261	85	14	antibiotics	antibiotic	NOUN
ajlm-1261	85	15	in	in	ADP
ajlm-1261	85	16	the	the	DET
ajlm-1261	85	17	month	month	NOUN
ajlm-1261	85	18	preceding	precede	VERB
ajlm-1261	85	19	presentation	presentation	NOUN
ajlm-1261	85	20	at	at	ADP
ajlm-1261	85	21	the	the	DET
ajlm-1261	85	22	healthcare	healthcare	NOUN
ajlm-1261	85	23	facilities	facility	NOUN
ajlm-1261	85	24	,	,	PUNCT
ajlm-1261	85	25	while	while	SCONJ
ajlm-1261	85	26	93.3	93.3	NUM
ajlm-1261	85	27	%	%	NOUN
ajlm-1261	85	28	(	(	PUNCT
ajlm-1261	85	29	n	n	NOUN
ajlm-1261	85	30	=	=	SYM
ajlm-1261	85	31	84	84	NUM
ajlm-1261	85	32	)	)	PUNCT
ajlm-1261	85	33	had	have	AUX
ajlm-1261	85	34	commenced	commence	VERB
ajlm-1261	85	35	antibiotics	antibiotic	NOUN
ajlm-1261	85	36	before	before	ADP
ajlm-1261	85	37	collection	collection	NOUN
ajlm-1261	85	38	of	of	ADP
ajlm-1261	85	39	wound	wound	NOUN
ajlm-1261	85	40	samples	sample	NOUN
ajlm-1261	85	41	(	(	PUNCT
ajlm-1261	85	42	table	table	NOUN
ajlm-1261	85	43	2	2	NUM
ajlm-1261	85	44	)	)	PUNCT
ajlm-1261	85	45	.	.	PUNCT
ajlm-1261	86	1	table	table	NOUN
ajlm-1261	86	2	2	2	NUM
ajlm-1261	86	3	:	:	PUNCT
ajlm-1261	86	4	 	 	SPACE
ajlm-1261	86	5	association	association	NOUN
ajlm-1261	86	6	between	between	ADP
ajlm-1261	86	7	clinical	clinical	ADJ
ajlm-1261	86	8	and	and	CCONJ
ajlm-1261	86	9	sociodemographic	sociodemographic	ADJ
ajlm-1261	86	10	variables	variable	NOUN
ajlm-1261	86	11	of	of	ADP
ajlm-1261	86	12	infected	infect	VERB
ajlm-1261	86	13	diabetic	diabetic	ADJ
ajlm-1261	86	14	foot	foot	NOUN
ajlm-1261	86	15	ulcer	ulcer	NOUN
ajlm-1261	86	16	patients	patient	NOUN
ajlm-1261	86	17	from	from	ADP
ajlm-1261	86	18	tertiary	tertiary	ADJ
ajlm-1261	86	19	healthcare	healthcare	NOUN
ajlm-1261	86	20	facilities	facility	NOUN
ajlm-1261	86	21	in	in	ADP
ajlm-1261	86	22	osun	osun	PROPN
ajlm-1261	86	23	state	state	PROPN
ajlm-1261	86	24	,	,	PUNCT
ajlm-1261	86	25	nigeria	nigeria	PROPN
ajlm-1261	86	26	,	,	PUNCT
ajlm-1261	86	27	july	july	PROPN
ajlm-1261	86	28	2016	2016	NUM
ajlm-1261	86	29	to	to	ADP
ajlm-1261	86	30	april	april	PROPN
ajlm-1261	86	31	2017	2017	NUM
ajlm-1261	86	32	.	.	PUNCT
ajlm-1261	87	1	predictors	predictor	NOUN
ajlm-1261	87	2	and	and	CCONJ
ajlm-1261	87	3	treatment	treatment	NOUN
ajlm-1261	87	4	outcomes	outcome	NOUN
ajlm-1261	87	5	of	of	ADP
ajlm-1261	87	6	multidrug	multidrug	NOUN
ajlm-1261	87	7	-	-	PUNCT
ajlm-1261	87	8	resistant	resistant	ADJ
ajlm-1261	87	9	bacterial	bacterial	ADJ
ajlm-1261	87	10	infections	infection	NOUN
ajlm-1261	87	11	in	in	ADP
ajlm-1261	87	12	infected	infected	ADJ
ajlm-1261	87	13	diabetic	diabetic	ADJ
ajlm-1261	87	14	foot	foot	NOUN
ajlm-1261	87	15	ulcer	ulcer	NOUN
ajlm-1261	87	16	significant	significant	ADJ
ajlm-1261	87	17	factors	factor	NOUN
ajlm-1261	87	18	associated	associate	VERB
ajlm-1261	87	19	with	with	ADP
ajlm-1261	87	20	the	the	DET
ajlm-1261	87	21	presence	presence	NOUN
ajlm-1261	87	22	of	of	ADP
ajlm-1261	87	23	mdr	mdr	PROPN
ajlm-1261	87	24	organisms	organism	NOUN
ajlm-1261	87	25	in	in	ADP
ajlm-1261	87	26	diabetic	diabetic	ADJ
ajlm-1261	87	27	foot	foot	NOUN
ajlm-1261	87	28	infections	infection	NOUN
ajlm-1261	87	29	included	include	VERB
ajlm-1261	87	30	peripheral	peripheral	ADJ
ajlm-1261	87	31	sensory	sensory	ADJ
ajlm-1261	87	32	neuropathy	neuropathy	ADJ
ajlm-1261	87	33	,	,	PUNCT
ajlm-1261	87	34	a	a	DET
ajlm-1261	87	35	foot	foot	NOUN
ajlm-1261	87	36	infection	infection	NOUN
ajlm-1261	87	37	duration	duration	NOUN
ajlm-1261	87	38	of	of	ADP
ajlm-1261	87	39	more	more	ADJ
ajlm-1261	87	40	than	than	ADP
ajlm-1261	87	41	a	a	PRON
ajlm-1261	87	42	month	month	NOUN
ajlm-1261	87	43	and	and	CCONJ
ajlm-1261	87	44	admission	admission	NOUN
ajlm-1261	87	45	duration	duration	NOUN
ajlm-1261	87	46	of	of	ADP
ajlm-1261	87	47	more	more	ADJ
ajlm-1261	87	48	than	than	ADP
ajlm-1261	87	49	a	a	PRON
ajlm-1261	87	50	month	month	NOUN
ajlm-1261	87	51	(	(	PUNCT
ajlm-1261	87	52	table	table	NOUN
ajlm-1261	87	53	2	2	NUM
ajlm-1261	87	54	)	)	PUNCT
ajlm-1261	87	55	.	.	PUNCT
ajlm-1261	88	1	further	further	ADJ
ajlm-1261	88	2	analysis	analysis	NOUN
ajlm-1261	88	3	with	with	ADP
ajlm-1261	88	4	logistic	logistic	ADJ
ajlm-1261	88	5	regression	regression	NOUN
ajlm-1261	88	6	however	however	ADV
ajlm-1261	88	7	identified	identify	VERB
ajlm-1261	88	8	only	only	ADV
ajlm-1261	88	9	peripheral	peripheral	ADJ
ajlm-1261	88	10	neuropathy	neuropathy	ADJ
ajlm-1261	88	11	(	(	PUNCT
ajlm-1261	88	12	adjusted	adjust	VERB
ajlm-1261	88	13	odds	odd	NOUN
ajlm-1261	88	14	ratio	ratio	NOUN
ajlm-1261	88	15	=	=	NOUN
ajlm-1261	88	16	4.05	4.05	NUM
ajlm-1261	88	17	,	,	PUNCT
ajlm-1261	88	18	95	95	NUM
ajlm-1261	88	19	%	%	NOUN
ajlm-1261	88	20	ci	ci	NOUN
ajlm-1261	88	21	:	:	PUNCT
ajlm-1261	88	22	1.08–15.13	1.08–15.13	NUM
ajlm-1261	88	23	)	)	PUNCT
ajlm-1261	88	24	and	and	CCONJ
ajlm-1261	88	25	foot	foot	NOUN
ajlm-1261	88	26	infection	infection	NOUN
ajlm-1261	88	27	duration	duration	NOUN
ajlm-1261	88	28	of	of	ADP
ajlm-1261	88	29	more	more	ADJ
ajlm-1261	88	30	than	than	ADP
ajlm-1261	88	31	a	a	PRON
ajlm-1261	88	32	month	month	NOUN
ajlm-1261	88	33	(	(	PUNCT
ajlm-1261	88	34	adjusted	adjust	VERB
ajlm-1261	88	35	odds	odd	NOUN
ajlm-1261	88	36	ratio	ratio	NOUN
ajlm-1261	88	37	=	=	SYM
ajlm-1261	88	38	7.63	7.63	NUM
ajlm-1261	88	39	,	,	PUNCT
ajlm-1261	88	40	ci	ci	NOUN
ajlm-1261	88	41	:	:	PUNCT
ajlm-1261	88	42	1.64–35.39	1.64–35.39	NUM
ajlm-1261	88	43	)	)	PUNCT
ajlm-1261	88	44	as	as	ADP
ajlm-1261	88	45	the	the	DET
ajlm-1261	88	46	predisposing	predispose	VERB
ajlm-1261	88	47	factors	factor	NOUN
ajlm-1261	88	48	for	for	ADP
ajlm-1261	88	49	acquisition	acquisition	NOUN
ajlm-1261	88	50	of	of	ADP
ajlm-1261	88	51	multidrug	multidrug	NOUN
ajlm-1261	88	52	-	-	PUNCT
ajlm-1261	88	53	resistant	resistant	ADJ
ajlm-1261	88	54	bacteria	bacteria	NOUN
ajlm-1261	88	55	among	among	ADP
ajlm-1261	88	56	patients	patient	NOUN
ajlm-1261	88	57	with	with	ADP
ajlm-1261	88	58	idfu	idfu	PROPN
ajlm-1261	88	59	.	.	PUNCT
ajlm-1261	89	1	a	a	DET
ajlm-1261	89	2	substantial	substantial	ADJ
ajlm-1261	89	3	proportion	proportion	NOUN
ajlm-1261	89	4	(	(	PUNCT
ajlm-1261	89	5	33/70	33/70	NUM
ajlm-1261	89	6	;	;	PUNCT
ajlm-1261	89	7	47.1	47.1	NUM
ajlm-1261	89	8	%	%	NOUN
ajlm-1261	89	9	)	)	PUNCT
ajlm-1261	89	10	of	of	ADP
ajlm-1261	89	11	the	the	DET
ajlm-1261	89	12	inpatients	inpatient	NOUN
ajlm-1261	89	13	had	have	VERB
ajlm-1261	89	14	poor	poor	ADJ
ajlm-1261	89	15	treatment	treatment	NOUN
ajlm-1261	89	16	outcomes	outcome	NOUN
ajlm-1261	89	17	;	;	PUNCT
ajlm-1261	89	18	poor	poor	ADJ
ajlm-1261	89	19	outcomes	outcome	NOUN
ajlm-1261	89	20	noted	note	VERB
ajlm-1261	89	21	in	in	ADP
ajlm-1261	89	22	53.4	53.4	NUM
ajlm-1261	89	23	%	%	NOUN
ajlm-1261	89	24	(	(	PUNCT
ajlm-1261	89	25	31/58	31/58	NUM
ajlm-1261	89	26	)	)	PUNCT
ajlm-1261	89	27	of	of	ADP
ajlm-1261	89	28	patients	patient	NOUN
ajlm-1261	89	29	with	with	ADP
ajlm-1261	89	30	mdr	mdr	PROPN
ajlm-1261	89	31	infections	infection	NOUN
ajlm-1261	89	32	included	include	VERB
ajlm-1261	89	33	major	major	ADJ
ajlm-1261	89	34	limb	limb	NOUN
ajlm-1261	89	35	amputation	amputation	NOUN
ajlm-1261	89	36	(	(	PUNCT
ajlm-1261	89	37	below	below	ADP
ajlm-1261	89	38	and	and	CCONJ
ajlm-1261	89	39	above	above	ADP
ajlm-1261	89	40	knee	knee	NOUN
ajlm-1261	89	41	amputation	amputation	NOUN
ajlm-1261	89	42	)	)	PUNCT
ajlm-1261	89	43	(	(	PUNCT
ajlm-1261	89	44	18/58	18/58	NUM
ajlm-1261	89	45	;	;	PUNCT
ajlm-1261	89	46	31.0	31.0	NUM
ajlm-1261	89	47	%	%	NOUN
ajlm-1261	89	48	)	)	PUNCT
ajlm-1261	89	49	and	and	CCONJ
ajlm-1261	89	50	death	death	NOUN
ajlm-1261	89	51	(	(	PUNCT
ajlm-1261	89	52	13/58	13/58	NUM
ajlm-1261	89	53	;	;	PUNCT
ajlm-1261	89	54	22.4	22.4	NUM
ajlm-1261	89	55	%	%	NOUN
ajlm-1261	89	56	)	)	PUNCT
ajlm-1261	89	57	.	.	PUNCT
ajlm-1261	90	1	infections	infection	NOUN
ajlm-1261	90	2	by	by	ADP
ajlm-1261	90	3	these	these	DET
ajlm-1261	90	4	mdr	mdr	PROPN
ajlm-1261	90	5	bacteria	bacteria	NOUN
ajlm-1261	90	6	have	have	VERB
ajlm-1261	90	7	significant	significant	ADJ
ajlm-1261	90	8	association	association	NOUN
ajlm-1261	90	9	with	with	ADP
ajlm-1261	90	10	poor	poor	ADJ
ajlm-1261	90	11	treatment	treatment	NOUN
ajlm-1261	90	12	outcomes	outcome	NOUN
ajlm-1261	90	13	(	(	PUNCT
ajlm-1261	90	14	adjusted	adjust	VERB
ajlm-1261	90	15	odds	odd	NOUN
ajlm-1261	90	16	ratio	ratio	NOUN
ajlm-1261	90	17	=	=	SYM
ajlm-1261	90	18	5.11	5.11	NUM
ajlm-1261	90	19	,	,	PUNCT
ajlm-1261	90	20	95	95	NUM
ajlm-1261	90	21	%	%	NOUN
ajlm-1261	90	22	ci	ci	NOUN
ajlm-1261	90	23	:	:	PUNCT
ajlm-1261	90	24	1.23–29.67	1.23–29.67	NUM
ajlm-1261	90	25	)	)	PUNCT
ajlm-1261	90	26	.	.	PUNCT
ajlm-1261	91	1	distribution	distribution	NOUN
ajlm-1261	91	2	of	of	ADP
ajlm-1261	91	3	isolates	isolate	NOUN
ajlm-1261	91	4	among	among	ADP
ajlm-1261	91	5	diabetic	diabetic	ADJ
ajlm-1261	91	6	foot	foot	NOUN
ajlm-1261	91	7	cases	case	NOUN
ajlm-1261	91	8	all	all	DET
ajlm-1261	91	9	93	93	NUM
ajlm-1261	91	10	wound	wound	NOUN
ajlm-1261	91	11	specimens	specimen	NOUN
ajlm-1261	91	12	obtained	obtain	VERB
ajlm-1261	91	13	from	from	ADP
ajlm-1261	91	14	the	the	DET
ajlm-1261	91	15	90	90	NUM
ajlm-1261	91	16	patients	patient	NOUN
ajlm-1261	91	17	(	(	PUNCT
ajlm-1261	91	18	three	three	NUM
ajlm-1261	91	19	patients	patient	NOUN
ajlm-1261	91	20	had	have	AUX
ajlm-1261	91	21	bilateral	bilateral	ADJ
ajlm-1261	91	22	foot	foot	NOUN
ajlm-1261	91	23	ulcers	ulcer	NOUN
ajlm-1261	91	24	)	)	PUNCT
ajlm-1261	91	25	in	in	ADP
ajlm-1261	91	26	the	the	DET
ajlm-1261	91	27	three	three	NUM
ajlm-1261	91	28	healthcare	healthcare	NOUN
ajlm-1261	91	29	facilities	facility	NOUN
ajlm-1261	91	30	were	be	AUX
ajlm-1261	91	31	positive	positive	ADJ
ajlm-1261	91	32	on	on	ADP
ajlm-1261	91	33	bacterial	bacterial	ADJ
ajlm-1261	91	34	culture	culture	NOUN
ajlm-1261	91	35	with	with	ADP
ajlm-1261	91	36	only	only	ADV
ajlm-1261	91	37	10	10	NUM
ajlm-1261	91	38	(	(	PUNCT
ajlm-1261	91	39	10.8	10.8	NUM
ajlm-1261	91	40	%	%	NOUN
ajlm-1261	91	41	)	)	PUNCT
ajlm-1261	91	42	of	of	ADP
ajlm-1261	91	43	them	they	PRON
ajlm-1261	91	44	yielding	yield	VERB
ajlm-1261	91	45	a	a	DET
ajlm-1261	91	46	single	single	ADJ
ajlm-1261	91	47	organism	organism	NOUN
ajlm-1261	91	48	each	each	PRON
ajlm-1261	91	49	.	.	PUNCT
ajlm-1261	92	1	among	among	ADP
ajlm-1261	92	2	the	the	DET
ajlm-1261	92	3	polymicrobial	polymicrobial	ADJ
ajlm-1261	92	4	cultures	culture	NOUN
ajlm-1261	92	5	,	,	PUNCT
ajlm-1261	92	6	45	45	NUM
ajlm-1261	92	7	(	(	PUNCT
ajlm-1261	92	8	48.4	48.4	NUM
ajlm-1261	92	9	%	%	NOUN
ajlm-1261	92	10	)	)	PUNCT
ajlm-1261	92	11	yielded	yield	VERB
ajlm-1261	92	12	two	two	NUM
ajlm-1261	92	13	organisms	organism	NOUN
ajlm-1261	92	14	per	per	ADP
ajlm-1261	92	15	culture	culture	NOUN
ajlm-1261	92	16	,	,	PUNCT
ajlm-1261	92	17	34	34	NUM
ajlm-1261	92	18	(	(	PUNCT
ajlm-1261	92	19	36.6	36.6	NUM
ajlm-1261	92	20	%	%	NOUN
ajlm-1261	92	21	)	)	PUNCT
ajlm-1261	92	22	yielded	yield	VERB
ajlm-1261	92	23	three	three	NUM
ajlm-1261	92	24	organisms	organism	NOUN
ajlm-1261	92	25	per	per	ADP
ajlm-1261	92	26	culture	culture	NOUN
ajlm-1261	92	27	while	while	SCONJ
ajlm-1261	92	28	4	4	NUM
ajlm-1261	92	29	(	(	PUNCT
ajlm-1261	92	30	4.3	4.3	NUM
ajlm-1261	92	31	%	%	NOUN
ajlm-1261	92	32	)	)	PUNCT
ajlm-1261	92	33	yielded	yield	VERB
ajlm-1261	92	34	four	four	NUM
ajlm-1261	92	35	organisms	organism	NOUN
ajlm-1261	92	36	per	per	ADP
ajlm-1261	92	37	culture	culture	NOUN
ajlm-1261	92	38	.	.	PUNCT
ajlm-1261	93	1	results	result	NOUN
ajlm-1261	93	2	further	far	ADV
ajlm-1261	93	3	showed	show	VERB
ajlm-1261	93	4	that	that	SCONJ
ajlm-1261	93	5	there	there	PRON
ajlm-1261	93	6	was	be	VERB
ajlm-1261	93	7	a	a	DET
ajlm-1261	93	8	total	total	NOUN
ajlm-1261	93	9	of	of	ADP
ajlm-1261	93	10	218	218	NUM
ajlm-1261	93	11	organisms	organism	NOUN
ajlm-1261	93	12	isolated	isolate	VERB
ajlm-1261	93	13	from	from	ADP
ajlm-1261	93	14	the	the	DET
ajlm-1261	93	15	93	93	NUM
ajlm-1261	93	16	specimens	specimen	NOUN
ajlm-1261	93	17	cultured	cultured	ADJ
ajlm-1261	93	18	with	with	ADP
ajlm-1261	93	19	an	an	DET
ajlm-1261	93	20	average	average	NOUN
ajlm-1261	93	21	of	of	ADP
ajlm-1261	93	22	2.34	2.34	NUM
ajlm-1261	93	23	organisms	organism	NOUN
ajlm-1261	93	24	per	per	ADP
ajlm-1261	93	25	sample	sample	NOUN
ajlm-1261	93	26	.	.	PUNCT
ajlm-1261	94	1	of	of	ADP
ajlm-1261	94	2	the	the	DET
ajlm-1261	94	3	organisms	organism	NOUN
ajlm-1261	94	4	,	,	PUNCT
ajlm-1261	94	5	129	129	NUM
ajlm-1261	94	6	(	(	PUNCT
ajlm-1261	94	7	59.2	59.2	NUM
ajlm-1261	94	8	%	%	NOUN
ajlm-1261	94	9	)	)	PUNCT
ajlm-1261	94	10	were	be	AUX
ajlm-1261	94	11	gram	gram	NOUN
ajlm-1261	94	12	-	-	PUNCT
ajlm-1261	94	13	negative	negative	ADJ
ajlm-1261	94	14	aerobic	aerobic	ADJ
ajlm-1261	94	15	and	and	CCONJ
ajlm-1261	94	16	facultative	facultative	ADJ
ajlm-1261	94	17	anaerobic	anaerobic	NOUN
ajlm-1261	94	18	bacilli	bacilli	NOUN
ajlm-1261	94	19	,	,	PUNCT
ajlm-1261	94	20	59	59	NUM
ajlm-1261	94	21	(	(	PUNCT
ajlm-1261	94	22	27.1	27.1	NUM
ajlm-1261	94	23	%	%	NOUN
ajlm-1261	94	24	)	)	PUNCT
ajlm-1261	94	25	were	be	AUX
ajlm-1261	94	26	gram	gram	NOUN
ajlm-1261	94	27	-	-	PUNCT
ajlm-1261	94	28	positive	positive	ADJ
ajlm-1261	94	29	aerobic	aerobic	ADJ
ajlm-1261	94	30	cocci	cocci	NOUN
ajlm-1261	94	31	and	and	CCONJ
ajlm-1261	94	32	29	29	NUM
ajlm-1261	94	33	(	(	PUNCT
ajlm-1261	94	34	13.3	13.3	NUM
ajlm-1261	94	35	%	%	NOUN
ajlm-1261	94	36	)	)	PUNCT
ajlm-1261	94	37	were	be	AUX
ajlm-1261	94	38	anaerobic	anaerobic	ADJ
ajlm-1261	94	39	bacteria	bacteria	NOUN
ajlm-1261	94	40	;	;	PUNCT
ajlm-1261	94	41	only	only	ADV
ajlm-1261	94	42	1	1	NUM
ajlm-1261	94	43	(	(	PUNCT
ajlm-1261	94	44	0.5	0.5	NUM
ajlm-1261	94	45	%	%	NOUN
ajlm-1261	94	46	)	)	PUNCT
ajlm-1261	94	47	was	be	AUX
ajlm-1261	94	48	yeast	yeast	NOUN
ajlm-1261	94	49	.	.	PUNCT
ajlm-1261	95	1	s.	s.	PROPN
ajlm-1261	95	2	aureus	aureus	PROPN
ajlm-1261	95	3	(	(	PUNCT
ajlm-1261	95	4	34	34	NUM
ajlm-1261	95	5	;	;	PUNCT
ajlm-1261	95	6	15.6	15.6	NUM
ajlm-1261	95	7	%	%	NOUN
ajlm-1261	95	8	)	)	PUNCT
ajlm-1261	95	9	was	be	AUX
ajlm-1261	95	10	the	the	DET
ajlm-1261	95	11	single	single	ADJ
ajlm-1261	95	12	most	most	ADV
ajlm-1261	95	13	common	common	ADJ
ajlm-1261	95	14	organism	organism	NOUN
ajlm-1261	95	15	followed	follow	VERB
ajlm-1261	95	16	by	by	ADP
ajlm-1261	95	17	e.	e.	PROPN
ajlm-1261	95	18	coli	coli	PROPN
ajlm-1261	95	19	(	(	PUNCT
ajlm-1261	95	20	23	23	NUM
ajlm-1261	95	21	;	;	PUNCT
ajlm-1261	95	22	10.6	10.6	NUM
ajlm-1261	95	23	%	%	NOUN
ajlm-1261	95	24	)	)	PUNCT
ajlm-1261	95	25	and	and	CCONJ
ajlm-1261	95	26	pseudomonas	pseudomona	NOUN
ajlm-1261	95	27	aeruginosa	aeruginosa	NOUN
ajlm-1261	95	28	(	(	PUNCT
ajlm-1261	95	29	20	20	NUM
ajlm-1261	95	30	;	;	PUNCT
ajlm-1261	95	31	9.2	9.2	NUM
ajlm-1261	95	32	%	%	NOUN
ajlm-1261	95	33	)	)	PUNCT
ajlm-1261	95	34	.	.	PUNCT
ajlm-1261	96	1	others	other	NOUN
ajlm-1261	96	2	included	include	VERB
ajlm-1261	96	3	klebsiella	klebsiella	PROPN
ajlm-1261	96	4	spp	spp	PROPN
ajlm-1261	96	5	.	.	PUNCT
ajlm-1261	97	1	(	(	PUNCT
ajlm-1261	97	2	19	19	NUM
ajlm-1261	97	3	;	;	PUNCT
ajlm-1261	97	4	8.7	8.7	NUM
ajlm-1261	97	5	%	%	NOUN
ajlm-1261	97	6	)	)	PUNCT
ajlm-1261	97	7	,	,	PUNCT
ajlm-1261	97	8	citrobacter	citrobacter	PROPN
ajlm-1261	97	9	spp	spp	NOUN
ajlm-1261	97	10	.	.	PUNCT
ajlm-1261	98	1	(	(	PUNCT
ajlm-1261	98	2	19	19	NUM
ajlm-1261	98	3	;	;	PUNCT
ajlm-1261	98	4	8.7	8.7	NUM
ajlm-1261	98	5	%	%	NOUN
ajlm-1261	98	6	)	)	PUNCT
ajlm-1261	98	7	,	,	PUNCT
ajlm-1261	98	8	enterococcus	enterococcus	NOUN
ajlm-1261	98	9	spp	spp	NOUN
ajlm-1261	98	10	.	.	PUNCT
ajlm-1261	99	1	(	(	PUNCT
ajlm-1261	99	2	14	14	NUM
ajlm-1261	99	3	;	;	PUNCT
ajlm-1261	99	4	6.4	6.4	NUM
ajlm-1261	99	5	%	%	NOUN
ajlm-1261	99	6	)	)	PUNCT
ajlm-1261	99	7	,	,	PUNCT
ajlm-1261	99	8	enterobacter	enterobacter	ADJ
ajlm-1261	99	9	spp	spp	NOUN
ajlm-1261	99	10	.	.	PUNCT
ajlm-1261	100	1	(	(	PUNCT
ajlm-1261	100	2	11	11	NUM
ajlm-1261	100	3	;	;	PUNCT
ajlm-1261	100	4	5.0	5.0	NUM
ajlm-1261	100	5	%	%	NOUN
ajlm-1261	100	6	)	)	PUNCT
ajlm-1261	100	7	,	,	PUNCT
ajlm-1261	100	8	proteus	proteus	NOUN
ajlm-1261	100	9	mirabilis	mirabilis	PROPN
ajlm-1261	100	10	(	(	PUNCT
ajlm-1261	100	11	10	10	NUM
ajlm-1261	100	12	;	;	PUNCT
ajlm-1261	100	13	4.6	4.6	NUM
ajlm-1261	100	14	%	%	NOUN
ajlm-1261	100	15	)	)	PUNCT
ajlm-1261	100	16	and	and	CCONJ
ajlm-1261	100	17	acinetobacter	acinetobacter	ADV
ajlm-1261	100	18	spp	spp	NOUN
ajlm-1261	100	19	(	(	PUNCT
ajlm-1261	100	20	9	9	NUM
ajlm-1261	100	21	;	;	PUNCT
ajlm-1261	100	22	4.1	4.1	NUM
ajlm-1261	100	23	%	%	NOUN
ajlm-1261	100	24	)	)	PUNCT
ajlm-1261	100	25	.	.	PUNCT
ajlm-1261	101	1	on	on	ADP
ajlm-1261	101	2	the	the	DET
ajlm-1261	101	3	other	other	ADJ
ajlm-1261	101	4	hand	hand	NOUN
ajlm-1261	101	5	,	,	PUNCT
ajlm-1261	101	6	the	the	DET
ajlm-1261	101	7	predominant	predominant	ADJ
ajlm-1261	101	8	anaerobic	anaerobic	NOUN
ajlm-1261	101	9	bacteria	bacteria	NOUN
ajlm-1261	101	10	were	be	AUX
ajlm-1261	101	11	bacteroides	bacteroide	VERB
ajlm-1261	101	12	spp	spp	NOUN
ajlm-1261	101	13	.	.	PUNCT
ajlm-1261	102	1	(	(	PUNCT
ajlm-1261	102	2	7	7	NUM
ajlm-1261	102	3	;	;	PUNCT
ajlm-1261	102	4	3.2	3.2	NUM
ajlm-1261	102	5	%	%	NOUN
ajlm-1261	102	6	)	)	PUNCT
ajlm-1261	102	7	and	and	CCONJ
ajlm-1261	102	8	p.	p.	NOUN
ajlm-1261	102	9	anaerobius	anaerobius	NOUN
ajlm-1261	102	10	(	(	PUNCT
ajlm-1261	102	11	6	6	NUM
ajlm-1261	102	12	;	;	PUNCT
ajlm-1261	102	13	2.8	2.8	NUM
ajlm-1261	102	14	%	%	NOUN
ajlm-1261	102	15	)	)	PUNCT
ajlm-1261	102	16	as	as	SCONJ
ajlm-1261	102	17	shown	show	VERB
ajlm-1261	102	18	in	in	ADP
ajlm-1261	102	19	table	table	NOUN
ajlm-1261	102	20	3	3	NUM
ajlm-1261	102	21	.	.	PUNCT
ajlm-1261	102	22	table	table	NOUN
ajlm-1261	102	23	3	3	NUM
ajlm-1261	102	24	:	:	PUNCT
ajlm-1261	102	25	 	 	SPACE
ajlm-1261	102	26	bacterial	bacterial	ADJ
ajlm-1261	102	27	aetiological	aetiological	ADJ
ajlm-1261	102	28	agents	agent	NOUN
ajlm-1261	102	29	of	of	ADP
ajlm-1261	102	30	infected	infected	ADJ
ajlm-1261	102	31	diabetic	diabetic	ADJ
ajlm-1261	102	32	foot	foot	NOUN
ajlm-1261	102	33	ulcers	ulcer	NOUN
ajlm-1261	102	34	in	in	ADP
ajlm-1261	102	35	tertiary	tertiary	ADJ
ajlm-1261	102	36	healthcare	healthcare	NOUN
ajlm-1261	102	37	facilities	facility	NOUN
ajlm-1261	102	38	in	in	ADP
ajlm-1261	102	39	osun	osun	PROPN
ajlm-1261	102	40	state	state	PROPN
ajlm-1261	102	41	,	,	PUNCT
ajlm-1261	102	42	nigeria	nigeria	PROPN
ajlm-1261	102	43	,	,	PUNCT
ajlm-1261	102	44	july	july	PROPN
ajlm-1261	102	45	2016	2016	NUM
ajlm-1261	102	46	to	to	ADP
ajlm-1261	102	47	april	april	PROPN
ajlm-1261	102	48	2017	2017	NUM
ajlm-1261	102	49	.	.	PUNCT
ajlm-1261	103	1	antibiotic	antibiotic	ADJ
ajlm-1261	103	2	resistance	resistance	NOUN
ajlm-1261	103	3	pattern	pattern	NOUN
ajlm-1261	103	4	of	of	ADP
ajlm-1261	103	5	aerobic	aerobic	ADJ
ajlm-1261	103	6	isolates	isolate	NOUN
ajlm-1261	103	7	gram	gram	NOUN
ajlm-1261	103	8	-	-	PUNCT
ajlm-1261	103	9	positive	positive	ADJ
ajlm-1261	103	10	bacteria	bacteria	NOUN
ajlm-1261	103	11	were	be	AUX
ajlm-1261	103	12	highly	highly	ADV
ajlm-1261	103	13	resistant	resistant	ADJ
ajlm-1261	103	14	to	to	ADP
ajlm-1261	103	15	trimethoprim	trimethoprim	NOUN
ajlm-1261	103	16	-	-	PUNCT
ajlm-1261	103	17	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-1261	103	18	(	(	PUNCT
ajlm-1261	103	19	69.5	69.5	NUM
ajlm-1261	103	20	%	%	NOUN
ajlm-1261	103	21	)	)	PUNCT
ajlm-1261	103	22	,	,	PUNCT
ajlm-1261	103	23	penicillin	penicillin	PROPN
ajlm-1261	103	24	g	g	PROPN
ajlm-1261	103	25	(	(	PUNCT
ajlm-1261	103	26	66.1	66.1	NUM
ajlm-1261	103	27	%	%	NOUN
ajlm-1261	103	28	)	)	PUNCT
ajlm-1261	103	29	and	and	CCONJ
ajlm-1261	103	30	gentamicin	gentamicin	NOUN
ajlm-1261	103	31	(	(	PUNCT
ajlm-1261	103	32	40.1	40.1	NUM
ajlm-1261	103	33	%	%	NOUN
ajlm-1261	103	34	)	)	PUNCT
ajlm-1261	103	35	but	but	CCONJ
ajlm-1261	103	36	demonstrated	demonstrate	VERB
ajlm-1261	103	37	low	low	ADJ
ajlm-1261	103	38	-	-	PUNCT
ajlm-1261	103	39	level	level	NOUN
ajlm-1261	103	40	resistance	resistance	NOUN
ajlm-1261	103	41	to	to	ADP
ajlm-1261	103	42	piperacillin	piperacillin	NOUN
ajlm-1261	103	43	/	/	SYM
ajlm-1261	103	44	tazobactam	tazobactam	NOUN
ajlm-1261	103	45	(	(	PUNCT
ajlm-1261	103	46	6.8	6.8	NUM
ajlm-1261	103	47	%	%	NOUN
ajlm-1261	103	48	)	)	PUNCT
ajlm-1261	103	49	and	and	CCONJ
ajlm-1261	103	50	amikacin	amikacin	PROPN
ajlm-1261	103	51	(	(	PUNCT
ajlm-1261	103	52	10.2	10.2	NUM
ajlm-1261	103	53	%	%	NOUN
ajlm-1261	103	54	)	)	PUNCT
ajlm-1261	103	55	.	.	PUNCT
ajlm-1261	104	1	on	on	ADP
ajlm-1261	104	2	the	the	DET
ajlm-1261	104	3	other	other	ADJ
ajlm-1261	104	4	hand	hand	NOUN
ajlm-1261	104	5	,	,	PUNCT
ajlm-1261	104	6	gram	gram	NOUN
ajlm-1261	104	7	-	-	PUNCT
ajlm-1261	104	8	negative	negative	ADJ
ajlm-1261	104	9	bacteria	bacteria	NOUN
ajlm-1261	104	10	were	be	AUX
ajlm-1261	104	11	highly	highly	ADV
ajlm-1261	104	12	resistant	resistant	ADJ
ajlm-1261	104	13	to	to	ADP
ajlm-1261	104	14	the	the	DET
ajlm-1261	104	15	third	third	ADJ
ajlm-1261	104	16	-	-	PUNCT
ajlm-1261	104	17	generation	generation	NOUN
ajlm-1261	104	18	cephalosporins	cephalosporin	NOUN
ajlm-1261	104	19	which	which	PRON
ajlm-1261	104	20	included	include	VERB
ajlm-1261	104	21	ceftriaxone	ceftriaxone	NOUN
ajlm-1261	104	22	(	(	PUNCT
ajlm-1261	104	23	56	56	NUM
ajlm-1261	104	24	%	%	NOUN
ajlm-1261	104	25	)	)	PUNCT
ajlm-1261	104	26	,	,	PUNCT
ajlm-1261	104	27	cefotaxime	cefotaxime	NOUN
ajlm-1261	104	28	(	(	PUNCT
ajlm-1261	104	29	55	55	NUM
ajlm-1261	104	30	%	%	NOUN
ajlm-1261	104	31	)	)	PUNCT
ajlm-1261	104	32	and	and	CCONJ
ajlm-1261	104	33	ceftazidime	ceftazidime	NOUN
ajlm-1261	104	34	(	(	PUNCT
ajlm-1261	104	35	48.1	48.1	NUM
ajlm-1261	104	36	%	%	NOUN
ajlm-1261	104	37	)	)	PUNCT
ajlm-1261	104	38	,	,	PUNCT
ajlm-1261	104	39	as	as	ADV
ajlm-1261	104	40	well	well	ADV
ajlm-1261	104	41	as	as	ADP
ajlm-1261	104	42	trimethoprim	trimethoprim	ADJ
ajlm-1261	104	43	-	-	PUNCT
ajlm-1261	104	44	sulfamethoxazole	sulfamethoxazole	NOUN
ajlm-1261	104	45	(	(	PUNCT
ajlm-1261	104	46	89	89	NUM
ajlm-1261	104	47	%	%	NOUN
ajlm-1261	104	48	)	)	PUNCT
ajlm-1261	104	49	,	,	PUNCT
ajlm-1261	104	50	gentamicin	gentamicin	NOUN
ajlm-1261	104	51	(	(	PUNCT
ajlm-1261	104	52	54.3	54.3	NUM
ajlm-1261	104	53	%	%	NOUN
ajlm-1261	104	54	)	)	PUNCT
ajlm-1261	104	55	and	and	CCONJ
ajlm-1261	104	56	ciprofloxacin	ciprofloxacin	PROPN
ajlm-1261	104	57	(	(	PUNCT
ajlm-1261	104	58	54.3	54.3	NUM
ajlm-1261	104	59	%	%	NOUN
ajlm-1261	104	60	)	)	PUNCT
ajlm-1261	104	61	.	.	PUNCT
ajlm-1261	105	1	low	low	ADJ
ajlm-1261	105	2	rates	rate	NOUN
ajlm-1261	105	3	of	of	ADP
ajlm-1261	105	4	resistance	resistance	NOUN
ajlm-1261	105	5	were	be	AUX
ajlm-1261	105	6	however	however	ADV
ajlm-1261	105	7	shown	show	VERB
ajlm-1261	105	8	to	to	ADP
ajlm-1261	105	9	ertapenem	ertapenem	PROPN
ajlm-1261	105	10	(	(	PUNCT
ajlm-1261	105	11	6.4	6.4	NUM
ajlm-1261	105	12	%	%	NOUN
ajlm-1261	105	13	)	)	PUNCT
ajlm-1261	105	14	,	,	PUNCT
ajlm-1261	105	15	piperacillin	piperacillin	NOUN
ajlm-1261	105	16	/	/	SYM
ajlm-1261	105	17	tazobactam	tazobactam	NOUN
ajlm-1261	105	18	(	(	PUNCT
ajlm-1261	105	19	9.3	9.3	NUM
ajlm-1261	105	20	%	%	NOUN
ajlm-1261	105	21	)	)	PUNCT
ajlm-1261	105	22	and	and	CCONJ
ajlm-1261	105	23	amikacin	amikacin	PROPN
ajlm-1261	105	24	(	(	PUNCT
ajlm-1261	105	25	12.4	12.4	NUM
ajlm-1261	105	26	%	%	NOUN
ajlm-1261	105	27	)	)	PUNCT
ajlm-1261	105	28	.	.	PUNCT
ajlm-1261	106	1	prevalence	prevalence	NOUN
ajlm-1261	106	2	and	and	CCONJ
ajlm-1261	106	3	pattern	pattern	NOUN
ajlm-1261	106	4	of	of	ADP
ajlm-1261	106	5	multidrug	multidrug	NOUN
ajlm-1261	106	6	resistance	resistance	NOUN
ajlm-1261	106	7	among	among	ADP
ajlm-1261	106	8	bacterial	bacterial	ADJ
ajlm-1261	106	9	isolates	isolate	NOUN
ajlm-1261	106	10	in	in	ADP
ajlm-1261	106	11	infected	infected	ADJ
ajlm-1261	106	12	diabetic	diabetic	ADJ
ajlm-1261	106	13	foot	foot	NOUN
ajlm-1261	106	14	ulcer	ulcer	NOUN
ajlm-1261	106	15	further	further	ADJ
ajlm-1261	106	16	analysis	analysis	NOUN
ajlm-1261	106	17	of	of	ADP
ajlm-1261	106	18	resistance	resistance	NOUN
ajlm-1261	106	19	profiles	profile	NOUN
ajlm-1261	106	20	in	in	ADP
ajlm-1261	106	21	the	the	DET
ajlm-1261	106	22	organisms	organism	NOUN
ajlm-1261	106	23	showed	show	VERB
ajlm-1261	106	24	that	that	SCONJ
ajlm-1261	106	25	of	of	ADP
ajlm-1261	106	26	the	the	DET
ajlm-1261	106	27	188	188	NUM
ajlm-1261	106	28	aerobic	aerobic	ADJ
ajlm-1261	106	29	isolates	isolate	NOUN
ajlm-1261	106	30	,	,	PUNCT
ajlm-1261	106	31	121	121	NUM
ajlm-1261	106	32	(	(	PUNCT
ajlm-1261	106	33	64.4	64.4	NUM
ajlm-1261	106	34	%	%	NOUN
ajlm-1261	106	35	)	)	PUNCT
ajlm-1261	106	36	were	be	AUX
ajlm-1261	106	37	mdr	mdr	PROPN
ajlm-1261	106	38	,	,	PUNCT
ajlm-1261	106	39	being	be	AUX
ajlm-1261	106	40	resistant	resistant	ADJ
ajlm-1261	106	41	to	to	ADP
ajlm-1261	106	42	one	one	NUM
ajlm-1261	106	43	or	or	CCONJ
ajlm-1261	106	44	more	more	ADJ
ajlm-1261	106	45	agents	agent	NOUN
ajlm-1261	106	46	in	in	ADP
ajlm-1261	106	47	at	at	ADV
ajlm-1261	106	48	least	least	ADV
ajlm-1261	106	49	three	three	NUM
ajlm-1261	106	50	antibiotic	antibiotic	ADJ
ajlm-1261	106	51	classes	class	NOUN
ajlm-1261	106	52	(	(	PUNCT
ajlm-1261	106	53	table	table	NOUN
ajlm-1261	106	54	4	4	NUM
ajlm-1261	106	55	)	)	PUNCT
ajlm-1261	106	56	.	.	PUNCT
ajlm-1261	107	1	the	the	DET
ajlm-1261	107	2	prevalence	prevalence	NOUN
ajlm-1261	107	3	rates	rate	NOUN
ajlm-1261	107	4	of	of	ADP
ajlm-1261	107	5	mdr	mdr	PROPN
ajlm-1261	107	6	among	among	ADP
ajlm-1261	107	7	gpc	gpc	PROPN
ajlm-1261	107	8	and	and	CCONJ
ajlm-1261	107	9	gnb	gnb	PROPN
ajlm-1261	107	10	were	be	AUX
ajlm-1261	107	11	55.9	55.9	NUM
ajlm-1261	107	12	%	%	NOUN
ajlm-1261	107	13	and	and	CCONJ
ajlm-1261	107	14	68.2	68.2	NUM
ajlm-1261	107	15	%	%	NOUN
ajlm-1261	107	16	.	.	PUNCT
ajlm-1261	108	1	multidrug	multidrug	NOUN
ajlm-1261	108	2	resistance	resistance	NOUN
ajlm-1261	108	3	rates	rate	NOUN
ajlm-1261	108	4	were	be	AUX
ajlm-1261	108	5	generally	generally	ADV
ajlm-1261	108	6	high	high	ADJ
ajlm-1261	108	7	among	among	ADP
ajlm-1261	108	8	the	the	DET
ajlm-1261	108	9	isolated	isolate	VERB
ajlm-1261	108	10	bacteria	bacteria	NOUN
ajlm-1261	108	11	especially	especially	ADV
ajlm-1261	108	12	acinetobacter	acinetobacter	ADV
ajlm-1261	108	13	species	specie	NOUN
ajlm-1261	108	14	(	(	PUNCT
ajlm-1261	108	15	88.9	88.9	NUM
ajlm-1261	108	16	%	%	NOUN
ajlm-1261	108	17	)	)	PUNCT
ajlm-1261	108	18	,	,	PUNCT
ajlm-1261	108	19	enterococcus	enterococcus	NOUN
ajlm-1261	108	20	species	specie	NOUN
ajlm-1261	108	21	(	(	PUNCT
ajlm-1261	108	22	84.6	84.6	NUM
ajlm-1261	108	23	%	%	NOUN
ajlm-1261	108	24	)	)	PUNCT
ajlm-1261	108	25	,	,	PUNCT
ajlm-1261	108	26	enterobacter	enterobacter	NOUN
ajlm-1261	108	27	species	specie	NOUN
ajlm-1261	108	28	(	(	PUNCT
ajlm-1261	108	29	81.8	81.8	NUM
ajlm-1261	108	30	%	%	NOUN
ajlm-1261	108	31	)	)	PUNCT
ajlm-1261	108	32	and	and	CCONJ
ajlm-1261	108	33	citrobacter	citrobacter	ADJ
ajlm-1261	108	34	species	specie	NOUN
ajlm-1261	108	35	(	(	PUNCT
ajlm-1261	108	36	73.7	73.7	NUM
ajlm-1261	108	37	%	%	NOUN
ajlm-1261	108	38	)	)	PUNCT
ajlm-1261	108	39	.	.	PUNCT
ajlm-1261	109	1	overall	overall	ADJ
ajlm-1261	109	2	prevalence	prevalence	NOUN
ajlm-1261	109	3	of	of	ADP
ajlm-1261	109	4	mdr	mdr	PROPN
ajlm-1261	109	5	bacteria	bacteria	NOUN
ajlm-1261	109	6	among	among	ADP
ajlm-1261	109	7	the	the	DET
ajlm-1261	109	8	idfu	idfu	ADJ
ajlm-1261	109	9	cases	case	NOUN
ajlm-1261	109	10	was	be	AUX
ajlm-1261	109	11	80	80	NUM
ajlm-1261	109	12	%	%	NOUN
ajlm-1261	109	13	(	(	PUNCT
ajlm-1261	109	14	n	n	NOUN
ajlm-1261	109	15	=	=	SYM
ajlm-1261	109	16	74	74	NUM
ajlm-1261	109	17	)	)	PUNCT
ajlm-1261	109	18	with	with	ADP
ajlm-1261	109	19	rates	rate	NOUN
ajlm-1261	109	20	among	among	ADP
ajlm-1261	109	21	in	in	ADP
ajlm-1261	109	22	-	-	PUNCT
ajlm-1261	109	23	patient	patient	ADJ
ajlm-1261	109	24	and	and	CCONJ
ajlm-1261	109	25	outpatient	outpatient	NOUN
ajlm-1261	109	26	cases	case	NOUN
ajlm-1261	109	27	being	be	AUX
ajlm-1261	109	28	82.9	82.9	NUM
ajlm-1261	109	29	%	%	NOUN
ajlm-1261	109	30	(	(	PUNCT
ajlm-1261	109	31	n	n	NOUN
ajlm-1261	109	32	=	=	SYM
ajlm-1261	109	33	58	58	NUM
ajlm-1261	109	34	)	)	PUNCT
ajlm-1261	109	35	and	and	CCONJ
ajlm-1261	109	36	69.6	69.6	NUM
ajlm-1261	109	37	%	%	NOUN
ajlm-1261	109	38	(	(	PUNCT
ajlm-1261	109	39	n	n	NOUN
ajlm-1261	109	40	=	=	SYM
ajlm-1261	109	41	16	16	NUM
ajlm-1261	109	42	)	)	PUNCT
ajlm-1261	109	43	.	.	PUNCT
ajlm-1261	110	1	twelve	twelve	NUM
ajlm-1261	110	2	(	(	PUNCT
ajlm-1261	110	3	35.3	35.3	NUM
ajlm-1261	110	4	%	%	NOUN
ajlm-1261	110	5	)	)	PUNCT
ajlm-1261	111	1	s.	s.	PROPN
ajlm-1261	111	2	aureus	aureus	PROPN
ajlm-1261	111	3	were	be	AUX
ajlm-1261	111	4	methicillin	methicillin	NOUN
ajlm-1261	111	5	-	-	PUNCT
ajlm-1261	111	6	resistant	resistant	ADJ
ajlm-1261	111	7	,	,	PUNCT
ajlm-1261	111	8	while	while	SCONJ
ajlm-1261	111	9	of	of	ADP
ajlm-1261	111	10	the	the	DET
ajlm-1261	111	11	129	129	NUM
ajlm-1261	111	12	gnb	gnb	PROPN
ajlm-1261	111	13	,	,	PUNCT
ajlm-1261	111	14	43	43	NUM
ajlm-1261	111	15	(	(	PUNCT
ajlm-1261	111	16	33.3	33.3	NUM
ajlm-1261	111	17	%	%	NOUN
ajlm-1261	111	18	)	)	PUNCT
ajlm-1261	111	19	were	be	AUX
ajlm-1261	111	20	esbl	esbl	NOUN
ajlm-1261	111	21	-	-	PUNCT
ajlm-1261	111	22	producing	produce	VERB
ajlm-1261	111	23	and	and	CCONJ
ajlm-1261	111	24	10	10	NUM
ajlm-1261	111	25	(	(	PUNCT
ajlm-1261	111	26	7.8	7.8	NUM
ajlm-1261	111	27	%	%	NOUN
ajlm-1261	111	28	)	)	PUNCT
ajlm-1261	111	29	were	be	AUX
ajlm-1261	111	30	carbapenem	carbapenem	NOUN
ajlm-1261	111	31	-	-	PUNCT
ajlm-1261	111	32	resistant	resistant	ADJ
ajlm-1261	111	33	(	(	PUNCT
ajlm-1261	111	34	table	table	NOUN
ajlm-1261	111	35	5	5	NUM
ajlm-1261	111	36	)	)	PUNCT
ajlm-1261	111	37	.	.	PUNCT
ajlm-1261	112	1	high	high	ADJ
ajlm-1261	112	2	esbl	esbl	PROPN
ajlm-1261	112	3	production	production	NOUN
ajlm-1261	112	4	rates	rate	NOUN
ajlm-1261	112	5	were	be	AUX
ajlm-1261	112	6	seen	see	VERB
ajlm-1261	112	7	among	among	ADP
ajlm-1261	112	8	enterobacter	enterobacter	ADJ
ajlm-1261	112	9	species	specie	NOUN
ajlm-1261	112	10	(	(	PUNCT
ajlm-1261	112	11	54.6	54.6	NUM
ajlm-1261	112	12	%	%	NOUN
ajlm-1261	112	13	)	)	PUNCT
ajlm-1261	112	14	,	,	PUNCT
ajlm-1261	112	15	klebsiella	klebsiella	PROPN
ajlm-1261	112	16	species	species	PROPN
ajlm-1261	112	17	(	(	PUNCT
ajlm-1261	112	18	52.6	52.6	NUM
ajlm-1261	112	19	%	%	NOUN
ajlm-1261	112	20	)	)	PUNCT
ajlm-1261	112	21	,	,	PUNCT
ajlm-1261	112	22	citrobacter	citrobacter	ADJ
ajlm-1261	112	23	species	specie	NOUN
ajlm-1261	112	24	(	(	PUNCT
ajlm-1261	112	25	52.6	52.6	NUM
ajlm-1261	112	26	%	%	NOUN
ajlm-1261	112	27	)	)	PUNCT
ajlm-1261	112	28	and	and	CCONJ
ajlm-1261	112	29	e.	e.	PROPN
ajlm-1261	112	30	coli	coli	PROPN
ajlm-1261	112	31	(	(	PUNCT
ajlm-1261	112	32	43.5	43.5	NUM
ajlm-1261	112	33	%	%	NOUN
ajlm-1261	112	34	)	)	PUNCT
ajlm-1261	112	35	.	.	PUNCT
ajlm-1261	113	1	other	other	ADJ
ajlm-1261	113	2	esbl	esbl	NOUN
ajlm-1261	113	3	-	-	PUNCT
ajlm-1261	113	4	producing	produce	VERB
ajlm-1261	113	5	species	specie	NOUN
ajlm-1261	113	6	found	find	VERB
ajlm-1261	113	7	were	be	AUX
ajlm-1261	113	8	hafnia	hafnia	NOUN
ajlm-1261	113	9	alvei	alvei	NOUN
ajlm-1261	113	10	(	(	PUNCT
ajlm-1261	113	11	1	1	NUM
ajlm-1261	113	12	;	;	PUNCT
ajlm-1261	113	13	20.0	20.0	NUM
ajlm-1261	113	14	%	%	NOUN
ajlm-1261	113	15	)	)	PUNCT
ajlm-1261	113	16	,	,	PUNCT
ajlm-1261	113	17	providencia	providencia	PROPN
ajlm-1261	113	18	spp	spp	NOUN
ajlm-1261	113	19	.	.	PUNCT
ajlm-1261	114	1	(	(	PUNCT
ajlm-1261	114	2	1	1	NUM
ajlm-1261	114	3	;	;	PUNCT
ajlm-1261	114	4	33.0	33.0	NUM
ajlm-1261	114	5	%	%	NOUN
ajlm-1261	114	6	)	)	PUNCT
ajlm-1261	114	7	and	and	CCONJ
ajlm-1261	114	8	morganella	morganella	NOUN
ajlm-1261	114	9	morganii	morganii	NOUN
ajlm-1261	114	10	(	(	PUNCT
ajlm-1261	114	11	2	2	NUM
ajlm-1261	114	12	;	;	PUNCT
ajlm-1261	114	13	28.6	28.6	NUM
ajlm-1261	114	14	%	%	NOUN
ajlm-1261	114	15	)	)	PUNCT
ajlm-1261	114	16	.	.	PUNCT
ajlm-1261	115	1	ampc	ampc	PROPN
ajlm-1261	115	2	β	β	NOUN
ajlm-1261	115	3	-	-	PUNCT
ajlm-1261	115	4	lactamase	lactamase	ADJ
ajlm-1261	115	5	production	production	NOUN
ajlm-1261	115	6	was	be	AUX
ajlm-1261	115	7	detected	detect	VERB
ajlm-1261	115	8	among	among	ADP
ajlm-1261	115	9	citrobacter	citrobacter	ADJ
ajlm-1261	115	10	spp	spp	NOUN
ajlm-1261	115	11	.	.	PUNCT
ajlm-1261	116	1	(	(	PUNCT
ajlm-1261	116	2	1	1	NUM
ajlm-1261	116	3	;	;	PUNCT
ajlm-1261	116	4	5.3	5.3	NUM
ajlm-1261	116	5	%	%	NOUN
ajlm-1261	116	6	)	)	PUNCT
ajlm-1261	116	7	,	,	PUNCT
ajlm-1261	116	8	e.	e.	PROPN
ajlm-1261	116	9	coli	coli	PROPN
ajlm-1261	116	10	(	(	PUNCT
ajlm-1261	116	11	2	2	NUM
ajlm-1261	116	12	;	;	PUNCT
ajlm-1261	116	13	8.7	8.7	NUM
ajlm-1261	116	14	%	%	NOUN
ajlm-1261	116	15	)	)	PUNCT
ajlm-1261	116	16	and	and	CCONJ
ajlm-1261	116	17	m.	m.	NOUN
ajlm-1261	116	18	morganii	morganii	PROPN
ajlm-1261	116	19	(	(	PUNCT
ajlm-1261	116	20	1	1	NUM
ajlm-1261	116	21	;	;	PUNCT
ajlm-1261	116	22	14.3	14.3	NUM
ajlm-1261	116	23	%	%	NOUN
ajlm-1261	116	24	)	)	PUNCT
ajlm-1261	116	25	.	.	PUNCT
ajlm-1261	117	1	carbapenem	carbapenem	PROPN
ajlm-1261	117	2	resistance	resistance	NOUN
ajlm-1261	117	3	was	be	AUX
ajlm-1261	117	4	seen	see	VERB
ajlm-1261	117	5	among	among	ADP
ajlm-1261	117	6	acinetobacter	acinetobacter	ADJ
ajlm-1261	117	7	baumannii	baumannii	NOUN
ajlm-1261	117	8	(	(	PUNCT
ajlm-1261	117	9	4	4	NUM
ajlm-1261	117	10	;	;	PUNCT
ajlm-1261	117	11	44.4	44.4	NUM
ajlm-1261	117	12	%	%	NOUN
ajlm-1261	117	13	)	)	PUNCT
ajlm-1261	117	14	,	,	PUNCT
ajlm-1261	117	15	h.	h.	PROPN
ajlm-1261	117	16	alvei	alvei	PROPN
ajlm-1261	117	17	(	(	PUNCT
ajlm-1261	117	18	2	2	NUM
ajlm-1261	117	19	;	;	PUNCT
ajlm-1261	117	20	40.0	40.0	NUM
ajlm-1261	117	21	%	%	NOUN
ajlm-1261	117	22	)	)	PUNCT
ajlm-1261	117	23	,	,	PUNCT
ajlm-1261	117	24	p.	p.	NOUN
ajlm-1261	117	25	aeruginosa	aeruginosa	PROPN
ajlm-1261	117	26	(	(	PUNCT
ajlm-1261	117	27	3	3	NUM
ajlm-1261	117	28	;	;	PUNCT
ajlm-1261	117	29	15.0	15.0	NUM
ajlm-1261	117	30	%	%	NOUN
ajlm-1261	117	31	)	)	PUNCT
ajlm-1261	117	32	and	and	CCONJ
ajlm-1261	117	33	m.	m.	NOUN
ajlm-1261	117	34	morganii	morganii	PROPN
ajlm-1261	117	35	(	(	PUNCT
ajlm-1261	117	36	1	1	NUM
ajlm-1261	117	37	;	;	PUNCT
ajlm-1261	117	38	14.3	14.3	NUM
ajlm-1261	117	39	%	%	NOUN
ajlm-1261	117	40	)	)	PUNCT
ajlm-1261	117	41	.	.	PUNCT
ajlm-1261	118	1	further	further	ADJ
ajlm-1261	118	2	tests	test	NOUN
ajlm-1261	118	3	showed	show	VERB
ajlm-1261	118	4	that	that	SCONJ
ajlm-1261	118	5	among	among	ADP
ajlm-1261	118	6	the	the	DET
ajlm-1261	118	7	10	10	NUM
ajlm-1261	118	8	carbapenem	carbapenem	NOUN
ajlm-1261	118	9	-	-	PUNCT
ajlm-1261	118	10	resistant	resistant	ADJ
ajlm-1261	118	11	isolates	isolate	NOUN
ajlm-1261	118	12	,	,	PUNCT
ajlm-1261	118	13	only	only	ADV
ajlm-1261	118	14	four	four	NUM
ajlm-1261	118	15	,	,	PUNCT
ajlm-1261	118	16	h.	h.	PROPN
ajlm-1261	118	17	alvei	alvei	PROPN
ajlm-1261	118	18	(	(	PUNCT
ajlm-1261	118	19	2/4	2/4	NUM
ajlm-1261	118	20	)	)	PUNCT
ajlm-1261	118	21	and	and	CCONJ
ajlm-1261	118	22	a.	a.	NOUN
ajlm-1261	118	23	baumannii	baumannii	PROPN
ajlm-1261	118	24	(	(	PUNCT
ajlm-1261	118	25	2/4	2/4	NUM
ajlm-1261	118	26	)	)	PUNCT
ajlm-1261	118	27	,	,	PUNCT
ajlm-1261	118	28	were	be	AUX
ajlm-1261	118	29	carbapenemase	carbapenemase	NOUN
ajlm-1261	118	30	-	-	PUNCT
ajlm-1261	118	31	producing	produce	VERB
ajlm-1261	118	32	.	.	PUNCT
ajlm-1261	118	33	table	table	NOUN
ajlm-1261	118	34	4	4	NUM
ajlm-1261	118	35	:	:	PUNCT
ajlm-1261	118	36	 	 	SPACE
ajlm-1261	118	37	prevalence	prevalence	NOUN
ajlm-1261	118	38	of	of	ADP
ajlm-1261	118	39	multidrug	multidrug	NOUN
ajlm-1261	118	40	resistance	resistance	NOUN
ajlm-1261	118	41	among	among	ADP
ajlm-1261	118	42	bacterial	bacterial	ADJ
ajlm-1261	118	43	isolates	isolate	NOUN
ajlm-1261	118	44	from	from	ADP
ajlm-1261	118	45	infected	infected	ADJ
ajlm-1261	118	46	diabetic	diabetic	ADJ
ajlm-1261	118	47	foot	foot	NOUN
ajlm-1261	118	48	ulcer	ulcer	NOUN
ajlm-1261	118	49	patients	patient	NOUN
ajlm-1261	118	50	from	from	ADP
ajlm-1261	118	51	tertiary	tertiary	ADJ
ajlm-1261	118	52	healthcare	healthcare	NOUN
ajlm-1261	118	53	facilities	facility	NOUN
ajlm-1261	118	54	in	in	ADP
ajlm-1261	118	55	osun	osun	PROPN
ajlm-1261	118	56	state	state	PROPN
ajlm-1261	118	57	,	,	PUNCT
ajlm-1261	118	58	nigeria	nigeria	PROPN
ajlm-1261	118	59	,	,	PUNCT
ajlm-1261	118	60	july	july	PROPN
ajlm-1261	118	61	2016	2016	NUM
ajlm-1261	118	62	to	to	ADP
ajlm-1261	118	63	april	april	PROPN
ajlm-1261	118	64	2017	2017	NUM
ajlm-1261	118	65	.	.	PUNCT
ajlm-1261	119	1	table	table	NOUN
ajlm-1261	119	2	5	5	NUM
ajlm-1261	119	3	:	:	PUNCT
ajlm-1261	119	4	 	 	SPACE
ajlm-1261	119	5	types	type	NOUN
ajlm-1261	119	6	and	and	CCONJ
ajlm-1261	119	7	mechanisms	mechanism	NOUN
ajlm-1261	119	8	of	of	ADP
ajlm-1261	119	9	antibiotic	antibiotic	ADJ
ajlm-1261	119	10	resistance	resistance	NOUN
ajlm-1261	119	11	among	among	ADP
ajlm-1261	119	12	bacterial	bacterial	ADJ
ajlm-1261	119	13	agents	agent	NOUN
ajlm-1261	119	14	of	of	ADP
ajlm-1261	119	15	infected	infect	VERB
ajlm-1261	119	16	diabetic	diabetic	ADJ
ajlm-1261	119	17	foot	foot	NOUN
ajlm-1261	119	18	ulcer	ulcer	NOUN
ajlm-1261	119	19	from	from	ADP
ajlm-1261	119	20	tertiary	tertiary	ADJ
ajlm-1261	119	21	healthcare	healthcare	NOUN
ajlm-1261	119	22	facilities	facility	NOUN
ajlm-1261	119	23	in	in	ADP
ajlm-1261	119	24	osun	osun	PROPN
ajlm-1261	119	25	state	state	PROPN
ajlm-1261	119	26	,	,	PUNCT
ajlm-1261	119	27	nigeria	nigeria	PROPN
ajlm-1261	119	28	,	,	PUNCT
ajlm-1261	119	29	july	july	PROPN
ajlm-1261	119	30	2016	2016	NUM
ajlm-1261	119	31	to	to	ADP
ajlm-1261	119	32	april	april	PROPN
ajlm-1261	119	33	2017	2017	NUM
ajlm-1261	119	34	.	.	PUNCT
ajlm-1261	120	1	detection	detection	NOUN
ajlm-1261	120	2	of	of	ADP
ajlm-1261	120	3	resistance	resistance	NOUN
ajlm-1261	120	4	genes	gene	NOUN
ajlm-1261	120	5	ten	ten	NUM
ajlm-1261	120	6	(	(	PUNCT
ajlm-1261	120	7	83.3	83.3	NUM
ajlm-1261	120	8	%	%	NOUN
ajlm-1261	120	9	)	)	PUNCT
ajlm-1261	120	10	of	of	ADP
ajlm-1261	120	11	the	the	DET
ajlm-1261	120	12	12	12	NUM
ajlm-1261	120	13	mrsa	mrsa	NOUN
ajlm-1261	120	14	isolates	isolate	NOUN
ajlm-1261	120	15	harboured	harbour	VERB
ajlm-1261	120	16	the	the	DET
ajlm-1261	120	17	meca	meca	NOUN
ajlm-1261	120	18	gene	gene	NOUN
ajlm-1261	120	19	.	.	PUNCT
ajlm-1261	121	1	at	at	ADV
ajlm-1261	121	2	least	least	ADJ
ajlm-1261	121	3	one	one	NUM
ajlm-1261	121	4	of	of	ADP
ajlm-1261	121	5	the	the	DET
ajlm-1261	121	6	esbl	esbl	NOUN
ajlm-1261	121	7	genes	gene	NOUN
ajlm-1261	121	8	investigated	investigate	VERB
ajlm-1261	121	9	was	be	AUX
ajlm-1261	121	10	detected	detect	VERB
ajlm-1261	121	11	in	in	ADP
ajlm-1261	121	12	86.0	86.0	NUM
ajlm-1261	121	13	%	%	NOUN
ajlm-1261	121	14	(	(	PUNCT
ajlm-1261	121	15	n	n	NOUN
ajlm-1261	121	16	=	=	SYM
ajlm-1261	121	17	37	37	NUM
ajlm-1261	121	18	)	)	PUNCT
ajlm-1261	121	19	of	of	ADP
ajlm-1261	121	20	the	the	DET
ajlm-1261	121	21	43	43	NUM
ajlm-1261	121	22	esbl	esbl	NOUN
ajlm-1261	121	23	-	-	PUNCT
ajlm-1261	121	24	producing	produce	VERB
ajlm-1261	121	25	organisms	organism	NOUN
ajlm-1261	121	26	.	.	PUNCT
ajlm-1261	122	1	the	the	DET
ajlm-1261	122	2	most	most	ADV
ajlm-1261	122	3	common	common	ADJ
ajlm-1261	122	4	esbl	esbl	NOUN
ajlm-1261	122	5	gene	gene	NOUN
ajlm-1261	122	6	detected	detect	VERB
ajlm-1261	122	7	was	be	AUX
ajlm-1261	122	8	blactx	blactx	NOUN
ajlm-1261	122	9	-	-	PUNCT
ajlm-1261	122	10	m	m	PROPN
ajlm-1261	122	11	,	,	PUNCT
ajlm-1261	122	12	harboured	harbour	VERB
ajlm-1261	122	13	by	by	ADP
ajlm-1261	122	14	30	30	NUM
ajlm-1261	122	15	(	(	PUNCT
ajlm-1261	122	16	69.8	69.8	NUM
ajlm-1261	122	17	%	%	NOUN
ajlm-1261	122	18	)	)	PUNCT
ajlm-1261	122	19	of	of	ADP
ajlm-1261	122	20	the	the	DET
ajlm-1261	122	21	phenotypically	phenotypically	ADV
ajlm-1261	122	22	confirmed	confirm	VERB
ajlm-1261	122	23	esbl	esbl	NOUN
ajlm-1261	122	24	-	-	PUNCT
ajlm-1261	122	25	producing	produce	VERB
ajlm-1261	122	26	isolates	isolate	NOUN
ajlm-1261	122	27	.	.	PUNCT
ajlm-1261	123	1	others	other	NOUN
ajlm-1261	123	2	were	be	AUX
ajlm-1261	123	3	blatem	blatem	ADJ
ajlm-1261	123	4	(	(	PUNCT
ajlm-1261	123	5	27	27	NUM
ajlm-1261	123	6	;	;	PUNCT
ajlm-1261	123	7	62.8	62.8	NUM
ajlm-1261	123	8	%	%	NOUN
ajlm-1261	123	9	)	)	PUNCT
ajlm-1261	123	10	and	and	CCONJ
ajlm-1261	123	11	blashv	blashv	NOUN
ajlm-1261	123	12	(	(	PUNCT
ajlm-1261	123	13	8	8	NUM
ajlm-1261	123	14	;	;	PUNCT
ajlm-1261	123	15	18.6	18.6	NUM
ajlm-1261	123	16	%	%	NOUN
ajlm-1261	123	17	)	)	PUNCT
ajlm-1261	123	18	(	(	PUNCT
ajlm-1261	123	19	table	table	NOUN
ajlm-1261	123	20	6	6	NUM
ajlm-1261	123	21	)	)	PUNCT
ajlm-1261	123	22	.	.	PUNCT
ajlm-1261	124	1	thirty	thirty	NUM
ajlm-1261	124	2	-	-	PUNCT
ajlm-1261	124	3	one	one	NUM
ajlm-1261	124	4	(	(	PUNCT
ajlm-1261	124	5	72.1	72.1	NUM
ajlm-1261	124	6	%	%	NOUN
ajlm-1261	124	7	)	)	PUNCT
ajlm-1261	124	8	of	of	ADP
ajlm-1261	124	9	the	the	DET
ajlm-1261	124	10	esbl	esbl	NOUN
ajlm-1261	124	11	-	-	PUNCT
ajlm-1261	124	12	producing	produce	VERB
ajlm-1261	124	13	gnb	gnb	NOUN
ajlm-1261	124	14	had	have	VERB
ajlm-1261	124	15	at	at	ADV
ajlm-1261	124	16	least	least	ADV
ajlm-1261	124	17	two	two	NUM
ajlm-1261	124	18	esbl	esbl	NOUN
ajlm-1261	124	19	genes	gene	NOUN
ajlm-1261	124	20	.	.	PUNCT
ajlm-1261	125	1	four	four	NUM
ajlm-1261	125	2	of	of	ADP
ajlm-1261	125	3	the	the	DET
ajlm-1261	125	4	10	10	NUM
ajlm-1261	125	5	carbapenem	carbapenem	NOUN
ajlm-1261	125	6	-	-	PUNCT
ajlm-1261	125	7	resistant	resistant	ADJ
ajlm-1261	125	8	species	specie	NOUN
ajlm-1261	125	9	were	be	AUX
ajlm-1261	125	10	phenotypically	phenotypically	ADV
ajlm-1261	125	11	confirmed	confirm	VERB
ajlm-1261	125	12	to	to	PART
ajlm-1261	125	13	be	be	AUX
ajlm-1261	125	14	carbapenemase	carbapenemase	NOUN
ajlm-1261	125	15	-	-	PUNCT
ajlm-1261	125	16	producers	producer	NOUN
ajlm-1261	125	17	.	.	PUNCT
ajlm-1261	126	1	carbapenemase	carbapenemase	NOUN
ajlm-1261	126	2	and	and	CCONJ
ajlm-1261	126	3	metallo	metallo	ADJ
ajlm-1261	126	4	-	-	PUNCT
ajlm-1261	126	5	beta	beta	NOUN
ajlm-1261	126	6	-	-	PUNCT
ajlm-1261	126	7	lactamase	lactamase	NOUN
ajlm-1261	126	8	genes	gene	NOUN
ajlm-1261	126	9	were	be	AUX
ajlm-1261	126	10	detected	detect	VERB
ajlm-1261	126	11	in	in	ADP
ajlm-1261	126	12	all	all	PRON
ajlm-1261	126	13	of	of	ADP
ajlm-1261	126	14	the	the	DET
ajlm-1261	126	15	four	four	NUM
ajlm-1261	126	16	phenotypically	phenotypically	ADV
ajlm-1261	126	17	confirmed	confirm	VERB
ajlm-1261	126	18	carbapenemase	carbapenemase	NOUN
ajlm-1261	126	19	-	-	PUNCT
ajlm-1261	126	20	producers	producer	NOUN
ajlm-1261	126	21	;	;	PUNCT
ajlm-1261	126	22	they	they	PRON
ajlm-1261	126	23	were	be	AUX
ajlm-1261	126	24	blavim	blavim	NOUN
ajlm-1261	126	25	(	(	PUNCT
ajlm-1261	126	26	n	n	NOUN
ajlm-1261	126	27	=	=	SYM
ajlm-1261	126	28	3	3	NUM
ajlm-1261	126	29	)	)	PUNCT
ajlm-1261	126	30	,	,	PUNCT
ajlm-1261	126	31	blakpc	blakpc	NOUN
ajlm-1261	126	32	(	(	PUNCT
ajlm-1261	126	33	n	n	NOUN
ajlm-1261	126	34	=	=	SYM
ajlm-1261	126	35	2	2	NUM
ajlm-1261	126	36	)	)	PUNCT
ajlm-1261	126	37	and	and	CCONJ
ajlm-1261	126	38	blandm	blandm	PROPN
ajlm-1261	126	39	(	(	PUNCT
ajlm-1261	126	40	n	n	NOUN
ajlm-1261	126	41	=	=	SYM
ajlm-1261	126	42	1	1	NUM
ajlm-1261	126	43	)	)	PUNCT
ajlm-1261	126	44	.	.	PUNCT
ajlm-1261	127	1	these	these	DET
ajlm-1261	127	2	genes	gene	NOUN
ajlm-1261	127	3	were	be	AUX
ajlm-1261	127	4	detected	detect	VERB
ajlm-1261	127	5	in	in	ADP
ajlm-1261	127	6	all	all	PRON
ajlm-1261	127	7	of	of	ADP
ajlm-1261	127	8	the	the	DET
ajlm-1261	127	9	carbapenemase	carbapenemase	NOUN
ajlm-1261	127	10	-	-	PUNCT
ajlm-1261	127	11	producing	produce	VERB
ajlm-1261	127	12	h.	h.	NOUN
ajlm-1261	127	13	alvei	alvei	NOUN
ajlm-1261	127	14	(	(	PUNCT
ajlm-1261	127	15	2/2	2/2	NUM
ajlm-1261	127	16	)	)	PUNCT
ajlm-1261	127	17	and	and	CCONJ
ajlm-1261	127	18	a.	a.	NOUN
ajlm-1261	127	19	baumannii	baumannii	PROPN
ajlm-1261	127	20	(	(	PUNCT
ajlm-1261	127	21	2/2	2/2	NUM
ajlm-1261	127	22	)	)	PUNCT
ajlm-1261	127	23	.	.	PUNCT
ajlm-1261	128	1	table	table	NOUN
ajlm-1261	128	2	6	6	NUM
ajlm-1261	128	3	:	:	PUNCT
ajlm-1261	128	4	 	 	SPACE
ajlm-1261	128	5	detection	detection	NOUN
ajlm-1261	128	6	of	of	ADP
ajlm-1261	128	7	extended	extend	VERB
ajlm-1261	128	8	-	-	PUNCT
ajlm-1261	128	9	spectrum	spectrum	NOUN
ajlm-1261	128	10	beta	beta	NOUN
ajlm-1261	128	11	-	-	PUNCT
ajlm-1261	128	12	lactamase	lactamase	NOUN
ajlm-1261	128	13	genes	gene	NOUN
ajlm-1261	128	14	among	among	ADP
ajlm-1261	128	15	phenotypically	phenotypically	ADV
ajlm-1261	128	16	confirmed	confirm	VERB
ajlm-1261	128	17	extended	extend	VERB
ajlm-1261	128	18	-	-	PUNCT
ajlm-1261	128	19	spectrum	spectrum	NOUN
ajlm-1261	128	20	beta	beta	NOUN
ajlm-1261	128	21	-	-	PUNCT
ajlm-1261	128	22	lactamase	lactamase	NOUN
ajlm-1261	128	23	producing	produce	VERB
ajlm-1261	128	24	isolates	isolate	NOUN
ajlm-1261	128	25	from	from	ADP
ajlm-1261	128	26	tertiary	tertiary	ADJ
ajlm-1261	128	27	healthcare	healthcare	NOUN
ajlm-1261	128	28	facilities	facility	NOUN
ajlm-1261	128	29	in	in	ADP
ajlm-1261	128	30	osun	osun	PROPN
ajlm-1261	128	31	state	state	PROPN
ajlm-1261	128	32	,	,	PUNCT
ajlm-1261	128	33	nigeria	nigeria	PROPN
ajlm-1261	128	34	,	,	PUNCT
ajlm-1261	128	35	july	july	PROPN
ajlm-1261	128	36	2016	2016	NUM
ajlm-1261	128	37	to	to	ADP
ajlm-1261	128	38	april	april	PROPN
ajlm-1261	128	39	2017	2017	NUM
ajlm-1261	128	40	.	.	PUNCT
ajlm-1261	129	1	discussion	discussion	NOUN
ajlm-1261	129	2	this	this	DET
ajlm-1261	129	3	study	study	NOUN
ajlm-1261	129	4	shows	show	VERB
ajlm-1261	129	5	that	that	SCONJ
ajlm-1261	129	6	a	a	DET
ajlm-1261	129	7	wide	wide	ADJ
ajlm-1261	129	8	range	range	NOUN
ajlm-1261	129	9	of	of	ADP
ajlm-1261	129	10	bacteria	bacteria	NOUN
ajlm-1261	129	11	are	be	AUX
ajlm-1261	129	12	agents	agent	NOUN
ajlm-1261	129	13	of	of	ADP
ajlm-1261	129	14	infection	infection	NOUN
ajlm-1261	129	15	of	of	ADP
ajlm-1261	129	16	diabetic	diabetic	ADJ
ajlm-1261	129	17	foot	foot	NOUN
ajlm-1261	129	18	ulcers	ulcer	NOUN
ajlm-1261	129	19	;	;	PUNCT
ajlm-1261	129	20	it	it	PRON
ajlm-1261	129	21	also	also	ADV
ajlm-1261	129	22	reveals	reveal	VERB
ajlm-1261	129	23	the	the	DET
ajlm-1261	129	24	high	high	ADJ
ajlm-1261	129	25	level	level	NOUN
ajlm-1261	129	26	of	of	ADP
ajlm-1261	129	27	antibiotic	antibiotic	ADJ
ajlm-1261	129	28	resistance	resistance	NOUN
ajlm-1261	129	29	among	among	ADP
ajlm-1261	129	30	the	the	DET
ajlm-1261	129	31	aerobic	aerobic	ADJ
ajlm-1261	129	32	and	and	CCONJ
ajlm-1261	129	33	facultative	facultative	ADJ
ajlm-1261	129	34	anaerobic	anaerobic	NOUN
ajlm-1261	129	35	bacteria	bacteria	NOUN
ajlm-1261	129	36	with	with	ADP
ajlm-1261	129	37	a	a	DET
ajlm-1261	129	38	large	large	ADJ
ajlm-1261	129	39	proportion	proportion	NOUN
ajlm-1261	129	40	of	of	ADP
ajlm-1261	129	41	patients	patient	NOUN
ajlm-1261	129	42	having	have	VERB
ajlm-1261	129	43	multidrug	multidrug	VERB
ajlm-1261	129	44	-	-	PUNCT
ajlm-1261	129	45	resistant	resistant	ADJ
ajlm-1261	129	46	infection	infection	NOUN
ajlm-1261	129	47	leading	lead	VERB
ajlm-1261	129	48	to	to	ADP
ajlm-1261	129	49	poor	poor	ADJ
ajlm-1261	129	50	treatment	treatment	NOUN
ajlm-1261	129	51	outcomes	outcome	NOUN
ajlm-1261	129	52	.	.	PUNCT
ajlm-1261	130	1	infected	infected	ADJ
ajlm-1261	130	2	diabetic	diabetic	ADJ
ajlm-1261	130	3	ulcers	ulcer	NOUN
ajlm-1261	130	4	continue	continue	VERB
ajlm-1261	130	5	to	to	PART
ajlm-1261	130	6	be	be	AUX
ajlm-1261	130	7	polymicrobial	polymicrobial	ADJ
ajlm-1261	130	8	infections	infection	NOUN
ajlm-1261	130	9	involving	involve	VERB
ajlm-1261	130	10	aerobic	aerobic	ADJ
ajlm-1261	130	11	as	as	ADV
ajlm-1261	130	12	well	well	ADV
ajlm-1261	130	13	as	as	ADP
ajlm-1261	130	14	obligate	obligate	NOUN
ajlm-1261	130	15	anaerobic	anaerobic	NOUN
ajlm-1261	130	16	organisms	organism	NOUN
ajlm-1261	130	17	.	.	PUNCT
ajlm-1261	131	1	infected	infect	VERB
ajlm-1261	131	2	diabetic	diabetic	ADJ
ajlm-1261	131	3	foot	foot	NOUN
ajlm-1261	131	4	ulcers	ulcer	NOUN
ajlm-1261	131	5	in	in	ADP
ajlm-1261	131	6	this	this	DET
ajlm-1261	131	7	study	study	NOUN
ajlm-1261	131	8	have	have	VERB
ajlm-1261	131	9	an	an	DET
ajlm-1261	131	10	average	average	NOUN
ajlm-1261	131	11	of	of	ADP
ajlm-1261	131	12	two	two	NUM
ajlm-1261	131	13	different	different	ADJ
ajlm-1261	131	14	bacteria	bacteria	NOUN
ajlm-1261	131	15	implicated	implicate	VERB
ajlm-1261	131	16	in	in	ADP
ajlm-1261	131	17	the	the	DET
ajlm-1261	131	18	disease	disease	NOUN
ajlm-1261	131	19	,	,	PUNCT
ajlm-1261	131	20	and	and	CCONJ
ajlm-1261	131	21	this	this	PRON
ajlm-1261	131	22	is	be	AUX
ajlm-1261	131	23	typical	typical	ADJ
ajlm-1261	131	24	of	of	ADP
ajlm-1261	131	25	diabetic	diabetic	ADJ
ajlm-1261	131	26	foot	foot	NOUN
ajlm-1261	131	27	infections	infection	NOUN
ajlm-1261	131	28	across	across	ADP
ajlm-1261	131	29	sub	sub	ADJ
ajlm-1261	131	30	-	-	ADJ
ajlm-1261	131	31	saharan	saharan	ADJ
ajlm-1261	131	32	africa	africa	PROPN
ajlm-1261	131	33	and	and	CCONJ
ajlm-1261	131	34	asia.29	asia.29	PROPN
ajlm-1261	131	35	gram	gram	NOUN
ajlm-1261	131	36	-	-	PUNCT
ajlm-1261	131	37	negative	negative	ADJ
ajlm-1261	131	38	aerobic	aerobic	ADJ
ajlm-1261	131	39	bacteria	bacteria	NOUN
ajlm-1261	131	40	including	include	VERB
ajlm-1261	131	41	e.	e.	PROPN
ajlm-1261	131	42	coli	coli	PROPN
ajlm-1261	131	43	,	,	PUNCT
ajlm-1261	131	44	p.	p.	NOUN
ajlm-1261	131	45	aeruginosa	aeruginosa	PROPN
ajlm-1261	131	46	,	,	PUNCT
ajlm-1261	131	47	klebsiella	klebsiella	PROPN
ajlm-1261	131	48	species	specie	NOUN
ajlm-1261	131	49	and	and	CCONJ
ajlm-1261	131	50	enterobacter	enterobacter	NOUN
ajlm-1261	131	51	species	specie	NOUN
ajlm-1261	131	52	predominate	predominate	ADJ
ajlm-1261	131	53	,	,	PUNCT
ajlm-1261	131	54	reflecting	reflect	VERB
ajlm-1261	131	55	the	the	DET
ajlm-1261	131	56	long	long	ADV
ajlm-1261	131	57	-	-	PUNCT
ajlm-1261	131	58	standing	stand	VERB
ajlm-1261	131	59	nature	nature	NOUN
ajlm-1261	131	60	of	of	ADP
ajlm-1261	131	61	these	these	DET
ajlm-1261	131	62	infections	infection	NOUN
ajlm-1261	131	63	as	as	ADP
ajlm-1261	131	64	a	a	DET
ajlm-1261	131	65	consequence	consequence	NOUN
ajlm-1261	131	66	of	of	ADP
ajlm-1261	131	67	poor	poor	ADJ
ajlm-1261	131	68	health	health	NOUN
ajlm-1261	131	69	-	-	PUNCT
ajlm-1261	131	70	seeking	seek	VERB
ajlm-1261	131	71	behaviour	behaviour	NOUN
ajlm-1261	131	72	in	in	ADP
ajlm-1261	131	73	low	low	ADV
ajlm-1261	131	74	-	-	PUNCT
ajlm-1261	131	75	resourced	resource	VERB
ajlm-1261	131	76	developing	develop	VERB
ajlm-1261	131	77	countries.8,30	countries.8,30	PROPN
ajlm-1261	131	78	gram	gram	NOUN
ajlm-1261	131	79	-	-	PUNCT
ajlm-1261	131	80	negative	negative	ADJ
ajlm-1261	131	81	bacteria	bacteria	NOUN
ajlm-1261	131	82	are	be	AUX
ajlm-1261	131	83	more	more	ADV
ajlm-1261	131	84	commonly	commonly	ADV
ajlm-1261	131	85	implicated	implicate	VERB
ajlm-1261	131	86	in	in	ADP
ajlm-1261	131	87	infected	infected	ADJ
ajlm-1261	131	88	diabetic	diabetic	ADJ
ajlm-1261	131	89	ulcers	ulcer	NOUN
ajlm-1261	131	90	in	in	ADP
ajlm-1261	131	91	developing	develop	VERB
ajlm-1261	131	92	countries	country	NOUN
ajlm-1261	131	93	where	where	SCONJ
ajlm-1261	131	94	most	most	ADJ
ajlm-1261	131	95	patients	patient	NOUN
ajlm-1261	131	96	present	present	VERB
ajlm-1261	131	97	late	late	ADV
ajlm-1261	131	98	to	to	ADP
ajlm-1261	131	99	healthcare	healthcare	NOUN
ajlm-1261	131	100	facilities	facility	NOUN
ajlm-1261	131	101	with	with	ADP
ajlm-1261	131	102	advanced	advanced	ADJ
ajlm-1261	131	103	diseases.29	diseases.29	NOUN
ajlm-1261	131	104	furthermore	furthermore	ADV
ajlm-1261	131	105	,	,	PUNCT
ajlm-1261	131	106	a	a	DET
ajlm-1261	131	107	wide	wide	ADJ
ajlm-1261	131	108	range	range	NOUN
ajlm-1261	131	109	of	of	ADP
ajlm-1261	131	110	anaerobic	anaerobic	ADJ
ajlm-1261	131	111	bacteria	bacteria	NOUN
ajlm-1261	131	112	primarily	primarily	ADV
ajlm-1261	131	113	bacteroides	bacteroide	VERB
ajlm-1261	131	114	species	specie	NOUN
ajlm-1261	131	115	and	and	CCONJ
ajlm-1261	131	116	p.	p.	NOUN
ajlm-1261	131	117	anaerobius	anaerobius	NOUN
ajlm-1261	131	118	are	be	AUX
ajlm-1261	131	119	important	important	ADJ
ajlm-1261	131	120	agents	agent	NOUN
ajlm-1261	131	121	of	of	ADP
ajlm-1261	131	122	the	the	DET
ajlm-1261	131	123	infections	infection	NOUN
ajlm-1261	131	124	and	and	CCONJ
ajlm-1261	131	125	were	be	AUX
ajlm-1261	131	126	isolated	isolate	VERB
ajlm-1261	131	127	from	from	ADP
ajlm-1261	131	128	a	a	DET
ajlm-1261	131	129	third	third	NOUN
ajlm-1261	131	130	of	of	ADP
ajlm-1261	131	131	the	the	DET
ajlm-1261	131	132	cases	case	NOUN
ajlm-1261	131	133	in	in	ADP
ajlm-1261	131	134	this	this	DET
ajlm-1261	131	135	study	study	NOUN
ajlm-1261	131	136	.	.	PUNCT
ajlm-1261	132	1	this	this	PRON
ajlm-1261	132	2	suggests	suggest	VERB
ajlm-1261	132	3	infections	infection	NOUN
ajlm-1261	132	4	that	that	PRON
ajlm-1261	132	5	are	be	AUX
ajlm-1261	132	6	chronic	chronic	ADJ
ajlm-1261	132	7	and	and	CCONJ
ajlm-1261	132	8	below	below	ADP
ajlm-1261	132	9	the	the	DET
ajlm-1261	132	10	superficial	superficial	ADJ
ajlm-1261	132	11	layers	layer	NOUN
ajlm-1261	132	12	of	of	ADP
ajlm-1261	132	13	the	the	DET
ajlm-1261	132	14	skin.31	skin.31	PROPN
ajlm-1261	132	15	anaerobic	anaerobic	NOUN
ajlm-1261	132	16	bacteria	bacteria	NOUN
ajlm-1261	132	17	account	account	VERB
ajlm-1261	132	18	for	for	ADP
ajlm-1261	132	19	13.3	13.3	NUM
ajlm-1261	132	20	%	%	NOUN
ajlm-1261	132	21	of	of	ADP
ajlm-1261	132	22	the	the	DET
ajlm-1261	132	23	organisms	organism	NOUN
ajlm-1261	132	24	isolated	isolate	VERB
ajlm-1261	132	25	in	in	ADP
ajlm-1261	132	26	this	this	DET
ajlm-1261	132	27	study	study	NOUN
ajlm-1261	132	28	,	,	PUNCT
ajlm-1261	132	29	a	a	DET
ajlm-1261	132	30	higher	high	ADJ
ajlm-1261	132	31	prevalence	prevalence	NOUN
ajlm-1261	132	32	than	than	SCONJ
ajlm-1261	132	33	previously	previously	ADV
ajlm-1261	132	34	reported	report	VERB
ajlm-1261	132	35	in	in	ADP
ajlm-1261	132	36	the	the	DET
ajlm-1261	132	37	institution32	institution32	NOUN
ajlm-1261	132	38	and	and	CCONJ
ajlm-1261	132	39	may	may	AUX
ajlm-1261	132	40	be	be	AUX
ajlm-1261	132	41	attributable	attributable	ADJ
ajlm-1261	132	42	to	to	ADP
ajlm-1261	132	43	deployment	deployment	NOUN
ajlm-1261	132	44	of	of	ADP
ajlm-1261	132	45	a	a	DET
ajlm-1261	132	46	better	well	ADJ
ajlm-1261	132	47	anaerobic	anaerobic	NOUN
ajlm-1261	132	48	culture	culture	NOUN
ajlm-1261	132	49	method	method	NOUN
ajlm-1261	132	50	in	in	ADP
ajlm-1261	132	51	which	which	PRON
ajlm-1261	132	52	specimens	specimen	NOUN
ajlm-1261	132	53	were	be	AUX
ajlm-1261	132	54	processed	process	VERB
ajlm-1261	132	55	and	and	CCONJ
ajlm-1261	132	56	incubated	incubate	VERB
ajlm-1261	132	57	in	in	ADP
ajlm-1261	132	58	a	a	DET
ajlm-1261	132	59	bactron	bactron	NOUN
ajlm-1261	132	60	anaerobic	anaerobic	PROPN
ajlm-1261	132	61	chamber	chamber	PROPN
ajlm-1261	132	62	.	.	PUNCT
ajlm-1261	133	1	higher	high	ADJ
ajlm-1261	133	2	prevalence	prevalence	NOUN
ajlm-1261	133	3	rates	rate	NOUN
ajlm-1261	133	4	of	of	ADP
ajlm-1261	133	5	obligate	obligate	NOUN
ajlm-1261	133	6	anaerobes	anaerobe	NOUN
ajlm-1261	133	7	were	be	AUX
ajlm-1261	133	8	however	however	ADV
ajlm-1261	133	9	reported	report	VERB
ajlm-1261	133	10	by	by	ADP
ajlm-1261	133	11	ikeh	ikeh	ADP
ajlm-1261	133	12	et	et	PROPN
ajlm-1261	133	13	al	al	PROPN
ajlm-1261	133	14	.	.	PROPN
ajlm-1261	134	1	in	in	ADP
ajlm-1261	134	2	jos	jos	PROPN
ajlm-1261	134	3	,	,	PUNCT
ajlm-1261	134	4	nigeria	nigeria	PROPN
ajlm-1261	134	5	(	(	PUNCT
ajlm-1261	134	6	17%),33	17%),33	PROPN
ajlm-1261	134	7	and	and	CCONJ
ajlm-1261	134	8	al	al	PROPN
ajlm-1261	134	9	-	-	PUNCT
ajlm-1261	134	10	benwan	benwan	PROPN
ajlm-1261	134	11	in	in	ADP
ajlm-1261	134	12	kuwait	kuwait	PROPN
ajlm-1261	134	13	(	(	PUNCT
ajlm-1261	134	14	15.3%).34	15.3%).34	NUM
ajlm-1261	134	15	low	low	ADJ
ajlm-1261	134	16	rates	rate	NOUN
ajlm-1261	134	17	noted	note	VERB
ajlm-1261	134	18	by	by	ADP
ajlm-1261	134	19	richard	richard	PROPN
ajlm-1261	134	20	et	et	PROPN
ajlm-1261	134	21	al	al	PROPN
ajlm-1261	134	22	.	.	PROPN
ajlm-1261	135	1	(	(	PUNCT
ajlm-1261	135	2	1%)35	1%)35	NUM
ajlm-1261	135	3	in	in	ADP
ajlm-1261	135	4	france	france	PROPN
ajlm-1261	135	5	and	and	CCONJ
ajlm-1261	135	6	yates	yates	PROPN
ajlm-1261	135	7	et	et	PROPN
ajlm-1261	135	8	al	al	PROPN
ajlm-1261	135	9	.	.	PUNCT
ajlm-1261	136	1	(	(	PUNCT
ajlm-1261	136	2	1%)36	1%)36	NUM
ajlm-1261	136	3	in	in	ADP
ajlm-1261	136	4	australia	australia	PROPN
ajlm-1261	136	5	may	may	AUX
ajlm-1261	136	6	be	be	AUX
ajlm-1261	136	7	due	due	ADJ
ajlm-1261	136	8	to	to	ADP
ajlm-1261	136	9	the	the	DET
ajlm-1261	136	10	fact	fact	NOUN
ajlm-1261	136	11	that	that	SCONJ
ajlm-1261	136	12	most	most	ADJ
ajlm-1261	136	13	patients	patient	NOUN
ajlm-1261	136	14	tend	tend	VERB
ajlm-1261	136	15	to	to	PART
ajlm-1261	136	16	seek	seek	VERB
ajlm-1261	136	17	medical	medical	ADJ
ajlm-1261	136	18	care	care	NOUN
ajlm-1261	136	19	early	early	ADV
ajlm-1261	136	20	enough	enough	ADV
ajlm-1261	136	21	in	in	ADP
ajlm-1261	136	22	countries	country	NOUN
ajlm-1261	136	23	with	with	ADP
ajlm-1261	136	24	good	good	ADJ
ajlm-1261	136	25	health	health	NOUN
ajlm-1261	136	26	insurance	insurance	NOUN
ajlm-1261	136	27	coverage	coverage	NOUN
ajlm-1261	136	28	which	which	PRON
ajlm-1261	136	29	will	will	AUX
ajlm-1261	136	30	enable	enable	VERB
ajlm-1261	136	31	a	a	DET
ajlm-1261	136	32	higher	high	ADJ
ajlm-1261	136	33	proportion	proportion	NOUN
ajlm-1261	136	34	to	to	PART
ajlm-1261	136	35	present	present	VERB
ajlm-1261	136	36	with	with	ADP
ajlm-1261	136	37	low	low	ADJ
ajlm-1261	136	38	-	-	PUNCT
ajlm-1261	136	39	grade	grade	NOUN
ajlm-1261	136	40	foot	foot	NOUN
ajlm-1261	136	41	infection.37	infection.37	NOUN
ajlm-1261	136	42	antibiotic	antibiotic	ADJ
ajlm-1261	136	43	resistance	resistance	NOUN
ajlm-1261	136	44	remains	remain	VERB
ajlm-1261	136	45	a	a	DET
ajlm-1261	136	46	huge	huge	ADJ
ajlm-1261	136	47	problem	problem	NOUN
ajlm-1261	136	48	among	among	ADP
ajlm-1261	136	49	diabetic	diabetic	ADJ
ajlm-1261	136	50	foot	foot	NOUN
ajlm-1261	136	51	ulcer	ulcer	NOUN
ajlm-1261	136	52	infections	infection	NOUN
ajlm-1261	136	53	;	;	PUNCT
ajlm-1261	136	54	it	it	PRON
ajlm-1261	136	55	worsens	worsen	VERB
ajlm-1261	136	56	prognosis	prognosis	NOUN
ajlm-1261	136	57	and	and	CCONJ
ajlm-1261	136	58	makes	make	VERB
ajlm-1261	136	59	treatment	treatment	NOUN
ajlm-1261	136	60	outcomes	outcome	NOUN
ajlm-1261	136	61	poor.38	poor.38	NOUN
ajlm-1261	136	62	multidrug	multidrug	NOUN
ajlm-1261	136	63	-	-	PUNCT
ajlm-1261	136	64	resistant	resistant	ADJ
ajlm-1261	136	65	bacteria	bacteria	NOUN
ajlm-1261	136	66	were	be	AUX
ajlm-1261	136	67	common	common	ADJ
ajlm-1261	136	68	(	(	PUNCT
ajlm-1261	136	69	74/93	74/93	NUM
ajlm-1261	136	70	;	;	PUNCT
ajlm-1261	136	71	80	80	NUM
ajlm-1261	136	72	%	%	NOUN
ajlm-1261	136	73	)	)	PUNCT
ajlm-1261	136	74	among	among	ADP
ajlm-1261	136	75	idfu	idfu	ADJ
ajlm-1261	136	76	cases	case	NOUN
ajlm-1261	136	77	in	in	ADP
ajlm-1261	136	78	this	this	DET
ajlm-1261	136	79	study	study	NOUN
ajlm-1261	136	80	,	,	PUNCT
ajlm-1261	136	81	and	and	CCONJ
ajlm-1261	136	82	this	this	PRON
ajlm-1261	136	83	is	be	AUX
ajlm-1261	136	84	possibly	possibly	ADV
ajlm-1261	136	85	due	due	ADJ
ajlm-1261	136	86	to	to	ADP
ajlm-1261	136	87	inappropriate	inappropriate	ADJ
ajlm-1261	136	88	antibiotics	antibiotic	NOUN
ajlm-1261	136	89	use	use	NOUN
ajlm-1261	136	90	and	and	CCONJ
ajlm-1261	136	91	unrestricted	unrestricted	ADJ
ajlm-1261	136	92	access	access	NOUN
ajlm-1261	136	93	to	to	ADP
ajlm-1261	136	94	antimicrobial	antimicrobial	ADJ
ajlm-1261	136	95	drugs	drug	NOUN
ajlm-1261	136	96	in	in	ADP
ajlm-1261	136	97	many	many	ADJ
ajlm-1261	136	98	lowand	lowand	ADJ
ajlm-1261	136	99	middle	middle	ADJ
ajlm-1261	136	100	-	-	PUNCT
ajlm-1261	136	101	income	income	NOUN
ajlm-1261	136	102	countries.39	countries.39	NOUN
ajlm-1261	136	103	this	this	PRON
ajlm-1261	136	104	is	be	AUX
ajlm-1261	136	105	similar	similar	ADJ
ajlm-1261	136	106	to	to	ADP
ajlm-1261	136	107	findings	finding	NOUN
ajlm-1261	136	108	in	in	ADP
ajlm-1261	136	109	studies	study	NOUN
ajlm-1261	136	110	conducted	conduct	VERB
ajlm-1261	136	111	in	in	ADP
ajlm-1261	136	112	other	other	ADJ
ajlm-1261	136	113	developing	develop	VERB
ajlm-1261	136	114	countries40,41	countries40,41	PROPN
ajlm-1261	136	115	but	but	CCONJ
ajlm-1261	136	116	contrasts	contrast	VERB
ajlm-1261	136	117	findings	finding	NOUN
ajlm-1261	136	118	of	of	ADP
ajlm-1261	136	119	several	several	ADJ
ajlm-1261	136	120	studies	study	NOUN
ajlm-1261	136	121	in	in	ADP
ajlm-1261	136	122	high	high	ADJ
ajlm-1261	136	123	-	-	PUNCT
ajlm-1261	136	124	income	income	NOUN
ajlm-1261	136	125	countries	country	NOUN
ajlm-1261	136	126	including	include	VERB
ajlm-1261	136	127	france	france	PROPN
ajlm-1261	136	128	which	which	PRON
ajlm-1261	136	129	reported	report	VERB
ajlm-1261	136	130	low	low	ADJ
ajlm-1261	136	131	prevalence	prevalence	NOUN
ajlm-1261	136	132	of	of	ADP
ajlm-1261	136	133	mdr	mdr	PROPN
ajlm-1261	136	134	bacteria	bacteria	NOUN
ajlm-1261	136	135	among	among	ADP
ajlm-1261	136	136	patients	patient	NOUN
ajlm-1261	136	137	with	with	ADP
ajlm-1261	136	138	idfu.38,42	idfu.38,42	NOUN
ajlm-1261	136	139	a	a	DET
ajlm-1261	136	140	wide	wide	ADJ
ajlm-1261	136	141	spectrum	spectrum	NOUN
ajlm-1261	136	142	of	of	ADP
ajlm-1261	136	143	aerobic	aerobic	ADJ
ajlm-1261	136	144	bacteria	bacteria	NOUN
ajlm-1261	136	145	isolated	isolate	VERB
ajlm-1261	136	146	in	in	ADP
ajlm-1261	136	147	this	this	DET
ajlm-1261	136	148	study	study	NOUN
ajlm-1261	136	149	were	be	AUX
ajlm-1261	136	150	found	find	VERB
ajlm-1261	136	151	to	to	PART
ajlm-1261	136	152	be	be	AUX
ajlm-1261	136	153	multidrug	multidrug	NOUN
ajlm-1261	136	154	-	-	PUNCT
ajlm-1261	136	155	resistant	resistant	ADJ
ajlm-1261	136	156	,	,	PUNCT
ajlm-1261	136	157	comparable	comparable	ADJ
ajlm-1261	136	158	to	to	ADP
ajlm-1261	136	159	findings	finding	NOUN
ajlm-1261	136	160	elsewhere	elsewhere	ADV
ajlm-1261	136	161	in	in	ADP
ajlm-1261	136	162	africa	africa	PROPN
ajlm-1261	136	163	and	and	CCONJ
ajlm-1261	136	164	asia	asia	PROPN
ajlm-1261	136	165	with	with	ADP
ajlm-1261	136	166	high	high	ADJ
ajlm-1261	136	167	mdr	mdr	PROPN
ajlm-1261	136	168	rates	rate	NOUN
ajlm-1261	136	169	involving	involve	VERB
ajlm-1261	136	170	mainly	mainly	ADV
ajlm-1261	136	171	s.	s.	PROPN
ajlm-1261	136	172	aureus	aureus	PROPN
ajlm-1261	136	173	,	,	PUNCT
ajlm-1261	136	174	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-1261	136	175	,	,	PUNCT
ajlm-1261	136	176	and	and	CCONJ
ajlm-1261	136	177	p.	p.	NOUN
ajlm-1261	136	178	aeruginosa.41,43	aeruginosa.41,43	VERB
ajlm-1261	136	179	one	one	NUM
ajlm-1261	136	180	in	in	ADP
ajlm-1261	136	181	every	every	DET
ajlm-1261	136	182	three	three	NUM
ajlm-1261	136	183	isolates	isolate	NOUN
ajlm-1261	136	184	of	of	ADP
ajlm-1261	136	185	s.	s.	PROPN
ajlm-1261	136	186	aureus	aureus	PROPN
ajlm-1261	136	187	in	in	ADP
ajlm-1261	136	188	this	this	DET
ajlm-1261	136	189	study	study	NOUN
ajlm-1261	136	190	was	be	AUX
ajlm-1261	136	191	mrsa	mrsa	NOUN
ajlm-1261	136	192	.	.	PUNCT
ajlm-1261	137	1	although	although	SCONJ
ajlm-1261	137	2	prevalence	prevalence	NOUN
ajlm-1261	137	3	of	of	ADP
ajlm-1261	137	4	mrsa	mrsa	NOUN
ajlm-1261	137	5	appears	appear	VERB
ajlm-1261	137	6	to	to	PART
ajlm-1261	137	7	be	be	AUX
ajlm-1261	137	8	rising	rise	VERB
ajlm-1261	137	9	in	in	ADP
ajlm-1261	137	10	africa	africa	PROPN
ajlm-1261	137	11	,	,	PUNCT
ajlm-1261	137	12	most	most	ADJ
ajlm-1261	137	13	of	of	ADP
ajlm-1261	137	14	the	the	DET
ajlm-1261	137	15	countries	country	NOUN
ajlm-1261	137	16	have	have	VERB
ajlm-1261	137	17	rates	rate	NOUN
ajlm-1261	137	18	lower	low	ADJ
ajlm-1261	137	19	than	than	ADP
ajlm-1261	137	20	50%.44	50%.44	NUM
ajlm-1261	137	21	our	our	PRON
ajlm-1261	137	22	study	study	NOUN
ajlm-1261	137	23	also	also	ADV
ajlm-1261	137	24	revealed	reveal	VERB
ajlm-1261	137	25	that	that	SCONJ
ajlm-1261	137	26	meca	meca	NOUN
ajlm-1261	137	27	,	,	PUNCT
ajlm-1261	137	28	the	the	DET
ajlm-1261	137	29	most	most	ADV
ajlm-1261	137	30	common	common	ADJ
ajlm-1261	137	31	determinant	determinant	ADJ
ajlm-1261	137	32	that	that	SCONJ
ajlm-1261	137	33	confers	confer	NOUN
ajlm-1261	137	34	methicillin	methicillin	NOUN
ajlm-1261	137	35	resistance	resistance	NOUN
ajlm-1261	137	36	on	on	ADP
ajlm-1261	137	37	s.	s.	PROPN
ajlm-1261	137	38	aureus	aureus	PROPN
ajlm-1261	137	39	,	,	PUNCT
ajlm-1261	137	40	was	be	AUX
ajlm-1261	137	41	detected	detect	VERB
ajlm-1261	137	42	in	in	ADP
ajlm-1261	137	43	83.3	83.3	NUM
ajlm-1261	137	44	%	%	NOUN
ajlm-1261	137	45	of	of	ADP
ajlm-1261	137	46	the	the	DET
ajlm-1261	137	47	mrsa	mrsa	NOUN
ajlm-1261	137	48	strains	strain	VERB
ajlm-1261	137	49	and	and	CCONJ
ajlm-1261	137	50	this	this	PRON
ajlm-1261	137	51	is	be	AUX
ajlm-1261	137	52	similar	similar	ADJ
ajlm-1261	137	53	to	to	ADP
ajlm-1261	137	54	the	the	DET
ajlm-1261	137	55	observation	observation	NOUN
ajlm-1261	137	56	of	of	ADP
ajlm-1261	137	57	chaudhry	chaudhry	PROPN
ajlm-1261	137	58	et	et	PROPN
ajlm-1261	137	59	al	al	PROPN
ajlm-1261	137	60	.	.	PROPN
ajlm-1261	137	61	who	who	PRON
ajlm-1261	137	62	detected	detect	VERB
ajlm-1261	137	63	the	the	DET
ajlm-1261	137	64	gene	gene	NOUN
ajlm-1261	137	65	in	in	ADP
ajlm-1261	137	66	20	20	NUM
ajlm-1261	137	67	(	(	PUNCT
ajlm-1261	137	68	84	84	NUM
ajlm-1261	137	69	%	%	NOUN
ajlm-1261	137	70	)	)	PUNCT
ajlm-1261	137	71	of	of	ADP
ajlm-1261	137	72	the	the	DET
ajlm-1261	137	73	25	25	NUM
ajlm-1261	137	74	phenotypically	phenotypically	ADV
ajlm-1261	137	75	confirmed	confirm	VERB
ajlm-1261	137	76	mrsa	mrsa	NOUN
ajlm-1261	137	77	isolates.45	isolates.45	NOUN
ajlm-1261	137	78	mrsa	mrsa	NOUN
ajlm-1261	137	79	strains	strain	VERB
ajlm-1261	137	80	that	that	PRON
ajlm-1261	137	81	lack	lack	VERB
ajlm-1261	137	82	the	the	DET
ajlm-1261	137	83	meca	meca	NOUN
ajlm-1261	137	84	gene	gene	NOUN
ajlm-1261	137	85	may	may	AUX
ajlm-1261	137	86	demonstrate	demonstrate	VERB
ajlm-1261	137	87	methicillin	methicillin	NOUN
ajlm-1261	137	88	resistance	resistance	NOUN
ajlm-1261	137	89	on	on	ADP
ajlm-1261	137	90	account	account	NOUN
ajlm-1261	137	91	of	of	ADP
ajlm-1261	137	92	alternate	alternate	ADJ
ajlm-1261	137	93	mechanisms	mechanism	NOUN
ajlm-1261	137	94	of	of	ADP
ajlm-1261	137	95	penicillin	penicillin	NOUN
ajlm-1261	137	96	resistance	resistance	NOUN
ajlm-1261	137	97	such	such	ADJ
ajlm-1261	137	98	as	as	ADP
ajlm-1261	137	99	the	the	DET
ajlm-1261	137	100	possession	possession	NOUN
ajlm-1261	137	101	of	of	ADP
ajlm-1261	137	102	mecc	mecc	NOUN
ajlm-1261	137	103	,	,	PUNCT
ajlm-1261	137	104	a	a	DET
ajlm-1261	137	105	variant	variant	NOUN
ajlm-1261	137	106	of	of	ADP
ajlm-1261	137	107	meca	meca	NOUN
ajlm-1261	137	108	discovered	discover	VERB
ajlm-1261	137	109	in	in	ADP
ajlm-1261	137	110	2011	2011	NUM
ajlm-1261	137	111	,	,	PUNCT
ajlm-1261	137	112	or	or	CCONJ
ajlm-1261	137	113	other	other	ADJ
ajlm-1261	137	114	mutations	mutation	NOUN
ajlm-1261	137	115	in	in	ADP
ajlm-1261	137	116	genes	gene	NOUN
ajlm-1261	137	117	encoding	encode	VERB
ajlm-1261	137	118	penicillin	penicillin	NOUN
ajlm-1261	137	119	-	-	PUNCT
ajlm-1261	137	120	binding	bind	VERB
ajlm-1261	137	121	proteins.46	proteins.46	PROPN
ajlm-1261	137	122	extended	extend	VERB
ajlm-1261	137	123	-	-	PUNCT
ajlm-1261	137	124	spectrum	spectrum	NOUN
ajlm-1261	137	125	β	β	NOUN
ajlm-1261	137	126	-	-	NOUN
ajlm-1261	137	127	lactamases	lactamase	NOUN
ajlm-1261	137	128	,	,	PUNCT
ajlm-1261	137	129	which	which	PRON
ajlm-1261	137	130	confer	confer	VERB
ajlm-1261	137	131	resistance	resistance	NOUN
ajlm-1261	137	132	to	to	ADP
ajlm-1261	137	133	expanded	expand	VERB
ajlm-1261	137	134	-	-	PUNCT
ajlm-1261	137	135	spectrum	spectrum	NOUN
ajlm-1261	137	136	cephalosporins	cephalosporin	NOUN
ajlm-1261	137	137	,	,	PUNCT
ajlm-1261	137	138	were	be	AUX
ajlm-1261	137	139	produced	produce	VERB
ajlm-1261	137	140	by	by	ADP
ajlm-1261	137	141	33.3	33.3	NUM
ajlm-1261	137	142	%	%	NOUN
ajlm-1261	137	143	of	of	ADP
ajlm-1261	137	144	all	all	PRON
ajlm-1261	137	145	gnb	gnb	NOUN
ajlm-1261	137	146	isolated	isolate	VERB
ajlm-1261	137	147	;	;	PUNCT
ajlm-1261	137	148	all	all	DET
ajlm-1261	137	149	but	but	SCONJ
ajlm-1261	137	150	two	two	NUM
ajlm-1261	137	151	of	of	ADP
ajlm-1261	137	152	the	the	DET
ajlm-1261	137	153	esbl	esbl	NOUN
ajlm-1261	137	154	-	-	PUNCT
ajlm-1261	137	155	producing	produce	VERB
ajlm-1261	137	156	gnb	gnb	NOUN
ajlm-1261	137	157	belonged	belong	VERB
ajlm-1261	137	158	to	to	ADP
ajlm-1261	137	159	the	the	DET
ajlm-1261	137	160	family	family	NOUN
ajlm-1261	137	161	enterobacteriaceae	enterobacteriaceae	PROPN
ajlm-1261	137	162	and	and	CCONJ
ajlm-1261	137	163	included	include	VERB
ajlm-1261	137	164	e.	e.	PROPN
ajlm-1261	137	165	coli	coli	PROPN
ajlm-1261	137	166	,	,	PUNCT
ajlm-1261	137	167	klebsiella	klebsiella	NOUN
ajlm-1261	137	168	and	and	CCONJ
ajlm-1261	137	169	citrobacter	citrobacter	ADJ
ajlm-1261	137	170	species	specie	NOUN
ajlm-1261	137	171	.	.	PUNCT
ajlm-1261	138	1	the	the	DET
ajlm-1261	138	2	burden	burden	NOUN
ajlm-1261	138	3	of	of	ADP
ajlm-1261	138	4	esbl	esbl	NOUN
ajlm-1261	138	5	-	-	PUNCT
ajlm-1261	138	6	producing	produce	VERB
ajlm-1261	138	7	gnb	gnb	NOUN
ajlm-1261	138	8	is	be	AUX
ajlm-1261	138	9	enormous	enormous	ADJ
ajlm-1261	138	10	among	among	ADP
ajlm-1261	138	11	patients	patient	NOUN
ajlm-1261	138	12	with	with	ADP
ajlm-1261	138	13	idfu	idfu	PROPN
ajlm-1261	138	14	especially	especially	ADV
ajlm-1261	138	15	in	in	ADP
ajlm-1261	138	16	poor	poor	ADV
ajlm-1261	138	17	-	-	PUNCT
ajlm-1261	138	18	resourced	resource	VERB
ajlm-1261	138	19	countries	country	NOUN
ajlm-1261	138	20	with	with	ADP
ajlm-1261	138	21	prevalence	prevalence	NOUN
ajlm-1261	138	22	rates	rate	NOUN
ajlm-1261	138	23	being	be	AUX
ajlm-1261	138	24	reported	report	VERB
ajlm-1261	138	25	to	to	PART
ajlm-1261	138	26	range	range	VERB
ajlm-1261	138	27	from	from	ADP
ajlm-1261	138	28	23	23	NUM
ajlm-1261	138	29	%	%	NOUN
ajlm-1261	138	30	to	to	PART
ajlm-1261	138	31	49	49	NUM
ajlm-1261	138	32	%	%	NOUN
ajlm-1261	138	33	across	across	ADP
ajlm-1261	138	34	africa	africa	PROPN
ajlm-1261	138	35	and	and	CCONJ
ajlm-1261	138	36	asia.22,43,45,47,48	asia.22,43,45,47,48	PRON
ajlm-1261	138	37	the	the	DET
ajlm-1261	138	38	most	most	ADV
ajlm-1261	138	39	prevalent	prevalent	ADJ
ajlm-1261	138	40	esbl	esbl	NOUN
ajlm-1261	138	41	gene	gene	NOUN
ajlm-1261	138	42	was	be	AUX
ajlm-1261	138	43	the	the	DET
ajlm-1261	138	44	ctx	ctx	NOUN
ajlm-1261	138	45	-	-	NOUN
ajlm-1261	138	46	m	m	VERB
ajlm-1261	138	47	which	which	PRON
ajlm-1261	138	48	has	have	AUX
ajlm-1261	138	49	been	be	AUX
ajlm-1261	138	50	reported	report	VERB
ajlm-1261	138	51	as	as	ADP
ajlm-1261	138	52	the	the	DET
ajlm-1261	138	53	most	most	ADV
ajlm-1261	138	54	predominant	predominant	ADJ
ajlm-1261	138	55	variant	variant	NOUN
ajlm-1261	138	56	worldwide.49	worldwide.49	NOUN
ajlm-1261	138	57	in	in	ADP
ajlm-1261	138	58	the	the	DET
ajlm-1261	138	59	present	present	ADJ
ajlm-1261	138	60	study	study	NOUN
ajlm-1261	138	61	,	,	PUNCT
ajlm-1261	138	62	only	only	ADV
ajlm-1261	138	63	10	10	NUM
ajlm-1261	138	64	(	(	PUNCT
ajlm-1261	138	65	7.8	7.8	NUM
ajlm-1261	138	66	%	%	NOUN
ajlm-1261	138	67	)	)	PUNCT
ajlm-1261	138	68	of	of	ADP
ajlm-1261	138	69	the	the	DET
ajlm-1261	138	70	gram	gram	NOUN
ajlm-1261	138	71	-	-	PUNCT
ajlm-1261	138	72	negative	negative	ADJ
ajlm-1261	138	73	bacteria	bacteria	NOUN
ajlm-1261	138	74	were	be	AUX
ajlm-1261	138	75	resistant	resistant	ADJ
ajlm-1261	138	76	to	to	ADP
ajlm-1261	138	77	the	the	DET
ajlm-1261	138	78	carbapenems	carbapenem	NOUN
ajlm-1261	138	79	.	.	PUNCT
ajlm-1261	139	1	carbapenem	carbapenem	PROPN
ajlm-1261	139	2	resistance	resistance	NOUN
ajlm-1261	139	3	-	-	PUNCT
ajlm-1261	139	4	determining	determine	VERB
ajlm-1261	139	5	genes	gene	NOUN
ajlm-1261	139	6	were	be	AUX
ajlm-1261	139	7	present	present	ADJ
ajlm-1261	139	8	in	in	ADP
ajlm-1261	139	9	a.	a.	NOUN
ajlm-1261	139	10	baumannii	baumannii	PROPN
ajlm-1261	139	11	,	,	PUNCT
ajlm-1261	139	12	h.	h.	PROPN
ajlm-1261	139	13	alvei	alvei	PROPN
ajlm-1261	139	14	and	and	CCONJ
ajlm-1261	139	15	m.	m.	NOUN
ajlm-1261	139	16	morganii	morganii	PROPN
ajlm-1261	139	17	.	.	PUNCT
ajlm-1261	140	1	carbapenems	carbapenem	NOUN
ajlm-1261	140	2	as	as	ADP
ajlm-1261	140	3	drugs	drug	NOUN
ajlm-1261	140	4	of	of	ADP
ajlm-1261	140	5	last	last	ADJ
ajlm-1261	140	6	resort	resort	NOUN
ajlm-1261	140	7	in	in	ADP
ajlm-1261	140	8	the	the	DET
ajlm-1261	140	9	treatment	treatment	NOUN
ajlm-1261	140	10	of	of	ADP
ajlm-1261	140	11	resistant	resistant	ADJ
ajlm-1261	140	12	gnb	gnb	PROPN
ajlm-1261	140	13	infections	infection	NOUN
ajlm-1261	140	14	have	have	VERB
ajlm-1261	140	15	variable	variable	ADJ
ajlm-1261	140	16	but	but	CCONJ
ajlm-1261	140	17	increasing	increase	VERB
ajlm-1261	140	18	rates	rate	NOUN
ajlm-1261	140	19	of	of	ADP
ajlm-1261	140	20	resistance.13	resistance.13	NOUN
ajlm-1261	140	21	independent	independent	ADJ
ajlm-1261	140	22	risk	risk	NOUN
ajlm-1261	140	23	factors	factor	NOUN
ajlm-1261	140	24	for	for	ADP
ajlm-1261	140	25	acquisition	acquisition	NOUN
ajlm-1261	140	26	of	of	ADP
ajlm-1261	140	27	mdr	mdr	PROPN
ajlm-1261	140	28	bacteria	bacteria	NOUN
ajlm-1261	140	29	found	find	VERB
ajlm-1261	140	30	in	in	ADP
ajlm-1261	140	31	our	our	PRON
ajlm-1261	140	32	study	study	NOUN
ajlm-1261	140	33	are	be	AUX
ajlm-1261	140	34	peripheral	peripheral	ADJ
ajlm-1261	140	35	sensory	sensory	ADJ
ajlm-1261	140	36	neuropathy	neuropathy	ADJ
ajlm-1261	140	37	and	and	CCONJ
ajlm-1261	140	38	foot	foot	NOUN
ajlm-1261	140	39	infection	infection	NOUN
ajlm-1261	140	40	duration	duration	NOUN
ajlm-1261	140	41	longer	long	ADV
ajlm-1261	140	42	than	than	ADP
ajlm-1261	140	43	a	a	DET
ajlm-1261	140	44	month	month	NOUN
ajlm-1261	140	45	.	.	PUNCT
ajlm-1261	141	1	peripheral	peripheral	ADJ
ajlm-1261	141	2	neuropathy	neuropathy	ADJ
ajlm-1261	141	3	does	do	AUX
ajlm-1261	141	4	not	not	PART
ajlm-1261	141	5	only	only	ADV
ajlm-1261	141	6	make	make	VERB
ajlm-1261	141	7	diabetics	diabetic	NOUN
ajlm-1261	141	8	susceptible	susceptible	ADJ
ajlm-1261	141	9	to	to	ADP
ajlm-1261	141	10	foot	foot	NOUN
ajlm-1261	141	11	ulceration	ulceration	NOUN
ajlm-1261	141	12	but	but	CCONJ
ajlm-1261	141	13	also	also	ADV
ajlm-1261	141	14	makes	make	VERB
ajlm-1261	141	15	insensate	insensate	ADJ
ajlm-1261	141	16	(	(	PUNCT
ajlm-1261	141	17	neuropathic	neuropathic	ADJ
ajlm-1261	141	18	)	)	PUNCT
ajlm-1261	141	19	foot	foot	NOUN
ajlm-1261	141	20	ulcers	ulcer	NOUN
ajlm-1261	141	21	become	become	VERB
ajlm-1261	141	22	more	more	ADV
ajlm-1261	141	23	extensive	extensive	ADJ
ajlm-1261	141	24	due	due	ADJ
ajlm-1261	141	25	to	to	ADP
ajlm-1261	141	26	continuous	continuous	ADJ
ajlm-1261	141	27	painless	painless	ADJ
ajlm-1261	141	28	trauma	trauma	NOUN
ajlm-1261	141	29	.	.	PUNCT
ajlm-1261	142	1	loss	loss	NOUN
ajlm-1261	142	2	of	of	ADP
ajlm-1261	142	3	protective	protective	ADJ
ajlm-1261	142	4	pains	pain	NOUN
ajlm-1261	142	5	could	could	AUX
ajlm-1261	142	6	cause	cause	VERB
ajlm-1261	142	7	patients	patient	NOUN
ajlm-1261	142	8	not	not	PART
ajlm-1261	142	9	to	to	PART
ajlm-1261	142	10	present	present	VERB
ajlm-1261	142	11	to	to	ADP
ajlm-1261	142	12	healthcare	healthcare	NOUN
ajlm-1261	142	13	facilities	facility	NOUN
ajlm-1261	142	14	early	early	ADV
ajlm-1261	142	15	enough	enough	ADV
ajlm-1261	142	16	.	.	PUNCT
ajlm-1261	143	1	in	in	ADP
ajlm-1261	143	2	developing	develop	VERB
ajlm-1261	143	3	countries	country	NOUN
ajlm-1261	143	4	,	,	PUNCT
ajlm-1261	143	5	such	such	ADJ
ajlm-1261	143	6	patients	patient	NOUN
ajlm-1261	143	7	with	with	ADP
ajlm-1261	143	8	more	more	ADJ
ajlm-1261	143	9	chronic	chronic	ADJ
ajlm-1261	143	10	infections	infection	NOUN
ajlm-1261	143	11	(	(	PUNCT
ajlm-1261	143	12	>	>	SYM
ajlm-1261	143	13	1	1	NUM
ajlm-1261	143	14	month	month	NOUN
ajlm-1261	143	15	duration	duration	NOUN
ajlm-1261	143	16	)	)	PUNCT
ajlm-1261	143	17	would	would	AUX
ajlm-1261	143	18	have	have	AUX
ajlm-1261	143	19	engaged	engage	VERB
ajlm-1261	143	20	in	in	ADP
ajlm-1261	143	21	self	self	NOUN
ajlm-1261	143	22	-	-	PUNCT
ajlm-1261	143	23	prescribed	prescribe	VERB
ajlm-1261	143	24	antibiotic	antibiotic	ADJ
ajlm-1261	143	25	use	use	NOUN
ajlm-1261	143	26	for	for	ADP
ajlm-1261	143	27	a	a	DET
ajlm-1261	143	28	prolonged	prolonged	ADJ
ajlm-1261	143	29	period	period	NOUN
ajlm-1261	143	30	of	of	ADP
ajlm-1261	143	31	time	time	NOUN
ajlm-1261	143	32	leading	lead	VERB
ajlm-1261	143	33	to	to	ADP
ajlm-1261	143	34	selective	selective	ADJ
ajlm-1261	143	35	pressure	pressure	NOUN
ajlm-1261	143	36	and	and	CCONJ
ajlm-1261	143	37	emergence	emergence	NOUN
ajlm-1261	143	38	of	of	ADP
ajlm-1261	143	39	mdr	mdr	PROPN
ajlm-1261	143	40	foot	foot	NOUN
ajlm-1261	143	41	infection.39,50	infection.39,50	VERB
ajlm-1261	143	42	this	this	PRON
ajlm-1261	143	43	is	be	AUX
ajlm-1261	143	44	similar	similar	ADJ
ajlm-1261	143	45	to	to	ADP
ajlm-1261	143	46	reports	report	NOUN
ajlm-1261	143	47	among	among	ADP
ajlm-1261	143	48	idfu	idfu	ADJ
ajlm-1261	143	49	cases	case	NOUN
ajlm-1261	143	50	from	from	ADP
ajlm-1261	143	51	india.40,51,52	india.40,51,52	PRON
ajlm-1261	143	52	other	other	ADJ
ajlm-1261	143	53	authors	author	NOUN
ajlm-1261	143	54	also	also	ADV
ajlm-1261	143	55	documented	document	VERB
ajlm-1261	143	56	the	the	DET
ajlm-1261	143	57	prolonged	prolonged	ADJ
ajlm-1261	143	58	duration	duration	NOUN
ajlm-1261	143	59	of	of	ADP
ajlm-1261	143	60	wound	wound	ADJ
ajlm-1261	143	61	infection	infection	NOUN
ajlm-1261	143	62	as	as	ADP
ajlm-1261	143	63	a	a	DET
ajlm-1261	143	64	predictor	predictor	NOUN
ajlm-1261	143	65	of	of	ADP
ajlm-1261	143	66	infection	infection	NOUN
ajlm-1261	143	67	of	of	ADP
ajlm-1261	143	68	diabetic	diabetic	ADJ
ajlm-1261	143	69	foot	foot	NOUN
ajlm-1261	143	70	ulcers	ulcer	NOUN
ajlm-1261	143	71	with	with	ADP
ajlm-1261	143	72	mdr	mdr	PROPN
ajlm-1261	143	73	bacteria.53,54	bacteria.53,54	PROPN
ajlm-1261	143	74	contrary	contrary	PROPN
ajlm-1261	143	75	findings	finding	NOUN
ajlm-1261	143	76	have	have	AUX
ajlm-1261	143	77	however	however	ADV
ajlm-1261	143	78	been	be	AUX
ajlm-1261	143	79	documented	document	VERB
ajlm-1261	143	80	from	from	ADP
ajlm-1261	143	81	other	other	ADJ
ajlm-1261	143	82	studies	study	NOUN
ajlm-1261	143	83	in	in	ADP
ajlm-1261	143	84	china	china	PROPN
ajlm-1261	143	85	,	,	PUNCT
ajlm-1261	143	86	iran	iran	PROPN
ajlm-1261	143	87	and	and	CCONJ
ajlm-1261	143	88	portugal.41,42,55	portugal.41,42,55	VERB
ajlm-1261	143	89	our	our	PRON
ajlm-1261	143	90	finding	finding	NOUN
ajlm-1261	143	91	is	be	AUX
ajlm-1261	143	92	also	also	ADV
ajlm-1261	143	93	discordant	discordant	ADJ
ajlm-1261	143	94	with	with	ADP
ajlm-1261	143	95	the	the	DET
ajlm-1261	143	96	report	report	NOUN
ajlm-1261	143	97	of	of	ADP
ajlm-1261	143	98	noor	noor	PROPN
ajlm-1261	143	99	et	et	PROPN
ajlm-1261	143	100	al	al	PROPN
ajlm-1261	143	101	.	.	PROPN
ajlm-1261	143	102	which	which	PRON
ajlm-1261	143	103	established	establish	VERB
ajlm-1261	143	104	that	that	DET
ajlm-1261	143	105	ulcer	ulcer	NOUN
ajlm-1261	143	106	size	size	NOUN
ajlm-1261	143	107	is	be	AUX
ajlm-1261	143	108	a	a	DET
ajlm-1261	143	109	risk	risk	NOUN
ajlm-1261	143	110	factor	factor	NOUN
ajlm-1261	143	111	for	for	ADP
ajlm-1261	143	112	infection	infection	NOUN
ajlm-1261	143	113	by	by	ADP
ajlm-1261	143	114	mdr	mdr	PROPN
ajlm-1261	143	115	organisms.54	organisms.54	PROPN
ajlm-1261	143	116	this	this	DET
ajlm-1261	143	117	study	study	NOUN
ajlm-1261	143	118	also	also	ADV
ajlm-1261	143	119	observed	observe	VERB
ajlm-1261	143	120	a	a	DET
ajlm-1261	143	121	significant	significant	ADJ
ajlm-1261	143	122	association	association	NOUN
ajlm-1261	143	123	between	between	ADP
ajlm-1261	143	124	presence	presence	NOUN
ajlm-1261	143	125	of	of	ADP
ajlm-1261	143	126	mdr	mdr	PROPN
ajlm-1261	143	127	bacteria	bacteria	NOUN
ajlm-1261	143	128	in	in	ADP
ajlm-1261	143	129	idfu	idfu	ADJ
ajlm-1261	143	130	and	and	CCONJ
ajlm-1261	143	131	long	long	ADJ
ajlm-1261	143	132	duration	duration	NOUN
ajlm-1261	143	133	of	of	ADP
ajlm-1261	143	134	hospitalisation	hospitalisation	NOUN
ajlm-1261	143	135	(	(	PUNCT
ajlm-1261	143	136	>	>	NOUN
ajlm-1261	143	137	1	1	NUM
ajlm-1261	143	138	month	month	NOUN
ajlm-1261	143	139	)	)	PUNCT
ajlm-1261	143	140	similar	similar	ADJ
ajlm-1261	143	141	to	to	ADP
ajlm-1261	143	142	previously	previously	ADV
ajlm-1261	143	143	documented	document	VERB
ajlm-1261	143	144	reports	report	NOUN
ajlm-1261	143	145	by	by	ADP
ajlm-1261	143	146	another	another	DET
ajlm-1261	143	147	author	author	NOUN
ajlm-1261	143	148	in	in	ADP
ajlm-1261	143	149	turkey.14	turkey.14	PROPN
ajlm-1261	143	150	we	we	PRON
ajlm-1261	143	151	did	do	AUX
ajlm-1261	143	152	not	not	PART
ajlm-1261	143	153	find	find	VERB
ajlm-1261	143	154	any	any	DET
ajlm-1261	143	155	sociodemographic	sociodemographic	ADJ
ajlm-1261	143	156	factors	factor	NOUN
ajlm-1261	143	157	that	that	PRON
ajlm-1261	143	158	were	be	AUX
ajlm-1261	143	159	significantly	significantly	ADV
ajlm-1261	143	160	associated	associate	VERB
ajlm-1261	143	161	with	with	ADP
ajlm-1261	143	162	the	the	DET
ajlm-1261	143	163	occurrence	occurrence	NOUN
ajlm-1261	143	164	of	of	ADP
ajlm-1261	143	165	mdr	mdr	PROPN
ajlm-1261	143	166	idfu	idfu	VERB
ajlm-1261	143	167	in	in	ADP
ajlm-1261	143	168	our	our	PRON
ajlm-1261	143	169	study	study	NOUN
ajlm-1261	143	170	in	in	ADP
ajlm-1261	143	171	agreement	agreement	NOUN
ajlm-1261	143	172	with	with	ADP
ajlm-1261	143	173	other	other	ADJ
ajlm-1261	143	174	reports.40,52,53	reports.40,52,53	NOUN
ajlm-1261	143	175	in	in	ADP
ajlm-1261	143	176	contrast	contrast	NOUN
ajlm-1261	143	177	,	,	PUNCT
ajlm-1261	143	178	trivedi	trivedi	PROPN
ajlm-1261	143	179	et	et	PROPN
ajlm-1261	143	180	al	al	PROPN
ajlm-1261	143	181	.	.	PROPN
ajlm-1261	144	1	in	in	ADP
ajlm-1261	144	2	the	the	DET
ajlm-1261	144	3	united	united	PROPN
ajlm-1261	144	4	states	states	PROPN
ajlm-1261	144	5	noted	note	VERB
ajlm-1261	144	6	smoking	smoking	NOUN
ajlm-1261	144	7	as	as	ADP
ajlm-1261	144	8	an	an	DET
ajlm-1261	144	9	independent	independent	ADJ
ajlm-1261	144	10	risk	risk	NOUN
ajlm-1261	144	11	factor	factor	NOUN
ajlm-1261	144	12	for	for	ADP
ajlm-1261	144	13	multidrug	multidrug	NOUN
ajlm-1261	144	14	-	-	PUNCT
ajlm-1261	144	15	resistant	resistant	ADJ
ajlm-1261	144	16	foot	foot	NOUN
ajlm-1261	144	17	wound	wound	NOUN
ajlm-1261	144	18	infection.56	infection.56	NOUN
ajlm-1261	144	19	furthermore	furthermore	ADV
ajlm-1261	144	20	,	,	PUNCT
ajlm-1261	144	21	in	in	ADP
ajlm-1261	144	22	this	this	DET
ajlm-1261	144	23	study	study	NOUN
ajlm-1261	144	24	,	,	PUNCT
ajlm-1261	144	25	infection	infection	NOUN
ajlm-1261	144	26	of	of	ADP
ajlm-1261	144	27	diabetic	diabetic	ADJ
ajlm-1261	144	28	foot	foot	NOUN
ajlm-1261	144	29	ulcers	ulcer	NOUN
ajlm-1261	144	30	by	by	ADP
ajlm-1261	144	31	mdr	mdr	PROPN
ajlm-1261	144	32	pathogens	pathogen	NOUN
ajlm-1261	144	33	was	be	AUX
ajlm-1261	144	34	found	find	VERB
ajlm-1261	144	35	to	to	PART
ajlm-1261	144	36	have	have	VERB
ajlm-1261	144	37	a	a	DET
ajlm-1261	144	38	significant	significant	ADJ
ajlm-1261	144	39	association	association	NOUN
ajlm-1261	144	40	with	with	ADP
ajlm-1261	144	41	poor	poor	ADJ
ajlm-1261	144	42	treatment	treatment	NOUN
ajlm-1261	144	43	outcomes	outcome	NOUN
ajlm-1261	144	44	including	include	VERB
ajlm-1261	144	45	major	major	ADJ
ajlm-1261	144	46	limb	limb	NOUN
ajlm-1261	144	47	amputation	amputation	NOUN
ajlm-1261	144	48	and	and	CCONJ
ajlm-1261	144	49	mortality	mortality	NOUN
ajlm-1261	144	50	.	.	PUNCT
ajlm-1261	145	1	in	in	ADP
ajlm-1261	145	2	agreement	agreement	NOUN
ajlm-1261	145	3	with	with	ADP
ajlm-1261	145	4	our	our	PRON
ajlm-1261	145	5	findings	finding	NOUN
ajlm-1261	145	6	,	,	PUNCT
ajlm-1261	145	7	the	the	DET
ajlm-1261	145	8	adverse	adverse	ADJ
ajlm-1261	145	9	effects	effect	NOUN
ajlm-1261	145	10	of	of	ADP
ajlm-1261	145	11	mdr	mdr	PROPN
ajlm-1261	145	12	diabetic	diabetic	ADJ
ajlm-1261	145	13	foot	foot	NOUN
ajlm-1261	145	14	infection	infection	NOUN
ajlm-1261	145	15	on	on	ADP
ajlm-1261	145	16	treatment	treatment	NOUN
ajlm-1261	145	17	had	have	AUX
ajlm-1261	145	18	been	be	AUX
ajlm-1261	145	19	underscored	underscore	VERB
ajlm-1261	145	20	in	in	ADP
ajlm-1261	145	21	a	a	DET
ajlm-1261	145	22	systematic	systematic	ADJ
ajlm-1261	145	23	review	review	NOUN
ajlm-1261	145	24	and	and	CCONJ
ajlm-1261	145	25	meta	meta	ADJ
ajlm-1261	145	26	-	-	PUNCT
ajlm-1261	145	27	analysis	analysis	NOUN
ajlm-1261	145	28	of	of	ADP
ajlm-1261	145	29	data	datum	NOUN
ajlm-1261	145	30	from	from	ADP
ajlm-1261	145	31	28	28	NUM
ajlm-1261	145	32	studies	study	NOUN
ajlm-1261	145	33	reporting	report	VERB
ajlm-1261	145	34	a	a	DET
ajlm-1261	145	35	treatment	treatment	NOUN
ajlm-1261	145	36	failure	failure	NOUN
ajlm-1261	145	37	rate	rate	NOUN
ajlm-1261	145	38	of	of	ADP
ajlm-1261	145	39	22.7	22.7	NUM
ajlm-1261	145	40	%	%	NOUN
ajlm-1261	145	41	and	and	CCONJ
ajlm-1261	145	42	significant	significant	ADJ
ajlm-1261	145	43	association	association	NOUN
ajlm-1261	145	44	between	between	ADP
ajlm-1261	145	45	mdr	mdr	PROPN
ajlm-1261	145	46	foot	foot	NOUN
ajlm-1261	145	47	infections	infection	NOUN
ajlm-1261	145	48	and	and	CCONJ
ajlm-1261	145	49	treatment	treatment	NOUN
ajlm-1261	145	50	failure.57	failure.57	PROPN
ajlm-1261	145	51	limitations	limitation	NOUN
ajlm-1261	145	52	the	the	DET
ajlm-1261	145	53	limitation	limitation	NOUN
ajlm-1261	145	54	of	of	ADP
ajlm-1261	145	55	the	the	DET
ajlm-1261	145	56	study	study	NOUN
ajlm-1261	145	57	was	be	AUX
ajlm-1261	145	58	that	that	SCONJ
ajlm-1261	145	59	the	the	DET
ajlm-1261	145	60	number	number	NOUN
ajlm-1261	145	61	of	of	ADP
ajlm-1261	145	62	patients	patient	NOUN
ajlm-1261	145	63	recruited	recruit	VERB
ajlm-1261	145	64	was	be	AUX
ajlm-1261	145	65	limited	limit	VERB
ajlm-1261	145	66	to	to	ADP
ajlm-1261	145	67	90	90	NUM
ajlm-1261	145	68	and	and	CCONJ
ajlm-1261	145	69	this	this	PRON
ajlm-1261	145	70	was	be	AUX
ajlm-1261	145	71	because	because	SCONJ
ajlm-1261	145	72	the	the	DET
ajlm-1261	145	73	study	study	NOUN
ajlm-1261	145	74	was	be	AUX
ajlm-1261	145	75	time	time	NOUN
ajlm-1261	145	76	-	-	PUNCT
ajlm-1261	145	77	bound	bind	VERB
ajlm-1261	145	78	.	.	PUNCT
ajlm-1261	146	1	also	also	ADV
ajlm-1261	146	2	,	,	PUNCT
ajlm-1261	146	3	outpatients	outpatient	NOUN
ajlm-1261	146	4	could	could	AUX
ajlm-1261	146	5	not	not	PART
ajlm-1261	146	6	be	be	AUX
ajlm-1261	146	7	followed	follow	VERB
ajlm-1261	146	8	up	up	ADP
ajlm-1261	146	9	because	because	SCONJ
ajlm-1261	146	10	of	of	ADP
ajlm-1261	146	11	the	the	DET
ajlm-1261	146	12	multicentre	multicentre	NOUN
ajlm-1261	146	13	nature	nature	NOUN
ajlm-1261	146	14	of	of	ADP
ajlm-1261	146	15	the	the	DET
ajlm-1261	146	16	study	study	NOUN
ajlm-1261	146	17	.	.	PUNCT
ajlm-1261	147	1	resistance	resistance	NOUN
ajlm-1261	147	2	profiles	profile	NOUN
ajlm-1261	147	3	of	of	ADP
ajlm-1261	147	4	obligate	obligate	NOUN
ajlm-1261	147	5	anaerobic	anaerobic	NOUN
ajlm-1261	147	6	bacteria	bacteria	NOUN
ajlm-1261	147	7	could	could	AUX
ajlm-1261	147	8	not	not	PART
ajlm-1261	147	9	be	be	AUX
ajlm-1261	147	10	determined	determine	VERB
ajlm-1261	147	11	and	and	CCONJ
ajlm-1261	147	12	whole	whole	ADJ
ajlm-1261	147	13	genome	genome	NOUN
ajlm-1261	147	14	sequencing	sequencing	NOUN
ajlm-1261	147	15	(	(	PUNCT
ajlm-1261	147	16	for	for	ADP
ajlm-1261	147	17	strain	strain	NOUN
ajlm-1261	147	18	relatedness	relatedness	NOUN
ajlm-1261	147	19	)	)	PUNCT
ajlm-1261	147	20	was	be	AUX
ajlm-1261	147	21	also	also	ADV
ajlm-1261	147	22	not	not	PART
ajlm-1261	147	23	done	do	VERB
ajlm-1261	147	24	due	due	ADP
ajlm-1261	147	25	to	to	ADP
ajlm-1261	147	26	lack	lack	NOUN
ajlm-1261	147	27	of	of	ADP
ajlm-1261	147	28	financial	financial	ADJ
ajlm-1261	147	29	support	support	NOUN
ajlm-1261	147	30	for	for	ADP
ajlm-1261	147	31	the	the	DET
ajlm-1261	147	32	study	study	NOUN
ajlm-1261	147	33	.	.	PUNCT
ajlm-1261	148	1	conclusion	conclusion	NOUN
ajlm-1261	148	2	the	the	DET
ajlm-1261	148	3	spectrum	spectrum	NOUN
ajlm-1261	148	4	of	of	ADP
ajlm-1261	148	5	agents	agent	NOUN
ajlm-1261	148	6	causing	cause	VERB
ajlm-1261	148	7	idfu	idfu	PROPN
ajlm-1261	148	8	is	be	AUX
ajlm-1261	148	9	wide	wide	ADJ
ajlm-1261	148	10	and	and	CCONJ
ajlm-1261	148	11	includes	include	VERB
ajlm-1261	148	12	numerous	numerous	ADJ
ajlm-1261	148	13	species	specie	NOUN
ajlm-1261	148	14	of	of	ADP
ajlm-1261	148	15	aerobic	aerobic	ADJ
ajlm-1261	148	16	and	and	CCONJ
ajlm-1261	148	17	anaerobic	anaerobic	ADJ
ajlm-1261	148	18	bacteria	bacteria	NOUN
ajlm-1261	148	19	.	.	PUNCT
ajlm-1261	149	1	there	there	PRON
ajlm-1261	149	2	is	be	VERB
ajlm-1261	149	3	a	a	DET
ajlm-1261	149	4	high	high	ADJ
ajlm-1261	149	5	prevalence	prevalence	NOUN
ajlm-1261	149	6	of	of	ADP
ajlm-1261	149	7	mdr	mdr	PROPN
ajlm-1261	149	8	aerobic	aerobic	ADJ
ajlm-1261	149	9	bacteria	bacteria	NOUN
ajlm-1261	149	10	among	among	ADP
ajlm-1261	149	11	them	they	PRON
ajlm-1261	149	12	which	which	PRON
ajlm-1261	149	13	poses	pose	VERB
ajlm-1261	149	14	a	a	DET
ajlm-1261	149	15	great	great	ADJ
ajlm-1261	149	16	limitation	limitation	NOUN
ajlm-1261	149	17	to	to	ADP
ajlm-1261	149	18	the	the	DET
ajlm-1261	149	19	effective	effective	ADJ
ajlm-1261	149	20	treatment	treatment	NOUN
ajlm-1261	149	21	of	of	ADP
ajlm-1261	149	22	cases	case	NOUN
ajlm-1261	149	23	.	.	PUNCT
ajlm-1261	150	1	acknowledgements	acknowledgement	NOUN
ajlm-1261	150	2	the	the	DET
ajlm-1261	150	3	authors	author	NOUN
ajlm-1261	150	4	are	be	AUX
ajlm-1261	150	5	grateful	grateful	ADJ
ajlm-1261	150	6	to	to	ADP
ajlm-1261	150	7	faith	faith	NOUN
ajlm-1261	150	8	bankole	bankole	NOUN
ajlm-1261	150	9	and	and	CCONJ
ajlm-1261	150	10	ayo	ayo	PROPN
ajlm-1261	150	11	isinkaye	isinkaye	NOUN
ajlm-1261	150	12	for	for	ADP
ajlm-1261	150	13	assistance	assistance	NOUN
ajlm-1261	150	14	in	in	ADP
ajlm-1261	150	15	data	data	NOUN
ajlm-1261	150	16	management	management	NOUN
ajlm-1261	150	17	and	and	CCONJ
ajlm-1261	150	18	babatunde	babatunde	NOUN
ajlm-1261	150	19	odetoyin	odetoyin	NOUN
ajlm-1261	150	20	for	for	ADP
ajlm-1261	150	21	technical	technical	ADJ
ajlm-1261	150	22	assistance	assistance	NOUN
ajlm-1261	150	23	in	in	ADP
ajlm-1261	150	24	the	the	DET
ajlm-1261	150	25	central	central	ADJ
ajlm-1261	150	26	science	science	NOUN
ajlm-1261	150	27	laboratory	laboratory	NOUN
ajlm-1261	150	28	,	,	PUNCT
ajlm-1261	150	29	obafemi	obafemi	ADP
ajlm-1261	150	30	awolowo	awolowo	PROPN
ajlm-1261	150	31	university	university	PROPN
ajlm-1261	150	32	,	,	PUNCT
ajlm-1261	150	33	ile	ile	PROPN
ajlm-1261	150	34	-	-	PUNCT
ajlm-1261	150	35	ife	ife	PROPN
ajlm-1261	150	36	,	,	PUNCT
ajlm-1261	150	37	nigeria	nigeria	PROPN
ajlm-1261	150	38	.	.	PUNCT
ajlm-1261	151	1	competing	compete	VERB
ajlm-1261	151	2	interests	interest	NOUN
ajlm-1261	151	3	the	the	DET
ajlm-1261	151	4	authors	author	NOUN
ajlm-1261	151	5	have	have	AUX
ajlm-1261	151	6	declared	declare	VERB
ajlm-1261	151	7	that	that	SCONJ
ajlm-1261	151	8	no	no	DET
ajlm-1261	151	9	competing	compete	VERB
ajlm-1261	151	10	interests	interest	NOUN
ajlm-1261	151	11	exist	exist	VERB
ajlm-1261	151	12	.	.	PUNCT
ajlm-1261	152	1	authors	author	NOUN
ajlm-1261	152	2	’	’	PART
ajlm-1261	152	3	contributions	contribution	NOUN
ajlm-1261	152	4	a.t.a	a.t.a	NOUN
ajlm-1261	152	5	.	.	PUNCT
ajlm-1261	153	1	and	and	CCONJ
ajlm-1261	153	2	a.o.a	a.o.a	PROPN
ajlm-1261	153	3	.	.	PUNCT
ajlm-1261	154	1	conceived	conceive	VERB
ajlm-1261	154	2	and	and	CCONJ
ajlm-1261	154	3	designed	design	VERB
ajlm-1261	154	4	the	the	DET
ajlm-1261	154	5	study	study	NOUN
ajlm-1261	154	6	.	.	PUNCT
ajlm-1261	155	1	b.k	b.k	INTJ
ajlm-1261	155	2	.	.	PROPN
ajlm-1261	155	3	and	and	CCONJ
ajlm-1261	155	4	v.o.r	v.o.r	PROPN
ajlm-1261	155	5	.	.	PUNCT
ajlm-1261	156	1	contributed	contribute	VERB
ajlm-1261	156	2	to	to	ADP
ajlm-1261	156	3	the	the	DET
ajlm-1261	156	4	design	design	NOUN
ajlm-1261	156	5	of	of	ADP
ajlm-1261	156	6	the	the	DET
ajlm-1261	156	7	study	study	NOUN
ajlm-1261	156	8	.	.	PUNCT
ajlm-1261	157	1	a.t.a	a.t.a	PROPN
ajlm-1261	157	2	.	.	PROPN
ajlm-1261	158	1	and	and	CCONJ
ajlm-1261	158	2	a.o.a	a.o.a	PROPN
ajlm-1261	158	3	.	.	PUNCT
ajlm-1261	159	1	conducted	conduct	VERB
ajlm-1261	159	2	laboratory	laboratory	NOUN
ajlm-1261	159	3	experiments	experiment	NOUN
ajlm-1261	159	4	.	.	PUNCT
ajlm-1261	160	1	a.t.a	a.t.a	NOUN
ajlm-1261	160	2	.	.	PROPN
ajlm-1261	161	1	and	and	CCONJ
ajlm-1261	161	2	a.o.a	a.o.a	PROPN
ajlm-1261	161	3	.	.	PUNCT
ajlm-1261	162	1	analysed	analyse	VERB
ajlm-1261	162	2	the	the	DET
ajlm-1261	162	3	data	datum	NOUN
ajlm-1261	162	4	.	.	PUNCT
ajlm-1261	163	1	a.t.a	a.t.a	PROPN
ajlm-1261	163	2	.	.	PROPN
ajlm-1261	163	3	,	,	PUNCT
ajlm-1261	163	4	a.o.a	a.o.a	PROPN
ajlm-1261	163	5	.	.	PUNCT
ajlm-1261	164	1	and	and	CCONJ
ajlm-1261	164	2	v.o.r	v.o.r	PROPN
ajlm-1261	164	3	.	.	PROPN
ajlm-1261	164	4	wrote	write	VERB
ajlm-1261	164	5	the	the	DET
ajlm-1261	164	6	final	final	ADJ
ajlm-1261	164	7	report	report	NOUN
ajlm-1261	164	8	.	.	PUNCT
ajlm-1261	165	1	all	all	DET
ajlm-1261	165	2	authors	author	NOUN
ajlm-1261	165	3	reviewed	review	VERB
ajlm-1261	165	4	and	and	CCONJ
ajlm-1261	165	5	approved	approve	VERB
ajlm-1261	165	6	the	the	DET
ajlm-1261	165	7	final	final	ADJ
ajlm-1261	165	8	report	report	NOUN
ajlm-1261	165	9	.	.	PUNCT
ajlm-1261	166	1	sources	source	NOUN
ajlm-1261	166	2	of	of	ADP
ajlm-1261	166	3	support	support	NOUN
ajlm-1261	166	4	this	this	DET
ajlm-1261	166	5	study	study	NOUN
ajlm-1261	166	6	was	be	AUX
ajlm-1261	166	7	supported	support	VERB
ajlm-1261	166	8	by	by	ADP
ajlm-1261	166	9	the	the	DET
ajlm-1261	166	10	obafemi	obafemi	PROPN
ajlm-1261	166	11	awolowo	awolowo	PROPN
ajlm-1261	166	12	university	university	PROPN
ajlm-1261	166	13	teaching	teaching	NOUN
ajlm-1261	166	14	hospitals	hospital	NOUN
ajlm-1261	166	15	complex	complex	ADJ
ajlm-1261	166	16	.	.	PUNCT
ajlm-1261	167	1	data	datum	NOUN
ajlm-1261	167	2	availability	availability	NOUN
ajlm-1261	167	3	the	the	DET
ajlm-1261	167	4	data	data	NOUN
ajlm-1261	167	5	sets	set	NOUN
ajlm-1261	167	6	used	use	VERB
ajlm-1261	167	7	and	and	CCONJ
ajlm-1261	167	8	analysed	analyse	VERB
ajlm-1261	167	9	during	during	ADP
ajlm-1261	167	10	the	the	DET
ajlm-1261	167	11	current	current	ADJ
ajlm-1261	167	12	study	study	NOUN
ajlm-1261	167	13	are	be	AUX
ajlm-1261	167	14	available	available	ADJ
ajlm-1261	167	15	from	from	ADP
ajlm-1261	167	16	the	the	DET
ajlm-1261	167	17	corresponding	corresponding	ADJ
ajlm-1261	167	18	author	author	NOUN
ajlm-1261	167	19	on	on	ADP
ajlm-1261	167	20	reasonable	reasonable	ADJ
ajlm-1261	167	21	request	request	NOUN
ajlm-1261	167	22	.	.	PUNCT
ajlm-1261	168	1	disclaimer	disclaimer	VERB
ajlm-1261	168	2	the	the	DET
ajlm-1261	168	3	views	view	NOUN
ajlm-1261	168	4	and	and	CCONJ
ajlm-1261	168	5	opinions	opinion	NOUN
ajlm-1261	168	6	expressed	express	VERB
ajlm-1261	168	7	in	in	ADP
ajlm-1261	168	8	this	this	DET
ajlm-1261	168	9	article	article	NOUN
ajlm-1261	168	10	are	be	AUX
ajlm-1261	168	11	those	those	PRON
ajlm-1261	168	12	of	of	ADP
ajlm-1261	168	13	the	the	DET
ajlm-1261	168	14	authors	author	NOUN
ajlm-1261	168	15	and	and	CCONJ
ajlm-1261	168	16	do	do	AUX
ajlm-1261	168	17	not	not	PART
ajlm-1261	168	18	necessarily	necessarily	ADV
ajlm-1261	168	19	reflect	reflect	VERB
ajlm-1261	168	20	the	the	DET
ajlm-1261	168	21	official	official	ADJ
ajlm-1261	168	22	policy	policy	NOUN
ajlm-1261	168	23	or	or	CCONJ
ajlm-1261	168	24	position	position	NOUN
ajlm-1261	168	25	of	of	ADP
ajlm-1261	168	26	any	any	DET
ajlm-1261	168	27	affiliated	affiliated	ADJ
ajlm-1261	168	28	agency	agency	NOUN
ajlm-1261	168	29	of	of	ADP
ajlm-1261	168	30	the	the	DET
ajlm-1261	168	31	authors	author	NOUN
ajlm-1261	168	32	.	.	PUNCT
ajlm-1261	169	1	references	reference	NOUN
ajlm-1261	169	2	lipsky	lipsky	PROPN
ajlm-1261	169	3	ba	ba	PROPN
ajlm-1261	169	4	,	,	PUNCT
ajlm-1261	169	5	senneville	senneville	NOUN
ajlm-1261	169	6	e	e	NOUN
ajlm-1261	169	7	,	,	PUNCT
ajlm-1261	169	8	abbas	abbas	PROPN
ajlm-1261	169	9	zg	zg	PROPN
ajlm-1261	169	10	,	,	PUNCT
ajlm-1261	169	11	et	et	PROPN
ajlm-1261	169	12	al	al	PROPN
ajlm-1261	169	13	.	.	PUNCT
ajlm-1261	170	1	guidelines	guideline	NOUN
ajlm-1261	170	2	on	on	ADP
ajlm-1261	170	3	the	the	DET
ajlm-1261	170	4	diagnosis	diagnosis	NOUN
ajlm-1261	170	5	and	and	CCONJ
ajlm-1261	170	6	treatment	treatment	NOUN
ajlm-1261	170	7	of	of	ADP
ajlm-1261	170	8	foot	foot	NOUN
ajlm-1261	170	9	infection	infection	NOUN
ajlm-1261	170	10	in	in	ADP
ajlm-1261	170	11	persons	person	NOUN
ajlm-1261	170	12	with	with	ADP
ajlm-1261	170	13	diabetes	diabetes	NOUN
ajlm-1261	170	14	(	(	PUNCT
ajlm-1261	170	15	iwgdf	iwgdf	NOUN
ajlm-1261	170	16	2019	2019	NUM
ajlm-1261	170	17	update	update	NOUN
ajlm-1261	170	18	)	)	PUNCT
ajlm-1261	170	19	.	.	PUNCT
ajlm-1261	171	1	diabetes	diabetes	NOUN
ajlm-1261	171	2	metab	metab	NOUN
ajlm-1261	171	3	res	re	NOUN
ajlm-1261	171	4	rev	rev	X
ajlm-1261	171	5	.	.	PUNCT
ajlm-1261	172	1	2020;36(s1):e3280	2020;36(s1):e3280	NUM
ajlm-1261	172	2	.	.	PUNCT
ajlm-1261	172	3	https://doi.org/10.1002/dmrr.3280	https://doi.org/10.1002/dmrr.3280	PROPN
ajlm-1261	172	4	zhang	zhang	PROPN
ajlm-1261	172	5	p	p	X
ajlm-1261	172	6	,	,	PUNCT
ajlm-1261	172	7	lu	lu	PROPN
ajlm-1261	172	8	j	j	PROPN
ajlm-1261	172	9	,	,	PUNCT
ajlm-1261	172	10	jing	je	VERB
ajlm-1261	172	11	y	y	PROPN
ajlm-1261	172	12	,	,	PUNCT
ajlm-1261	172	13	tang	tang	PROPN
ajlm-1261	172	14	s	s	PROPN
ajlm-1261	172	15	,	,	PUNCT
ajlm-1261	172	16	zhu	zhu	PROPN
ajlm-1261	173	1	d	d	NOUN
ajlm-1261	173	2	,	,	PUNCT
ajlm-1261	173	3	bi	bi	PROPN
ajlm-1261	173	4	y.	y.	PROPN
ajlm-1261	173	5	global	global	PROPN
ajlm-1261	173	6	epidemiology	epidemiology	NOUN
ajlm-1261	173	7	of	of	ADP
ajlm-1261	173	8	diabetic	diabetic	ADJ
ajlm-1261	173	9	foot	foot	NOUN
ajlm-1261	173	10	ulceration	ulceration	NOUN
ajlm-1261	173	11	:	:	PUNCT
ajlm-1261	173	12	a	a	DET
ajlm-1261	173	13	systematic	systematic	ADJ
ajlm-1261	173	14	review	review	NOUN
ajlm-1261	173	15	and	and	CCONJ
ajlm-1261	173	16	meta	meta	ADJ
ajlm-1261	173	17	-	-	PUNCT
ajlm-1261	173	18	analysis	analysis	NOUN
ajlm-1261	173	19	(	(	PUNCT
ajlm-1261	173	20	?	?	PUNCT
ajlm-1261	173	21	)	)	PUNCT
ajlm-1261	173	22	.	.	PUNCT
ajlm-1261	174	1	ann	ann	PROPN
ajlm-1261	174	2	med	med	PROPN
ajlm-1261	174	3	.	.	PROPN
ajlm-1261	175	1	2017	2017	NUM
ajlm-1261	175	2	mar;49(2):106–116	mar;49(2):106–116	PROPN
ajlm-1261	175	3	.	.	PUNCT
ajlm-1261	175	4	https://doi.org/10.1080/07853890.2016.1231932	https://doi.org/10.1080/07853890.2016.1231932	X
ajlm-1261	176	1	atun	atun	PROPN
ajlm-1261	176	2	r	r	NOUN
ajlm-1261	176	3	,	,	PUNCT
ajlm-1261	176	4	gale	gale	NOUN
ajlm-1261	176	5	ea	ea	NOUN
ajlm-1261	176	6	.	.	PUNCT
ajlm-1261	177	1	the	the	DET
ajlm-1261	177	2	challenge	challenge	NOUN
ajlm-1261	177	3	of	of	ADP
ajlm-1261	177	4	diabetes	diabetes	NOUN
ajlm-1261	177	5	in	in	ADP
ajlm-1261	177	6	sub	sub	ADJ
ajlm-1261	177	7	-	-	ADJ
ajlm-1261	177	8	saharan	saharan	ADJ
ajlm-1261	177	9	africa	africa	PROPN
ajlm-1261	177	10	.	.	PUNCT
ajlm-1261	178	1	lancet	lancet	NOUN
ajlm-1261	178	2	diabetes	diabetes	NOUN
ajlm-1261	178	3	endocrinol	endocrinol	NOUN
ajlm-1261	178	4	.	.	PUNCT
ajlm-1261	179	1	2015	2015	NUM
ajlm-1261	179	2	sep;3(9):675–677	sep;3(9):675–677	NOUN
ajlm-1261	179	3	.	.	PUNCT
ajlm-1261	180	1	https://doi.org/10.1016/s2213-8587(15)00236-3	https://doi.org/10.1016/s2213-8587(15)00236-3	PROPN
ajlm-1261	180	2	jia	jia	PROPN
ajlm-1261	180	3	l	l	PROPN
ajlm-1261	180	4	,	,	PUNCT
ajlm-1261	180	5	parker	parker	PROPN
ajlm-1261	180	6	cn	cn	PROPN
ajlm-1261	180	7	,	,	PUNCT
ajlm-1261	180	8	parker	parker	PROPN
ajlm-1261	180	9	tj	tj	PROPN
ajlm-1261	180	10	,	,	PUNCT
ajlm-1261	180	11	et	et	PROPN
ajlm-1261	180	12	al	al	PROPN
ajlm-1261	180	13	.	.	PROPN
ajlm-1261	180	14	incidence	incidence	NOUN
ajlm-1261	180	15	and	and	CCONJ
ajlm-1261	180	16	risk	risk	NOUN
ajlm-1261	180	17	factors	factor	NOUN
ajlm-1261	180	18	for	for	ADP
ajlm-1261	180	19	developing	develop	VERB
ajlm-1261	180	20	infection	infection	NOUN
ajlm-1261	180	21	in	in	ADP
ajlm-1261	180	22	patients	patient	NOUN
ajlm-1261	180	23	presenting	present	VERB
ajlm-1261	180	24	with	with	ADP
ajlm-1261	180	25	uninfected	uninfected	ADJ
ajlm-1261	180	26	diabetic	diabetic	ADJ
ajlm-1261	180	27	foot	foot	NOUN
ajlm-1261	180	28	ulcers	ulcer	NOUN
ajlm-1261	180	29	.	.	PUNCT
ajlm-1261	181	1	jan	jan	PROPN
ajlm-1261	181	2	y	y	PROPN
ajlm-1261	181	3	-	-	PUNCT
ajlm-1261	181	4	k	k	PROPN
ajlm-1261	181	5	,	,	PUNCT
ajlm-1261	181	6	ed	ed	NOUN
ajlm-1261	181	7	.	.	PUNCT
ajlm-1261	182	1	plos	plos	PROPN
ajlm-1261	182	2	one	one	NUM
ajlm-1261	182	3	.	.	PUNCT
ajlm-1261	183	1	2017;12(5):e0177916	2017;12(5):e0177916	NUM
ajlm-1261	183	2	.	.	PUNCT
ajlm-1261	184	1	https://doi.org/10.1371/journal.pone.0177916	https://doi.org/10.1371/journal.pone.0177916	PROPN
ajlm-1261	184	2	adigun	adigun	VERB
ajlm-1261	184	3	i	i	PRON
ajlm-1261	184	4	,	,	PUNCT
ajlm-1261	184	5	olarinoye	olarinoye	PROPN
ajlm-1261	184	6	j.	j.	PROPN
ajlm-1261	184	7	foot	foot	PROPN
ajlm-1261	184	8	complications	complication	NOUN
ajlm-1261	184	9	in	in	ADP
ajlm-1261	184	10	people	people	NOUN
ajlm-1261	184	11	with	with	ADP
ajlm-1261	184	12	diabetes	diabetes	NOUN
ajlm-1261	184	13	:	:	PUNCT
ajlm-1261	184	14	experience	experience	NOUN
ajlm-1261	184	15	with	with	ADP
ajlm-1261	184	16	105	105	NUM
ajlm-1261	184	17	nigerian	nigerian	ADJ
ajlm-1261	184	18	africans	africans	PROPN
ajlm-1261	184	19	.	.	PUNCT
ajlm-1261	185	1	diab	diab	PROPN
ajlm-1261	185	2	foot	foot	PROPN
ajlm-1261	185	3	j.	j.	PROPN
ajlm-1261	185	4	2008;11(1):36–42	2008;11(1):36–42	PROPN
ajlm-1261	185	5	.	.	PROPN
ajlm-1261	185	6	alavi	alavi	PROPN
ajlm-1261	185	7	sm	sm	PROPN
ajlm-1261	185	8	,	,	PUNCT
ajlm-1261	185	9	khosravi	khosravi	VERB
ajlm-1261	185	10	ad	ad	NOUN
ajlm-1261	185	11	,	,	PUNCT
ajlm-1261	185	12	sarami	sarami	NOUN
ajlm-1261	185	13	a	a	NOUN
ajlm-1261	185	14	,	,	PUNCT
ajlm-1261	185	15	dashtebozorg	dashtebozorg	PROPN
ajlm-1261	185	16	a	a	PRON
ajlm-1261	185	17	,	,	PUNCT
ajlm-1261	185	18	montazeri	montazeri	NOUN
ajlm-1261	185	19	ea	ea	NOUN
ajlm-1261	185	20	.	.	PUNCT
ajlm-1261	185	21	bacteriologic	bacteriologic	ADJ
ajlm-1261	185	22	study	study	NOUN
ajlm-1261	185	23	of	of	ADP
ajlm-1261	185	24	diabetic	diabetic	ADJ
ajlm-1261	185	25	foot	foot	NOUN
ajlm-1261	185	26	ulcer	ulcer	NOUN
ajlm-1261	185	27	.	.	PUNCT
ajlm-1261	186	1	pakistan	pakistan	PROPN
ajlm-1261	186	2	j	j	PROPN
ajlm-1261	186	3	med	med	PROPN
ajlm-1261	186	4	sci	sci	PROPN
ajlm-1261	186	5	.	.	PUNCT
ajlm-1261	187	1	2007;23(5):681–684	2007;23(5):681–684	INTJ
ajlm-1261	187	2	.	.	PUNCT
ajlm-1261	188	1	khanolkar	khanolkar	PROPN
ajlm-1261	188	2	mp	mp	PROPN
ajlm-1261	188	3	,	,	PUNCT
ajlm-1261	188	4	bain	bain	PROPN
ajlm-1261	188	5	sc	sc	PROPN
ajlm-1261	188	6	,	,	PUNCT
ajlm-1261	188	7	stephens	stephens	PROPN
ajlm-1261	188	8	jw	jw	PROPN
ajlm-1261	188	9	.	.	PUNCT
ajlm-1261	189	1	the	the	DET
ajlm-1261	189	2	diabetic	diabetic	ADJ
ajlm-1261	189	3	foot	foot	NOUN
ajlm-1261	189	4	.	.	PUNCT
ajlm-1261	190	1	quart	quart	PROPN
ajlm-1261	190	2	j	j	PROPN
ajlm-1261	190	3	med	med	PROPN
ajlm-1261	190	4	.	.	PUNCT
ajlm-1261	191	1	2008;101(9):685–695	2008;101(9):685–695	X
ajlm-1261	191	2	.	.	PUNCT
ajlm-1261	192	1	https://doi.org/10.1093/qjmed/hcn027	https://doi.org/10.1093/qjmed/hcn027	PROPN
ajlm-1261	192	2	lipsky	lipsky	PROPN
ajlm-1261	192	3	ba	ba	PROPN
ajlm-1261	192	4	,	,	PUNCT
ajlm-1261	192	5	berendt	berendt	PROPN
ajlm-1261	192	6	ar	ar	PROPN
ajlm-1261	192	7	,	,	PUNCT
ajlm-1261	192	8	cornia	cornia	PROPN
ajlm-1261	192	9	pb	pb	PROPN
ajlm-1261	192	10	,	,	PUNCT
ajlm-1261	192	11	et	et	PROPN
ajlm-1261	192	12	al	al	PROPN
ajlm-1261	192	13	.	.	PROPN
ajlm-1261	193	1	infectious	infectious	ADJ
ajlm-1261	193	2	diseases	disease	NOUN
ajlm-1261	193	3	society	society	NOUN
ajlm-1261	193	4	of	of	ADP
ajlm-1261	193	5	america	america	PROPN
ajlm-1261	193	6	clinical	clinical	ADJ
ajlm-1261	193	7	practice	practice	NOUN
ajlm-1261	193	8	guideline	guideline	NOUN
ajlm-1261	193	9	for	for	ADP
ajlm-1261	193	10	the	the	DET
ajlm-1261	193	11	diagnosis	diagnosis	NOUN
ajlm-1261	193	12	and	and	CCONJ
ajlm-1261	193	13	treatment	treatment	NOUN
ajlm-1261	193	14	of	of	ADP
ajlm-1261	193	15	diabetic	diabetic	ADJ
ajlm-1261	193	16	foot	foot	NOUN
ajlm-1261	193	17	infections	infection	NOUN
ajlm-1261	193	18	.	.	PUNCT
ajlm-1261	194	1	clin	clin	PROPN
ajlm-1261	194	2	infect	infect	PROPN
ajlm-1261	194	3	dis	dis	PROPN
ajlm-1261	194	4	.	.	PUNCT
ajlm-1261	195	1	2012;54(12):132–173	2012;54(12):132–173	NUM
ajlm-1261	195	2	.	.	PUNCT
ajlm-1261	196	1	https://doi.org/10.1093/cid/cis346	https://doi.org/10.1093/cid/cis346	PROPN
ajlm-1261	196	2	ventola	ventola	PROPN
ajlm-1261	196	3	cl	cl	NOUN
ajlm-1261	196	4	.	.	PUNCT
ajlm-1261	197	1	the	the	DET
ajlm-1261	197	2	antibiotic	antibiotic	ADJ
ajlm-1261	197	3	resistance	resistance	NOUN
ajlm-1261	197	4	crisis	crisis	NOUN
ajlm-1261	197	5	:	:	PUNCT
ajlm-1261	197	6	part	part	NOUN
ajlm-1261	197	7	1	1	NUM
ajlm-1261	197	8	:	:	PUNCT
ajlm-1261	197	9	causes	cause	NOUN
ajlm-1261	197	10	and	and	CCONJ
ajlm-1261	197	11	threats	threat	NOUN
ajlm-1261	197	12	.	.	PUNCT
ajlm-1261	198	1	pharm	pharm	NOUN
ajlm-1261	198	2	therap	therap	NOUN
ajlm-1261	198	3	.	.	PUNCT
ajlm-1261	199	1	2015;40(4):277–283	2015;40(4):277–283	X
ajlm-1261	199	2	.	.	PUNCT
ajlm-1261	200	1	magiorakos	magiorakos	PROPN
ajlm-1261	200	2	ap	ap	PROPN
ajlm-1261	200	3	,	,	PUNCT
ajlm-1261	200	4	srinivasan	srinivasan	PROPN
ajlm-1261	200	5	a	a	PROPN
ajlm-1261	200	6	,	,	PUNCT
ajlm-1261	200	7	carey	carey	PROPN
ajlm-1261	200	8	rb	rb	PROPN
ajlm-1261	200	9	,	,	PUNCT
ajlm-1261	200	10	et	et	PROPN
ajlm-1261	200	11	al	al	PROPN
ajlm-1261	200	12	.	.	PROPN
ajlm-1261	200	13	multidrug	multidrug	NOUN
ajlm-1261	200	14	-	-	PUNCT
ajlm-1261	200	15	resistant	resistant	ADJ
ajlm-1261	200	16	,	,	PUNCT
ajlm-1261	200	17	extensively	extensively	ADV
ajlm-1261	200	18	drug	drug	NOUN
ajlm-1261	200	19	-	-	PUNCT
ajlm-1261	200	20	resistant	resistant	ADJ
ajlm-1261	200	21	and	and	CCONJ
ajlm-1261	200	22	pandrug	pandrug	ADJ
ajlm-1261	200	23	-	-	PUNCT
ajlm-1261	200	24	resistant	resistant	ADJ
ajlm-1261	200	25	bacteria	bacteria	NOUN
ajlm-1261	200	26	:	:	PUNCT
ajlm-1261	200	27	an	an	DET
ajlm-1261	200	28	international	international	ADJ
ajlm-1261	200	29	expert	expert	NOUN
ajlm-1261	200	30	proposal	proposal	NOUN
ajlm-1261	200	31	for	for	ADP
ajlm-1261	200	32	interim	interim	ADJ
ajlm-1261	200	33	standard	standard	ADJ
ajlm-1261	200	34	definitions	definition	NOUN
ajlm-1261	200	35	for	for	ADP
ajlm-1261	200	36	acquired	acquire	VERB
ajlm-1261	200	37	resistance	resistance	NOUN
ajlm-1261	200	38	.	.	PUNCT
ajlm-1261	201	1	clin	clin	PROPN
ajlm-1261	201	2	microb	microb	PROPN
ajlm-1261	201	3	inf	inf	PROPN
ajlm-1261	201	4	.	.	PUNCT
ajlm-1261	202	1	2012;18(3):268–281	2012;18(3):268–281	NUM
ajlm-1261	202	2	.	.	PUNCT
ajlm-1261	202	3	laxminarayan	laxminarayan	PROPN
ajlm-1261	202	4	r	r	NOUN
ajlm-1261	202	5	,	,	PUNCT
ajlm-1261	202	6	matsoso	matsoso	NOUN
ajlm-1261	202	7	p	p	NOUN
ajlm-1261	202	8	,	,	PUNCT
ajlm-1261	202	9	pant	pant	NOUN
ajlm-1261	202	10	s	s	PROPN
ajlm-1261	202	11	,	,	PUNCT
ajlm-1261	202	12	et	et	PROPN
ajlm-1261	202	13	al	al	PROPN
ajlm-1261	202	14	.	.	PROPN
ajlm-1261	202	15	access	access	NOUN
ajlm-1261	202	16	to	to	ADP
ajlm-1261	202	17	effective	effective	ADJ
ajlm-1261	202	18	antimicrobials	antimicrobial	NOUN
ajlm-1261	202	19	:	:	PUNCT
ajlm-1261	202	20	a	a	DET
ajlm-1261	202	21	worldwide	worldwide	ADJ
ajlm-1261	202	22	challenge	challenge	NOUN
ajlm-1261	202	23	.	.	PUNCT
ajlm-1261	203	1	lancet	lancet	NOUN
ajlm-1261	203	2	.	.	PUNCT
ajlm-1261	204	1	2016	2016	NUM
ajlm-1261	204	2	jan	jan	PROPN
ajlm-1261	204	3	9;387(10014):168–175	9;387(10014):168–175	NUM
ajlm-1261	204	4	.	.	PUNCT
ajlm-1261	205	1	https://doi.org/10.1016/s0140-6736(15)00474-2	https://doi.org/10.1016/s0140-6736(15)00474-2	PROPN
ajlm-1261	205	2	serra	serra	PROPN
ajlm-1261	205	3	-	-	PUNCT
ajlm-1261	205	4	burriel	burriel	PROPN
ajlm-1261	205	5	m	m	PROPN
ajlm-1261	205	6	,	,	PUNCT
ajlm-1261	205	7	keys	key	NOUN
ajlm-1261	205	8	m	m	PROPN
ajlm-1261	205	9	,	,	PUNCT
ajlm-1261	205	10	campillo	campillo	PROPN
ajlm-1261	205	11	-	-	PUNCT
ajlm-1261	205	12	artero	artero	NOUN
ajlm-1261	205	13	c	c	NOUN
ajlm-1261	205	14	,	,	PUNCT
ajlm-1261	205	15	et	et	PROPN
ajlm-1261	205	16	al	al	PROPN
ajlm-1261	205	17	.	.	PROPN
ajlm-1261	205	18	impact	impact	NOUN
ajlm-1261	205	19	of	of	ADP
ajlm-1261	205	20	multi	multi	ADJ
ajlm-1261	205	21	-	-	ADJ
ajlm-1261	205	22	drug	drug	ADJ
ajlm-1261	205	23	resistant	resistant	ADJ
ajlm-1261	205	24	bacteria	bacteria	NOUN
ajlm-1261	205	25	on	on	ADP
ajlm-1261	205	26	economic	economic	ADJ
ajlm-1261	205	27	and	and	CCONJ
ajlm-1261	205	28	clinical	clinical	ADJ
ajlm-1261	205	29	outcomes	outcome	NOUN
ajlm-1261	205	30	of	of	ADP
ajlm-1261	205	31	healthcare	healthcare	NOUN
ajlm-1261	205	32	-	-	PUNCT
ajlm-1261	205	33	associated	associate	VERB
ajlm-1261	205	34	infections	infection	NOUN
ajlm-1261	205	35	in	in	ADP
ajlm-1261	205	36	adults	adult	NOUN
ajlm-1261	205	37	:	:	PUNCT
ajlm-1261	205	38	systematic	systematic	ADJ
ajlm-1261	205	39	review	review	NOUN
ajlm-1261	205	40	and	and	CCONJ
ajlm-1261	205	41	meta	meta	ADJ
ajlm-1261	205	42	-	-	PUNCT
ajlm-1261	205	43	analysis	analysis	NOUN
ajlm-1261	205	44	.	.	PUNCT
ajlm-1261	206	1	plos	plos	PROPN
ajlm-1261	206	2	one	one	NUM
ajlm-1261	206	3	.	.	PUNCT
ajlm-1261	207	1	2020;15(1):e0227139	2020;15(1):e0227139	X
ajlm-1261	207	2	.	.	PUNCT
ajlm-1261	208	1	https://doi.org/10.1371/journal.pone.0227139	https://doi.org/10.1371/journal.pone.0227139	ADJ
ajlm-1261	208	2	pitocco	pitocco	PROPN
ajlm-1261	208	3	d	d	NOUN
ajlm-1261	208	4	,	,	PUNCT
ajlm-1261	208	5	spanu	spanu	PROPN
ajlm-1261	208	6	t	t	PROPN
ajlm-1261	208	7	,	,	PUNCT
ajlm-1261	208	8	di	di	PROPN
ajlm-1261	208	9	leo	leo	PROPN
ajlm-1261	208	10	m	m	PROPN
ajlm-1261	208	11	,	,	PUNCT
ajlm-1261	208	12	et	et	PROPN
ajlm-1261	208	13	al	al	PROPN
ajlm-1261	208	14	.	.	PUNCT
ajlm-1261	209	1	diabetic	diabetic	ADJ
ajlm-1261	209	2	foot	foot	NOUN
ajlm-1261	209	3	infections	infection	NOUN
ajlm-1261	209	4	:	:	PUNCT
ajlm-1261	209	5	a	a	DET
ajlm-1261	209	6	comprehensive	comprehensive	ADJ
ajlm-1261	209	7	overview	overview	NOUN
ajlm-1261	209	8	.	.	PUNCT
ajlm-1261	210	1	eur	eur	PROPN
ajlm-1261	210	2	rev	rev	PROPN
ajlm-1261	210	3	med	med	PROPN
ajlm-1261	210	4	pharmacol	pharmacol	PROPN
ajlm-1261	210	5	sci	sci	PROPN
ajlm-1261	210	6	.	.	PUNCT
ajlm-1261	211	1	2019;23(2):26–37	2019;23(2):26–37	NUM
ajlm-1261	211	2	.	.	PUNCT
ajlm-1261	212	1	kandemir	kandemir	PROPN
ajlm-1261	212	2	ö	ö	NOUN
ajlm-1261	212	3	,	,	PUNCT
ajlm-1261	212	4	akbay	akbay	PROPN
ajlm-1261	212	5	e	e	PROPN
ajlm-1261	212	6	,	,	PUNCT
ajlm-1261	212	7	şahin	şahin	PROPN
ajlm-1261	212	8	e	e	PROPN
ajlm-1261	212	9	,	,	PUNCT
ajlm-1261	212	10	milcan	milcan	PROPN
ajlm-1261	212	11	a	a	NOUN
ajlm-1261	212	12	,	,	PUNCT
ajlm-1261	212	13	gen	gen	PROPN
ajlm-1261	212	14	r.	r.	PROPN
ajlm-1261	212	15	risk	risk	NOUN
ajlm-1261	212	16	factors	factor	NOUN
ajlm-1261	212	17	for	for	ADP
ajlm-1261	212	18	infection	infection	NOUN
ajlm-1261	212	19	of	of	ADP
ajlm-1261	212	20	the	the	DET
ajlm-1261	212	21	diabetic	diabetic	ADJ
ajlm-1261	212	22	foot	foot	NOUN
ajlm-1261	212	23	with	with	ADP
ajlm-1261	212	24	multi	multi	ADJ
ajlm-1261	212	25	-	-	ADJ
ajlm-1261	212	26	antibiotic	antibiotic	ADJ
ajlm-1261	212	27	resistant	resistant	ADJ
ajlm-1261	212	28	microorganisms	microorganism	NOUN
ajlm-1261	212	29	.	.	PUNCT
ajlm-1261	213	1	j	j	PROPN
ajlm-1261	213	2	infect	infect	PROPN
ajlm-1261	213	3	.	.	PUNCT
ajlm-1261	214	1	2007;54(5):439–445	2007;54(5):439–445	NOUN
ajlm-1261	214	2	.	.	PUNCT
ajlm-1261	215	1	https://doi.org/10.1016/j.jinf.2006.08.013	https://doi.org/10.1016/j.jinf.2006.08.013	PROPN
ajlm-1261	215	2	shahi	shahi	PROPN
ajlm-1261	215	3	sk	sk	PROPN
ajlm-1261	215	4	,	,	PUNCT
ajlm-1261	215	5	kumar	kumar	PROPN
ajlm-1261	215	6	a	a	PROPN
ajlm-1261	215	7	,	,	PUNCT
ajlm-1261	215	8	kumar	kumar	PROPN
ajlm-1261	215	9	s	s	PROPN
ajlm-1261	215	10	,	,	PUNCT
ajlm-1261	215	11	singh	singh	PROPN
ajlm-1261	215	12	sk	sk	PROPN
ajlm-1261	215	13	,	,	PUNCT
ajlm-1261	215	14	gupta	gupta	PROPN
ajlm-1261	215	15	sk	sk	VERB
ajlm-1261	215	16	,	,	PUNCT
ajlm-1261	215	17	singh	singh	PROPN
ajlm-1261	215	18	tb	tb	NOUN
ajlm-1261	215	19	.	.	PUNCT
ajlm-1261	216	1	prevalence	prevalence	NOUN
ajlm-1261	216	2	of	of	ADP
ajlm-1261	216	3	diabetic	diabetic	ADJ
ajlm-1261	216	4	foot	foot	NOUN
ajlm-1261	216	5	ulcer	ulcer	NOUN
ajlm-1261	216	6	and	and	CCONJ
ajlm-1261	216	7	associated	associate	VERB
ajlm-1261	216	8	risk	risk	NOUN
ajlm-1261	216	9	factors	factor	NOUN
ajlm-1261	216	10	in	in	ADP
ajlm-1261	216	11	diabetic	diabetic	ADJ
ajlm-1261	216	12	patients	patient	NOUN
ajlm-1261	216	13	from	from	ADP
ajlm-1261	216	14	north	north	PROPN
ajlm-1261	216	15	india	india	PROPN
ajlm-1261	216	16	.	.	PUNCT
ajlm-1261	217	1	j	j	PROPN
ajlm-1261	217	2	diab	diab	PROPN
ajlm-1261	217	3	foot	foot	NOUN
ajlm-1261	217	4	compl	compl	PROPN
ajlm-1261	217	5	.	.	PUNCT
ajlm-1261	218	1	2012;4(4):83–91	2012;4(4):83–91	NUM
ajlm-1261	218	2	.	.	PUNCT
ajlm-1261	219	1	kaur	kaur	PROPN
ajlm-1261	219	2	n	n	PROPN
ajlm-1261	219	3	,	,	PUNCT
ajlm-1261	219	4	kaur	kaur	PROPN
ajlm-1261	219	5	n	n	CCONJ
ajlm-1261	219	6	,	,	PUNCT
ajlm-1261	219	7	kumar	kumar	PROPN
ajlm-1261	219	8	r	r	PROPN
ajlm-1261	219	9	,	,	PUNCT
ajlm-1261	219	10	gill	gill	PROPN
ajlm-1261	219	11	ak	ak	PROPN
ajlm-1261	219	12	.	.	PROPN
ajlm-1261	219	13	clinical	clinical	ADJ
ajlm-1261	219	14	and	and	CCONJ
ajlm-1261	219	15	susceptibility	susceptibility	NOUN
ajlm-1261	219	16	profile	profile	NOUN
ajlm-1261	219	17	from	from	ADP
ajlm-1261	219	18	diabetic	diabetic	ADJ
ajlm-1261	219	19	foot	foot	NOUN
ajlm-1261	219	20	patients	patient	NOUN
ajlm-1261	219	21	in	in	ADP
ajlm-1261	219	22	tertiary	tertiary	ADJ
ajlm-1261	219	23	care	care	NOUN
ajlm-1261	219	24	hospital	hospital	NOUN
ajlm-1261	219	25	.	.	PUNCT
ajlm-1261	220	1	scholars	scholar	NOUN
ajlm-1261	220	2	j	j	PROPN
ajlm-1261	220	3	appl	appl	PROPN
ajlm-1261	220	4	med	med	PROPN
ajlm-1261	220	5	sci	sci	PROPN
ajlm-1261	220	6	.	.	PUNCT
ajlm-1261	221	1	2014;2(2d):865–869	2014;2(2d):865–869	NOUN
ajlm-1261	221	2	.	.	PUNCT
ajlm-1261	222	1	vasnessa	vasnessa	NOUN
ajlm-1261	222	2	pds	pds	NOUN
ajlm-1261	222	3	,	,	PUNCT
ajlm-1261	222	4	denise	denise	PROPN
ajlm-1261	222	5	rds	rds	PROPN
ajlm-1261	222	6	,	,	PUNCT
ajlm-1261	222	7	roberto	roberto	PROPN
ajlm-1261	222	8	ac	ac	PROPN
ajlm-1261	222	9	.	.	PUNCT
ajlm-1261	222	10	risk	risk	NOUN
ajlm-1261	222	11	factor	factor	NOUN
ajlm-1261	222	12	for	for	ADP
ajlm-1261	222	13	primary	primary	ADJ
ajlm-1261	222	14	major	major	ADJ
ajlm-1261	222	15	amputation	amputation	NOUN
ajlm-1261	222	16	in	in	ADP
ajlm-1261	222	17	diabetic	diabetic	ADJ
ajlm-1261	222	18	patients	patient	NOUN
ajlm-1261	222	19	.	.	PUNCT
ajlm-1261	223	1	sao	sao	PROPN
ajlm-1261	223	2	paulo	paulo	PROPN
ajlm-1261	223	3	med	med	PROPN
ajlm-1261	223	4	j.	j.	PROPN
ajlm-1261	223	5	2006;124(2):66–70	2006;124(2):66–70	PROPN
ajlm-1261	223	6	.	.	PUNCT
ajlm-1261	224	1	https://doi.org/10.1590/s1516-31802006000200004	https://doi.org/10.1590/s1516-31802006000200004	PROPN
ajlm-1261	224	2	adeleye	adeleye	PROPN
ajlm-1261	224	3	jo	jo	PROPN
ajlm-1261	224	4	.	.	PUNCT
ajlm-1261	225	1	diabetic	diabetic	ADJ
ajlm-1261	225	2	foot	foot	NOUN
ajlm-1261	225	3	disease	disease	NOUN
ajlm-1261	225	4	:	:	PUNCT
ajlm-1261	225	5	the	the	DET
ajlm-1261	225	6	perspective	perspective	NOUN
ajlm-1261	225	7	of	of	ADP
ajlm-1261	225	8	a	a	DET
ajlm-1261	225	9	nigerian	nigerian	ADJ
ajlm-1261	225	10	tertiary	tertiary	ADJ
ajlm-1261	225	11	health	health	NOUN
ajlm-1261	225	12	care	care	NOUN
ajlm-1261	225	13	centre	centre	PROPN
ajlm-1261	225	14	.	.	PUNCT
ajlm-1261	226	1	pract	pract	PROPN
ajlm-1261	226	2	diab	diab	PROPN
ajlm-1261	226	3	int	int	PROPN
ajlm-1261	226	4	.	.	PUNCT
ajlm-1261	227	1	2005;22(6):211–214	2005;22(6):211–214	X
ajlm-1261	227	2	.	.	PUNCT
ajlm-1261	228	1	https://doi.org/10.1002/pdi.819	https://doi.org/10.1002/pdi.819	PROPN
ajlm-1261	228	2	bekele	bekele	PROPN
ajlm-1261	228	3	f	f	PROPN
ajlm-1261	228	4	,	,	PUNCT
ajlm-1261	228	5	chelkeba	chelkeba	PROPN
ajlm-1261	228	6	l	l	PROPN
ajlm-1261	228	7	,	,	PUNCT
ajlm-1261	228	8	fekadu	fekadu	ADJ
ajlm-1261	228	9	g	g	NOUN
ajlm-1261	228	10	,	,	PUNCT
ajlm-1261	228	11	bekele	bekele	PROPN
ajlm-1261	228	12	k.	k.	PROPN
ajlm-1261	228	13	risk	risk	PROPN
ajlm-1261	228	14	factors	factor	NOUN
ajlm-1261	228	15	and	and	CCONJ
ajlm-1261	228	16	outcomes	outcome	NOUN
ajlm-1261	228	17	of	of	ADP
ajlm-1261	228	18	diabetic	diabetic	ADJ
ajlm-1261	228	19	foot	foot	NOUN
ajlm-1261	228	20	ulcer	ulcer	NOUN
ajlm-1261	228	21	among	among	ADP
ajlm-1261	228	22	diabetes	diabetes	NOUN
ajlm-1261	228	23	mellitus	mellitus	NOUN
ajlm-1261	228	24	patients	patient	NOUN
ajlm-1261	228	25	admitted	admit	VERB
ajlm-1261	228	26	to	to	ADP
ajlm-1261	228	27	nekemte	nekemte	PROPN
ajlm-1261	228	28	referral	referral	ADJ
ajlm-1261	228	29	hospital	hospital	NOUN
ajlm-1261	228	30	,	,	PUNCT
ajlm-1261	228	31	western	western	ADJ
ajlm-1261	228	32	ethiopia	ethiopia	PROPN
ajlm-1261	228	33	:	:	PUNCT
ajlm-1261	228	34	prospective	prospective	ADJ
ajlm-1261	228	35	observational	observational	ADJ
ajlm-1261	228	36	study	study	NOUN
ajlm-1261	228	37	.	.	PUNCT
ajlm-1261	229	1	ann	ann	PROPN
ajlm-1261	229	2	med	med	PROPN
ajlm-1261	229	3	surg	surg	PROPN
ajlm-1261	229	4	(	(	PUNCT
ajlm-1261	229	5	lond	lond	PROPN
ajlm-1261	229	6	)	)	PUNCT
ajlm-1261	229	7	.	.	PUNCT
ajlm-1261	230	1	2020	2020	NUM
ajlm-1261	230	2	mar;51:17–23	mar;51:17–23	NOUN
ajlm-1261	230	3	.	.	PUNCT
ajlm-1261	231	1	https://doi.org/10.1016/j.amsu.2020.01.005	https://doi.org/10.1016/j.amsu.2020.01.005	PROPN
ajlm-1261	231	2	caruso	caruso	NOUN
ajlm-1261	231	3	p	p	NOUN
ajlm-1261	231	4	,	,	PUNCT
ajlm-1261	231	5	longo	longo	PROPN
ajlm-1261	231	6	m	m	PROPN
ajlm-1261	231	7	,	,	PUNCT
ajlm-1261	231	8	gicchino	gicchino	PROPN
ajlm-1261	231	9	m	m	PROPN
ajlm-1261	231	10	,	,	PUNCT
ajlm-1261	231	11	scappaticcio	scappaticcio	NOUN
ajlm-1261	231	12	l	l	PROPN
ajlm-1261	231	13	,	,	PUNCT
ajlm-1261	231	14	caputo	caputo	PROPN
ajlm-1261	231	15	m	m	PROPN
ajlm-1261	231	16	,	,	PUNCT
ajlm-1261	231	17	maiorino	maiorino	PROPN
ajlm-1261	231	18	mi	mi	PROPN
ajlm-1261	231	19	,	,	PUNCT
ajlm-1261	231	20	et	et	PROPN
ajlm-1261	231	21	al	al	PROPN
ajlm-1261	231	22	.	.	PUNCT
ajlm-1261	232	1	long	long	ADJ
ajlm-1261	232	2	-	-	PUNCT
ajlm-1261	232	3	term	term	NOUN
ajlm-1261	232	4	diabetic	diabetic	ADJ
ajlm-1261	232	5	complications	complication	NOUN
ajlm-1261	232	6	as	as	ADP
ajlm-1261	232	7	predictors	predictor	NOUN
ajlm-1261	232	8	of	of	ADP
ajlm-1261	232	9	foot	foot	NOUN
ajlm-1261	232	10	ulcers	ulcer	NOUN
ajlm-1261	232	11	healing	heal	VERB
ajlm-1261	232	12	failure	failure	NOUN
ajlm-1261	232	13	:	:	PUNCT
ajlm-1261	232	14	a	a	DET
ajlm-1261	232	15	retrospective	retrospective	ADJ
ajlm-1261	232	16	study	study	NOUN
ajlm-1261	232	17	in	in	ADP
ajlm-1261	232	18	a	a	DET
ajlm-1261	232	19	tertiary	tertiary	ADJ
ajlm-1261	232	20	-	-	PUNCT
ajlm-1261	232	21	care	care	NOUN
ajlm-1261	232	22	center	center	NOUN
ajlm-1261	232	23	.	.	PUNCT
ajlm-1261	233	1	diab	diab	PROPN
ajlm-1261	233	2	res	res	PROPN
ajlm-1261	233	3	clin	clin	PROPN
ajlm-1261	233	4	pract	pract	PROPN
ajlm-1261	233	5	.	.	PUNCT
ajlm-1261	234	1	2020;163:108147	2020;163:108147	NUM
ajlm-1261	234	2	.	.	PUNCT
ajlm-1261	235	1	https://doi.org/10.1016/j.diabres.2020.108147	https://doi.org/10.1016/j.diabres.2020.108147	ADJ
ajlm-1261	235	2	clsi	clsi	NOUN
ajlm-1261	235	3	.	.	PUNCT
ajlm-1261	236	1	performance	performance	NOUN
ajlm-1261	236	2	standards	standard	NOUN
ajlm-1261	236	3	for	for	ADP
ajlm-1261	236	4	antimicrobial	antimicrobial	ADJ
ajlm-1261	236	5	susceptibility	susceptibility	NOUN
ajlm-1261	236	6	testing	testing	NOUN
ajlm-1261	236	7	.	.	PUNCT
ajlm-1261	237	1	twenty	twenty	NUM
ajlm-1261	237	2	-	-	PUNCT
ajlm-1261	237	3	fifth	fifth	ADJ
ajlm-1261	237	4	informational	informational	ADJ
ajlm-1261	237	5	supplement	supplement	NOUN
ajlm-1261	237	6	.	.	PUNCT
ajlm-1261	238	1	clsi	clsi	PROPN
ajlm-1261	238	2	document	document	NOUN
ajlm-1261	238	3	m100	m100	PROPN
ajlm-1261	238	4	-	-	PUNCT
ajlm-1261	238	5	s25	s25	PROPN
ajlm-1261	238	6	.	.	PUNCT
ajlm-1261	238	7	wayne	wayne	PROPN
ajlm-1261	238	8	,	,	PUNCT
ajlm-1261	238	9	pa	pa	PROPN
ajlm-1261	238	10	:	:	PUNCT
ajlm-1261	238	11	clinical	clinical	ADJ
ajlm-1261	238	12	and	and	CCONJ
ajlm-1261	238	13	laboratory	laboratory	NOUN
ajlm-1261	238	14	standards	standard	NOUN
ajlm-1261	238	15	institute	institute	NOUN
ajlm-1261	238	16	;	;	PUNCT
ajlm-1261	238	17	2015	2015	NUM
ajlm-1261	238	18	.	.	PUNCT
ajlm-1261	239	1	anjli	anjli	PROPN
ajlm-1261	239	2	sj	sj	PROPN
ajlm-1261	239	3	,	,	PUNCT
ajlm-1261	239	4	shadija	shadija	VERB
ajlm-1261	239	5	pg	pg	PROPN
ajlm-1261	239	6	,	,	PUNCT
ajlm-1261	239	7	ghosh	ghosh	PROPN
ajlm-1261	239	8	sj	sj	PROPN
ajlm-1261	239	9	.	.	PUNCT
ajlm-1261	239	10	detection	detection	NOUN
ajlm-1261	239	11	of	of	ADP
ajlm-1261	239	12	multidrug	multidrug	NOUN
ajlm-1261	239	13	resistant	resistant	ADJ
ajlm-1261	239	14	gram	gram	NOUN
ajlm-1261	239	15	negative	negative	ADJ
ajlm-1261	239	16	bacilli	bacilli	NOUN
ajlm-1261	239	17	in	in	ADP
ajlm-1261	239	18	type	type	NOUN
ajlm-1261	239	19	ii	ii	PROPN
ajlm-1261	239	20	diabetic	diabetic	ADJ
ajlm-1261	239	21	foot	foot	NOUN
ajlm-1261	239	22	infections	infection	NOUN
ajlm-1261	239	23	.	.	PUNCT
ajlm-1261	240	1	inter	inter	PROPN
ajlm-1261	240	2	j	j	PROPN
ajlm-1261	240	3	med	med	PROPN
ajlm-1261	240	4	health	health	PROPN
ajlm-1261	240	5	sci	sci	PROPN
ajlm-1261	240	6	.	.	PUNCT
ajlm-1261	241	1	2013;2(2):186–194	2013;2(2):186–194	X
ajlm-1261	241	2	.	.	PUNCT
ajlm-1261	242	1	sidjabat	sidjabat	NOUN
ajlm-1261	242	2	he	he	PRON
ajlm-1261	242	3	,	,	PUNCT
ajlm-1261	242	4	paterson	paterson	PROPN
ajlm-1261	242	5	dl	dl	PROPN
ajlm-1261	242	6	,	,	PUNCT
ajlm-1261	242	7	adams	adams	PROPN
ajlm-1261	242	8	-	-	PUNCT
ajlm-1261	242	9	haduch	haduch	PROPN
ajlm-1261	242	10	jm	jm	PROPN
ajlm-1261	242	11	,	,	PUNCT
ajlm-1261	242	12	et	et	PROPN
ajlm-1261	242	13	al	al	PROPN
ajlm-1261	242	14	.	.	PROPN
ajlm-1261	243	1	molecular	molecular	ADJ
ajlm-1261	243	2	epidemiology	epidemiology	NOUN
ajlm-1261	243	3	of	of	ADP
ajlm-1261	243	4	ctx	ctx	NOUN
ajlm-1261	243	5	-	-	ADJ
ajlm-1261	243	6	m	m	ADV
ajlm-1261	243	7	-	-	PUNCT
ajlm-1261	243	8	producing	produce	VERB
ajlm-1261	243	9	escherichia	escherichia	NOUN
ajlm-1261	243	10	coli	coli	NOUN
ajlm-1261	243	11	isolates	isolate	NOUN
ajlm-1261	243	12	at	at	ADP
ajlm-1261	243	13	a	a	DET
ajlm-1261	243	14	tertiary	tertiary	ADJ
ajlm-1261	243	15	medical	medical	ADJ
ajlm-1261	243	16	center	center	NOUN
ajlm-1261	243	17	in	in	ADP
ajlm-1261	243	18	western	western	ADJ
ajlm-1261	243	19	pennsylvania	pennsylvania	PROPN
ajlm-1261	243	20	.	.	PUNCT
ajlm-1261	244	1	antimicrob	antimicrob	PROPN
ajlm-1261	244	2	agents	agents	PROPN
ajlm-1261	244	3	chemother	chemother	PROPN
ajlm-1261	244	4	.	.	PUNCT
ajlm-1261	245	1	2009;53(11):4733–4739	2009;53(11):4733–4739	X
ajlm-1261	245	2	.	.	PUNCT
ajlm-1261	246	1	https://doi.org/10.1128/aac.00533-09	https://doi.org/10.1128/aac.00533-09	PROPN
ajlm-1261	246	2	monstein	monstein	ADJ
ajlm-1261	246	3	hj	hj	PROPN
ajlm-1261	246	4	,	,	PUNCT
ajlm-1261	246	5	ostholm	ostholm	NOUN
ajlm-1261	246	6	-	-	PUNCT
ajlm-1261	246	7	balkhed	balkhe	VERB
ajlm-1261	246	8	a	a	PRON
ajlm-1261	246	9	,	,	PUNCT
ajlm-1261	246	10	nilsson	nilsson	PROPN
ajlm-1261	246	11	mv	mv	PROPN
ajlm-1261	246	12	,	,	PUNCT
ajlm-1261	246	13	dornbusch	dornbusch	PROPN
ajlm-1261	246	14	nl	nl	PROPN
ajlm-1261	246	15	.	.	PUNCT
ajlm-1261	247	1	multiplex	multiplex	PROPN
ajlm-1261	247	2	pcr	pcr	PROPN
ajlm-1261	247	3	amplification	amplification	NOUN
ajlm-1261	247	4	assay	assay	VERB
ajlm-1261	247	5	for	for	ADP
ajlm-1261	247	6	rapid	rapid	ADJ
ajlm-1261	247	7	detection	detection	NOUN
ajlm-1261	247	8	of	of	ADP
ajlm-1261	247	9	shv	shv	PROPN
ajlm-1261	247	10	,	,	PUNCT
ajlm-1261	247	11	tem	tem	PROPN
ajlm-1261	247	12	and	and	CCONJ
ajlm-1261	247	13	ctx	ctx	NOUN
ajlm-1261	247	14	-	-	NOUN
ajlm-1261	247	15	m	m	NOUN
ajlm-1261	247	16	genes	gene	NOUN
ajlm-1261	247	17	in	in	ADP
ajlm-1261	247	18	enterobateriacea	enterobateriacea	PROPN
ajlm-1261	247	19	.	.	PUNCT
ajlm-1261	248	1	apmis	apmis	PROPN
ajlm-1261	248	2	.	.	PUNCT
ajlm-1261	249	1	2007;115(12):1400–1408	2007;115(12):1400–1408	NUM
ajlm-1261	249	2	.	.	PUNCT
ajlm-1261	249	3	https://doi.org/10.1111/j.1600-0463.2007.00722.x	https://doi.org/10.1111/j.1600-0463.2007.00722.x	PROPN
ajlm-1261	249	4	pasanen	pasanen	PROPN
ajlm-1261	249	5	t	t	PROPN
ajlm-1261	249	6	,	,	PUNCT
ajlm-1261	249	7	koskela	koskela	VERB
ajlm-1261	249	8	s	s	PROPN
ajlm-1261	249	9	,	,	PUNCT
ajlm-1261	249	10	mero	mero	PROPN
ajlm-1261	249	11	s	s	PROPN
ajlm-1261	249	12	,	,	PUNCT
ajlm-1261	249	13	et	et	PROPN
ajlm-1261	249	14	al	al	PROPN
ajlm-1261	249	15	.	.	PROPN
ajlm-1261	250	1	rapid	rapid	ADJ
ajlm-1261	250	2	molecular	molecular	ADJ
ajlm-1261	250	3	characterization	characterization	NOUN
ajlm-1261	250	4	of	of	ADP
ajlm-1261	250	5	acinetobacter	acinetobacter	ADJ
ajlm-1261	250	6	baumannii	baumannii	ADJ
ajlm-1261	250	7	clones	clone	NOUN
ajlm-1261	250	8	with	with	ADP
ajlm-1261	250	9	rep	rep	NOUN
ajlm-1261	250	10	-	-	ADJ
ajlm-1261	250	11	pcr	pcr	ADJ
ajlm-1261	250	12	and	and	CCONJ
ajlm-1261	250	13	evaluation	evaluation	NOUN
ajlm-1261	250	14	of	of	ADP
ajlm-1261	250	15	carbapenemase	carbapenemase	NOUN
ajlm-1261	250	16	genes	gene	NOUN
ajlm-1261	250	17	by	by	ADP
ajlm-1261	250	18	new	new	ADJ
ajlm-1261	250	19	multiplex	multiplex	PROPN
ajlm-1261	250	20	pcr	pcr	PROPN
ajlm-1261	250	21	in	in	ADP
ajlm-1261	250	22	hospital	hospital	NOUN
ajlm-1261	250	23	district	district	NOUN
ajlm-1261	250	24	of	of	ADP
ajlm-1261	250	25	helsinki	helsinki	PROPN
ajlm-1261	250	26	and	and	CCONJ
ajlm-1261	250	27	uusimaa	uusimaa	PROPN
ajlm-1261	250	28	.	.	PUNCT
ajlm-1261	251	1	plos	plos	PROPN
ajlm-1261	251	2	one	one	NUM
ajlm-1261	251	3	.	.	PUNCT
ajlm-1261	252	1	2014;9(1):e85854	2014;9(1):e85854	NUM
ajlm-1261	252	2	.	.	PUNCT
ajlm-1261	253	1	https://doi.org/10.1371/journal.pone.0085854	https://doi.org/10.1371/journal.pone.0085854	PROPN
ajlm-1261	253	2	zhao	zhao	PROPN
ajlm-1261	253	3	s	s	PROPN
ajlm-1261	253	4	,	,	PUNCT
ajlm-1261	253	5	jang	jang	PROPN
ajlm-1261	253	6	d	d	PROPN
ajlm-1261	253	7	,	,	PUNCT
ajlm-1261	253	8	xu	xu	PROPN
ajlm-1261	254	1	p	p	X
ajlm-1261	254	2	,	,	PUNCT
ajlm-1261	254	3	et	et	PROPN
ajlm-1261	254	4	al	al	PROPN
ajlm-1261	254	5	.	.	PUNCT
ajlm-1261	255	1	an	an	DET
ajlm-1261	255	2	investigation	investigation	NOUN
ajlm-1261	255	3	of	of	ADP
ajlm-1261	255	4	drug	drug	NOUN
ajlm-1261	255	5	-	-	PUNCT
ajlm-1261	255	6	resistant	resistant	ADJ
ajlm-1261	255	7	acinetobacter	acinetobacter	ADJ
ajlm-1261	255	8	baumannii	baumannii	ADJ
ajlm-1261	255	9	infection	infection	NOUN
ajlm-1261	255	10	in	in	ADP
ajlm-1261	255	11	a	a	DET
ajlm-1261	255	12	comprehensive	comprehensive	ADJ
ajlm-1261	255	13	hospital	hospital	NOUN
ajlm-1261	255	14	in	in	ADP
ajlm-1261	255	15	east	east	PROPN
ajlm-1261	255	16	india	india	PROPN
ajlm-1261	255	17	.	.	PUNCT
ajlm-1261	256	1	ann	ann	PROPN
ajlm-1261	256	2	clin	clin	PROPN
ajlm-1261	256	3	microbiol	microbiol	PROPN
ajlm-1261	256	4	antimicrob	antimicrob	PROPN
ajlm-1261	256	5	.	.	PUNCT
ajlm-1261	257	1	2015;14:7	2015;14:7	NOUN
ajlm-1261	257	2	.	.	PUNCT
ajlm-1261	258	1	https://doi.org/10.1186/s12941-015-0066-4	https://doi.org/10.1186/s12941-015-0066-4	NUM
ajlm-1261	258	2	khan	khan	PROPN
ajlm-1261	258	3	aks	aks	PROPN
ajlm-1261	258	4	,	,	PUNCT
ajlm-1261	258	5	shetty	shetty	PROPN
ajlm-1261	258	6	pj	pj	PROPN
ajlm-1261	258	7	,	,	PUNCT
ajlm-1261	258	8	sarayu	sarayu	ADJ
ajlm-1261	258	9	yl	yl	NOUN
ajlm-1261	258	10	,	,	PUNCT
ajlm-1261	258	11	chidambaram	chidambaram	PROPN
ajlm-1261	258	12	a	a	PROPN
ajlm-1261	258	13	,	,	PUNCT
ajlm-1261	258	14	ranganathan	ranganathan	PROPN
ajlm-1261	258	15	r.	r.	PROPN
ajlm-1261	258	16	detection	detection	PROPN
ajlm-1261	258	17	of	of	ADP
ajlm-1261	258	18	meca	meca	NOUN
ajlm-1261	258	19	genes	gene	NOUN
ajlm-1261	258	20	of	of	ADP
ajlm-1261	258	21	methicillin	methicillin	NOUN
ajlm-1261	258	22	-	-	PUNCT
ajlm-1261	258	23	resistant	resistant	ADJ
ajlm-1261	258	24	staphylococcus	staphylococcus	NOUN
ajlm-1261	258	25	aureus	aureus	NOUN
ajlm-1261	258	26	by	by	ADP
ajlm-1261	258	27	polymerase	polymerase	NOUN
ajlm-1261	258	28	chain	chain	NOUN
ajlm-1261	258	29	reaction	reaction	NOUN
ajlm-1261	258	30	.	.	PUNCT
ajlm-1261	259	1	int	int	PROPN
ajlm-1261	259	2	j	j	PROPN
ajlm-1261	259	3	health	health	PROPN
ajlm-1261	259	4	rehabil	rehabil	PROPN
ajlm-1261	259	5	sci	sci	PROPN
ajlm-1261	259	6	.	.	PUNCT
ajlm-1261	259	7	2012;1:64–68	2012;1:64–68	PROPN
ajlm-1261	259	8	.	.	PROPN
ajlm-1261	259	9	https://doi.org/10.5455/ijhrs.000000011	https://doi.org/10.5455/ijhrs.000000011	PROPN
ajlm-1261	259	10	dashti	dashti	VERB
ajlm-1261	259	11	aa	aa	PROPN
ajlm-1261	259	12	,	,	PUNCT
ajlm-1261	259	13	jadaon	jadaon	PROPN
ajlm-1261	259	14	mm	mm	PROPN
ajlm-1261	259	15	,	,	PUNCT
ajlm-1261	259	16	abdulsamad	abdulsamad	NOUN
ajlm-1261	259	17	am	be	AUX
ajlm-1261	259	18	,	,	PUNCT
ajlm-1261	259	19	dashti	dashti	VERB
ajlm-1261	259	20	hm	hm	INTJ
ajlm-1261	259	21	.	.	PUNCT
ajlm-1261	259	22	heat	heat	PROPN
ajlm-1261	259	23	treatment	treatment	NOUN
ajlm-1261	259	24	of	of	ADP
ajlm-1261	259	25	bacteria	bacteria	NOUN
ajlm-1261	259	26	:	:	PUNCT
ajlm-1261	259	27	a	a	DET
ajlm-1261	259	28	simple	simple	ADJ
ajlm-1261	259	29	method	method	NOUN
ajlm-1261	259	30	of	of	ADP
ajlm-1261	259	31	dna	dna	PROPN
ajlm-1261	259	32	extraction	extraction	NOUN
ajlm-1261	259	33	for	for	ADP
ajlm-1261	259	34	molecular	molecular	ADJ
ajlm-1261	259	35	techniques	technique	NOUN
ajlm-1261	259	36	.	.	PUNCT
ajlm-1261	260	1	kuwait	kuwait	PROPN
ajlm-1261	260	2	med	med	PROPN
ajlm-1261	260	3	j.	j.	PROPN
ajlm-1261	260	4	2009;41(2):117–122	2009;41(2):117–122	PROPN
ajlm-1261	260	5	.	.	PUNCT
ajlm-1261	260	6	zubair	zubair	PROPN
ajlm-1261	260	7	m.	m.	PROPN
ajlm-1261	260	8	prevalence	prevalence	NOUN
ajlm-1261	260	9	and	and	CCONJ
ajlm-1261	260	10	interrelationships	interrelationship	NOUN
ajlm-1261	260	11	of	of	ADP
ajlm-1261	260	12	foot	foot	NOUN
ajlm-1261	260	13	ulcer	ulcer	NOUN
ajlm-1261	260	14	,	,	PUNCT
ajlm-1261	260	15	risk	risk	NOUN
ajlm-1261	260	16	-	-	PUNCT
ajlm-1261	260	17	factors	factor	NOUN
ajlm-1261	260	18	and	and	CCONJ
ajlm-1261	260	19	antibiotic	antibiotic	ADJ
ajlm-1261	260	20	resistance	resistance	NOUN
ajlm-1261	260	21	in	in	ADP
ajlm-1261	260	22	foot	foot	NOUN
ajlm-1261	260	23	ulcers	ulcer	NOUN
ajlm-1261	260	24	in	in	ADP
ajlm-1261	260	25	diabetic	diabetic	ADJ
ajlm-1261	260	26	populations	population	NOUN
ajlm-1261	260	27	:	:	PUNCT
ajlm-1261	260	28	a	a	DET
ajlm-1261	260	29	systematic	systematic	ADJ
ajlm-1261	260	30	review	review	NOUN
ajlm-1261	260	31	and	and	CCONJ
ajlm-1261	260	32	meta	meta	ADJ
ajlm-1261	260	33	-	-	PUNCT
ajlm-1261	260	34	analysis	analysis	NOUN
ajlm-1261	260	35	.	.	PUNCT
ajlm-1261	261	1	world	world	PROPN
ajlm-1261	261	2	j	j	PROPN
ajlm-1261	261	3	diabetes	diabetes	NOUN
ajlm-1261	261	4	.	.	PUNCT
ajlm-1261	262	1	2020;11(3):78–89	2020;11(3):78–89	X
ajlm-1261	262	2	.	.	PUNCT
ajlm-1261	263	1	https://doi.org/10.4239/wjd.v11.i3.78	https://doi.org/10.4239/wjd.v11.i3.78	ADJ
ajlm-1261	263	2	desalu	desalu	PROPN
ajlm-1261	263	3	oo	oo	INTJ
ajlm-1261	263	4	,	,	PUNCT
ajlm-1261	263	5	salawu	salawu	VERB
ajlm-1261	263	6	fk	fk	PROPN
ajlm-1261	263	7	,	,	PUNCT
ajlm-1261	263	8	jimoh	jimoh	PROPN
ajlm-1261	263	9	ak	ak	PROPN
ajlm-1261	263	10	,	,	PUNCT
ajlm-1261	263	11	adekoya	adekoya	ADJ
ajlm-1261	263	12	ao	ao	PROPN
ajlm-1261	263	13	,	,	PUNCT
ajlm-1261	263	14	busari	busari	PROPN
ajlm-1261	263	15	oa	oa	PROPN
ajlm-1261	263	16	,	,	PUNCT
ajlm-1261	263	17	olokoba	olokoba	PROPN
ajlm-1261	263	18	ab	ab	PROPN
ajlm-1261	263	19	.	.	PUNCT
ajlm-1261	264	1	diabetic	diabetic	ADJ
ajlm-1261	264	2	foot	foot	NOUN
ajlm-1261	264	3	care	care	NOUN
ajlm-1261	264	4	:	:	PUNCT
ajlm-1261	264	5	self	self	NOUN
ajlm-1261	264	6	reported	report	VERB
ajlm-1261	264	7	knowledge	knowledge	NOUN
ajlm-1261	264	8	and	and	CCONJ
ajlm-1261	264	9	practice	practice	NOUN
ajlm-1261	264	10	among	among	ADP
ajlm-1261	264	11	patients	patient	NOUN
ajlm-1261	264	12	attending	attend	VERB
ajlm-1261	264	13	three	three	NUM
ajlm-1261	264	14	tertiary	tertiary	ADJ
ajlm-1261	264	15	hospital	hospital	NOUN
ajlm-1261	264	16	in	in	ADP
ajlm-1261	264	17	nigeria	nigeria	PROPN
ajlm-1261	264	18	.	.	PUNCT
ajlm-1261	265	1	ghana	ghana	PROPN
ajlm-1261	265	2	med	med	PROPN
ajlm-1261	265	3	j.	j.	PROPN
ajlm-1261	265	4	2011;45(2):60–65	2011;45(2):60–65	PROPN
ajlm-1261	265	5	.	.	PUNCT
ajlm-1261	266	1	https://doi.org/10.4314/gmj.v45i2.68930	https://doi.org/10.4314/gmj.v45i2.68930	PROPN
ajlm-1261	266	2	mendes	mende	NOUN
ajlm-1261	266	3	jj	jj	PROPN
ajlm-1261	266	4	,	,	PUNCT
ajlm-1261	266	5	nerves	nerve	NOUN
ajlm-1261	266	6	j.	j.	PROPN
ajlm-1261	266	7	diabetic	diabetic	ADJ
ajlm-1261	266	8	foot	foot	NOUN
ajlm-1261	266	9	infections	infection	NOUN
ajlm-1261	266	10	:	:	PUNCT
ajlm-1261	266	11	current	current	ADJ
ajlm-1261	266	12	diagnosis	diagnosis	NOUN
ajlm-1261	266	13	and	and	CCONJ
ajlm-1261	266	14	treatment	treatment	NOUN
ajlm-1261	266	15	.	.	PUNCT
ajlm-1261	267	1	j	j	PROPN
ajlm-1261	267	2	diab	diab	PROPN
ajlm-1261	267	3	foot	foot	NOUN
ajlm-1261	267	4	compl	compl	NOUN
ajlm-1261	267	5	.	.	PUNCT
ajlm-1261	268	1	2012;4(1):26–45	2012;4(1):26–45	NUM
ajlm-1261	268	2	.	.	PUNCT
ajlm-1261	269	1	ako	ako	PROPN
ajlm-1261	269	2	-	-	PUNCT
ajlm-1261	269	3	nai	nai	PROPN
ajlm-1261	269	4	ka	ka	PROPN
ajlm-1261	269	5	,	,	PUNCT
ajlm-1261	269	6	ikem	ikem	PROPN
ajlm-1261	269	7	ci	ci	PROPN
ajlm-1261	269	8	,	,	PUNCT
ajlm-1261	269	9	akinloye	akinloye	VERB
ajlm-1261	269	10	oo	oo	ADV
ajlm-1261	269	11	,	,	PUNCT
ajlm-1261	269	12	aboderin	aboderin	PROPN
ajlm-1261	269	13	oa	oa	INTJ
ajlm-1261	269	14	,	,	PUNCT
ajlm-1261	269	15	ikem	ikem	ADJ
ajlm-1261	269	16	tr	tr	VERB
ajlm-1261	269	17	,	,	PUNCT
ajlm-1261	269	18	kassim	kassim	PROPN
ajlm-1261	269	19	oo	oo	PROPN
ajlm-1261	269	20	.	.	PUNCT
ajlm-1261	270	1	characterization	characterization	NOUN
ajlm-1261	270	2	of	of	ADP
ajlm-1261	270	3	bacterial	bacterial	ADJ
ajlm-1261	270	4	isolates	isolate	NOUN
ajlm-1261	270	5	from	from	ADP
ajlm-1261	270	6	diabetic	diabetic	ADJ
ajlm-1261	270	7	foot	foot	NOUN
ajlm-1261	270	8	infections	infection	NOUN
ajlm-1261	270	9	in	in	ADP
ajlm-1261	270	10	ile	ile	PROPN
ajlm-1261	270	11	-	-	PUNCT
ajlm-1261	270	12	ife	ife	PROPN
ajlm-1261	270	13	,	,	PUNCT
ajlm-1261	270	14	southwestern	southwestern	PROPN
ajlm-1261	270	15	nigeria	nigeria	PROPN
ajlm-1261	270	16	.	.	PUNCT
ajlm-1261	271	1	foot	foot	NOUN
ajlm-1261	271	2	.	.	PUNCT
ajlm-1261	272	1	2006;16(3):158–164	2006;16(3):158–164	X
ajlm-1261	272	2	.	.	PUNCT
ajlm-1261	273	1	https://doi.org/10.1016/j.foot.2006.05.001	https://doi.org/10.1016/j.foot.2006.05.001	NOUN
ajlm-1261	273	2	ikeh	ikeh	ADJ
ajlm-1261	273	3	ei	ei	PROPN
ajlm-1261	273	4	,	,	PUNCT
ajlm-1261	273	5	puepet	puepet	NOUN
ajlm-1261	273	6	f	f	PROPN
ajlm-1261	273	7	,	,	PUNCT
ajlm-1261	273	8	nwadiaro	nwadiaro	ADJ
ajlm-1261	273	9	c.	c.	PROPN
ajlm-1261	273	10	studies	study	NOUN
ajlm-1261	273	11	on	on	ADP
ajlm-1261	273	12	diabetic	diabetic	ADJ
ajlm-1261	273	13	foot	foot	NOUN
ajlm-1261	273	14	ulcers	ulcer	NOUN
ajlm-1261	273	15	in	in	ADP
ajlm-1261	273	16	patients	patient	NOUN
ajlm-1261	273	17	at	at	ADP
ajlm-1261	273	18	jos	jos	PROPN
ajlm-1261	273	19	university	university	PROPN
ajlm-1261	273	20	teaching	teaching	NOUN
ajlm-1261	273	21	hospital	hospital	NOUN
ajlm-1261	273	22	,	,	PUNCT
ajlm-1261	273	23	nigeria	nigeria	PROPN
ajlm-1261	273	24	.	.	PUNCT
ajlm-1261	274	1	afr	afr	PROPN
ajlm-1261	274	2	j	j	PROPN
ajlm-1261	274	3	clin	clin	PROPN
ajlm-1261	274	4	exp	exp	PROPN
ajlm-1261	274	5	microb	microb	PROPN
ajlm-1261	274	6	.	.	PUNCT
ajlm-1261	275	1	2003;4(2):52–61	2003;4(2):52–61	NUM
ajlm-1261	275	2	.	.	PUNCT
ajlm-1261	276	1	https://doi.org/10.4314/ajcem.v4i1.7324	https://doi.org/10.4314/ajcem.v4i1.7324	PROPN
ajlm-1261	276	2	al	al	PROPN
ajlm-1261	276	3	-	-	PUNCT
ajlm-1261	276	4	benwan	benwan	PROPN
ajlm-1261	276	5	ka	ka	PROPN
ajlm-1261	276	6	,	,	PUNCT
ajlm-1261	276	7	al	al	PROPN
ajlm-1261	276	8	mulla	mulla	PROPN
ajlm-1261	276	9	a	a	PRON
ajlm-1261	276	10	,	,	PUNCT
ajlm-1261	276	11	rotimi	rotimi	PROPN
ajlm-1261	276	12	vo	vo	X
ajlm-1261	276	13	.	.	PUNCT
ajlm-1261	277	1	a	a	DET
ajlm-1261	277	2	study	study	NOUN
ajlm-1261	277	3	of	of	ADP
ajlm-1261	277	4	the	the	DET
ajlm-1261	277	5	microbiology	microbiology	NOUN
ajlm-1261	277	6	of	of	ADP
ajlm-1261	277	7	diabetic	diabetic	ADJ
ajlm-1261	277	8	foot	foot	NOUN
ajlm-1261	277	9	infections	infection	NOUN
ajlm-1261	277	10	in	in	ADP
ajlm-1261	277	11	a	a	DET
ajlm-1261	277	12	teaching	teaching	NOUN
ajlm-1261	277	13	hospital	hospital	NOUN
ajlm-1261	277	14	in	in	ADP
ajlm-1261	277	15	kuwait	kuwait	PROPN
ajlm-1261	277	16	.	.	PUNCT
ajlm-1261	278	1	j	j	PROPN
ajlm-1261	278	2	infect	infect	VERB
ajlm-1261	278	3	public	public	ADJ
ajlm-1261	278	4	health	health	NOUN
ajlm-1261	278	5	.	.	PUNCT
ajlm-1261	279	1	2012;5(1):1–8	2012;5(1):1–8	X
ajlm-1261	279	2	.	.	PUNCT
ajlm-1261	280	1	https://doi.org/10.1016/j.jiph.2011.07.004	https://doi.org/10.1016/j.jiph.2011.07.004	PROPN
ajlm-1261	280	2	richard	richard	PROPN
ajlm-1261	280	3	jl	jl	PROPN
ajlm-1261	280	4	,	,	PUNCT
ajlm-1261	280	5	lavigne	lavigne	PROPN
ajlm-1261	280	6	jp	jp	PROPN
ajlm-1261	280	7	,	,	PUNCT
ajlm-1261	280	8	got	get	VERB
ajlm-1261	280	9	i	i	PRON
ajlm-1261	280	10	,	,	PUNCT
ajlm-1261	280	11	et	et	PROPN
ajlm-1261	280	12	al	al	PROPN
ajlm-1261	280	13	.	.	PUNCT
ajlm-1261	280	14	management	management	NOUN
ajlm-1261	280	15	of	of	ADP
ajlm-1261	280	16	patients	patient	NOUN
ajlm-1261	280	17	hospitalized	hospitalize	VERB
ajlm-1261	280	18	for	for	ADP
ajlm-1261	280	19	diabetic	diabetic	ADJ
ajlm-1261	280	20	foot	foot	NOUN
ajlm-1261	280	21	infection	infection	NOUN
ajlm-1261	280	22	:	:	PUNCT
ajlm-1261	280	23	results	result	NOUN
ajlm-1261	280	24	of	of	ADP
ajlm-1261	280	25	the	the	DET
ajlm-1261	280	26	french	french	ADJ
ajlm-1261	280	27	opidia	opidia	NOUN
ajlm-1261	280	28	study	study	NOUN
ajlm-1261	280	29	.	.	PUNCT
ajlm-1261	281	1	diabetes	diabetes	NOUN
ajlm-1261	281	2	metab	metab	NOUN
ajlm-1261	281	3	.	.	PUNCT
ajlm-1261	282	1	2011;37(3):208–15	2011;37(3):208–15	NUM
ajlm-1261	282	2	.	.	PUNCT
ajlm-1261	283	1	https://doi.org/10.1016/j.diabet.2010.10.003	https://doi.org/10.1016/j.diabet.2010.10.003	NUM
ajlm-1261	283	2	yates	yates	PROPN
ajlm-1261	283	3	c	c	PROPN
ajlm-1261	283	4	,	,	PUNCT
ajlm-1261	283	5	may	may	AUX
ajlm-1261	283	6	k	k	PROPN
ajlm-1261	283	7	,	,	PUNCT
ajlm-1261	283	8	hale	hale	PROPN
ajlm-1261	283	9	t	t	PROPN
ajlm-1261	283	10	,	,	PUNCT
ajlm-1261	283	11	allard	allard	PROPN
ajlm-1261	283	12	b	b	PROPN
ajlm-1261	283	13	,	,	PUNCT
ajlm-1261	283	14	rowlings	rowling	NOUN
ajlm-1261	283	15	n	n	PRON
ajlm-1261	283	16	,	,	PUNCT
ajlm-1261	283	17	freeman	freeman	PROPN
ajlm-1261	283	18	a	a	PROPN
ajlm-1261	283	19	,	,	PUNCT
ajlm-1261	283	20	et	et	PROPN
ajlm-1261	283	21	al	al	PROPN
ajlm-1261	283	22	.	.	PROPN
ajlm-1261	283	23	wound	wound	PROPN
ajlm-1261	283	24	chronicity	chronicity	NOUN
ajlm-1261	283	25	,	,	PUNCT
ajlm-1261	283	26	inpatient	inpatient	NOUN
ajlm-1261	283	27	care	care	NOUN
ajlm-1261	283	28	,	,	PUNCT
ajlm-1261	283	29	and	and	CCONJ
ajlm-1261	283	30	chronic	chronic	ADJ
ajlm-1261	283	31	kidney	kidney	NOUN
ajlm-1261	283	32	disease	disease	NOUN
ajlm-1261	283	33	predispose	predispose	VERB
ajlm-1261	283	34	to	to	ADP
ajlm-1261	283	35	mrsa	mrsa	NOUN
ajlm-1261	283	36	infection	infection	NOUN
ajlm-1261	283	37	in	in	ADP
ajlm-1261	283	38	diabetic	diabetic	ADJ
ajlm-1261	283	39	foot	foot	NOUN
ajlm-1261	283	40	ulcers	ulcer	NOUN
ajlm-1261	283	41	.	.	PUNCT
ajlm-1261	284	1	diabetes	diabetes	NOUN
ajlm-1261	284	2	care	care	NOUN
ajlm-1261	284	3	.	.	PUNCT
ajlm-1261	285	1	2009;32(10):1907–1909	2009;32(10):1907–1909	X
ajlm-1261	285	2	.	.	PUNCT
ajlm-1261	286	1	https://doi.org/10.2337/dc09-0295	https://doi.org/10.2337/dc09-0295	PROPN
ajlm-1261	286	2	oecd	oecd	PROPN
ajlm-1261	286	3	(	(	PUNCT
ajlm-1261	286	4	june	june	PROPN
ajlm-1261	286	5	27	27	NUM
ajlm-1261	286	6	,	,	PUNCT
ajlm-1261	286	7	2013	2013	NUM
ajlm-1261	286	8	)	)	PUNCT
ajlm-1261	286	9	.	.	PUNCT
ajlm-1261	287	1	oecd	oecd	PROPN
ajlm-1261	287	2	health	health	PROPN
ajlm-1261	287	3	data	data	PROPN
ajlm-1261	287	4	:	:	PUNCT
ajlm-1261	287	5	social	social	ADJ
ajlm-1261	287	6	protection	protection	NOUN
ajlm-1261	287	7	.	.	PUNCT
ajlm-1261	288	1	oecd	oecd	PROPN
ajlm-1261	288	2	health	health	PROPN
ajlm-1261	288	3	statistics	statistic	NOUN
ajlm-1261	288	4	(	(	PUNCT
ajlm-1261	288	5	database	database	NOUN
ajlm-1261	288	6	)	)	PUNCT
ajlm-1261	288	7	.	.	PUNCT
ajlm-1261	289	1	paris	paris	PROPN
ajlm-1261	289	2	:	:	PUNCT
ajlm-1261	290	1	oecd	oecd	PROPN
ajlm-1261	290	2	.	.	PROPN
ajlm-1261	290	3	https://doi.org/10.1787/data-00544-en	https://doi.org/10.1787/data-00544-en	PROPN
ajlm-1261	290	4	richard	richard	PROPN
ajlm-1261	290	5	jl	jl	PROPN
ajlm-1261	290	6	,	,	PUNCT
ajlm-1261	290	7	sotto	sotto	PROPN
ajlm-1261	290	8	a	a	PROPN
ajlm-1261	290	9	,	,	PUNCT
ajlm-1261	290	10	jourdan	jourdan	PROPN
ajlm-1261	290	11	n	n	PROPN
ajlm-1261	290	12	,	,	PUNCT
ajlm-1261	290	13	et	et	PROPN
ajlm-1261	290	14	al	al	PROPN
ajlm-1261	290	15	.	.	PUNCT
ajlm-1261	290	16	risk	risk	NOUN
ajlm-1261	290	17	factors	factor	NOUN
ajlm-1261	290	18	and	and	CCONJ
ajlm-1261	290	19	healing	healing	NOUN
ajlm-1261	290	20	impact	impact	NOUN
ajlm-1261	290	21	of	of	ADP
ajlm-1261	290	22	multidrug	multidrug	NOUN
ajlm-1261	290	23	-	-	PUNCT
ajlm-1261	290	24	resistant	resistant	ADJ
ajlm-1261	290	25	bacteria	bacteria	NOUN
ajlm-1261	290	26	in	in	ADP
ajlm-1261	290	27	diabetic	diabetic	ADJ
ajlm-1261	290	28	foot	foot	NOUN
ajlm-1261	290	29	ulcers	ulcer	NOUN
ajlm-1261	290	30	.	.	PUNCT
ajlm-1261	291	1	diab	diab	PROPN
ajlm-1261	291	2	metab	metab	PROPN
ajlm-1261	291	3	.	.	PUNCT
ajlm-1261	292	1	2008;34(2):363–369	2008;34(2):363–369	X
ajlm-1261	292	2	.	.	PUNCT
ajlm-1261	293	1	https://doi.org/10.1016/j.diabet.2008.02.005	https://doi.org/10.1016/j.diabet.2008.02.005	NUM
ajlm-1261	293	2	omolase	omolase	NOUN
ajlm-1261	293	3	co	co	NOUN
ajlm-1261	293	4	,	,	PUNCT
ajlm-1261	293	5	adeleke	adeleke	VERB
ajlm-1261	293	6	oe	oe	PROPN
ajlm-1261	293	7	,	,	PUNCT
ajlm-1261	293	8	afolabi	afolabi	NOUN
ajlm-1261	293	9	ao	ao	NOUN
ajlm-1261	293	10	,	,	PUNCT
ajlm-1261	293	11	afolabi	afolabi	NOUN
ajlm-1261	293	12	ot	ot	NOUN
ajlm-1261	293	13	.	.	PUNCT
ajlm-1261	293	14	self	self	NOUN
ajlm-1261	293	15	medication	medication	NOUN
ajlm-1261	293	16	amongst	amongst	ADP
ajlm-1261	293	17	general	general	ADJ
ajlm-1261	293	18	out	out	ADJ
ajlm-1261	293	19	-	-	PUNCT
ajlm-1261	293	20	patients	patient	NOUN
ajlm-1261	293	21	in	in	ADP
ajlm-1261	293	22	a	a	DET
ajlm-1261	293	23	nigerian	nigerian	ADJ
ajlm-1261	293	24	community	community	NOUN
ajlm-1261	293	25	hospital	hospital	NOUN
ajlm-1261	293	26	.	.	PUNCT
ajlm-1261	294	1	ann	ann	PROPN
ajlm-1261	294	2	ibadan	ibadan	PROPN
ajlm-1261	294	3	postgrad	postgrad	PROPN
ajlm-1261	294	4	med	med	PROPN
ajlm-1261	294	5	.	.	PUNCT
ajlm-1261	295	1	2007;5(2):64–67	2007;5(2):64–67	NUM
ajlm-1261	295	2	.	.	PUNCT
ajlm-1261	296	1	https://doi.org/10.4314/aipm.v5i2.64032	https://doi.org/10.4314/aipm.v5i2.64032	PROPN
ajlm-1261	296	2	gadepalli	gadepalli	NOUN
ajlm-1261	296	3	r	r	NOUN
ajlm-1261	296	4	,	,	PUNCT
ajlm-1261	296	5	dhawan	dhawan	PROPN
ajlm-1261	296	6	b	b	PROPN
ajlm-1261	296	7	,	,	PUNCT
ajlm-1261	296	8	sreenivas	sreenivas	PROPN
ajlm-1261	296	9	v	v	PROPN
ajlm-1261	296	10	,	,	PUNCT
ajlm-1261	296	11	kapil	kapil	PROPN
ajlm-1261	296	12	a	a	PROPN
ajlm-1261	296	13	,	,	PUNCT
ajlm-1261	296	14	amini	amini	PROPN
ajlm-1261	296	15	ac	ac	PROPN
ajlm-1261	296	16	,	,	PUNCT
ajlm-1261	296	17	chaudhry	chaudhry	PROPN
ajlm-1261	296	18	ra	ra	PROPN
ajlm-1261	296	19	.	.	PUNCT
ajlm-1261	297	1	clinico	clinico	NOUN
ajlm-1261	297	2	-	-	PUNCT
ajlm-1261	297	3	microbiological	microbiological	ADJ
ajlm-1261	297	4	study	study	NOUN
ajlm-1261	297	5	of	of	ADP
ajlm-1261	297	6	diabetic	diabetic	ADJ
ajlm-1261	297	7	foot	foot	NOUN
ajlm-1261	297	8	ulcers	ulcer	NOUN
ajlm-1261	297	9	in	in	ADP
ajlm-1261	297	10	an	an	DET
ajlm-1261	297	11	indian	indian	ADJ
ajlm-1261	297	12	tertiary	tertiary	ADJ
ajlm-1261	297	13	care	care	NOUN
ajlm-1261	297	14	hospital	hospital	NOUN
ajlm-1261	297	15	.	.	PUNCT
ajlm-1261	298	1	diabetes	diabetes	NOUN
ajlm-1261	298	2	care	care	NOUN
ajlm-1261	298	3	.	.	PUNCT
ajlm-1261	299	1	2006;29(8):1727–1732	2006;29(8):1727–1732	NUM
ajlm-1261	299	2	.	.	PUNCT
ajlm-1261	300	1	https://doi.org/10.2337/dc06-0116	https://doi.org/10.2337/dc06-0116	PROPN
ajlm-1261	300	2	amini	amini	PROPN
ajlm-1261	300	3	m	m	PROPN
ajlm-1261	300	4	,	,	PUNCT
ajlm-1261	300	5	davati	davati	VERB
ajlm-1261	300	6	a	a	PRON
ajlm-1261	300	7	,	,	PUNCT
ajlm-1261	300	8	piri	piri	NOUN
ajlm-1261	300	9	m.	m.	NOUN
ajlm-1261	300	10	determination	determination	NOUN
ajlm-1261	300	11	of	of	ADP
ajlm-1261	300	12	the	the	DET
ajlm-1261	300	13	resistance	resistance	NOUN
ajlm-1261	300	14	pattern	pattern	NOUN
ajlm-1261	300	15	of	of	ADP
ajlm-1261	300	16	prevalent	prevalent	ADJ
ajlm-1261	300	17	aerobic	aerobic	ADJ
ajlm-1261	300	18	bacterial	bacterial	ADJ
ajlm-1261	300	19	infections	infection	NOUN
ajlm-1261	300	20	of	of	ADP
ajlm-1261	300	21	diabetic	diabetic	ADJ
ajlm-1261	300	22	foot	foot	NOUN
ajlm-1261	300	23	ulcer	ulcer	NOUN
ajlm-1261	300	24	.	.	PUNCT
ajlm-1261	301	1	iranian	iranian	PROPN
ajlm-1261	301	2	j	j	PROPN
ajlm-1261	301	3	pathol	pathol	PROPN
ajlm-1261	301	4	.	.	PUNCT
ajlm-1261	302	1	2013;8(1):21–26	2013;8(1):21–26	NUM
ajlm-1261	302	2	.	.	PUNCT
ajlm-1261	303	1	mendes	mendes	PROPN
ajlm-1261	303	2	jj	jj	PROPN
ajlm-1261	303	3	,	,	PUNCT
ajlm-1261	303	4	marques	marques	PROPN
ajlm-1261	303	5	-	-	PROPN
ajlm-1261	303	6	costa	costa	PROPN
ajlm-1261	303	7	a	a	NOUN
ajlm-1261	303	8	,	,	PUNCT
ajlm-1261	303	9	vilela	vilela	NOUN
ajlm-1261	303	10	c	c	NOUN
ajlm-1261	303	11	,	,	PUNCT
ajlm-1261	303	12	et	et	PROPN
ajlm-1261	303	13	al	al	PROPN
ajlm-1261	303	14	.	.	PROPN
ajlm-1261	304	1	clinical	clinical	ADJ
ajlm-1261	304	2	and	and	CCONJ
ajlm-1261	304	3	bacteriological	bacteriological	ADJ
ajlm-1261	304	4	survey	survey	NOUN
ajlm-1261	304	5	of	of	ADP
ajlm-1261	304	6	diabetic	diabetic	ADJ
ajlm-1261	304	7	foot	foot	NOUN
ajlm-1261	304	8	infections	infection	NOUN
ajlm-1261	304	9	in	in	ADP
ajlm-1261	304	10	lisbon	lisbon	PROPN
ajlm-1261	304	11	.	.	PUNCT
ajlm-1261	305	1	diab	diab	PROPN
ajlm-1261	305	2	res	res	PROPN
ajlm-1261	305	3	clin	clin	PROPN
ajlm-1261	305	4	pract	pract	PROPN
ajlm-1261	305	5	.	.	PUNCT
ajlm-1261	306	1	2012;95(1):153–161	2012;95(1):153–161	NUM
ajlm-1261	306	2	.	.	PUNCT
ajlm-1261	307	1	https://doi.org/10.1016/j.diabres.2011.10.001	https://doi.org/10.1016/j.diabres.2011.10.001	PROPN
ajlm-1261	307	2	dwedar	dwedar	PROPN
ajlm-1261	307	3	r	r	NOUN
ajlm-1261	307	4	,	,	PUNCT
ajlm-1261	307	5	ismail	ismail	NOUN
ajlm-1261	307	6	dk	dk	PROPN
ajlm-1261	307	7	,	,	PUNCT
ajlm-1261	307	8	abdulbaky	abdulbaky	ADJ
ajlm-1261	307	9	a.	a.	NOUN
ajlm-1261	307	10	lecturer	lecturer	PROPN
ajlm-1261	307	11	diabetic	diabetic	ADJ
ajlm-1261	307	12	foot	foot	NOUN
ajlm-1261	307	13	infection	infection	NOUN
ajlm-1261	307	14	:	:	PUNCT
ajlm-1261	307	15	microbiological	microbiological	ADJ
ajlm-1261	307	16	causes	cause	NOUN
ajlm-1261	307	17	with	with	ADP
ajlm-1261	307	18	special	special	ADJ
ajlm-1261	307	19	reference	reference	NOUN
ajlm-1261	307	20	to	to	ADP
ajlm-1261	307	21	their	their	PRON
ajlm-1261	307	22	antibiotic	antibiotic	ADJ
ajlm-1261	307	23	resistance	resistance	NOUN
ajlm-1261	307	24	pattern	pattern	NOUN
ajlm-1261	307	25	.	.	PUNCT
ajlm-1261	308	1	egyptian	egyptian	PROPN
ajlm-1261	308	2	j	j	PROPN
ajlm-1261	308	3	med	med	PROPN
ajlm-1261	308	4	microbiol	microbiol	PROPN
ajlm-1261	308	5	.	.	PUNCT
ajlm-1261	309	1	2015;24(3):95–102	2015;24(3):95–102	NUM
ajlm-1261	309	2	.	.	PUNCT
ajlm-1261	309	3	https://doi.org/10.12816/0024935	https://doi.org/10.12816/0024935	PROPN
ajlm-1261	309	4	falagas	falagas	VERB
ajlm-1261	309	5	me	i	PRON
ajlm-1261	309	6	,	,	PUNCT
ajlm-1261	309	7	karageorgopoulos	karageorgopoulo	NOUN
ajlm-1261	309	8	de	de	PROPN
ajlm-1261	309	9	,	,	PUNCT
ajlm-1261	309	10	leptidis	leptidis	PROPN
ajlm-1261	309	11	j	j	PROPN
ajlm-1261	309	12	,	,	PUNCT
ajlm-1261	309	13	korbila	korbila	PROPN
ajlm-1261	309	14	ip	ip	NOUN
ajlm-1261	309	15	.	.	PUNCT
ajlm-1261	309	16	mrsa	mrsa	NOUN
ajlm-1261	309	17	in	in	ADP
ajlm-1261	309	18	africa	africa	PROPN
ajlm-1261	309	19	:	:	PUNCT
ajlm-1261	309	20	filling	fill	VERB
ajlm-1261	309	21	the	the	DET
ajlm-1261	309	22	global	global	ADJ
ajlm-1261	309	23	map	map	NOUN
ajlm-1261	309	24	of	of	ADP
ajlm-1261	309	25	antimicrobial	antimicrobial	ADJ
ajlm-1261	309	26	resistance	resistance	NOUN
ajlm-1261	309	27	.	.	PUNCT
ajlm-1261	310	1	plos	plos	PROPN
ajlm-1261	310	2	one	one	NUM
ajlm-1261	310	3	.	.	PUNCT
ajlm-1261	311	1	2013;8(7):e68024	2013;8(7):e68024	NUM
ajlm-1261	311	2	.	.	PUNCT
ajlm-1261	312	1	https://doi.org/10.1371/journal.pone.0068024	https://doi.org/10.1371/journal.pone.0068024	PROPN
ajlm-1261	312	2	chaudhry	chaudhry	PROPN
ajlm-1261	312	3	wn	wn	PROPN
ajlm-1261	312	4	,	,	PUNCT
ajlm-1261	312	5	badar	badar	PROPN
ajlm-1261	312	6	r	r	PROPN
ajlm-1261	312	7	,	,	PUNCT
ajlm-1261	312	8	jamal	jamal	PROPN
ajlm-1261	312	9	m	m	PROPN
ajlm-1261	312	10	,	,	PUNCT
ajlm-1261	312	11	jeong	jeong	PROPN
ajlm-1261	312	12	j	j	PROPN
ajlm-1261	312	13	,	,	PUNCT
ajlm-1261	312	14	zafar	zafar	PROPN
ajlm-1261	312	15	j	j	PROPN
ajlm-1261	312	16	,	,	PUNCT
ajlm-1261	312	17	andleeb	andleeb	PROPN
ajlm-1261	312	18	s.	s.	PROPN
ajlm-1261	312	19	clinico	clinico	PROPN
ajlm-1261	312	20	-	-	PUNCT
ajlm-1261	312	21	microbiological	microbiological	ADJ
ajlm-1261	312	22	study	study	NOUN
ajlm-1261	312	23	and	and	CCONJ
ajlm-1261	312	24	antibiotic	antibiotic	ADJ
ajlm-1261	312	25	resistance	resistance	NOUN
ajlm-1261	312	26	profile	profile	NOUN
ajlm-1261	312	27	of	of	ADP
ajlm-1261	312	28	meca	meca	PROPN
ajlm-1261	312	29	and	and	CCONJ
ajlm-1261	312	30	esbl	esbl	NOUN
ajlm-1261	312	31	gene	gene	NOUN
ajlm-1261	312	32	prevalence	prevalence	NOUN
ajlm-1261	312	33	in	in	ADP
ajlm-1261	312	34	patients	patient	NOUN
ajlm-1261	312	35	with	with	ADP
ajlm-1261	312	36	diabetic	diabetic	ADJ
ajlm-1261	312	37	foot	foot	NOUN
ajlm-1261	312	38	infections	infection	NOUN
ajlm-1261	312	39	.	.	PUNCT
ajlm-1261	313	1	exp	exp	NOUN
ajlm-1261	313	2	ther	ther	PROPN
ajlm-1261	313	3	med	med	PROPN
ajlm-1261	313	4	.	.	PUNCT
ajlm-1261	313	5	2016;11(3):1031–1038	2016;11(3):1031–1038	PROPN
ajlm-1261	313	6	.	.	PUNCT
ajlm-1261	314	1	https://doi.org/10.3892/etm.2016.2996	https://doi.org/10.3892/etm.2016.2996	NOUN
ajlm-1261	314	2	shore	shore	PROPN
ajlm-1261	314	3	ac	ac	PROPN
ajlm-1261	314	4	,	,	PUNCT
ajlm-1261	314	5	deasy	deasy	NOUN
ajlm-1261	314	6	ec	ec	PROPN
ajlm-1261	314	7	,	,	PUNCT
ajlm-1261	314	8	slickers	slicker	NOUN
ajlm-1261	314	9	p	p	AUX
ajlm-1261	314	10	,	,	PUNCT
ajlm-1261	314	11	et	et	PROPN
ajlm-1261	314	12	al	al	PROPN
ajlm-1261	314	13	.	.	PUNCT
ajlm-1261	315	1	detection	detection	NOUN
ajlm-1261	315	2	of	of	ADP
ajlm-1261	315	3	staphylococcal	staphylococcal	ADJ
ajlm-1261	315	4	cassette	cassette	NOUN
ajlm-1261	315	5	chromosomemec	chromosomemec	ADJ
ajlm-1261	315	6	type	type	NOUN
ajlm-1261	315	7	xi	xi	ADP
ajlm-1261	315	8	carrying	carry	VERB
ajlm-1261	315	9	highly	highly	ADV
ajlm-1261	315	10	divergent	divergent	ADJ
ajlm-1261	315	11	meca	meca	NOUN
ajlm-1261	315	12	,	,	PUNCT
ajlm-1261	315	13	meci	meci	PROPN
ajlm-1261	315	14	,	,	PUNCT
ajlm-1261	315	15	mecr1	mecr1	PROPN
ajlm-1261	315	16	,	,	PUNCT
ajlm-1261	315	17	blaz	blaz	NOUN
ajlm-1261	315	18	,	,	PUNCT
ajlm-1261	315	19	and	and	CCONJ
ajlm-1261	315	20	ccr	ccr	PROPN
ajlm-1261	315	21	genes	gene	NOUN
ajlm-1261	315	22	in	in	ADP
ajlm-1261	315	23	human	human	ADJ
ajlm-1261	315	24	clinical	clinical	ADJ
ajlm-1261	315	25	isolates	isolate	NOUN
ajlm-1261	315	26	of	of	ADP
ajlm-1261	315	27	clonal	clonal	ADJ
ajlm-1261	315	28	complex	complex	ADJ
ajlm-1261	315	29	130	130	NUM
ajlm-1261	315	30	methicillin	methicillin	NOUN
ajlm-1261	315	31	-	-	PUNCT
ajlm-1261	315	32	resistant	resistant	ADJ
ajlm-1261	315	33	staphylococcus	staphylococcus	NOUN
ajlm-1261	315	34	aureus	aureus	NOUN
ajlm-1261	315	35	.	.	PUNCT
ajlm-1261	316	1	antimicrob	antimicrob	PROPN
ajlm-1261	316	2	agents	agents	PROPN
ajlm-1261	316	3	chemother	chemother	PROPN
ajlm-1261	316	4	.	.	PUNCT
ajlm-1261	317	1	2011;55:3765–3773	2011;55:3765–3773	NUM
ajlm-1261	317	2	.	.	PUNCT
ajlm-1261	318	1	https://doi.org/10.1128/aac.00187-11	https://doi.org/10.1128/aac.00187-11	VERB
ajlm-1261	318	2	varaiya	varaiya	PROPN
ajlm-1261	318	3	a	a	PROPN
ajlm-1261	318	4	,	,	PUNCT
ajlm-1261	318	5	dogra	dogra	PROPN
ajlm-1261	318	6	j	j	PROPN
ajlm-1261	318	7	,	,	PUNCT
ajlm-1261	318	8	kulkarni	kulkarni	PROPN
ajlm-1261	318	9	m	m	PROPN
ajlm-1261	318	10	,	,	PUNCT
ajlm-1261	319	1	bhalekar	bhalekar	PROPN
ajlm-1261	319	2	p.	p.	PROPN
ajlm-1261	319	3	extended	extend	VERB
ajlm-1261	319	4	spectrum	spectrum	NOUN
ajlm-1261	319	5	beta	beta	NOUN
ajlm-1261	319	6	lactamase	lactamase	NOUN
ajlm-1261	319	7	(	(	PUNCT
ajlm-1261	319	8	esbl	esbl	NOUN
ajlm-1261	319	9	)	)	PUNCT
ajlm-1261	319	10	producing	produce	VERB
ajlm-1261	319	11	escherichia	escherichia	NOUN
ajlm-1261	319	12	coli	coli	NOUN
ajlm-1261	319	13	and	and	CCONJ
ajlm-1261	319	14	klebsiella	klebsiella	NOUN
ajlm-1261	319	15	pneumoniae	pneumoniae	ADJ
ajlm-1261	319	16	in	in	ADP
ajlm-1261	319	17	diabetic	diabetic	ADJ
ajlm-1261	319	18	foot	foot	NOUN
ajlm-1261	319	19	infection	infection	NOUN
ajlm-1261	319	20	.	.	PUNCT
ajlm-1261	320	1	indian	indian	PROPN
ajlm-1261	320	2	j	j	PROPN
ajlm-1261	320	3	med	med	PROPN
ajlm-1261	320	4	microbiol	microbiol	PROPN
ajlm-1261	320	5	.	.	PUNCT
ajlm-1261	321	1	2008;26(3):281–282	2008;26(3):281–282	NUM
ajlm-1261	321	2	.	.	PUNCT
ajlm-1261	322	1	https://doi.org/10.4103/0377-4929.42513	https://doi.org/10.4103/0377-4929.42513	PROPN
ajlm-1261	322	2	saltoglu	saltoglu	PROPN
ajlm-1261	322	3	n	n	CCONJ
ajlm-1261	322	4	,	,	PUNCT
ajlm-1261	322	5	ergonul	ergonul	NOUN
ajlm-1261	322	6	o	o	NOUN
ajlm-1261	322	7	,	,	PUNCT
ajlm-1261	322	8	tulek	tulek	NOUN
ajlm-1261	322	9	n	n	CCONJ
ajlm-1261	322	10	,	,	PUNCT
ajlm-1261	322	11	et	et	PROPN
ajlm-1261	322	12	al	al	PROPN
ajlm-1261	322	13	.	.	PUNCT
ajlm-1261	322	14	influence	influence	NOUN
ajlm-1261	322	15	of	of	ADP
ajlm-1261	322	16	multidrug	multidrug	NOUN
ajlm-1261	322	17	resistant	resistant	ADJ
ajlm-1261	322	18	organisms	organism	NOUN
ajlm-1261	322	19	on	on	ADP
ajlm-1261	322	20	the	the	DET
ajlm-1261	322	21	outcome	outcome	NOUN
ajlm-1261	322	22	of	of	ADP
ajlm-1261	322	23	diabetic	diabetic	ADJ
ajlm-1261	322	24	foot	foot	NOUN
ajlm-1261	322	25	infection	infection	NOUN
ajlm-1261	322	26	.	.	PUNCT
ajlm-1261	323	1	int	int	NOUN
ajlm-1261	323	2	j	j	PROPN
ajlm-1261	323	3	infect	infect	VERB
ajlm-1261	323	4	dis	dis	PROPN
ajlm-1261	323	5	.	.	PUNCT
ajlm-1261	324	1	2018;70:10–14	2018;70:10–14	X
ajlm-1261	324	2	.	.	PUNCT
ajlm-1261	325	1	https://doi.org/10.1016/j.ijid.2018.02.013	https://doi.org/10.1016/j.ijid.2018.02.013	VERB
ajlm-1261	325	2	shaikh	shaikh	PROPN
ajlm-1261	325	3	s	s	PROPN
ajlm-1261	325	4	,	,	PUNCT
ajlm-1261	325	5	fatima	fatima	PROPN
ajlm-1261	325	6	j	j	PROPN
ajlm-1261	325	7	,	,	PUNCT
ajlm-1261	325	8	shakil	shakil	PROPN
ajlm-1261	325	9	s	s	PROPN
ajlm-1261	325	10	,	,	PUNCT
ajlm-1261	325	11	rizvi	rizvi	PROPN
ajlm-1261	325	12	smd	smd	PROPN
ajlm-1261	325	13	,	,	PUNCT
ajlm-1261	325	14	kamal	kamal	PROPN
ajlm-1261	325	15	ma	ma	PROPN
ajlm-1261	325	16	.	.	PROPN
ajlm-1261	326	1	antibiotic	antibiotic	ADJ
ajlm-1261	326	2	resistance	resistance	NOUN
ajlm-1261	326	3	and	and	CCONJ
ajlm-1261	326	4	extended	extend	VERB
ajlm-1261	326	5	spectrum	spectrum	NOUN
ajlm-1261	326	6	beta	beta	NOUN
ajlm-1261	326	7	-	-	PUNCT
ajlm-1261	326	8	lactamases	lactamase	NOUN
ajlm-1261	326	9	:	:	PUNCT
ajlm-1261	326	10	types	type	NOUN
ajlm-1261	326	11	,	,	PUNCT
ajlm-1261	326	12	epidemiology	epidemiology	NOUN
ajlm-1261	326	13	and	and	CCONJ
ajlm-1261	326	14	treatment	treatment	NOUN
ajlm-1261	326	15	.	.	PUNCT
ajlm-1261	327	1	saudi	saudi	PROPN
ajlm-1261	327	2	j	j	PROPN
ajlm-1261	327	3	biol	biol	PROPN
ajlm-1261	327	4	sci	sci	PROPN
ajlm-1261	327	5	.	.	PUNCT
ajlm-1261	328	1	2015;22(1):90–101	2015;22(1):90–101	NUM
ajlm-1261	328	2	.	.	PUNCT
ajlm-1261	329	1	https://doi.org/10.1016/j.sjbs.2014.08.002	https://doi.org/10.1016/j.sjbs.2014.08.002	PROPN
ajlm-1261	329	2	levin	levin	PROPN
ajlm-1261	329	3	me	i	PRON
ajlm-1261	329	4	.	.	PUNCT
ajlm-1261	330	1	an	an	DET
ajlm-1261	330	2	overview	overview	NOUN
ajlm-1261	330	3	of	of	ADP
ajlm-1261	330	4	the	the	DET
ajlm-1261	330	5	diabetic	diabetic	ADJ
ajlm-1261	330	6	foot	foot	NOUN
ajlm-1261	330	7	:	:	PUNCT
ajlm-1261	330	8	pathogenesis	pathogenesis	NOUN
ajlm-1261	330	9	,	,	PUNCT
ajlm-1261	330	10	management	management	NOUN
ajlm-1261	330	11	and	and	CCONJ
ajlm-1261	330	12	prevention	prevention	NOUN
ajlm-1261	330	13	of	of	ADP
ajlm-1261	330	14	lesions	lesion	NOUN
ajlm-1261	330	15	.	.	PUNCT
ajlm-1261	331	1	inter	inter	PROPN
ajlm-1261	331	2	j.	j.	PROPN
ajlm-1261	331	3	diab	diab	PROPN
ajlm-1261	331	4	dev	dev	PROPN
ajlm-1261	331	5	countr	countr	PROPN
ajlm-1261	331	6	.	.	PUNCT
ajlm-1261	332	1	1994;14:39–47	1994;14:39–47	NUM
ajlm-1261	332	2	.	.	PUNCT
ajlm-1261	332	3	valappil	valappil	PROPN
ajlm-1261	332	4	rk	rk	PROPN
ajlm-1261	332	5	,	,	PUNCT
ajlm-1261	332	6	krishnan	krishnan	PROPN
ajlm-1261	332	7	s	s	PROPN
ajlm-1261	332	8	,	,	PUNCT
ajlm-1261	332	9	bai	bai	PROPN
ajlm-1261	332	10	sdk	sdk	PROPN
ajlm-1261	332	11	.	.	PUNCT
ajlm-1261	333	1	multidrug	multidrug	VERB
ajlm-1261	333	2	resistant	resistant	ADJ
ajlm-1261	333	3	organisms	organism	NOUN
ajlm-1261	333	4	in	in	ADP
ajlm-1261	333	5	diabetic	diabetic	ADJ
ajlm-1261	333	6	foot	foot	NOUN
ajlm-1261	333	7	ulcers	ulcer	NOUN
ajlm-1261	333	8	-	-	PUNCT
ajlm-1261	333	9	analysis	analysis	NOUN
ajlm-1261	333	10	of	of	ADP
ajlm-1261	333	11	risk	risk	NOUN
ajlm-1261	333	12	factors	factor	NOUN
ajlm-1261	333	13	and	and	CCONJ
ajlm-1261	333	14	clinical	clinical	ADJ
ajlm-1261	333	15	outcome	outcome	NOUN
ajlm-1261	333	16	.	.	PUNCT
ajlm-1261	334	1	j	j	PROPN
ajlm-1261	334	2	med	med	PROPN
ajlm-1261	334	3	sci	sci	PROPN
ajlm-1261	334	4	clin	clin	PROPN
ajlm-1261	334	5	res	res	PROPN
ajlm-1261	334	6	.	.	PUNCT
ajlm-1261	335	1	2017;9(2):18138–18143	2017;9(2):18138–18143	NOUN
ajlm-1261	335	2	.	.	PUNCT
ajlm-1261	336	1	https://doi.org/10.18535/jmscr/v5i2.144	https://doi.org/10.18535/jmscr/v5i2.144	PROPN
ajlm-1261	336	2	zubair	zubair	PROPN
ajlm-1261	336	3	m	m	PROPN
ajlm-1261	336	4	,	,	PUNCT
ajlm-1261	336	5	abida	abida	PROPN
ajlm-1261	336	6	m	m	PROPN
ajlm-1261	336	7	,	,	PUNCT
ajlm-1261	336	8	jamal	jamal	PROPN
ajlm-1261	336	9	a.	a.	NOUN
ajlm-1261	336	10	clinicobacteriology	clinicobacteriology	PROPN
ajlm-1261	336	11	and	and	CCONJ
ajlm-1261	336	12	risk	risk	NOUN
ajlm-1261	336	13	factors	factor	NOUN
ajlm-1261	336	14	for	for	ADP
ajlm-1261	336	15	the	the	DET
ajlm-1261	336	16	diabetic	diabetic	ADJ
ajlm-1261	336	17	foot	foot	NOUN
ajlm-1261	336	18	infection	infection	NOUN
ajlm-1261	336	19	with	with	ADP
ajlm-1261	336	20	multidrug	multidrug	NOUN
ajlm-1261	336	21	resistant	resistant	ADJ
ajlm-1261	336	22	microorganisms	microorganism	NOUN
ajlm-1261	336	23	in	in	ADP
ajlm-1261	336	24	north	north	PROPN
ajlm-1261	336	25	india	india	PROPN
ajlm-1261	336	26	.	.	PUNCT
ajlm-1261	337	1	biol	biol	PROPN
ajlm-1261	337	2	med	med	PROPN
ajlm-1261	337	3	.	.	PUNCT
ajlm-1261	338	1	2010;2(4):22–34	2010;2(4):22–34	X
ajlm-1261	338	2	.	.	PUNCT
ajlm-1261	338	3	hartemann	hartemann	PROPN
ajlm-1261	338	4	-	-	PUNCT
ajlm-1261	338	5	heurtier	heurtier	NOUN
ajlm-1261	338	6	a	a	NOUN
ajlm-1261	338	7	,	,	PUNCT
ajlm-1261	338	8	robert	robert	PROPN
ajlm-1261	338	9	j	j	PROPN
ajlm-1261	338	10	,	,	PUNCT
ajlm-1261	338	11	jacqueminet	jacqueminet	PROPN
ajlm-1261	338	12	s	s	PROPN
ajlm-1261	338	13	,	,	PUNCT
ajlm-1261	338	14	et	et	PROPN
ajlm-1261	338	15	al	al	PROPN
ajlm-1261	338	16	.	.	PUNCT
ajlm-1261	339	1	diabetic	diabetic	ADJ
ajlm-1261	339	2	foot	foot	NOUN
ajlm-1261	339	3	ulcer	ulcer	NOUN
ajlm-1261	339	4	and	and	CCONJ
ajlm-1261	339	5	multidrug	multidrug	NOUN
ajlm-1261	339	6	-	-	PUNCT
ajlm-1261	339	7	resistant	resistant	ADJ
ajlm-1261	339	8	organisms	organism	NOUN
ajlm-1261	339	9	:	:	PUNCT
ajlm-1261	339	10	risk	risk	NOUN
ajlm-1261	339	11	factors	factor	NOUN
ajlm-1261	339	12	and	and	CCONJ
ajlm-1261	339	13	impact	impact	NOUN
ajlm-1261	339	14	.	.	PUNCT
ajlm-1261	340	1	diabet	diabet	PROPN
ajlm-1261	340	2	med	med	PROPN
ajlm-1261	340	3	.	.	PUNCT
ajlm-1261	341	1	2004;21(7):710–715	2004;21(7):710–715	X
ajlm-1261	341	2	.	.	PUNCT
ajlm-1261	341	3	https://doi.org/10.1111/j.1464-5491.2004.01237.x	https://doi.org/10.1111/j.1464-5491.2004.01237.x	PROPN
ajlm-1261	341	4	noor	noor	PROPN
ajlm-1261	341	5	s	s	PROPN
ajlm-1261	341	6	,	,	PUNCT
ajlm-1261	341	7	borse	borse	PROPN
ajlm-1261	341	8	ag	ag	PROPN
ajlm-1261	341	9	,	,	PUNCT
ajlm-1261	341	10	ozair	ozair	NOUN
ajlm-1261	341	11	m	m	PROPN
ajlm-1261	341	12	,	,	PUNCT
ajlm-1261	341	13	raghav	raghav	PROPN
ajlm-1261	341	14	a	a	PROPN
ajlm-1261	341	15	,	,	PUNCT
ajlm-1261	341	16	parwez	parwez	NOUN
ajlm-1261	341	17	i	i	PROPN
ajlm-1261	341	18	,	,	PUNCT
ajlm-1261	341	19	ahmad	ahmad	PROPN
ajlm-1261	341	20	j.	j.	PROPN
ajlm-1261	341	21	inflammatory	inflammatory	ADJ
ajlm-1261	341	22	markers	marker	NOUN
ajlm-1261	341	23	as	as	ADP
ajlm-1261	341	24	risk	risk	NOUN
ajlm-1261	341	25	factors	factor	NOUN
ajlm-1261	341	26	for	for	ADP
ajlm-1261	341	27	infection	infection	NOUN
ajlm-1261	341	28	with	with	ADP
ajlm-1261	341	29	multidrug	multidrug	NOUN
ajlm-1261	341	30	-	-	PUNCT
ajlm-1261	341	31	resistant	resistant	ADJ
ajlm-1261	341	32	microbes	microbe	NOUN
ajlm-1261	341	33	in	in	ADP
ajlm-1261	341	34	diabetic	diabetic	ADJ
ajlm-1261	341	35	foot	foot	NOUN
ajlm-1261	341	36	subjects	subject	NOUN
ajlm-1261	341	37	.	.	PUNCT
ajlm-1261	342	1	foot	foot	NOUN
ajlm-1261	342	2	(	(	PUNCT
ajlm-1261	342	3	edinb	edinb	NOUN
ajlm-1261	342	4	)	)	PUNCT
ajlm-1261	342	5	.	.	PUNCT
ajlm-1261	343	1	2017;32:44–48	2017;32:44–48	NUM
ajlm-1261	343	2	.	.	PUNCT
ajlm-1261	344	1	https://doi.org/10.1016/j.foot.2017.05.001	https://doi.org/10.1016/j.foot.2017.05.001	VERB
ajlm-1261	344	2	ji	ji	PROPN
ajlm-1261	344	3	x	x	PROPN
ajlm-1261	344	4	,	,	PUNCT
ajlm-1261	344	5	jin	jin	NOUN
ajlm-1261	344	6	p	p	X
ajlm-1261	344	7	,	,	PUNCT
ajlm-1261	344	8	chu	chu	PROPN
ajlm-1261	344	9	y	y	PROPN
ajlm-1261	344	10	,	,	PUNCT
ajlm-1261	344	11	feng	feng	PROPN
ajlm-1261	344	12	s	s	PROPN
ajlm-1261	344	13	,	,	PUNCT
ajlm-1261	344	14	wang	wang	PROPN
ajlm-1261	344	15	p.	p.	PROPN
ajlm-1261	344	16	clinical	clinical	ADJ
ajlm-1261	344	17	characteristics	characteristic	NOUN
ajlm-1261	344	18	and	and	CCONJ
ajlm-1261	344	19	risk	risk	NOUN
ajlm-1261	344	20	factors	factor	NOUN
ajlm-1261	344	21	of	of	ADP
ajlm-1261	344	22	diabetic	diabetic	ADJ
ajlm-1261	344	23	foot	foot	NOUN
ajlm-1261	344	24	ulcer	ulcer	NOUN
ajlm-1261	344	25	with	with	ADP
ajlm-1261	344	26	multidrug	multidrug	NOUN
ajlm-1261	344	27	-	-	PUNCT
ajlm-1261	344	28	resistant	resistant	ADJ
ajlm-1261	344	29	organism	organism	NOUN
ajlm-1261	344	30	infection	infection	NOUN
ajlm-1261	344	31	.	.	PUNCT
ajlm-1261	345	1	inter	inter	PROPN
ajlm-1261	345	2	j	j	PROPN
ajlm-1261	345	3	lower	lower	X
ajlm-1261	345	4	extrem	extrem	PROPN
ajlm-1261	345	5	wounds	wound	NOUN
ajlm-1261	345	6	.	.	PUNCT
ajlm-1261	346	1	2014;13(1):64–71	2014;13(1):64–71	NOUN
ajlm-1261	346	2	.	.	PUNCT
ajlm-1261	347	1	https://doi.org/10.1177/1534734614521236	https://doi.org/10.1177/1534734614521236	PROPN
ajlm-1261	347	2	trivedi	trivedi	PROPN
ajlm-1261	347	3	u	u	PROPN
ajlm-1261	347	4	,	,	PUNCT
ajlm-1261	347	5	parameswaran	parameswaran	NOUN
ajlm-1261	347	6	s	s	PROPN
ajlm-1261	347	7	,	,	PUNCT
ajlm-1261	347	8	armstrong	armstrong	PROPN
ajlm-1261	347	9	a	a	PROPN
ajlm-1261	347	10	,	,	PUNCT
ajlm-1261	347	11	et	et	PROPN
ajlm-1261	347	12	al	al	PROPN
ajlm-1261	347	13	.	.	PUNCT
ajlm-1261	348	1	prevalence	prevalence	NOUN
ajlm-1261	348	2	of	of	ADP
ajlm-1261	348	3	multiple	multiple	ADJ
ajlm-1261	348	4	antibiotic	antibiotic	ADJ
ajlm-1261	348	5	resistant	resistant	ADJ
ajlm-1261	348	6	infections	infection	NOUN
ajlm-1261	348	7	in	in	ADP
ajlm-1261	348	8	diabetic	diabetic	ADJ
ajlm-1261	348	9	versus	versus	ADP
ajlm-1261	348	10	nondiabetic	nondiabetic	ADJ
ajlm-1261	348	11	wounds	wound	NOUN
ajlm-1261	348	12	.	.	PUNCT
ajlm-1261	349	1	j	j	PROPN
ajlm-1261	349	2	pathog	pathog	PROPN
ajlm-1261	349	3	.	.	PUNCT
ajlm-1261	350	1	2014;2014:173053	2014;2014:173053	NUM
ajlm-1261	350	2	.	.	PUNCT
ajlm-1261	351	1	http://doi.org/10.1155/2014/173053	http://doi.org/10.1155/2014/173053	VERB
ajlm-1261	351	2	vardakas	vardakas	PROPN
ajlm-1261	351	3	kz	kz	PROPN
ajlm-1261	351	4	,	,	PUNCT
ajlm-1261	351	5	horianopoulou	horianopoulou	PROPN
ajlm-1261	351	6	m	m	PROPN
ajlm-1261	351	7	,	,	PUNCT
ajlm-1261	351	8	falagas	falagas	VERB
ajlm-1261	351	9	me	i	PRON
ajlm-1261	351	10	.	.	PUNCT
ajlm-1261	352	1	factors	factor	NOUN
ajlm-1261	352	2	associated	associate	VERB
ajlm-1261	352	3	with	with	ADP
ajlm-1261	352	4	treatment	treatment	NOUN
ajlm-1261	352	5	failure	failure	NOUN
ajlm-1261	352	6	in	in	ADP
ajlm-1261	352	7	patients	patient	NOUN
ajlm-1261	352	8	with	with	ADP
ajlm-1261	352	9	diabetic	diabetic	ADJ
ajlm-1261	352	10	foot	foot	NOUN
ajlm-1261	352	11	infections	infection	NOUN
ajlm-1261	352	12	:	:	PUNCT
ajlm-1261	352	13	an	an	DET
ajlm-1261	352	14	analysis	analysis	NOUN
ajlm-1261	352	15	of	of	ADP
ajlm-1261	352	16	data	datum	NOUN
ajlm-1261	352	17	from	from	ADP
ajlm-1261	352	18	randomized	randomized	ADJ
ajlm-1261	352	19	controlled	control	VERB
ajlm-1261	352	20	trials	trial	NOUN
ajlm-1261	352	21	.	.	PUNCT
ajlm-1261	353	1	diabetes	diabetes	NOUN
ajlm-1261	353	2	res	re	VERB
ajlm-1261	353	3	clin	clin	PROPN
ajlm-1261	353	4	pract	pract	PROPN
ajlm-1261	353	5	.	.	PUNCT
ajlm-1261	354	1	2008;80:344–351	2008;80:344–351	NOUN
ajlm-1261	354	2	.	.	PUNCT
ajlm-1261	355	1	https://doi.org/10.1016/j.diabres.2008.01.009	https://doi.org/10.1016/j.diabres.2008.01.009	PROPN